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Abstract 
The general aim of the present PhD thesis is to investigate the effects of two common 
treatments of Parkinson’s disease (PD), dopamine medication and deep brain 
stimulation (DBS) of the subthalamic nucleus (STN), on executive functions (EFs) 
including the abilities of shifting, updating and inhibition in patients relative to 
age-matched healthy controls. The thesis consisted of four studies. Study 1 examined 
the acute effect of dopamine medication on PD patients who had been previously 
diagnosed with impulsive control disorders (ICDs) using a moving dots paradigm to 
assess their abilities of context monitoring. Study 2 created predictive models using 
behavioural data from the previous studies to build classification predictive models, to 
demonstrate that behavioural patterns on a moving dots task could potentially be used 
as a screening tool in predicting vulnerability to develop ICDs in PD patients. Study 3 
examined the acute effects of STN DBS on task switching using a moving dots 
paradigm in PD patients. Study 4 investigated the acute effects of STN DBS on 
reprogramming actions when encountering surprising events, using a probabilistic 
reaction time (RT) task. It was hypothesised that for both treatments, being ON states 
would induce impaired executive functions that lead to faster RTs and more incorrect 
responses in PD patients, due to the ‘dopamine overdose hypothesis’ and the DBS 
interrupting the role of the STN in inhibitory control. In summary, the acute 
manipulation of both treatments did not render significantly negative effects on PD 
patients behaviourally. However, PD patients still showed certain difference on task 
performance compared to age-matched healthy controls, which may shed lights on the 
role of basal ganglia in basic abilities of EFs. Furthermore, the behavioural patterns 
on tasks involving core aspects of EFs may potentially be used to predict the onset of 
ICDs, which provides benefits to clinical purpose.  
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Impact statement 
Parkinson’s disease (PD) is the second most common neurodegenerative movement 
disorder, which affects 1% of the population over the age of 60 (de Lau & Breteler, 
2006). The basal ganglia dysfunction is closely related to the motor and non-motor 
symptoms observed in PD. Two common treatments for PD include dopamine 
medication and deep brain stimulation (DBS) of the subthalamic nucleus (STN). 
Despite effectively ameliorating motor symptoms, clinical observations have shown 
that PD patients may develop side effects on cognitive functions such as diminished 
verbal fluency, impaired executive functions and impulse control disorders (ICD) 
induced by the treatments. By collecting behavioural data from PD patients ON 
versus OFF treatments, the present PhD thesis investigated the acute effects of both 
treatments on behavioural tasks in PD patients. The behavioural data were further 
compared to age-matched healthy controls (HCs). In addition, hierarchical drift 
diffusion models (HDDM) were applied to the behavioural data to derive the 
underlying mental processes.  
 
In general, the results showed that both treatments are robustly effective in 
ameliorating motor symptoms and produced no significantly negative effects on task 
performance and psychological measures in PD patients. Both treatments are 
therefore supported to be safe procedures in treating patients with PD. Theoretically 
speaking, the present results are in line with the hypothesis that action execution is 
associated with both the quality/reliability of sensory information and the inner drive 
to be fast and accurate, instead of simply related to speed and accuracy trade-off 
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modulation. In addition, the results support the roles of dopamine and the STN in 
motor control and inhibition through the basal ganglia pathways. Clinically speaking, 
the results suggest that while some evidence has shown that medical and surgical 
treatments can induce negative side effects on cognition for PD patients, such side 
effects may be small and specific to individuals. Despite receiving benefits from both 
treatments, PD patients still showed certain deficits when performing the tasks 
compared to age-matched HCs. The results thus indicate that factors other than acute 
influence of treatments are involved in controlling executive functions in PD patients. 
Effects of long term treatments, disease progress, individual difference, genetic 
factors, environmental as well as social factors are in need to be considered for 
patient-centred care. More importantly, PD patients who had been clinically 
diagnosed with impulse control disorders (ICD) have been shown to have different 
behavioural patterns on a moving dots task compared to PD patients who had never 
been diagnosed with ICDs. The results suggest that tasks of similar characteristics 
may potentially be used as a screening tool to prevent the medication-induced ICDs 
by identifying PD patients who may be vulnerable to developing ICDs before the 
medication treatment.  
 
Taken together, the present thesis proposes a potential new screening tool for ICDs in 
PD patients that can have clinical benefits on preventing the negative side effects, and 
provides insights on the theoretical roles of dopamine and the STN in executive 
functions associated with the abilities of shifting, updating and inhibition.  
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Chapter 1 General introduction 
Parkinson’s disease (PD) is the second most common neurodegenerative movement 
disorder, which affects 1% of the population over the age of 60 (de Lau & Breteler, 
2006). It has been established that the basal ganglia dysfunction directly connects to 
the movement disorder (DeLong, 1990). Currently there is no cure for the disease, 
however there are two common treatments that have been developed to treat PD 
patients: dopamine medication and deep brain stimulation (DBS) of the subthalamic 
nucleus (STN). Both treatments have been suggested to efficiently ameliorate motor 
symptoms in PD, however, the treatments have also been suggested to induce 
cognitive side effects such as impulsive behaviours, impaired executive functions 
(EFs) and impaired verbal fluency (Weintraub, David, Evans, Grant & Stacy, 2015; 
Gotham, Brown, & Marsden, 1988; Cools, Barker, Sahakian, & Robbins, 2001; 
Swainson et al, 2000; Walter & Vitek, 2004). It is hypothesised that dopamine 
medication inude side effects in PD patients could be the results of ‘dopmaine 
overdose hypothesis’, which suggest that while dopamine medication remedies the 
dopamine depleted areas in the brain it would overstimulate relatively intact brain 
areas thus leads to impaired cognitive functions (Cools et al., 2001, 2006), and DBS 
of the STN would interrupt the inhibition function of the STN, leading to impaired 
inhibitory control in PD patients (Frank et al., 2007; Green et al., 2013). Broadly 
speaking, these side effects induced by treatments in PD patients could potentially be 
generalised to the impairment on three basic EFs: shifting, updating and inhibition. 
which is also closely associated with the basal ganglia dysfunctions. In addition, 
behavioural tasks such as moving dots paradigm and probabilistic reaction time (RT) 
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task can provide links associating cognitive and motor processes that are involved in 
the basic EFs. Therefore, in the present thesis I attempt to investigate the acute effects 
of treatments of PD, namely dopamine medication and STN DBS, on basic EFs 
including shifting, updating and inhibition using moving dots paradigm and a 
probabilistic RT task. 
 
The acute effects of treatments were assessed by comparing the behavioural data ON 
treatment and OFF treatment within PD patients. RTs and response accuracy of the 
behavioural tasks were collected as the dependent variables. Computational models 
such as hierarchical drift diffusion model were further applied to the behavioural data 
to study the underlying mental processes. Performance of PD patients OFF/ON 
treatments was further compared to age-matched healthy controls. The present thesis 
is composed of the following chapters:  
Chapter 1 is the general introduction including reviews on (1) general concepts on the 
three basic EFs including shifting, updating and inhibition, (2) the anatomy and 
structure of the basal ganglia, and the circuits linking action and cognition; (3) 
pathology, symptoms and the treatments of PD; (4) the acute effects of the two 
treatments (i.e. dopamine medication and STN DBS) on cognitive functions 
associated with context monitoring in PD patients; (5) general aims and 
methodologies of the studies.  
Chapter 2 introduces a behavioural study investigating the acute effect of dopamine 
medication on PD patients who had been previously diagnosed with ICDs, using a 
random moving dots paradigm. It was hypothesised that based on ‘dopamine 
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overdose hypothesis’, when response speed was emphasised while making a response, 
PD patients with ICDs ‘ON medication’ would show faster RTs and more incorrect 
responses due to impaired basic EFs that leads to failed context monitoring, in 
contrast to when response accuracy was emphasised. Contrary to prediction, the 
results showed that acute manipulation of dopamine medication did not have 
significant negative effects on the behavioural parameters of PD patients. Moreover, 
the application of hierarchical drift diffusion model (HDDM) to the behavioural data 
showed that PD patients with ICD history did not show significant impairments on 
context monitoring. The results seem to suggest that PD patients with ICD history and 
PD patients without ICD may show difference when performing certain tasks 
compared to previosuu study (Huang et al., 2015), which may further indicate that the 
behavioural parameters of the tasks could potentially be used as an input in building 
predictive models, providing clinical benefits to patient-centred health care.  
Following the previous results, Chapter 3 presents a study using behavioural data 
from the moving dots tasks as one of the input variables in training a predictive model 
with machine learning algorithms to classify PD patients with and without an ICD 
history. It was hypothesised that performance on the moving dots task could be used 
as a screening tool to predict potential development of ICDs. The results showed that 
behavioural parameters from moving dots tasks could potentially be used as a 
screening tool in predicting vulnerability to develop ICDs in PD patients. The results 
combining previous studies suggest that it is possible to use behavioural parameters to 
predict the onset of ICDs in PD patients, tasks associated with the abilities of shifting, 
updating and inhibition may be used in unmedicated PD patients, so that clinicians are 
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more likely to take appropriate precautionary action to prevent the onset of ICDs.  
 
On the other hand, to explore the acute effects of STN DBS on the basic EFs in PD 
patients, Chapter 4 & Chapter 5 each presents a behavioural study on the subject. 
Chapter 4 presents a behavioural study examining the acute effect of STN DBS on 
how PD patients performed a block-designed moving dots task that attempted to 
assess the effects of STN DBS on task-switching. In addition, the mioving dots task 
also provide the investigation of making resposnes under speed and accuracy 
instructions (Speed/Accuracy trade-off) and at the same time estimating the reliability 
of sensory information. It was hypothesised that PD patients ON stimulation would 
have impaired task-swithcing abilities dues to the hypothetical effects of DBS on 
interrupting functions of STN on inhibitory control, resulting in faster RTs and more 
incorrect responses when it is required to switch between automatic and controlled 
behaviours. Contrary to prediction, the present study shows no negative effect on task 
switching behaviours induced by the acute manipulations of STN DBS on a 
block-designed moving dots task. However, PD patients with STN DBS ON did show 
deficits on task switching during the Inhibition/Switching part of the Colour Word 
Interference Test compared to age-matched HCs. The evidence suggests that 
task-switching may involve fundamentally different but related cognitive processes, 
which are controlled by distinct brain areas. Moreover, the above results are in line 
with the hypothesis that the reliability of sensory information plays an important role 
on modulating SAT. Furthermore, PD patients still showed subtle difference on 
underlying cognitive components under the effects of DBS, which supports a role of 
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the STN on SAT and sensory information integration. It may be due to the suboptimal 
design of the behavioural tasks that the effects of STN DBS on impairing inhibitory 
control.  
 
To further explore the hypothesis of STN DBS impairing inhibitory control in PD 
patients, Chapter 5 introduces a study assessing the acute effect of STN DBS on how 
PD patients reprogamme their actions after encpuntering unexpected events, which is 
closely related to inhibition, and cognitive flexibility. It was hypothesised that when 
ON STN DBS, PD patients would fail to reprogram the action while environmental 
context changed, which leads to faster RTs and more incorrect responses during the 
trials that are unexpected (in the study the unexpectedness was defined as improbable 
trials that was based on the frequency of the sequence). The results show that all 
participants were able to react fast during Predictable blocks/Probable trials than 
Unpredictable blocks/Improbable trials. In addition, response accuracy did not differ 
between Predictable and Unpredictable blocks for all participants, but for HCs 
response accuracy was higher during Probable trials than Improbable trials, such a 
difference was not observed in PD patients across stimulation states. 
Furthermore, PD patients exhibited robust speed and accuracy trade-offs when 
performing the probabilistic RT task, which may indicate that PD patients, especially 
PD patients OFF stimulation, were predominately aiming to act fast therefore 
sacrificed response accuracy. In summary, the two studies did not show an effect of 
DBS on inducing impairedinhibitory control in PD patients, however it did not rule 
out the the possibility of STN DBS to impaire motor/cognition control through 
 27 
 
inhibiton in PD patients. Moreover, in both studies PD patients treated with STN DBS 
were assessed ON medication, which may be the reason why the results did not reflect 
the hypothetical effects of DBS on interrupting the role of STN in cognitive and 
motor control. 
Chapter 6 summarises and discusses the findings from previous experimental chapters 
and provides directions for future studies investigating relevant research topics. The 
appendices contain the questionnaires and consent forms used in the studies, and the 
programming codes with additional figures for the statistical and computational 
models. Figure 1.1 illustrates a schematic framework of the present thesis. 
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Figure 1.1 A schematic framework of the present PhD thesis. The role of dopmamine 
was investigated by assessing the acute effect of dopamine medication on behavioural 
data in PD patients based on dopamine overdose hypopthesis. The rold of the 
subthalamic nucleus (STN) was investigated by assessing deep brain stimulation 
(DBS) of STN on behavioural data in PD patients based on the role of the STN 
hyperdirect pathway in motor control.  
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1-1 Executive functions 
Executive functions (EFs) is an umbrella term that refers to a family of top-down 
mental processes that control other brain processes (Diamond, 2013; Najdowski, 
Persicke, & Kung, 2014), which are skills essential for mental health, physical health, 
and almost every aspect of life. Table 1.1 lists the associations between EFs and the 
aspect of life and their references. In summary, impaired EFs may result from 
impaired inhibitory control, thus resulting in mental health and physical health 
problems (Baler & Volkow, 2006; Diamond, 2005; Lui & Tannock, 2007; Fairchild et 
al., 2009). In addition, ‘cognitive control’, which refers to the ability to coordinate 
lower-level sensory, memory and/or motor operations in relation with internal goals 
(Miller, 2000; Koechlin, Ody & Kouneiher, 2003), is sometimes interchangeable to 
EFs by some researchers (Aron, 2007; Miller & Cohen, 2001). Cognitive control is 
essential for higher cognition processes such as solving complex or novel tasks, 
correcting errors and overcoming habitual responses. Some studies associate 
cognitive control closely to the ability of task switching (Monsell. 2003; Kim, Cilles, 
Johnson, & Gold, 2012). In the present thesis I use the term ‘executive functions’ to 
represent the broad functions, whereas ‘cognitive control’ in the present thesis would 
be considered as a synonym to cognitive flexibility (task-switching) which would be 
further explored in later sections.  
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Table 1.1 Executive functions (EFs) are important to many aspects of life. Table from 
Diamond (2013). 
 
In addition to the difficulty to precisely define EFs, the study of EFs is challenging 
due to task-impurity (Miyake, Friedman, Emerson, Witzki, & Howerter, 2000), as any 
target EF must be embedded within a particular task context, the measures derived 
from any laboratory tasks to assess EFs would necessarily include non-EF processes 
(Miyake & Friedman, 2012). To ease such an issue, Miyake & Friedman (2012) have 
been using a ‘latent-variable’ approach, of which researchers select multiple exemplar 
tasks sharing little non-EF variance and statistically extract the common variables, 
resulting in ‘purer’ latent variable as the measures to study EFs. Moreover, the 
researchers have primarily focused on the study of three EFs: updating (constant 
monitoring and modifying working memory contents based on sampled information), 
shifting (switching flexibly between tasks and/or mental sets), and inhibition 
(deliberately suppressing intended or prepotent actions) (Miyake & Friedman, 2012). 
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Figure 1.2 illustrates the unity/diversity framework that reflects a shift in recent 
research goal to specifying the cognitive and biological underpinnings of the unity 
and diversity (Miyake & Friedman, 2012). 
  
 
Figure 1.2 Schematic representation of the unity and diversity of three executive 
functions (EFs). Each EF is hypothesised to be the combination of a unity component 
(i.e. common EF) and a diversity component that is specific to the particular EF (e.g. 
updating-specific EF for updating ability). In this figure, a specific diversity 
component for inhibition is missing due to previous studies showing that once the 
unity component (i.e. common EF) is accounted for, no unique variance would be left 
for the inhibition ability (Friedman et al., 2008; 2011). Figure adapted from Miyake & 
Friedman (2012).  
 
In association with the three EFs (i.e. updating, shifting, and inhibition) proposed by 
Miyakie & Friedman (2012), there is also an agreement on the existence of three core 
EFs: working memory, inhibition, and cognitive flexibility (Lehto, Juujarvi, Kooistra, 
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& Pulkkinen, 2003; Miyake et al., 2000). Figure 1.3 illustrates the basic level EFs 
(such as working memory, inhibitory control, and cognitive flexibility), higher level 
EFs (such as reasoning, problem-solving, and planning), and their associated 
concepts.  
 
 
Figure 1.3 Executive functions and related terms. Figure and caption from 
Diamond (2013). 
 
Working memory (WM) contains the cognitive capacity that is responsible to hold 
information in mind and mentally working with it (Baddeley & Hitch, 1994; Smith & 
Jonides, 1999). One of the most common concepts linked to executive functions is the 
multicomponent model of WM proposed by Baddeley & Hitch (1974), which 
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suggests that WM comprises a phonological loop for manipulating and storing 
speech-based information and a visuospatial sketchpad for visual and spatial 
information. In addition, WM is critical for reasoning and planning (Suß, Oberauer, 
Wittmann, Wilhelm, & Schulze, 2002; Owen et al., 2010), and is crucial for inhibitory 
control as information must be hold in mind to guide future behaviours (Diamond, 
2013). Conversely, inhibitory control is crucial for WM as the mind is required to 
inhibit internal and external distractions to keep the goal in mind and to avoid 
mind-wandering (Kane et al., 2007; Mason et al., 2007; Smallwood & Schooler, 
2009). In addition, inhibitory control supports WM by suppressing irrelevant 
information from the limited-capacity workspace (Hasher & Zacks, 1998; Zacks & 
Hashers, 2006). Duncan et al (2008) showed that participants with poorer EFs failed 
to switch rules when being instructed to, which has been associated to failure in 
clearing up irrelevant information from the limited-capacity WM workspace. Despite 
evidence showing that inhibitory control and WM are intertwined, the influence of 
each skill may be controlled for (Diamond, 2013). It has been suggested that WM and 
inhibitory control rely on the same limited-capacity system, therefore increasing 
demands on one would affect the performance of the other (Engle & Kane, 2004; 
Wais & Gazzaley, 2011). The neural basis of WM involves the activation of the 
prefrontal cortex in top-down modulation (D’Esposito et al., 1995; Bunge, Klingberg, 
Jacobsen, & Gabrieli, 2000; Zento et al., 2011). Some researchers view WM as the 
primary skill and that inhibitory control is the derivative (Egner & Hirsch, 2005; 
Hanania & Smith, 2010; Nieuwenhuis & Yeung, 2005), while another group of 
researchers find the two skills separable by viewing WM as the activation of goal and 
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inhibitory control as suppression on irrelevant tasks (Davidson, Amso, Anderson, & 
Diamond, 2006; Zanto, Rubens, Thangavel, & Gazzaley, 2011). It remains debatable 
on the exact relationships between WM and inhibitory control, however it is 
undeniable that the two cognitive skills are associable and that WM is an important 
part of EFs.  
 
Inhibition includes self-control (behavioural inhibition) and interference control 
(selective attention and cognitive inhibition), which involves the ability to control 
one’s attention, thoughts, behaviours, and/or emotions to override existing 
internal/external cues or goals, in order to adapt to current environment and execute 
more appropriate actions (Diamond, 2013). Inhibitory control of attention includes 
selectively choosing to pay attention or ignore (i.e. inhibit attention) specific stimuli 
in order to fulfil a set goal or intention (Posner & DiGirolamo, 1998; Theeuwes, 
2010). Another aspect of inhibitory control is self-control or self-regulation ability, 
which includes (1) controlling over one’s behaviour and emotions to prevent from 
acting impulsively, (2) having the discipline to overlook distractions and focus on 
completing a task despite temptation to quit and (3) delayed gratification that involves 
giving up a small immediate reward in exchange for a larger reward later (Diamond, 
2013). Psychological measures of inhibitory control include the Stroop task 
(MacLeod, 1991), Simon task (Hommel, 2011), Flanker task (Eriksen & Eriksen, 
1974; Mullane, Corkum, Klein, & McLaughlin, 2009), antisaccade tasks (Luna, 2009; 
Munoz & Everling, 2004), delay-of-gratification tasks (Kochanska, Coy, & Murray, 
2001; Sethi, Mischel, Aber, Shoda, & Rodriguez, 2000), Go/NoGo tasks (Cragg & 
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Nation, 2008), and stop-signal tasks (Verbruggen & Logan, 2008). Note that despite 
the effect of Stroop task is sometimes referred to as ‘Stroop inhibition’, it has also 
been suggested that Stroop task demonstrates more of an interference effect resulting 
from conflict (MacLeod, Dodd, Sheard, Wilson, & Bibi, 2003). In addition, Stroop 
task has also been considered to be a type of cognitive flexibility task (Golden & 
Freshwater, 1978; Moore & Malinowski, 2009). Most of the mentioned tasks require 
the inhibitory control to execute an action over another, whereas the Go/NoGo tasks 
and stop-signal tasks require participants to inhibit an action without making another. 
The basal ganglia are closely associated with the underlying neural mechanisms of 
inhibitory control, which is one of the core hypotheses of the present thesis and would 
be further discussed in later sections.  
 
Cognitive flexibility also refers to as set shifting, mental flexibility or mental set 
shifting, which relies on both WM and inhibition and is closely related to creativity 
and theory of mind (Diamond, 2013). The aspects of cognitive flexibility include: (1) 
the ability to change perspectives spatially and interpersonally that requires the 
inhibition of previous perspective and activating WM to switch to a different 
perspective, which is associated with ‘thinking outside the box’ (i.e. creativity) and 
‘put yourself in someone else’s shoes’ (i.e. theory of mind), and (2) the ability to 
adjust in accordance to the dynamically changing environment such as task demands, 
priorities, admitting being wrong and reacting to unexpected events. Cognitive 
flexibility has been suggested to be crucial to problem-solving abilities especially 
when facing novel and surprising condition, which is also closely related to 
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attentional processes (Canas, Quesada, Antoli, & Fajardo, 2003). With the growing 
interest in the beneficial effects of buddhist meditation on well-beings and emotions 
(Barinaga, 2003; Ekman, Davidson, Ricard, & Wallace, 2005), recent studies have 
also focused on how meditation and mindfulness may have on cognitive flexibility. 
Evidence has revealed that meditation improves mood (Davidson et al., 2003), 
cognitive performance (Cahn & Polich, 2006) and enhances attentional processes (Jha, 
Krpmpinger, & Baime, 2007; Moore & Malinowski, 2009) not only in clinical 
researches but in nonclinical populations as well (Eberth & Sedlmeier, 2012). 
Psychological measures including the Stroop Color and Word Test (Golden, 1975), 
Trail Making Test Part B (TMT; Reitan & Wolfson, 1993), Wisconsin Card Sorting 
Test (WCST; Berg, 1948), self-report measures such as the Alternate Uses Test 
(Wilson et al., 1975), Attributional Style Questionnaire (ASQ; Peterson et al., 1982) 
and Cognitive Flexibility Scale (CFS; Martin & Rubin, 1995) have been used to 
measure cognitive flexibility. Human studies have shown that left ventrolateral 
prefrontal cortex plays an important role in facilitating flexible performance (Miller & 
Cohen, 2001; Badre & Wagner, 2007; 2009). Furthermore, studies have shown that 
brain areas such as anterior cingulate cortex (ACC), and the basal ganglia are 
involved in conflict resolution and controlling the execution of actions (Koechlin et 
al., 2003; Chein & Schneider, 2005; Aron, Robbins & Poldrack, 2004; Frank, 2005; 
Aron & Poldrack, 2006; Aron, 2007). In later sections I would further explore the 
crucial involvement of the basal ganglia in cognitive flexibility especially task 
switching.  
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Taken together from the above studies, the fundamental abilities of EFs include 
shifting, updating and inhibition. In addition, the underlying neural mechanisms of 
these EFs are closely related to the functions of the basal ganglia, which is impaired 
due to dopamine neuron loss in patients with PD. The research interest of the present 
thesis therefore lies in investigating the acute effects of treatments of PD on these EFs 
associated in PD patients, in the following sections of Chapter 1 I explore different 
functions that are considered to be associated with the EFs, including (1) context 
monitoring, (2) controlled and automatic processing and task-switching paradigm, (3) 
speed and accuracy trade-offs, and their underlying neural mechanisms. In addition, 
the selected functions have been suggested to be impaired in PD patients by previous 
studies, which would also be explored in later sections.  
 
 
1-1-1 Context monitoring 
Through evolution the human brain has developed the abilities to adapt to the 
constantly changing environment by gathering and interpreting limited sensory 
information, compute the desired decisions directed by different goals and 
motivations to execute appropriate actions, which is an important skill for survival in 
a dynamic world. Among these vital abilities, inhibition is an exceptionally critical 
part to control behaviours in order to perform more context-appropriate actions 
(Chatham et al., 2013).  
 
In the field of neuroscience and psychology, inhibition has many meanings and has 
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been studied extensively (Aron, 2007). Response inhibition, which is a particular 
domain of inhibition, has been widely used in experimental studies to account for the 
concept of inhibitory control (MacLeod, Dodd, Sheard, Wilson, & Bibi, 2003), and 
has been linked to the functioning of frontal cortex and basal ganglia (Wiecki & Frank, 
2012). Logan & Cowen (1984) proposed a formal model stating that a control signal, 
including error during performance or an external indication to stop, would activate a 
‘stopping process’ that suppresses the underlying ongoing thoughts and actions. The 
model introduced the stop-signal procedure to account for the act of control when 
actions/thoughts are no longer relevant to the current goals, however the estimate of 
the model cannot untangled the time spent detecting and/or interpreting the stop 
signals and the time for motor stopping per se to take place (Logan & Cowen, 1984). 
Moreover, Chatham et al (2012) proposed that in order to effectively demonstrate 
inhibitory control, it is important to first monitor the environmental signals to support 
behaviours that may be contingent on the specific context, such a concept is termed 
‘context monitoring’. In most laboratory studies of response inhibition, motor 
stopping and context monitoring are inseparable as subjects were required to cancel a 
prepotent or a planned response after receiving a signal indicating the subjects to stop 
(Chikazoe et al., 2009; Logan & Gowan, 1984; Hampshire, Chamberlain, Monti, 
Duncan, & Owen, 2010; Sharp et al., 2010; Cai & Leung, 2011; Dodds, 
Morein-Zamir, & Robbins, 2011; Aron, 2010). To determine whether context 
monitoring or motor stopping may reflect the cognitively-controlled processes 
required for response inhibition, Chatham et al (2012) used computational, 
hemodynamic, electrophysiological and pupillometric techniques to assess the 
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characteristics of cognitive control. The results showed that context monitoring, rather 
than motor stopping, requires more effortful, controlled, and prefrontal-based 
processes during response inhibition task. The concept of context monitoring is in a 
sense intermingled with information updating and the ability to adapt to the 
dynamically changing environment (i.e. shifting).  
 
1-1-2 Controlled and automatic processing and task-switching paradigm 
Many daily tasks are well-learned routines; however, it is important to maintain the 
flexibility as to adjust to the dynamically changing environment if alternative tasks 
need to be performed. Imaging driving or walking the same route to work every day, 
the constant practicing of the same task has become habitual that evokes similar 
actions therefore the behaviour becomes automatic. However, if the usual road to 
work has been closed due to constructions, the human brain needs to be able to adapt 
to the new situation, collect new data and re-direct the way to work in time.  
 
Effective cognition requires an optimal balance between endogenous control (i.e. 
goal-directed deliberate intentions) that prevents disruption of an ongoing task, and 
the exogenous influences that modulate the flexibility to perform other task when 
appropriate, such effective cognition is referred to as task switching (Monsell, 2003). 
For highly practiced tasks such as daily routines, it has been proposed that the 
neocortex consolidates the associations between stimuli and actions, which are 
initially encoded in the basal ganglia (Ashby et al., 2007; Hadj-Bouziane et al., 2003). 
Therefore, the basal ganglia have more involvement when learning a new task and/or 
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during task switching compared to when performing a well-practiced task (Piton et al., 
2016). The behavioural switching may occur after receiving error feedback 
(retroactive switching) or when the subject detects the change of context and responds 
to it (proactive switching) (Isoda & Hikosaka, 2010). It has been proposed that the 
two switching are controlled by different regions in the medial frontal cortex, anterior 
cingulate cortex (ACC) and the pre-supplementary motor area (pre-SMA) (Isoda & 
Hikosaka, 2010). While different brain regions may be separately involved in 
mediating retroactive and proactive switching, it has been proposed that the two type 
of behavioural switching are both related to motor suppression as the outcome of 
behavioural switching is the change of motor behaviour (Hikosada & Isoda, 2010). As 
previously discussed, the ACC has been proposed to modulate the conflict monitoring 
system that detect and integrate response conflict, and send signals to the basal 
ganglia to control the execution of actions (Botvinick et al., 1999). In particular, the 
STN receives direct projections from the pre-SMA and cingulate cortex that compose 
conflict monitoring systems, which allows the STN to implement cognitive control by 
sending NoGo signals via diffuse excitatory projections to basal ganglia output nuclei 
(Mink, 1996; Parent & Hazrati, 1995; Frank et al., 2007). 
 
Theoretically, a dual processing of automatic and controlled processing cognitive may 
be used to explain cognitive control (Schneider & Schiffrin, 1977; Schiffrib & 
Schneider, 1977). Schneider & Chein (2003) have proposed a detailed computational 
model, which employs a large network of distributed data modules that can categorize, 
buffer, associate and prioritize information. Each module communicates with a central 
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control system, which is composed of five processors including a goal processor, an 
attention controller, an activity monitor, an episodic store and a gating & report relay. 
Furthermore, when the data modules are able to transmit the outputs without he 
mediation of the control system, the transition from controlled to automatic 
processing arises in the model. Figure 1.4 illustrates the hypothetical mapping of the 
five processors to brain regions, which shows that the executive Goal Processor is 
assumed to be located in dorsolateral prefrontal cortex (DLPFC). The Attention 
Controller maps to posterior parietal cortex (PPC) and the Activity Monitor to ACC. 
The Episodic Store maps to the medial temporal lobe (MTL), including the structures 
of the hippocampal complex. The Gating & Report Relay maps to the thalamus 
(THAL), with different thalamic nuclei connecting to alternative Control System 
processors, receiving report signals from the Data Matrix modules, and sending 
output gain signals to the modules.  
 
 
Figure 1.4 Hypothetical mapping of the five processors to brain regions. The 
arrows between regions illustrate known anatomical pathways. Shown on the right are 
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sample modules in the visual region of the Data Matrix, with report and control 
signals form each tier connecting to the thalamus. Figure from Schneider & Chein 
(2003). 
 
Functional imaging studies have proved evidence on supporting the roles of prefrontal 
cortex (PFC) and ACC in modulating cognitive control (Koechlin et al., 2003; Chein 
& Schneider, 2005). In addition, MacDonald et al (2000) proposed that the two brain 
regions had dissociable roles in cognitive control: the DLPFC provides top-down 
control of the behaviour whereas the ACC evaluates the processes during conflicts, 
using event-related functional magnetic resonance imaging (fMRI) techniques. 
Moreover, Botvinick et al (2004) have further proposed the role of the ACC during 
conflict monitoring that triggers compensatory adjustments in cognitive control. As 
briefly mentioned in previous sections, frontal-basal ganglia circuits have been 
proposed to be involved in conflict resolution and controlling the execution of actions 
(Aron, Robbins & Poldrack, 2004; Frank, 2005; Aron & Poldrack, 2006; Aron, 2007; 
van den Wildenberg et al., 2006; Wylie et al., 2009), which suggests a potential role of 
the basal ganglia in cognitive control. Moreover, switching from automatic to 
controlled responses requires control monitoring and suppressing the automatic 
processing. Hikosaka & Isoda (2010) have proposed two modes of behavioural 
switching: retroactive switching and proactive switching (Figure 1.5). Suppose there 
exist context αand context β that are associated with procedure A and procedure B 
separately. The correct mapping between the context and the procedure would lead to 
reward. Retroactive switching refers to when context cue is absent or unknown, an 
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agent must learn from errors (i.e. failed to receive reward) to switch from procedure A 
to procedure B, whereas the proactive switching is triggered by a cue that is 
associated with the context change, so that the agent would switch procedures without 
experiencing errors. Note that Braver et al (2007) have proposed proactive control and 
reactive control of cognitive function, which refers to the continuing process before 
the onset of a crucial stimulus and the temporal process after the onset of the crucial 
stimulus. The proactive and reactive control of cognitive function (Braver et al., 2007) 
do not explain how behaviours may switch under different context, whereas the 
retroactive switching and proactive switching proposed by Hikosaka & Isoda (2010) 
specifically defined the switching process.   
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Figure 1.5 Retroactive switching (left) is triggered by a failure (decreased reward 
value or an error). In this case the context cue is either absent or unknown to the 
animal (indicated by gray rectangles). Proactive switching (right) is triggered by a cue 
signaling a context change so that the subject will not experience the failure. This is 
possible, however, only after the subject has learned the meaning of the cue (indicated 
by purple and green rectangles). Highlighted in yellow are triggers of behavioral 
switching and switched procedures. Figure from Isoda & Hikosaka (2010). 
 
It has been proposed that the two switching are controlled by different regions in the 
medial frontal cortex, ACC and the pre-supplementary motor area (pre-SMA) (Isoda 
& Hikosaka, 2010). Retroactive switching consists of learning from negative 
feedbacks and implementing alternative actions therefore brain regions associated 
with these functions such as ACC are highly likely to be involved. In primate studies, 
evidence has shown that ACC neurons were activated when switching movements 
based on the reduced amount of reward (Shima & Tanji, 1998; Johnston et al., 2007), 
and that ACC neurons generated error-related potentials after making incorrect 
responses (Gemba et al., 1986; Wang et al., 2005; Emeric et al., 2008). Human as well 
as primate studies have suggested a prominent role of pre-SMA on motor suppression 
and conflict monitoring (Luders et al., 1995; Rushworth et al., 2002; Nachev et al., 
2005, 2007; Isoda, 2005; Ullsperger & Cramon, 2001; Garavan et al., 2003). In 
addition, human studies such as fMRI and EEG studies have found activation of the 
ACC activity after error trials or error feedback, supporting the role of the ACC in 
retroactive switching (Garavan et al., 2003; Li et al., 2008; Menon et al., 2001; 
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Ullsperger et al., 2001; Modirrousta et al., 2008; Holroyd & Coles, 2002). 
Furthermore, it has been proposed that the retroactive switching function of the ACC 
may be mediated by its connection to the lateral prefrontal cortex (LPFC) or to the 
striatum, where the former connection is believed to be involved in the execution of 
procedure implementation (Pandya et al., 1981; Morecraft & Hoesen, 1993) and the 
later connection is associated with its role in action selection and associative learning 
(Haber et al., 2006; Hikosaka et al., 2000; Pasupathy & Miller, 2005).  
 
On the other hand, the feature of proactive switching includes conflicts in information 
processing, which is closely related to the updating ability of basic EFs. There are 
four basic phenomena defined within the task-switching paradigm: switch cost 
(response are slower on a switch trail than on a non-switch trial), preparation effect 
(the average switch cost is reduced if practice is allowed prior the task), residual cost 
(switch cost would not completely be eliminated by preparation, instead it reaches a 
substantial asymptote) and mix cost (Monsell, 2003). Among these four phenomena, 
the occurrence of switch cost has been proposed to be due to the suppression of the 
old procedure and the facilitation of the new procedure (Isoada & Hikosaka, 2010). 
Human studies using fMRI techniques have found that the activation of the pre-SMA 
strongly associated with proactive switching (Tanji, 1994; Dove et al., 2000; 
Rushmore et al., 2002). Such an association between pre-SMA activity and proactive 
switching may be related to its role in motor suppression and action selection during 
conflict monitoring (Luders et al., 1995; Rushworth et al., 2002; Nachev et al., 2005, 
2007; Isoda, 2005; Ullsperger & Cramon, 2001; Garavan et al., 2003). Figure 1.6 
 46 
 
illustrates the neural mechanism of proactive switching in oculomotor behaviour.  
 
 
Figure 1.6 Neural mechanism of proactive switching in oculomotor behaviour. A 
neural mechanism of behavioral switching must be able to (1) detect a change in the 
context, (2) suppress the prepotent, automatic process, and (3) facilitate the alternative, 
controlled process (conceptual scheme). The suppression must occur quickly because 
the automatic process emits a motor signal quickly; the facilitation can occur 
thereafter because the controlled process is slow. Recent studies have suggested that 
the pre-SMA, together with other frontal cortical areas, acts as a switch mechanism 
and the basal ganglia may mediate the switch-related signal from the cortical areas. In 
our study using saccadic eye movement, many neurons in the pre-SMA became active 
selectively and proactively on switch trials (Box 2). It was also shown, using a 
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go-nogo task, that some pre-SMA neurons suppress the prepotent saccade, others 
facilitate the alternative saccade, and the rest have both functions. The suppressive 
pre-SMA neurons tended to be active earlier than the facilitatory pre-SMA neurons, 
consistent with the conceptual scheme. In the basal ganglia, the STN may serve to 
suppress the automatic saccade by enhancing the inhibitory output of the basal 
ganglia (SNr) on the SC or the thalamo-cortical network. The caudate nucleus might 
serve to facilitate the controlled saccade by disinhibiting the target of the basal 
ganglia. We speculate that the signals for the automatic and controlled saccades are 
carried mainly by the frontal eye field (FEF) and the supplementary eye field (SEF) 
respectively. In the possible neural network, excitatory and inhibitory connections are 
indicated by (+) and (−) respectively. Figure and caption from Isoda & Hikosaka 
(2010). 
 
1-1-3 Speed/Accuracy Trade-off and moving dots paradigm 
In order to make an accurate or appropriate decision/action, one has to inhibit the urge 
to act in order to gather more information to guide behaviour, however such an 
inhibition may lead to failure in making timely responses. Such a dilemma is known 
as speed and accuracy trade-off (SAT) (Schouten et al., 1967; Wickelgren et al., 1977; 
Chittka et al., 2009). In the present section I would briefly introduce SAT, moving 
dots paradigm, and more importantly, their relationships with executive functions and 
context monitoring.    
 
Abstract mathematical models have been exclusively used to study SAT for almost 
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half a century (Bogacz, Wagenmakers, Forstmann, & Nieuwenhuis, 2010). Sequential 
sampling models attribute SAT effects to changes in the amount of evidence needed 
for a response, which in the model is represented by the changes in the value of the 
decision criteria (Ratcliff & Smith, 2004). In sequential sampling models, the gradual 
process of gathering sensory information in favour of one choice is defined as the 
drift of an abstract decision variable toward a decision threshold (Domenech & 
Dreher, 2010). Mathematical models can account for SAT in two ways: either by 
changing the baseline of the accumulator or by changing the threshold (Bogacz et al., 
2010). In addition, most models assume that SAT is controlled by the distance 
between the initial starting point (i.e. the baseline activity) and the decision threshold. 
If this interval is large, decisions are accurate but slow; conversely, if the interval is 
small, decisions are fast but error-prone (Bogacz et al., 2010). In the sequential 
sampling framework, two factors would determine the performance in experimental 
task, firstly the quality of the information derived from processing the stimuli and 
secondly the quantity of information needed before a decision is made. The 
framework thus may account for the main relationship between accuracy and response 
time in two-choice decisions. Theoretically, whether to make a fast but prone to error 
response/decision or make an accurate but slow response/decision should be 
determined by (1) an internal and/or an external drive to be accurate or fast, and (2) 
the quality of information necessary for achieving the goals. The former may be 
reflected as the distance between decision threshold and the baseline in the 
mathematical models, whereas the latter may be represented by the rate of 
accumulation of information (Ratcliff & McKoon, 2008). The diffusion model 
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(Ratcliff, 1978) provides a framework for the study of SAT modulation based on 
behavioural data collected from binary decision-making tasks. The model separates 
the quality of evidence accumulated to reach decision threshold and other 
non-decision processes such as stimulus encoding and response execution (Ratcliff & 
McKoon, 2008). In this model, it is assumed that a decision is made through the noisy 
process that gathers information over time to reach decision boundaries or criteria. 
The decision-making process begins from the starting point, once it reaches one of the 
decision boundaries a decision is made and a response is initiated. Within the drift 
diffusion model framework, SAT leads to the decrease of the boundary separation 
results, which means that RTs decrease at the cost of making more errors. The rate of 
accumulating information is defined as the drift rate in the diffusion model, which is 
usually determined by the quality of the information provided by the stimuli. The top 
panel of Figure 1.7 illustrates the framework of the diffusion model. 
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Figure 1.7 The drift diffusion model. Top Panel: Three simulated paths with drift 
rate (v), boundary separation (a) and starting point (z). Middle Panel: An equal size 
slowdown in drift rate (X) produces a small shift in the leading edge of the response 
time distribution (Y) and larger shift in the tail (Z) on fast and slow processes from 
each of two drift rates. Bottom Panel: Encoding time (u), Decision time (d) and 
response output time (w). The non-decision component equals the sum of (u) and (w) 
with mean (Ter) and with variability represented by a uniform distribution with range 
St. Figure and caption from Ratcliff & McKoon (2008). 
 
With the advanced development of neural imaging techniques, the neural basis of SAT 
has attracted much attention in recent years. Despite different task design and analysis, 
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fMRI studies on SAT showed that when speed was emphasised to make responses, 
activity in the striatum was increased (Forstmann et al., 2008; Ivanoff et al., 2008; van 
Veen et al., 2008). Consistent with such results, a recent fMRI study also 
demonstrated that striatal activation is associated with an ‘urgent signal’ during 
perceptual decision making in human participants (van Maanen, Fontanesi, Hawkins, 
& Forstmann, 2016). Four theories have been proposed to account for the underlying 
neural mechanisms of such a trade-off: the cortical theory, the striatal theory, the STN 
theory and the synaptic theory, which stand for different circuits that modulate the 
balance between making a fast and making an accurate response (Bogacz et al., 2010). 
Three of the four theories (the cortical theory, the striatal theory, the synaptic theory) 
are based on the mechanism that the speed instructions increase the baseline of 
cortical integrators and cause changes in the corresponding circuits (Forstmann et al., 
2008; Furman & Wang, 2008; Roxin & Ledberg, 2008; van Veen et al., 2008; Lo & 
Wang, 2006). Previous fMRI studies support the striatal theory and the cortical theory 
on suggesting that speed pressure is interpreted as an increased control signal that 
modulates cortical and striatal activity (Forstmann et al., 2008; Ivanoff et al., 2008; 
van Veen et al., 2008; Forstmann et al., 2016). In addition, the STN theory proposes 
that when accuracy is emphasised, frontal areas send additional; excitatory signals to 
the STN, leading to increased STN activity that results in slower and more accurate 
choices (Frank, Scheres, & Sherman, 2007; Utter & Basso, 2008). The STN theory is 
supported by the fMRI studies showing that when participants attempt to stop an 
initiated action, frontal areas that project to the STN and the STN activity would 
increase (Aron & Poldrack, 2006; Aron, Behrens, Smith, Frank, & Poldrack, 2007). It 
 52 
 
can therefore be assumed that the SAT is controlled by a dual process that when speed 
is emphasised to make responses, frontal activation sends signals to the striatum and 
creates the urgent signal to promote timely action. Conversely, when accuracy is 
emphasised the frontal areas would send excitatory signals to the STN, increased STN 
activity would therefore support the inhibition of an intended action to allow more 
time for information accumulation. Such processes are associated with context 
monitoring as in the laboratory environment, whether to be fast or to be accurate is 
explicitly instructed by external cues, at the same time the noise of the stimuli can be 
manipulated.      
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Figure 1.8 Schematic representation of the cortico–basal-ganglia–thalamic circuit. 
STN = subthalamic nucleus. Output = substantia nigra pars reticulata and the external 
segment of globus pallidus in primates. Thin arrows denote excitatory connections; 
lines with filled circles denote inhibitory connections. Blue arrows indicate the areas 
where the input controlling SAT could be provided. Figure and caption from Bogacz, 
Wagenmakers, Forstmann & Nieuwenhuis (2010)..  
 
Moving dots paradigm is often used to investigate SAT both in animal and in human 
studies (Britten, Shadlen, Newsome, & Movshon, 1992; Gold & Shadlen, 2007). The 
task requires participants to decide whether a cloud of dots, which is visually 
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presented on a computer screen, is moving to the left or to the right. When Speed is 
emphasised while making a response, animals and humans may be able to act in a 
timely manner, but may sacrifice the accuracy of responses and vice versa. This 
characteristic of the moving dots paradigm permits the investigation on the cognitive 
flexibility to switch between acting fast and acting accurately. Moreover, the different 
coherence of moving dots provides a chance to manipulate different task difficulty, 
namely, the quality of sensory information. The paradigm therefore provides a 
suitable candidate to study the SAT and the underlying neural mechanism. In the 
present thesis, different moving dots tasks were selected to assess the abilities to (1) 
shift the internal drive or adapt to the external experimental instructions either to be 
fast or to be accurate, and (2) to sample and integrate environmental information to 
meet the intended goals. The former is related to the basic EF shifting whereas the 
latter is considered to be associated with the basic EF updating proposed by Miyake 
& Friedman (2012). Detail of the computerised tasks would be further introduced in 
Chapter 1 section 5.   
 
1-2 The Basal Ganglia  
1-2-1. Structure  
Anatomically, the basal ganglia (Figure 1.9) are subcortical nuclei consisting of the 
striatum, the subthalamic nucleus, the substantia nigra pars compacta and pars 
reticulata (SNc, SNr), the globus pallidus (internal and external segments; GPi, GPe). 
The GPi and the SNr are the main output nuclei of the basal ganglia. The neostriatum 
is composed of the putamen and the caudate nucleus, with the former being the motor 
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part of this brain region. Figure 1.9 shows that the basal ganglia are the largest 
subcortical structures in the human forebrain. The basal ganglia receive inputs from 
the neocortex and project massively to thalamic nuclei, which in turn project to the 
frontal cortex. 
 
Figure 1.9 Basic anatomy of the brain that shows the major regions within the 
basal ganglia. The blue part indicates striatum, which is composed of putamen and 
caudate nucleus. The pink part represents pallidum, which made up of outer and inner 
segments. The green part represents the thalamus and the yellow part represents the 
substantia nigra. Figure and caption from Graybiel (2000).  
 
Figure 1.10 shows the basal ganglia-thalamocortical circuits that are composed of the 
combination of ‘open’ and ‘closed-loops’ features.  As part of the ‘motor circuit’ the 
putamen, the posterior part of the striatum, receives substantial and somatotopically 
organized projections from the motor and somatosensory cortices, the arcuate 
premotor area, and the supplementary motor area (Alexander, DeLong & Strick, 
1986). The associative circuit between the dorsal caudate and the dorsolateral 
prefrontal cortex, the limbic circuit between the ventral striatum and the anterior 
cingulate cortex, the orbitofrontal circuit between the ventral striatum and the 
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orbitofrontal cortex and finally the oculomotor circuit between the body of the 
caudate and the frontal eye fields are the other four fronto-striatal circuits described 
by Alexander et al (1986). 
 
 
Figure 1.10 Parallel organization of the five basal ganglia-thalamocortical circuits. 
Each circuit engages specific regions of the cerebral cortex, striatum, pallidum, 
substantia nigra and thalamus. Abbreviations are as follows: ACA : anterior cingulate 
area; APA: arcuate premotor area; CAUD: caudate, (b) body (h) head; DLC: 
dorsolateral prefrontal cortex; EC: entorhinal cortex; FEF: frontal eye fields; GPi: 
internal segment of globus pallidus; HC: hippocampal cortex; ITG: inferior temporal 
gyrus; LOF: lateral orbitofrontal cortex; MC: motor cortex; MDpl : medialis dorsalis 
pars paralamellaris; MDmc: medialis dorsalis pars magnocell ularis ; MDpc: medialis 
dorsalis pars parvocellularis; PPC : posterior parietal cortex; PUT: putamen; SC : 
somatosensory cortex; SMA : supplementary motor area; SNr: substantia nigra pars 
reticulata; STG: superior temporal gyrus; V Amc: ventralis anterior pars 
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magnocellularis; Vapc: ventralis anterior pars parvocellularis; VLm: ventralis lateralis 
pars medialis; VLo: ventralis lateralis pars oralis; VP: ventral pallidum; VS : ventral 
striatum; c1-: caudolateral; cdm- : caudal dorsomedial; dl-: dorsolateral; 1-: lateral; 
Idm-: lateral dorsomedial; m-: medial; mdm-: medial dorsomedial; pm: posteromedial; 
rd-: rostrodorsal; r1-: rostrolateral; rm-: rostromedial; vm-: ventromedial. Figure and 
caption from Alexander, DeLong & Strick (1986) 
 
 
1-2-2. The basal ganglia and executive functions: updating, shifting, and 
inhibition  
The brain contains many motor pattern generators that each of them is responsible in 
generating a specific body movement (Kim & Hikosaka, 2015; Grillner et al., 1998). 
By receiving sensory inputs or internal states, these mechanisms are activated to 
produce corresponding actions. However, the overall behaviour can be uncontrollable 
if all mechanisms are triggered at the same time without management. To prevent 
such chaotic situation, the brain has developed a mechanism to supress all of the 
motor circuits. The basal ganglia have been identified to play the major role in such 
function. The final output neurons are all GABAergic and inhibitory in the basal 
ganglia, and are connected to the motor mechanisms (Takakusaki et al., 2004; Grillner 
et al., 2005). Dysfunction of the basal ganglia often leads to motor deficits including 
involuntary movement such as PD (DeLong, 1990). Extensive studies in human and 
in animal models (Marsden & Obeso, 1994; Aron & Poldrack, 2006; Hikosaka, 2002; 
Jin, Tecuapetla & Costa, 2014; Cui et al., 2013) have provided large evidence for the 
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involvement of the basal ganglia in action suppression and motor control. 
 
Figure 1.11 shows the direct, indirect and hyperdirect pathways in the basal ganglia. 
Classical models of the basal ganglia function circuit suggest that the direct pathway 
serves as the ‘Go’ pathway as the GABAergic inhibitory connections from the 
striatum to the SNr/GPi that lead to a reduction of inhibition on action, whereas the 
SNr/GPi neurons receive indirect inputs from the striatum via the GPe and possibly 
the STN to inhibit motor action (indirect ‘No Go’ pathway) (DeLong, 1990; Albin, 
Young & Penney, 1989; Kravitz et al., 2010). However, recent studies on animals 
suggest that both direct and indirect pathways are active during the initiation, 
execution and termination of action sequences, which indicate that the basal ganglia 
circuits may have a more complex functional organization (Jin et al., 2014; Cui et al., 
2013). The hyperdirect pathway (Nambu, Tokuno & Takada, 2002) consists of 
glutamatergic excitatory neurons that transmit signals quickly from the cerebral cortex 
to SNr/GPi via the STN, producing a net effect of motor inhibition. It has been 
proposed that the major role of the STN is behavioural switching (Aron & Poldrack, 
2006; Isoada & Hikosaka, 2008; Hikosaka & Isoda, 2010), which suggests that the 
STN activity is associated with supressing automatic and fast actions to initiate 
controlled and slow actions. Moreover, inactivation of the STN ameliorates some of 
the motor deficits observed in PD patients (Limousin et al., 1995, 1998). 
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Figure 1.11 Direct, indirect and hyperdirect pathways. The striatum receives inputs 
mainly from the cerebral cortex. D1R-expressing neurons in the striatum connect to 
SNr/GPi directly (direct pathway). D2R-expressing neurons connect to SNr/GPi 
indirectly through GPe and STN (indirect pathway). STN receives inputs directly 
from the cerebral cortex and send outputs to SNr/GPi (hyperdirect pathway). 
Dopaminergic neurons in SNc/VTA heavily innervate the striatum. D1R = dopamine 
receptor D1; D2R = dopamine receptor D2. Figure and caption from Kim & Hikosaka 
(2015). 
 
Together with the striatum, the STN is the principle input nucleus of the basal ganglia.  
It receives afferents from the cerebral cortex, the thalamus and the limbic system 
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(Gurney, Prescott & Redgrave, 2001). It has been proposed that the STN has a role in 
processing the conflict between evidence for different decision/action options (Frank, 
2006; Bogacz, 2007; Gurney, Humphries, Wood, Prescott & Redgrave, 2004; Herz et 
al., 2014). Studies have been proposed to support the role of the STN in inter-related 
processes including: switching from automatic to controlled processing (Isoda & 
Hikosaka, 2008), slowing down when encountering surprising events (Wessel et al., 
2016; Wessel & Aron, 2017), inhibitory and executive control (Frank, 2006; Frank et 
al., 2007) and adjusting response thresholds during speed and accuracy trade-offs 
(Bogacz et al., 2010). By recording the local field potentials of STN activity in PD 
patients, Herz, Zavala, Bogacz & Brown (2016) showed that STN low-frequency 
oscillations modulates decision threshold, and that the relationship between the STN 
activity and decision threshold modulation is context dependent. Furthermore, it has 
been shown that the cortico-basal ganglia networks modulate the speed and accuracy 
trade-offs during decision-making (Herz et al., 2017). On the other hand, Isoda & 
Hikosaka (2008) reported more phasic change in the neural activity of the STN during 
the inhibition of automatic inappropriate actions compared to the facilitation of 
controlled actions, indicating a role of the STN in behavioural switching. The findings 
of neural activity recordings are in consistent with the functional imaging study of 
Aron & Poldrack (2006), which has shown a role of the STN in the stop-signal 
paradigm (details in Figure 1.12). The studies thus suggest that STN plays a crucial 
role in all three basic executive functions.  
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Figure 1.12 A basal-ganglia model and the Stop-signal paradigm. A. An influential 
model proposes three pathways through the basal ganglia (direct, indirect, and 
hyperdirect). SNr, Substantia nigra; THAL, thalamus; STR, striatum. Open arrows are 
excitatory (glutamatergic); filled arrows are inhibitory (GABAergic). Figure adapted 
from Nambu et al. (2002). B. The Stop-signal paradigm consists of Go- and 
Stop-signal trials. On Go trials, the subject has 1 s (the hold period) to make a left or 
right button press in response to the stimulus. As soon as the subject responds 
(reaction time), the stimulus is replaced by a blank screen for a variable period of time 
(1 s − RT = jitter time, where jitter ranges between 0.5 and 4 s, mean of 1 s). On a 
Stop trial, a tone is played at some delay (SSD) after the arrow stimulus. If the 
response is inhibited, the arrow remains for 1 s, followed by the blank screen jitter 
period; if the subject does not inhibit (i.e., responds), then the timing is the same as 
the Go trial. SSD changes dynamically throughout the experiment to produce a 50% 
inhibition rate. C. Stop-signal reaction time (SSRT) is estimated using the race model 
(Logan & Cowan, 1984). This assumes that Go and Stop processes are in a race and 
are independent of each other. The independence assumption implies that the 
distribution of Go processes on Stop trials (whether a response is made or not) is the 
same as the observed distribution of Go responses (when there is no Stop signal). On 
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Stop trials, a tone occurs at some delay, the SSD after the Stop signal. If this delay is 
short, then P (inhibit) is high and this is likely to be a Stop-Inhibit trial; if the delay is 
long, then P (inhibit) is low and this is likely to be a Stop-Respond trial. If SSD is 
varied so that P (inhibit)=0.5, then SSRT can be estimated by subtracting the SSD 
from the median value of the Go distribution. Figure and caption from Aron & 
Poldrack (2006). 
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1-2-3. The basal ganglia circuits for conflict monitoring and action selection  
To make an appropriate response in the visual environment requires the accumulation 
of external information and the internal information about current behavioural needs. 
An agent is required to activate the collection of signals and inhibit the influence of 
noise in the environment and concurrently in the meantime balance the speed and 
accuracy of responding before producing a response. The characteristics of such 
ability involve context monitoring, inhibitory control and action selection.  
 
Botvinick, Braver, Barch, Carter & Cohen (2001) have proposed that there exists a 
conflict monitoring system, potentially involving the anterior cingulate cortex (ACC) 
of the human frontal lobe, which monitors for the occurrence of conflict in 
information processing. In other words, this conflict monitoring system evaluates 
current levels of conflict and passes the information to control centres, which 
eventually trigger the centres to adjust the strength of their influence on processing 
(Botvinick et al., 2001). Frontal-basal ganglia circuits have been proposed to be 
involved in conflict resolution and controlling the execution of actions (Aron, 
Robbins & Poldrack, 2004; Frank, 2005; Aron & Poldrack, 2006; Aron, 2007; van den 
Wildenberg et al., 2006; Wylie et al., 2009). According to the response selection 
hypothesis, the cortex sends excitatory signals that represent response commands 
elicited by cognitive computations carried out at the cortical level to the basal ganglia, 
which suggests that the basal ganglia are involved in response selection (Brown & 
Marsden, 1998; Robbins & Brown, 1990; Wylie, Stout & Bashore, 2005; Mink, 1996; 
Redgrave et al, 1999). Traditional theories of motor control regard it as the output end 
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of a serial process that includes perceptual, cognitive and executive processes (Cisek, 
2005). It has been proposed that planning and execution are distinct processes 
separated by neural representation of a ‘desired trajectory’ (Abend, Bizzi & Morasso, 
1982). However, Cisek (2005) has argued that, based on the neural data obtained from 
studies of the activity of the primary motor cortex (Scott & Kalaska, 1997; Sergio & 
Kalaska, 2003) and muscle activity (Karst & Hasan, 1991; Gordon, Ghilardi, Cooper 
& Ghez, 1993), behaviour may instead be viewed as parallel processes that specify 
the potential actions currently made possible by the environment and processes that 
select one of those actions for execution. Furthermore, Cisek (2007) has proposed an 
‘affordance competition hypothesis’, which suggested that sensory information 
received from the environment is continuously processed, while other kinds of 
information are also collected in order to select a single action from several potential 
actions. The term ‘affordance’ defined by Gibson (2014) regards the behaviour as a 
competition between internal representations of the potential actions. In other words, 
the process of action selection and the specification of an action occur simultaneously 
and continue even during the performance of movements (Cisek, 2007). Note that 
only currently available actions are specified in this manner and selective attentional 
mechanisms can eliminate many alternative actions during the process of 
transforming sensory information into representations of action. The concept is 
consistent with one of the key roles of precision of the active inference model 
proposed by Friston et al (2013) as precision modulates the biased competition among 
future control states. Action selection is modulated by the biasing inputs from various 
areas that support potential actions in a competition. 
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The basal ganglia through the direct and indirect pathways have been suggested to 
selectively execute one action command while suppressing the other alternatives 
(Mink, 1996; Redgrave, Prescott & Gurney, 1999; Frank, Samanta, Moustafa & 
Sherman, 2007; Cisek, 2007). In addition, the basal ganglia exhibit activity that is 
related to movement parameters (Alexander & Crutcher, 1990) and decision variables 
such as reward (Schultz, 1998) and expectations (Lauwereyns, Watanabe, Coe & 
Hikosaka, 2002). Theoretically it has been proposed that the connectivity between the 
basal ganglia potentially bias the competition between potential actions represented in 
the fronto-parietal system (Cisek, 2007). Building on previous work, the latest model 
proposed by Thura & Cisek (2017) suggested that instead of contributing to the 
choice between potential movements, the basal ganglia actually provide a 
time-dependent signal that controls the urgency to commit to a choice, which could 
lead to the adjustment of the speed and accuracy trade-off when making decisions 
(Thura, Cos, Trung & Cisek, 2014; Thura & Cisek, 2016). In this ‘urgency-gating 
model’, the cortical regions are hypothesised to the selection of optimal action choices 
whereas the basal ganglia are hypothesised to control the speed-accuracy trade-off 
between committing to a choice versus continuing the selection (Thura & Cisek, 
2017). An animal study showed that the STN activity is triggered in association with 
presentation of a stop cue during action cancellation; in particular, the STN transmits 
the stop cue information to SNr before the increased striatal input creates action 
suppression (Schmidt, Leventhal, Mallet, Chen & Berke, 2013). The results of this 
study supported the idea of a race between a go and a stop process, with the outcome 
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of this race determining the success or failure of motor inhibition on each trial. 
Furthermore, another major function of the hyperdirect pathway seems to be 
behavioural switching as it suppresses quick and automatic movements to switch to 
more controlled processing (Aron & Poldrack, 2006; Isoda & Hikasoka, 2008). 
Despite the urgency gating model proposing that the basal ganglia do not contribute to 
which actions to select but the urgency of committing to the responses intended by the 
cortical areas, studies in PD patients treated with STN DBS have shown that the STN 
plays a role in integrating sensory information during decision-making (Frank et al., 
2007; Frank, 2011; Green et al., 2013). In summary, while the involvement of the 
basal ganglia in the processes of information accumulation remains debatable, the 
above evidence suggests that the basal ganglia play an important role in action 
selection and inhibitory control.  
 
 
1-3. Parkinson’s disease (PD) 
The pathological hallmark of PD is the degeneration of dopamine neurons in the 
substantia pars compacta of the basal ganglia; which results in dopamine depletion in 
the nigro-striatal pathway. PD therefore provides an ideal human model to investigate 
the effect of basal ganglia dysfunction and dopamine depletion on motor and 
cognitive function. In this section I will briefly review the motor and non-motor 
symptoms in PD from early stage to advanced PD, and the neural mechanisms 
underlying these motor and cognitive deficits.  
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Table 1.2 lists the most frequent clinical features associated with PD. The loss of the 
nigrostriatal dopaminergic neurons and the presence of intraneuronal proteinacious 
cytoplasmic inclusions termed “Lewy Bodies” (LBs) are the main pathological 
hallmarks of PD (Dauer & Przedborski, 2003). The dopamine neurons in the 
substantia nigra compacta that degenerate, primarily project to the putamen. It is 
generally agreed that dopaminergic cell death of the neostriatum results in the motor 
abnormalities of hypokinesia/bradykinesia, rigidity and tremor that are observed as 
the primary symptoms of PD patients (Olanow, Stern & Sethi, 2009; Crossman, 1990). 
Dopamine deficiency in the basal ganglia causes excessive thalamic inhibition that 
suppresses the cortical motor system, which potentially results in akinesia (DeLong, 
1990), rigidity and tremor, whereas the abnormalities of gait and posture may be 
attributed to inhibitory descending projections (Lang & Lozano, 1998). In addition to 
the core motor symptoms, PD is associated with a host of other motor and non-motor 
symptoms (Jankovic, 2008). Table 1.2 lists the motor and non-motor symptoms in PD.  
 
Table 1.2 Parkinson’s disease symptoms 
Table from Jankovic (2008).  
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While motor symptoms have been the major focus in treating PD, cognitive 
dysfunction has gained much attention in recent years. Studies have shown the 
occurrence of cognitive deficits in patients with PD including attention and executive 
dysfunction from the early stages of the illness (Dubois & Pillon, 1996; Brown & 
Marsden, 1998; Dirnberger & Jahanshahi, 2013) and dementia in the later stages 
(Gratwicke, Jahanshahi & Foltynie, 2015). In addition, dopaminergic medication, 
particularly dopaminergic agonists used to ameliorate the motor symptoms of PD may 
potentially introduce side effects such as impulsivity in PD patients presenting as 
impulse control disorders (ICDs), it has been suggested that up to 25% of patients 
treated with dopaminergic agonists may experience an ICD (Weintraub, David, Evans, 
Grant & Stacy, 2015). Non-motor symptoms such as depression, anxiety, apathy, 
hallucinations and fatigue are also common features in PD (Aarsland, Brønnick, 
Larsen, Tysnes & Alves, 2009). 
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1-3-1. Non-motor symptoms in PD: impaired executive functions, mild 
cognitive impairment, deficits in decision-making 
The neuropsychological deficits in PD range from mild executive dysfunction in the 
early stages to mild cognitive impairment and dementia in later stage (Litvan et al., 
2012; Dirnberger & Jahanshahi, 2013). As previously discussed, EFs can be defined 
broadly and variously, generally they refer to complex cognitive processes such as 
goal formulation, planning and action execution that are required to reach a certain 
goal (Kudlicka, Clare & Hindle, 2011). Table 1.3 presents a list of standardized tests 
commonly used for the neuropsychological assessment of executive deficits in PD 
(Dirnberger & Jahanshahi, 2013).  
 
Table 1.3 List of standardized tests commonly used for the neuropsychological 
assessment of executive deficits in PD 
Test Creators Procedure Processes involved 
Wisconsin 
Card 
Sorting Test 
(WCST) 
Nelson, 
1976 
To learn and classify different cards to the 
same categories 
Cognitive flexibility 
Inhibition 
Stroop 
interference 
task 
Stroop, 
1935 
To name the incongruent ink colour of the 
printed colour words as fast as and as 
accurate as possible 
Inhibition 
Cognitive flexibility 
Trail 
Making 
Reitan, 
1958 
To trace a number sequence (e.g. 1-2-3...) 
or a number-letter sequence (e.g. 
Inhibition 
Cognitive flexibility 
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Test 1-A-2-B...) with a pen or pencil on the test 
sheet 
Word 
fluency 
Benton, 
1968 
To produce as many words as possible that 
begins with a particular letter (phonemic) 
or belonging to a particular category 
(semantic) in 60 seconds 
Inhibition  
Cognitive flexibility  
Context Monitoring 
Digit Span 
Backwards 
Wechsler, 
1984 
To repeat sequences of numbers of 
increasing length (2-9 items) in the reverse 
order of presentation by the examiner 
Working memory 
Tower of 
London test 
Owen et al., 
1992 
To move coloured balls across 
different-sized pegs to match a target 
configuration in as minimal moves as 
possible. Only one ball is allowed to move 
at a time 
Planning 
Inhibition 
Hayling 
Sentences 
Completion 
Task 
Burgess & 
Shallice 
1997 
To complete incomplete sentences in (1) 
with highly associated missing words to 
make sentence meaningful and (2) with 
words completely unconnected with the 
meaning of the sentence 
Inhibition 
Random 
Generation 
of Numbers  
Spatt & 
Goldenberg
, 1993 
To generate a random sequence of number Context monitoring 
Inhibition 
Kudlicka et al (2011) conducted a meta-analysis and systemic review of the pattern of 
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executive impairment in early-stage PD, the results showed consistent evidence for 
cognitive difficulties across five executive function tests including verbal fluency, 
digit span backward, Wisconsin Card Sorting Test (WCST), Stroop test and Trail 
Making Test (TMT). These tests assess a broad range of executive functions including 
cognitive flexibility (verbal fluency), set switching (TMT, WCST), selection 
attention/working memory (digit span backward), and concept formation (WCST) 
(Kudlicka et al., 2011). The results of the meta-analysis provide consistent evidence 
for cognitive deficits in PD patients. Frank (2005) has proposed that cognitive deficits 
in PD patients can be categorised into two classes: one that requires the attentional 
process or working memory (Partiot et al., 1996; Gotham et al., 1988; Dubois et al., 
1994; Woodward, Bub & Hunter, 2002; Henik, Singh, Beckley & Rafal, 1993; Rogers 
et al., 1998), which is believed to be associated with frontal cortex connection; 
whereas the other one involves implicit learning and probabilistic classification 
(Jackson, Jackson, Harrison, Henderson & Kennard, 1995; Ashby, Noble, Filoteo, 
Waldron & Ell, 2003; Maddox, Ashby & Bohil, 2003). Evidence has suggested that 
patients with PD showed inability to plan motor tasks and mental inflexibility (Taylor, 
Saint-Cyr & Lang, 1986; Brown & Marsden, 1998; Berardelli, Accornero, Argenta, 
Meco & Manfredi, 1986). Such impairment in executive functions may be viewed as 
deficits in behaviours that are based on updating information continuously, which is 
potentially caused by dopamine degeneration (Nieoullon, 2002).  
 
In addition to executive dysfunctions, mild cognitive impairment is also a common 
feature in PD and is associated with higher risk to develop dementia (Litvan et al., 
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2011, 2012; Janvin, Larsen, Aarslan & Hugdahl, 2006). Different criteria in defining 
mild cognitive impairment have been proposed, for example, Petersens (2004) 
suggested the criteria for amnestic mild cognitive impairment include (1) memory 
complaint usually corroborated by an informant; (2) objective memory impairment 
for age; (3) essentially preserved general cognitive function; (4) largely intact 
functional activities and (5) not demented. Moreover, Aarsland et al (2009) 
investigated mild cognitive impairment in non-demented, drug-naïve patients with PD. 
The results showed that patients are significantly impaired on all neuropsychological 
tests compared to healthy controls, the largest effect sizes were found for verbal 
memory and psychomotor speed. A total of 18.9% of the patients with PD were 
classified as having mild cognitive impairment, among these patients two-thirds of 
them had a non-amnestic subtype and one-third had an amnestic subtype (Aarsland et 
al., 2009). By using fMRI techniques, Beyer, Janvin, Larsen & Aarsland (2007) 
showed that PD patients with mild cognitive impairment had reduced grey matter in 
the left frontal and both temporal lobes. The Movement Disorder Society 
commissioned a task forced to mark the edge of diagnostic criteria for mild cognitive 
impairment in PD, of which the results show a significant heterogeneity within PD 
mild cognitive impairment in the number and types of cognitive domain impairments 
(Litvan et al., 2011) 
 
Moreover, a number of studies have demonstrated that PD patients show deficits in 
decision-making when performing gambling tasks compared to age-matched healthy 
controls. One of the commonly used gambling tasks on investigating decision-making 
 73 
 
and strategies is the Game of Dice Task. GDT is a gambling task based on the concept 
of Iowa Gambling Task (IGT) of Bechara, Damasio, Damasio & Anderson (1994). 
GDT requires participants to predict which number will be face upwards after rolling 
a dice, whereas IGT asks the participants to choose from four decks of cards to gain 
the maximum gain. Participants will be provided with a starting capital and the goals 
for both tasks are to increase the capital and avoid losing. The difference between the 
GDT and the IGT is that in the GDT, rules and the amounts of gains and losses are 
explicitly presented on the computer screen; participants will also be informed of the 
actual number of the bets they have to make. Whereas for the IGT, participants have 
to implicitly learn from the outcome of each selection to develop the best strategy as 
to choose the decks of cards with small reward but even smaller losses, rather than the 
decks of cards with large rewards but even larger losses. The core difference between 
the GDT and the IGT can therefore categorise the GDT as decision-making under 
‘risk’, and the IGT as decision-making under ‘ambiguity’. Euteneuer et al (2009) 
investigated the performance of PD patients on both the IGT and the GDT, the results 
showed that PD patients were impaired in the GDT but not the IGT, which is 
consistent with some previous studies that found no significant difference between PD 
patients and healthy controls on the performance of the IGT (Mimura, Oeda & 
Kawamura, 2006; Stout, Rodawalt & Siemers, 2001; Czernecki et al., 2002), but is 
inconsistent with other studies that showed impairments of PD patients on the IGT 
(Pagonabarraga et al., 2007; Kobayakawa, Koyama, Mimura & Kawamura, 2008; 
Perretta, Pari & Beninger, 2005; Thiel et al., 2003). The altered decision-making was 
not associated with age of onset, duration of PD and motor severity (Czernecki et al., 
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2002; Perretta et al., 2005; Mimura et al., 2006; Pagonabarraga et al., 2007).  
 
The tendency to risky choices observed in PD patients on the IGT has been proposed 
to be related to the dysfunction of the amygdala, which is known to be involved in 
risk evaluation (Kobayakawa et al., 2008). It has been suggested that impaired 
executive functions are associated with poorer GDT performance, which is modulated 
by the dorsolateral prefrontal loop (Brand et al., 2006; Euteneuer et al., 2009). On the 
other hand, the limbic loop has been shown to play a major role in the IGT 
performance (Bechara et al., 1994; Thiel et al., 2003; Lawrence, Jollant, O’daly, 
Zelaya & Phillips, 2008). The contradictory findings suggest that depending on the 
stage of illness of the patients in the various samples, the limbic loop might not be 
principally affected in PD patients to a degree that is sufficient to affect the IGT 
performance substantially (Euteneuer et al., 2009). Labudda et al (2010) investigated 
the performance of the GDT on PD patients with fMRI techniques. While 
behaviourally the patients showed impairments in making profitable decisions, on the 
fMRI version of the task that did not include a feedback component, PD patients 
showed no difference compared to healthy controls. PD patients and healthy controls 
had similar behavioural patterns in the fMRI task but patients exhibited reduced 
parietal activation, which potentially indicate different strategy application when 
using explicit information for the decision process (Labudda et al., 2010). In general, 
most studies showed that PD patients have impairment in selecting profitable choices; 
such impairment is linked to executive functions and feedback processing, which is 
potentially due to dorsolateral prefrontal loop dysfunction and/or dopaminergic 
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medication. Taken together, clinical studies have found that in addition to motor 
symptoms, non-motor symptoms including executive dysfunctions, mild cognitive 
impairments, and impaired decision-making.  
 
 
1-3-2. Neural network model of dopamine in Parkinsonism 
Following the loss of dopamine neurons and cognitive dysfunctions in Parkinsonism, 
Frank (2005) has proposed a neural network model (Figure 1.13) about the dynamic 
dopamine modulation of basal ganglia to account for the cognitive deficits, which 
involves deficits in attentional processes, working memory and implicit learning, in 
PD patients. The model suggests that reduced dynamic range of the dopamine signal 
affects the modulation of Go/NoGo representations in the direct and indirect pathways 
of the basal ganglia that facilitate or suppress a response. Furthermore, phasic 
dopamine release during error feedback is critical for the implicit learning of 
stimulus-reward-response contingencies as in probabilistic classification and reversal 
tasks, which provides a mechanistic description of how dopaminergic medication may 
lead to reversal impairments that is generally consistent with the ‘overdose hypothesis’ 
(Frank, 2005; Gotham et al., 1988; Cools et al., 2001; Swainson et al, 2000). The loss 
of dopamine neurons in the dorsal striatum in PD thus leads to cognitive deficits in 
reinforcement learning and potentially information updating, which are also 
associated with context monitoring. 
 
The neural mechanisms of dopamine release can be viewed as the expression of two 
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dopamine subgroups of receptors: D1 and D2. The D1 receptor is predominately 
expressed in the direct ‘Go’ pathway that promotes the repeat of an action and 
favoured outcomes, whereas the D2 group is mainly expressed in the indirect ‘No Go’ 
pathway, which supresses an action to avoid negative outcomes (Keefe & Gerfen, 
1995; Gerfen, 2000; Frank, 2005). The increase of dopamine levels thus activates the 
D1 group and the direct ‘GO’ pathway, meanwhile inhibiting NoGo activity via D2 
receptors, leading to repeated actions. The balance of activity between the direct and 
indirect pathways is altered and the resulting disruption in GPi/SNr output may lead 
to abnormalities in movements featured in basal ganglia disorders (DeLong, 1990; 
Albin et al., 1989). Dysfunction of such a system thus may account for the motor 
deficits in patients with PD. Without enough dopamine release, the brain is constantly 
in the state of NoGo due to the overly active indirect pathway that inhibits motor 
execution (Frank, 2005). Dopaminergic medication ameliorates the motor symptoms 
by elevating dopamine levels in the depleted areas, activating the D1 receptors and 
Go activity. However, it has been suggested that dopaminergic medications may 
impair the ability to learn from negative outcomes in PD patients, leading to 
impulsive behaviours (Frank, Seeberger & O’reilly, 2004; Cools, Altamirano & 
D’Esposito, 2006). Figure 1.13B shows the dopamine modulation effect on the Go 
and NoGo pathways.  
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Figure 1.13 (A) The cortico-striato-thalamo-cortical loops, including the direct (Go) 
and indirect (NoGo) pathways of the basal ganglia. The Go cells disinhibit the 
thalamus via the internal segment of the globus pallidus (GPi) and thereby facilitate 
the execution of an action. The NoGo cells conversely increase the inhibition of the 
thalamus that supresses actions. Dopamine from the substantia nigra pars compacta 
(SNc) projects to the dorsal striatum, exciting Go cells via D1 receptors and inhibiting 
NoGo cells via D2 receptors. GPe: external segment of globus pallidus; SNr: 
substantia nigra pars reticulate. (B) The Frank neural network of the basal ganglia 
circuit (squares represent units, with height and colour reflecting neural activity; 
yellow means most active, red means less active and grey means not active). The 
premotor cortex selects an output response via direct projections from the thalamus. 
Go units are in the left half of the striatum layer whereas the NoGo units are in the 
right half, with separate columns for the two responses [Response 1(R1, left button), 
Response 2 (R2, right button)]. In this example, the Go pathway is stronger than the 
NoGo for R1, which inhibits the GPi and disinhibits the thalamus that facilitates the 
execution of an action in the cortex.  A tonic level of dopamine is shown in the SNc. 
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Figure from Frank et al (2007). 
 
The circuitry that implements such a selection function involves the striatum, which 
receives inputs from multiple cortical areas and projects outputs to the GPi and SNr to 
the thalamus, eventually projecting back to the cortical areas (Frank, 2005). In 
addition, the anterior cingulate cortex (ACC) projections to the ventro-medial striatum 
mediate different aspects of reward-based behaviours, whereas the dorsal premotor 
cortex projections to the dorsal striatum/putamen and the lateral caudate nucleus are 
suggested to play an important role in monitoring and planning action (Hadland, 
Rushworth, Gaffan & Passingham, 2003; Roesch & Olson, 2004; Haber & Calzavara, 
2009). Therefore, the degenerated nigrostriatal pathway in patients with PD may not 
only cause motor symptoms but also account for the non-motor symptoms. The 
amount of medication necessary to increase the dopamine-depleted areas in PD such 
as the dorsal striatum might overdose the relatively intact ventral striatum in early PD 
(Frank, 2005). Dopamine has long been identified to be a core neurotransmitter in 
reinforcement learning processes (Schultz, Apicella & Ljungberg, 1993). In addition, 
the basal ganglia have been proposed to be involved in reinforcement learning (Frank 
et al., 2004; Bayer & Glimcher. 2005). Based on reinforcement learning theory, Frank 
et al (2004) investigated the role of dopamine in leaning from positive and negative 
outcomes by testing PD patients on and off medication on two cognitive procedural 
learning tasks. The results showed that when off medication, patients were better at 
learning from negative outcomes, conversely, when on medication, patients learned 
better from positive outcomes (Frank et al., 2004). The observation was consistent 
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with the model of the direct and indirect pathways that separate ‘GO’ and ‘NoGo’ 
responses modulated by differential signals of positive and negative outcomes, which 
suggest that dopamine burst increase activity in the ‘Go’ pathway in the basal ganglia 
circuit and therefore reinforce choices from good outcomes. Conversely, dopamine 
dips lead to the activation of the ‘NoGo’ pathway that facilitates the avoidance of 
negative outcomes (Hikosaka, 1989; Frank et al, 2004). Frank (2005) has also 
suggested that the basal ganglia and specifically the STN can act as a temporary brake 
to raise response thresholds to prevent premature responses and allow time for 
information accumulation to enable selection of that is able to execute the most 
appropriate motor command during the competition between motor actions 
represented in the motor or the premotor cortex. In particular, the STN receives direct 
projections from the pre-SMA and cingulate cortex regions (Parent & Hazrati, 1995) 
which allows it to fulfil these proposed roles. 
 
 
1-3-3. Dopamine Overdose Hypothesis 
Since the establishment of dopaminergic depletion as the pathophysiological basis of 
PD, dopamine substitutions such as levodopa and dopamine agonists have been 
widely used pharmacotherapies in treating PD patients (Vaillancourt et al., 2013). 
While dopamine medication has been proven to be effective in ameliorating motor 
symptoms of PD, an increasing number of studies have been suggesting that 
dopaminergic medication may improve cognitive functions in some patients but 
impair them in others (Gotham et al., 1988; Cools et al., 2001; Dirnberger & 
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Jahanshahi, 2013). Gotham et al (1988) showed that PD patients exhibited improved 
verbal fluency but impaired performance in an associative conditional learning task 
and a subjective-ordered pointing task when on medication. The findings led to the 
formulation of ‘dopamine overdose hypothesis’. The dopamine overdose hypothesis 
proposed by Cools et al (2001) states that, the administration of dopamine medication 
to PD patients may replete dopamine-depleted regions such as the dorsal, rostral head 
of the caudate nucleus and the putamen, but may overstimulate relatively intact 
regions such as the ventral striatum in early PD, leading to poorer performance on 
tasks mediated through these circuits such as reversal learning (Cools et al, 2001), 
conditional associative learning (Gotham et al, 1998), complex discrimination 
learning (Swainson et al, 2000), and probabilistic classification learning (Jahanshahi 
et al 2010). This overdose hypothesis is consistent with the proposal of an ‘inverted U’ 
relationship between dopamine levels and cognitive performance (Figure 1.14; Cools 
et al., 2001; Cools, 2006).  
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Figure 1.14 Schematic of the ‘L-DOPA over-dose’ hypothesis in PD. The black 
‘Inverted-U-shaped’ curve refers to the finding that performance on the probabilistic 
reversal learning task, associated with the ventral striatum, is intact in patients OFF 
medication (PD OFF L-DOPA) but impaired in the same patients ON medication as 
the left black arrows shown. The grey ‘Inverted-U-shaped’ curve refers to the finding 
that performance on the switching task, associated with the dorsal striatum, is intact in 
patients ON medication (PD ON L-DOPA) but impaired in the same patients OFF 
medication. Figure from Cools (2006).  
 
Empirical studies have revealed inconsistent results on the effects of dopamine 
medication on task performance. While some studies found that PD patients 
performed worse om sequential learning tasks when being ON medication than OFF 
medication (Feigin et al., 2003; Kwak, Muller, Bohnen, Dayalu, & Seidler, 2010, 
2012; Muslimovic et al., 2007), other studies have shown no such effects of 
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medication on sequential learning task performance (Pascual-Leone et al., 1993; 
Ghilardi et al., 2007). Kwak et al (2010, 2012) suggest that such inconsistent results 
may be due to the differential effects of dopamine medication on early versus later 
stage of sequence learning processes. The early phase of sequence learning has been 
hypothesised to be associated with ventral striatum, whereas the later phase of 
sequence learning is more closely related to activity in the dorsal striatum (Doyon, 
Penhune, Ungerleider, 2003; Lehericy et al., 2005; Miyachi, Hikosaka, & Lu, 2002). 
In consistent with the hypothesis, Kwak et al (2010) observed that PD patients OFF 
medication as well as healthy controls showed better performance on sequence 
learning compared to PD patients ON medication. Moreover, PD patients OFF 
medication and healthy controls have been found to show activity in the ventral 
striatum during early sequence learning but not observed in PD patients ON 
medication (Kwak et al., 2012). In addition to the differential involvement of striatal 
functions in sequence learning, factors such as stage of disease, striatal structure used 
in the task, and genotype for genetic polymorphisms may also play a role in 
dopaminergic metabolism in striatum and prefrontal cortex, thus contribute to the 
inconsistent results on the effects of dopamine medication (Vaillancourt et al., 2013).  
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Figure 1.15 Factors such as genetic polymorphisms, striatal structure used in the 
task, disease progression may collectively contribute to each patient’s starting 
location on the inverted-U shaped function describing the association between 
dopamine and task performance, which in turn determines whether performance will 
worsen, improve, or show no change with dopaminergic medications. Figure from 
Vaillancourt et al (2013).  
 
 
1-3-4. The computational role of the subthalamic nucleus (STN) in inhibitory 
control 
In addition to degeneration of dopamine neurons, another pathological feature of PD 
is the overactivity of the STN and GPi. It has been suggested that the excessive 
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inhibitory output from the GPi and SNr to the thalamus and underactivation of 
cortical areas contributes to akinesia and bradykinesia in PD (DeLong, 1990; Albin et 
al, 1989). In animal studies, lesions of the STN lead to involuntary movements, which 
can resemble the dyskinesias observed in Parkinson’s disease (PD) patients and 
hemiballism (Crossman, Sambrook & Jackson, 1984). On the other hand, lesions of 
the STN has also been found to alleviate akinetic-rigid syndromes in parkinsonian 
monkeys (Aziz et al., 1992; Aziz, Peggs, Sambrook & Crossman, 1991; Bergman, 
Wichmann & DeLong, 1990), providing a potential treatment for motor deficits 
related to rigidity in PD patients. In human studies, inactivation of the STN have also 
been found to ameliorate some of the motor deficits observed in PD patients 
(Limousin et al., 1995, 1998) 
 
As discussed in Chapter 1-2-2, the hyperdirect pathway in the basal ganglia consists 
of glutamatergic excitatory neurons that transmit signals quickly from the cerebral 
cortex to SNr/GPi via the STN, producing a net effect of motor inhibition (Nambu, 
Tokuno & Takada, 2002). In addition to motor inhibition, it has been proposed that 
the STN also plays an important role in cognitive flexibility (Aron & Poldrack, 2006; 
Isoada & Hikosaka, 2008; Hikosaka & Isoda, 2010), which suggests that the STN 
activity is associated with supressing automatic and fast actions to initiate controlled 
and slow actions. Frank (2006) has proposed a computational role of the STN in 
dynamically controlling the threshold for executing a response, which is 
fundamentally modulated by the intensity of competing possible actions. In other 
words, STN is essential to integrate all information before action selection, thereby 
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prevents premature responses especially in high-conflict situations. Studies have 
shown that high-frequency stimulation induced impairments during decision-making 
when decision conflict was presented in PD patients (Frank et al., 2007; Green et al., 
2013). One potential hypothesis for the impairment could be the stimulation-induced 
disruption of the activity of the limbic circuit between the anterior cingulate cortex 
(ACC) and the ventral striatum as revealed by the imaging study of Schroeder et al. 
(2002). As previously discussed, the ACC has been proposed to modulate the conflict 
monitoring system that detect and integrate response conflict, and send signals to the 
basal ganglia to control the execution of actions (Botvinick, Nystrom, Fissell, Carter 
& Cohen, 1999). In particular, the STN receives direct projections from the 
pre-supplementary motor area (pre-SMA) and cingulate cortex that compose conflict 
monitoring systems, which allows the STN to implement cognitive control by sending 
NoGo signals via diffuse excitatory projections to basal ganglia output nuclei (Mink, 
1996; Parent & Hazrati, 1995; Frank et al., 2007). Consistent with the proposed 
computational role of the STN, Cavanagh et al (2011) showed that mPFC activity 
increased and decision threshold decreased with STN DBS on during decision conflict. 
Figure 1.16 illustrates the computational role of the STN in action selection during 
decision conflict.  
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Figure 1.16 The subthalamic nucleus is incorporated into a scaled-up model that 
includes four competing responses (R1–R4). The STN receives excitatory projections 
from pre/motor cortex in the “hyperdirect pathway” and excites both GPi and GPe; 
GPe provides inhibitory feedback on STN activity. Figure and caption from Frank 
(2006).  
 
Bogacz et al (2010) have proposed that the STN is essential in balancing the 
competing demands of response speed and response accuracy (i.e. the speed-accuracy 
trade-off), especially under accuracy emphasis the STN receives additional excitatory 
inputs and such increased STN activity produces slower and more accurate 
decisions/actions. Moreover, Green et al (2013) showed that PD patients OFF 
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stimulation exhibited reduced reaction time under high decision conflict on a moving 
dots task, and conversely, the effect of high conflict declined when PD patients were 
ON stimulation. Individual data sets are described by two models: when PD patients 
were OFF stimulation, the fast-diffusion model best described the behavioural data, 
while on stimulation, the race model accounted better for the behaviour under DBS 
(Green et al., 2013). The fast-diffusion model applied to two alternative choices tasks 
indicates that the information favouring each of the two alternative options is 
integrated over each trial and that a decision is reached when the accumulated 
information exceeds a critical threshold (Bogacz, Brown, Moehlis, Holmes & Cohen, 
2006), whereas the race model indicated that sensory information for the two 
alternatives are integrated independently (Bogacz & Gurney, 2007). In other words, 
the results of the Green et al (2013) study have provided evidence supporting that 
cortico-basal ganglia networks implement system-level computations that optimise 
decision-makings and potentially further action selection. Figure 1.17 illustrates the 
computational architectures for models of binary decision making. 
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Figure 1.17 (A) A network model implementing the multihypothesis sequential 
probability ratio test. The black and gray circles denote neural populations selective 
for movement toward the left and right, respectively. Labels next to the populations 
denote the brain areas where they are located (‘‘Integrators’’ denotes cortical 
integrator neurons, and ‘‘Output’’ denotes the output nuclei of the BG: the internal 
segment of the globus pallidus and the substantia nigra pars reticulata). The arrows 
denote excitatory connections, and the lines ending with circles denote inhibitory 
connections. The labels above and below the models indicate the values of inputs and 
outputs, respectively. The labels xtL and xtR denote the activities of sensory neurons 
selective for motion toward the left and right, respectively, at the current time T. f is a 
monotonic function equal to f(s) = –log[1 + exp(2gs)], where g is a positive model 
parameter and s the sum of the difference between both alternatives for each output 
unit. (B) In the diffusion model, the difference between sensory inputs for the two 
alternative choices is integrated. A choice is made once this integrated difference 
exceeds a decision threshold. Only the difference between sensory inputs affects the 
values of the integrators. (C) The simplest model of binary choice is the race model. 
Two independent integrators accumulate sensory evidence supporting each of the two 
choice alternatives (here, motion to the left or right). A choice is made once the 
activity of any integrator exceeds a fixed threshold. Figure and captions from Green et 
al (2013).  
 
In addition to decision conflict, Pote et al (2016) found that when decision conflict 
was set at a constant 50% coherence for the moving dots task, patients with STN DBS 
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on responded faster but made more errors and had reduced decision thresholds under 
speed instructions, suggesting that STN DBS induced impulsive responses under 
speed pressure. Together, the results support the imaging studies that suggest the STN 
is involved in the modulation of SAT through the adjustments of response thresholds 
during decision-making (Forstmann et al., 2008; van Veen et al., 2008; Ivanoff et al., 
2008; Domenech & Dreher, 2010). In addition, by recording local field potentials 
(LFP) from the STN DBS electrodes while performing a moving dots task in PD 
patients, Zavala et al (2014) demonstrated that dynamic coupling of neural activity 
between midline frontal cortex and the STN is dominated by information flow from 
the cortex to the STN, and that the elevated STN theta activity is specific to conflict. 
The results thus provide robust support for the hypothesis that the connections 
between the STN and the mPFC modulate decision thresholds during decision conflict 
in decision-making (Zavala et al., 2014). Moreover, Leimbach et al (2018) showed 
that when reward, decision conflict and/or time pressure to make decisions were 
absent during the decision-making processes, the STN plays no critical role in 
modulating the decision threshold.   
 
 
1-3-5 Deep brain stimulation (DBS) of the subthalamic nucleus (STN) 
Once levodopa induced complications such as dyskinesias or on-off fluctuations 
develop, patients are considered appropriate potential candidates for deep-brain 
stimulation (Okun, Fernandez, Rodriguez, Foote, 2007). The selection criteria for 
DBS surgery include: motor symptoms that are dopamine responsive, aged below 70 
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or 80 (this varies across centres), no evidence of brain atrophy on MRI, no dementia, 
no major psychiatric illness, no other major physical illness which would be a 
contra-indication for surgery. Deep brain stimulation is a surgical technique in which 
one or more electrodes attached to leads are implanted in specific regions of the brain, 
the STN or GPi that are hyperactive in PD (Figure 1.18) (Okun, 2012).  
 
 
Figure 1.18 Electrode Implantation for Deep-Brain Stimulation. The electrode for 
deep-brain stimulation is implanted in either the subthalamic nucleus or the internal 
segment of the globus pallidus. The lead passes through a burr hole in the skull. 
Attached to the lead is a connecting wire, which is tunneled under the skin of the 
scalp and neck to the anterior chest wall, where it is connected to an impulse 
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generator. Figure from Okun (2012).  
 
Furthermore, it has been sown in rodent studies that STN high-frequency stimulation 
(HFS) could increase striatal dopamine release and metabolism (Bruet et al., 2001; 
Meissner et al., 2003; Lacombe et al., 2007; Zhao et al., 2009; Pazo, Hocht, Barcelo, 
Fillipini & Lomastro, 2010), such increase is thought to account for the improvement 
of parkinsonian symptoms in animal models of PD. Glutaminergic output on the 
dopaminergic neurons of the SNc from the STN is believed to be involved in the 
degeneration of dopamine neurons, STN-HSF may slow down such 
neurodegeneration process by decreasing glutamate output (Benabid, Chabardes, 
Mitofanis & Pollak, 2009). The clinical observations on PD patients have shown that 
STN DBS is effective against levodopa sensitive motor symptoms (Benabid et al., 
1998; Moro et al., 1999) and it is generally observed that patients reduce 
dopaminergic medication after surgery (Krack et al., 2003; Kleiner-Fisman et al., 
2003), it has therefore been proposed that STN DBS has an effect on increasing 
striatal dopamine release. However, human imaging studies of STN DBS have found 
no evidence supporting the hypothesis that STN DBS is associated with striatal 
dopamine release (Hilker et al., 2003; Strafella, Sadikot & Dagher, 2003; Nozaki et al., 
2013; Thobois et al, 2003). For example, Hilker et al (2003) has found no correlation 
between the changes of dopamine radioligand binding and the simulation amplitudes 
in a positron emission tomography (PET) study.  
 
Despite the growing clinical practice of STN-HFS, the underlying mechanisms of 
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DBS STN remains undetermined (Meissner et al., 2005; Montgomery & Gale, 2008; 
McIntyre & Hahn, 2010). Two general theories have been strongly debated regarding 
the effects of STN DBS: (1) DBS suppresses or inhibits the stimulated nucleus that 
mimics the effects of ablation; (2) DBS results in activation of the stimulated nucleus 
that is transmitted throughout the network (McIntyre, Savasta, Goff & Vitek, 2004). 
Nevertheless, lesions or DBS of the STN in primates reduce the symptoms of 
parkinsonism in MPTP-treated monkeys (Bergman et al., 1990; Benazzouz et al., 
1993). Moreover, DBS of the STN has been shown to remarkably improve the motor 
impairments in PD as now established in randomized clinical trials (Deuschl et al, 
2006; Weaver et al, 2012; Follett & Torres-Russotto, 2012; Williams et al, 2010). A 
few experimental studies have shown that STN-HFS reduces the activity of STN 
neurons (Benazzouz, Gross, Feger, Boraud, & Bioulac, 1993; Benazzouz et al., 2004; 
Salin, Manrique, Forni, & Goff, 2002; Tai et al., 2003). Studies have shown that in 
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-(MPTP)-lesioned non-human primates, 
STN-HFS increases the mean firing rate of GPi neurons and modifies the 
spontaneously irregular firing pattern into regular firing pattern (Bergman, Wichmann, 
Karmon, & DeLong, 1994; Hashimoto, Elder, Okun, Patrick, & Vitek, 2003). 
Electrophysiological recordings of local field potentials and unit activity in human 
STN suggest that increased oscillatory activity in beta frequency band may contribute 
to parkinsonian pathophysiology (Brown et al., 2001; Levy et al., 2002; Brown, 2003; 
Kuhn et al, 2004). Moreover, studies have shown that DBS attenuate oscillatory beta 
activity in PD patients, which may result in motor improvement (Kuhn et al., 2008; 
Bronte-Stewart et al., 2009; Giannicola et al., 2010).    
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In addition, studies have found that deep brain stimulation of the STN and GPi are 
equally effective in improving motor deficits in PD (Anderson, Burchiel, Hogarth, 
Favre & Hammerstad, 2005; Follett et al., 2010). More reports on the mood, 
behavioural and cognitive side-effects associated with STN DBS than GPi DBS 
stimulation have been found, potentially due to higher STN implantation rate; 
however the relatively smaller size and anatomical location of the STN may also 
account for the effect (Walter & Vitek, 2004). Combs et al (2015) conducted a 
meta-analysis to compare the cognitive, behavioural and mood symptoms between the 
two targets. The results showed that GPi DBS produced relatively fewer 
neurocognitive declines than STN DBS. While the former resulted in a small decline 
in attention and a small-moderate decline in verbal fluency; the latter produced small 
declines in psychomotor speed, memory, attention, executive functions, and overall 
cognition, and also moderate declines in both semantic and phonemic fluency (Combs 
et al., 2015). In addition, in a recent review of the cognitive literature and the 
available meta-analyses of this literature; Troster et al (2017) concluded that bilateral 
STN DBS is reasonably cognitively safe except for decrements in verbal fluency and 
on the Stroop task. 
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1-4.  The effect of acute manipulations of treatments on cognitive functions 
associated with context monitoring in PD patients 
One of the goals of the present PhD thesis is to investigate the acute effects of 
treatments (i.e. dopamine medication and STN DBS) on cognitive functions 
associated with context monitoring in PD patients. In the present section I will 
selectively review studies that manipulated acute effects of either of these treatments 
on cognitive functions in PD patients.  
 
1-4-1 The acute effects of dopaminergic medication on executive functions in 
PD patients 
Progressive degeneration of dopaminergic neurons in the SNc is the main feature of 
PD. The most common therapeutic strategy is dopaminergic medication including 
dopamine precursors such as levodopa and dopaminergic agonists. While both types 
of medication significantly ameliorate motor deficits in PD patients, as discussed in 
Chapter 1-2-4, dopamine overdose effect on aspects of cognitive function and 
neuropsychological and psychiatric side effects have also been reported for patients in 
the early stages of PD treated with medication (Saint-Cyr, Taylor & Lang, 1993). As 
briefly mentioned in previous sections, Frank et al (2004) have proposed a 
computational model of basal ganglia-dopamine interactions in cognition, which 
predicts that PD patients are impaired in learning form positive feedback and have 
enhanced learning from negative feedback when being OFF medication due to the 
reduced level of dopamine; whereas when being ON medication, PD patients would 
have sufficient dopamine to learn from positive feedback but relatively impaired at 
 95 
 
learning from negative feedback. The proposed model may provide explanations on 
the observation that dopaminergic medication alleviates some cognitive deficits but 
impairs other cognitive functions that are associated with the intact basal ganglia 
regions (due to dopamine overdose hypothesis, which was discussed in Chapter 1-3-3) 
(Frank, 2005).   
 
The early stages of PD are associated more with nigrostriatal dopamine depletion and 
to a lesser extent associated with mesocorticolimbic dopamine depletion. The 
impairment of PD on the performance of gambling tasks is often reflected as 
impulsive choices that lead to large losses. In addition, it has been shown that PD 
patients treated with dopaminergic medication, especially dopaminergic agonists, 
potentially develop impulse control disorders (ICDs) (Voon & Fox, 2007; Wu, Politis 
& Piccini, 2009; Weintraub et al., 2015). ICDs are defined as behaviours that are 
performed repetitively, excessively, and compulsively to a degree that greatly 
interferes with major aspects of daily life (Grant, Schreiber, & Odlaug, 2011). In 
addition to pathological gambling, shopping, hypersexuality and binge eating, other 
impulsive-compulsive behaviours including punding, hobbyism, walk-about and 
hoarding have also been described in PD (Weintraub et al., 2015). Molina et al (2000) 
first reported the association between PD and pathological gambling, potentially due 
to the pharmacological treatment. Dodd et al (2005) assessed 11 PD patients who 
developed pathological disorders and their medical therapy, showing a correlation 
between dopaminergic agonists and the development of pathological gambling. 
Weintraub et al (2010) conducted a cross-sectional study of 3090 patients in America 
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and Canada, which showed that 13.6% of patients developed one risk, and 3.9% had 2 
or more ICDs. ICDs were more common in patients treated with dopamine agonists, 
showing a 2-3.5 fold increased odds of inducing ICDs for dopamine agonist treatment 
(Weintraub et al., 2010).  
 
Dopamine-receptor binding profiles may provide a neurobiological explanation for 
the association between dopamine agonist treatment and ICDs. 93 % of the prescribed 
dopamine agonists that were associated with ICDs were relatively selective for the 
dopamine D3 receptors (Dodd et al., 2005). D3 receptors are proposed to be abundant 
in the ventral striatum (Gurevich & Joyce, 1999), which is also a brain region that is 
associated with the hedonic response to amphetamine, addictions and impulsivity 
(Drevets et al., 2001; Lee et al., 2009). In addition to dopaminergic medication, 
factors such as male gender, younger age at PD onset, being single, higher novelty 
seeking personality, and personal or family history of substance abuse are factors 
relevant to development of ICDs in PD (Voon et al., 2007; Weintraub et al., 2010, 
2015). The association of ICDs with other risk factors may suggest involvement of a 
complicated network in human impulsivity and compulsivity. In addition, studies 
have shown that PD patients without ICDs and PD patients with ICDs showed 
different behavioural patterns in decision-making (Djamshidian et al., 2010; 
Djamshidian et al., 2012). While all PD patients showed reflection impulsivity as 
reflected by less information sampled before making a decision, PD patients without 
ICDs showed a behavioural pattern similar to pathological gamblers, whereas PD 
patients with ICDs exhibited a pattern resembling more to substance users 
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(Djamshidian et al., 2012). Moreover, PD patients without ICDs performed worse on 
working memory tests (Djamshidian et al., 2012). The results suggest that tasks 
investigating evidence accumulation might be powerful for detecting 
impulsive-compulsive behaviours in PD. Studies in rodents showed that blockade of 
dopamine receptors reduces preference to wait longer or work harder to obtain large 
rewards (Cardinal, Robbins & Everitt, 2000; Salamone, Wisniecki, Carlson & Correa, 
2001). Drugs increasing dopamine transmission such as amphetamine can exert 
differential effects on decision-making, while lower doses of amphetamine enhances 
tolerance for delays to reward delivery. These results suggest that acute manipulation 
of dopaminergic transmission is involved in cost/benefit decision-making. In addition 
to the acute effects, chronic administration of drugs, especially dopaminergic agonists, 
has been demonstrated to impair inhibitory control and decision-making (Everitt & 
Robbins, 2005).  
 
In the review that discussed chronic dopaminergic stimulation in PD patients on 
inducing motor and behavioural side-effects, Voon et al (2009) suggested that chronic 
dopaminergic medication (both levodopa and dopaminergic agonists) seems to alter 
presynaptic dopamine transmission that leads to both levodopa-induced dyskinesias 
and ICDs. In addition, never-medicated PD patients showed impaired 
stimulus-response learning ability compared to healthy controls (Nagy et al., 2007). 
Ryterska, Jahanshahi & Osman (2013) conducted a meta-analysis in an attempt to 
determine the motor and cognitive factors that determined impairment of 
decision-making in PD patients. The results revealed two key predictors of 
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decision-making impairment in PD: (1) the feedback structure of the decision-making 
task and (2) the medication status of patients while performing the task. Behavioural 
studies on patients with PD tested on and off medication have shown the effects of 
acute dopaminergic medication on probabilistic classification learning, perceptual 
decision-making and action selection (Czernecki et al., 2002; Shohamy, Myers, 
Geghman, Sage, & Gluck, 2006; Frank et al., 2007; Moustafa, Sherman & Frank, 
2008; Jahanshahi, Wilkinson, Gahir, Dharminda & Lagnado, 2010; Galea, Bestmann, 
Beigi, Jahanshahi & Rothwell., 2012; Huang et al., 2015). For example, Moustafa et 
al (2008) have shown that PD patients both on and off medication showed attentional 
shifting deficits in an information updating related task, but for different reasons. 
Moreover, medication seemed to improve working memory. More specifically, 
unmedicated PD patients showed deficits in updating attentional set, whereas 
medicated PD patients were impaired in ignoring distractors that were previously 
relevant to the task (Moustafa et al., 2008). Jahanshahi et al (2010) suggested that PD 
patients on medication performed worse on than off medication and healthy controls 
on a probabilistic classification learning task. On a moving dots task, Huang et al 
(2015) have shown that dopaminergic medication did not induce impulsivity when 
acting under time pressure or in situations of decision conflict; instead it impaired the 
ability to extract sensory information in PD patients, resulting in patients making 
more errors in a perceptual decision-making task when faced with decision conflict. 
In contrast, Castrioto et al (2015) showed no effect of acute manipulation of 
dopaminergic medication on the IGT scores, however, PD patients off medication 
showed significantly worse performance compared to age-matched healthy controls. 
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While the acute manipulation of dopaminergic medication may improve working 
memory and the subjective evaluation of motivation, it may also impair attentional 
shifting and perceptual decision-making. The results suggest that dopaminergic 
medication is effective in reducing the negative symptoms caused by the loss of 
dopamine neurons in multiple neural mechanisms that involved dopamine 
transmission. Timmer, Sescousse, Esselink, Piray & Cools (2018) showed that 
dopaminergic medication increased a value-dependent gambling bias in 
non-depressed PD patients, which is associated with the dopamine overdose 
hypothesis (Cools et al., 2006). In contrast to previous studies reporting dopaminergic 
medication inducing impulsive decisions in PD, Foerde et al (2016) showed that PD 
patients (who did not have ICDs) tested on medication made more farsighted choices, 
which suggests that dopamine influences the evaluation of larger later rewards. Note 
that the Foerde et al (2016) study investigated different groups of PD patients when 
ON versus OFF medication, individual differences in levels of dopamine deficiency 
and in making intertemporal decisions should also be taken into account in future 
studies. 
 
In summary, despite a few studies suggesting that dopamine medication used in 
treating PD produced no side effects in patients, most studies have found that 
dopamine medication induced side effects such as executive dysfunctions, impaired 
decision-making and potential development of ICDs in PD patients.   
 
 
 100 
 
1-4-2. The acute effects of STN-DBS on executive functions in PD 
In addition to dopamine medication, STN DBS is also a common treatment for PD. 
As previously discussed, the exact mechanism of STN DBS and how specifically it 
improves the motor symptoms pf in PD remains unclear (Montgomery & Gale, 2008; 
McIntyre & Hahn, 2010). Moreover, experimental studies have shown inconsistent 
results on the effects of acute manipulation of STN DBS on executive functions in PD 
patients.  
While STN DBS has been clinically demonstrated to alleviate tremor, rigidity, 
bradykinesia, and levodopa-induced dyskinesias, its effects on cognition are less clear 
and depend on the cognitive domains under consideration (Parsons, Rogers, Braaten, 
Woods & Tröster, 2006; Woods, Fields & Troster, 2002; Comb et al, 2015; Jahanshahi, 
2013). Woods et al (2002) concluded in a critical review that most common findings 
for the effects of STN DBS, in addition to improving the motor deficits, are 
improvements in self-reported symptoms of depression and diminished verbal fluency. 
Consistent with this conclusion, Funkiewiez et al (2004) investigated 77 PD patients 
before, 1 and 3 years after surgery and found that STN stimulation did not lead to 
global cognitive deterioration however, verbal fluency was found to worsen. Such 
verbal fluency decline has been related to apathy and a decrease in self activation 
(Funkiewiez et al., 2004). A meta-analysis study of 28 neuropsychological cohort 
studies published between 1999 and 2006 including 612 patients revealed significant 
but small declines in executive functions, vernal learning and memory in PD patients 
treated with STN DBS (Parsons et al., 2006). Table 1.4 shows the average weighted 
effect sizes, standard errors of the effect sizes and confidence limit. The 
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neuroanatomical and cognitive mechanisms underlying the negative effect of STN 
DBS on verbal fluency are not mutually exclusive. Intraoperative electrical 
stimulation studies suggested that the striatum might have dissociable roles in the 
motor and cognitive control of language (Robles, Gatignol, Capelle, Mitchell & 
Duffau, 2005). In addition to the effects of STN DBS on neuropsychological tests, it 
has been suggested that DBS of the STN has an impact on executive control or 
inhibition of prepotent responses (Jahanshahi, 2013). 
 
Table 1.4    Random effect sizes for the neuropsychological domains 
 Average random 
effect size 
Effect size 
variance 
95% CI 
Cognitive screening 0·04 0·001 −0·05 to 0·12 
Attention and 
concentration 
0·02 0·001 −0·08 to 0·12 
Executive functions 0·08* 0·001 −0·03 to 0·20 
Psychomotor speed 0·22 0·020 −0·02 to 0·54 
Verbal functions 0·21* 0·020 −0·04 to 0·46 
Visual functions 0·06 0·010 −0·16 to 0·27 
Verbal fluency 0·64* 0·030 0·32 to 0·96 
Phonemic fluency 0·51* 0·080 −0·05 to 1·08 
Semantic fluency 0·73* 0·030 0·41 to 1·04 
Table from Parsons, Rogers, Braaten, Woods & Tröster, 2006.  
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To investigate the dynamic role of the STN in modulating decision thresholds in 
proportion to reinforcement and decision conflict, Frank et al (2007) administrated 
computerized decision-making tasks to PD patients treated with DBS of the STN in 
different sessions (i.e. ON and OFF). The results showed that patients on stimulation 
failed to slow down with increased decision conflict, supporting the hypothesis that 
the STN provides a control signal that prevents premature responses depending on 
decision conflict (Frank, 2006; Frank et al, 2007). Moreover, Green et al (2013) have 
demonstrated that PD patient with STN DBS ON made more fast and incorrect 
responses during the modulation of SAT (i.e. speed-accuracy trade-off) when making 
decisions compared to PD patients OFF stimulation and age-matched healthy controls. 
Together the results thus suggest that the STN is involved in information integration 
during decision making and/or action selection.  
 
In addition to its role in information integration, the STN is proposed to be involved 
in the accumulation of probabilistic information (Bogacz & Gurney, 2007). Coulthard 
et al (2012) showed that DBS of the STN impairs response choice requiring 
information integration and induces failures to slow down to incorporate new 
information before making a decision in PD patients. Studies investigating the effect 
of DBS of the STN on the Iowa Gambling task (IGT) report no significant difference 
in overall performance between ON and OFF sessions 2-4 weeks or 10 months after 
surgery (Oyama et al., 2011; Czernecki et al., 2005). Evens, Hoefler, Biber, & Lueken 
(2016) showed that acute DBS of the STN increased risky choices in the IGT. 
However, DBS of the STN had no effect on incentive salience attribution or the 
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evaluation of delayed rewards. In contrast, Brandt et al (2015) showed that 
stimulation of the STN tempered risk-seeking behaviours in PD patients, additionally 
the stimulation made patients more risk-aversive in ambiguous-risk situations. While 
results on experimental tasks suggest that in general DBS of the STN causes little to 
no negative effect on decision-making (Czernecki et al., 2005; Yugeta et al., 2010; 
Swann et al., 2011; Torta et al., 2012; Boller et al., 2014; Fumagalli et al 2015; Brandt 
et al., 2015), Smeding et al (2007) have suggested that pathological gambling is 
related to a combination of STN stimulation and treatment with dopamine agonists 
based on a case report. Consistent with this hypothesis, Castrioto et al (2015) reported 
that patients after surgery improved performance on the IGT due to the reduction of 
the dopaminergic medication. By contrast, Rogers et al (2011) showed that DBS of 
the STN enhanced loss-chasing behaviours on the Cambridge gambling task. In 
contrast with the previous findings, Torta et al (2012) revealed no such effects, instead 
patients reported being more impulsive subjectively during off stimulation periods. 
 
Neuropsychological tests have shown inconsistent results regarding the effects of 
STN DBS on inhibitory control related EFs in PD patients. To examine the effect of 
STN DBS in PD on controlling inhibition, the stop-signal paradigm and the 
estimation of stop-signal reaction time (SSRT) based on the horse race model (Logan 
& Cowan, 1984) have been used in several studies (van den Wildenberg et al., 2006; 
Swann et al., 2011; Mirabella et al., 2011; Greenhouse et al, 2011; Ray et al, 2009; 
Obeso et al, 2013). A few studies have shown prolonged SSRTs in patients ON 
compared to OFF stimulation, indicating that STN DBS impairs inhibitory control in 
 104 
 
PD patients (Ray et al, 2009; Ballanger, Poisson, Broussolle, & Thobois, 2012; Obeso 
et al, 2013). However, three studies that investigated the effect of STN DBS SSRT 
have reported significantly shorter SSRTs in PD patients with stimulation ON than 
OFF, suggesting that DBS of the STN improves inhibitory control on the stop signal 
task (van den Wildenberg et al., 2006; Swann et al., 2011; Mirabella et al., 2011). 
Moreover, other studies using different tasks such as a cue-target detection task and a 
Status quo task also showed behavioural improvements for PD patients on tasks 
involving proactive inhibition (Favre et al., 2013; Zaehle et al., 2017). In addition to 
SSRT, Go/NoGo task has also been widely used to assess inhibitory control. While 
most studies suggested that STN DBS impaired inhibitory control on the Go/NoGo 
task performance (Hershey et al., 2004; Ballanger et al., 2009; Hershey et al., 2010), 
one study showed that STN DBS improved action execution when rewards were 
anticipated (Wagenbreth et al., 2015). Moreover, Georgiev et al (2016) showed that 
STN DBS selectively decreased discriminability on tasks with high probability but 
not low probability of GO stimuli. Factors such as medication state when performing 
the behavioural tasks, disease duration, the difference of the SSRT tasks used, 
baseline SSRTs in PD patients relative to healthy controls, the exact location of the 
stimulating electrode in the STN and surgical procedure variations may contribute to 
the inconsistency in these results. Despite these studies provide contrary results, the 
results of these studies suggest a direct involvement of the STN in inhibitory and 
executive control (Table 1.5). 
 
Table 1.5 Studies investigating the effects of STN DBS on inhibitory control and 
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cognitive flexibility 
Task used Impaired by STN 
DBS 
Enhanced by STN 
DBS  
Related executive 
functions 
SSRT 
(Stop-signal 
reaction time) 
Jahanshahi et al 
(2000) 
Schroeder et al 
(2002) 
Ray et al (2009) 
Obeso et al (2013) 
Van den 
Wildenberg et al 
(2006) 
Greenhouse et al 
(2011) 
Swann et al 
(2011) 
Mirabella et al 
(2011) 
Inhibition 
Go/NoGo task Hershey et al (2004) 
Ballanger et al 
(2009) 
Hershey et al (2010) 
Wagenbreth et al 
(2015) 
Georgiev et al 
(2016) 
Wagenbreth et al 
(2015) 
Inhibition 
Stroop 
interference 
task/ Simon 
Jahanshahi et al 
(2000) 
Schroeder et al 
 Cognitive flexibility 
Inhibition 
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task (2002)  
Witt et al (2008) 
Wylie et al (2010) 
 
 
1-5. General Aims, hypotheses and methodology 
The general aims of the present thesis were to investigate the acute effects of 
dopamine and STN DBS on basic executive functions such as shifting, updating and 
inhibition. PD patients are recruited as a human model of dopamine depletion. 
Dopaminergic medication and STN DBS are used to further investigate how these 
treatments both ameliorate motor deficits and affect executive functions in PD. 
Behavioural performance on computerised tasks on/off medication or on/off 
stimulation is compared for each patient. In addition, performance of PD patients was 
compared to age-matched healthy controls (HCs). On one hand, in accordance with 
the ‘dopamine overdose hypothesis’ (Cools et al., 2006), PD patients would have 
poorer performance on probabilistic learning tasks, which involves the presentation of 
one discrimination to learn at a time, when being ON medication than OFF 
medication, due to medication overstimulates dopamine-intact ventral striatum in PD 
patients. On the other hand, based on the theories of STN DBS in inhibitory control 
and previous results observed in PD patients, it is hypothesised that STN DBS would 
impair the basic EFs including shifting, updating and inhibition in PD patients, 
resulting in poorer performance on behavioural tasks when being ON stimulation.  
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1-5-1. Computerised tasks 
In the present section I introduce the computerised tasks used in the present PhD 
thesis in detail.  
 
Moving dots tasks: Speed/Accuracy trade-off and Difficulty 
The ‘speed-accuracy’ moving-dots task (Britten, Shadlen, Newsome & Movshon, 
1992) required participants to decide whether a cloud of dots moved to the left or the 
right of the screen. Out of 120 dots, 50% moved coherently in one direction and the 
remaining 50% moved randomly. Each dot consisted of three pixels, and the diameter 
of the entire cloud of dots was 250 pixels. At the beginning of each trial, a written cue 
(i.e. FAST for speed and ACCURATE for accuracy) was presented, instructing 
participants to adopt different levels of cautiousness. Participants would decide the 
direction of the dots by pressing one of two buttons with either their left (for dots 
moving left) or right (for dots moving right) index finger. The cues were 
pseudo-randomly intermixed and there were equal numbers of FAST and 
ACCURATE cues in a block of 200 trials. At the end of each trial, participants 
received feedback, which depended on the previously presented cue. Under speed 
conditions, whenever participants exceeded the reaction time criterion of 500 ms, a 
“too slow” feedback was presented. If participants responded within the time criterion 
for the speed condition, they received the feedback “in time.” At the end of the 
accuracy trials, participants were presented with an “incorrect” or “correct” feedback, 
depending on whether they had made an error or provided a correct response. The 
negative feedbacks were presented in red, while the positive feedbacks appeared in 
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green. Feedback provided an additional incentive for participants to adopt different 
levels of caution in response to the different cues. 
 
The ‘difficulty’ moving-dots task also required participants to decide the direction in 
which a cloud of dots moved. No cues for Speed or Accuracy were used in this task. 
The coherence of moving dots ranged from 5%, 10%, 15%, 25%, 35% to 50%, 
respectively making it harder (5%) or easier (50%) to decide the direction of the 
moving dots. The higher the coherence was, the easier it was to judge the direction of 
the moving cloud of dots, thus leading to faster responses. Conversely, the lower the 
coherence was, the more difficult it was to decide the direction of the moving dots and 
therefore leading to slower response time. At the end of each trial, participants 
received “incorrect”, “correct” or “no response” feedbacks depending on their 
responses (Figure 1.9). 
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Figure 1.19 The speed–accuracy version of the moving dots task. The task 
difficulty version of the task was similar but without the speed/accuracy instructions 
and the coherence of the dots varied from5%, 10%, 15%, 25%, 35% to 50%. 
 
Block-designed moving dots task  
A block-designed moving dots task was used which consisted of two kinds of blocks: 
controlled blocks and automatic blocks to investigate the role of the STN in switching 
between different tasks. At the same time the moving dots paradigm also allow the 
study of how DBS STN may affect the modulation of the SAT during perceptual 
decision-making under various moving dots coherence.  
 
The “automatic” (100% coherence) blocks required participants to decide whether a 
cloud of dots moved to the left or the right of the screen. All the dots moved 
coherently in the same direction. The participants were given two different 
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instructions before every trial: FAST (for speed) and ACCURATE (for accuracy), 
while the level of coherence being kept constantly at 100%. The participants then 
decided on the direction of the moving dots by pressing one of two buttons with either 
their left (for dots moving left) or right (for dots moving right) index finger. in 
accordance to the instruction. The cues were pseudo-randomly intermixed and there 
were equal numbers of FAST and ACCURATE cues in 2 blocks of 60 trials, which 
made it a total of 120 trials. At the end of each trial, participants received feedback, 
which depended on the previously presented cue. In the speed condition, whenever 
the participants made a response within 500 ms, the feedback ‘in time’ was presented, 
otherwise a ‘too slow’ feedback. In the accuracy condition, participants received the 
feedback ‘correct’ or ‘incorrect’ depending on their responses. ‘No response’ was 
presented on the screen if the participants failed to make any response on the trial 
within a time-frame of 1500ms. In the “controlled” blocks, the participants were also 
required to decide the direction in which a cloud of dots moved. They were instructed 
to do the task as fast and as accurately as possible. Cues for speed or accuracy were 
also used in this version of the task, as outlined above. The coherence (“difficulty”) 
level of the moving dots were set at 5%, 10%, 15%, 25%, 35% and 50%, making it 
harder (5%) or easier (50%) to decide the direction of the moving dots, since the 
higher the level of coherence was, the easier it was to judge the direction of the 
moving cloud of dots, thus leading to faster responses. In each block, there were equal 
numbers of trials at each level of coherence, pseudo-randomally mixed, with half 
presented under ‘speed’ and half under ‘accuracy’ instructions.  At the end of each 
trial, participants received the feedback “in time”, “too slow” or “no response” 
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depending on their responses, as outlined above. The numbers of trials were selected 
to obtain reliable measures of perceptual decision-making while at the same time 
avoiding causing fatigue for the patients (Lerche, Voss & Nagler, 2017) 
 
The probabilistic RT Task 
The probabilistic RT task requires participants to learn the association between the 
presented imperative stimuli (IS) and specific finger presses (Galea et al., 2012) 
(Figure 1.20 a). The order of the IS can be predictable or unpredictable (Figure 1.20 
b&c).  
 
 
Figure 1.20 The probabilistic reaction time task. a, Schematic representation of a 
single trial. A visual warning sign is presented followed by a fixation cross. One of the 
four novel IS is then presented and participants are required to respond as fast and 
accurate as possible when the next fixation cross is presented; b and c show that the 
order of the visual stimuli can either be predictable or unpredictable. Predictable 
sequences were generated from a first-order Markov sequence in which there are 16 
combinations that determined the relationship between the IS on trial t and on trial t-1. 
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Numbers within the probability matrices represent the transition probabilities. The 
overall probability of each IS on trial t was equal across all blocks. Figure adapted 
from Galea et al., (2012). 
 
Participants sit in front of a computer screen 30 cm away. A custom button box with 
four buttons is placed in front of the dominant hand. The participants are instructed to 
place each one of their fingers on each of the four buttons and to maintain this 
position throughout the task. Initially, an un-informative warning cue (“!”) was 
displayed for 250 ms. Then a fixation cross was presented for 1000 ms, one of the 
four IS was shown in the centre of the screen for 250 ms. The fixation cross then 
reappeared during the response period (2500 ms). During this time, the participant 
was required to respond to the IS as fast as possible but not at the expense of accuracy. 
Each IS image is associated with pressing a specific button. The task is divided into 4 
blocks, with block 1 and 4 being unpredictable conditions, block 2 and 3 being 
predictable conditions. No explicit information about the underlying patterns in each 
block is provided to participants. Participants were simply instructed to react with 
speed and accuracy. During the main experiment, error feedback is removed, and 
participants conduct four blocks of 100 trials with short rest periods between blocks. 
In the first and last blocks, stimuli sequences are unpredictable with a 0.25 probability 
of each IS being presented on trial t (Figure 1.20b). Conversely, in the middle of the 
two blocks, the IS is drawn from a predictable first-order Markov sequence. The 
design creates a structure that the probability of the current stimuli t is conditionally 
dependent on the stimulus of the previous trial t-1. There are 16 possible 
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combinations that determine the relationship between the IS on trial t and on trial t-1. 
Importantly, the overall probability of each IS is equal across all blocks. For all 
correct responses, RT is calculated as the time between IS onset and the subsequent 
button press. Moreover, the RT in predictable conditions is further compared between 
probable and improbable trials. The predictability of the current trial is also quantified, 
ti, based on the IS presented on the previous trial, ti -1, given by the mutual 
information (MI) between consecutive IS (Harrison et al., 2006). MI is the reduction 
in uncertainty of the IS on the current trial t as a result of the knowledge of the IS on 
the previous trial ti -1.  
 
1-5-2. Computational Models 
Hierarchical Drift Diffusion Model 
Based on the concept of the drift diffusion model (detail in previous section), Voss & 
Voss (2007) proposed a fast-dm software for the parameter estimation, which 
provides a novel and flexible tool for fast and precise diffusion model by using partial 
differential equation method and Kolmogorov-Smirnov statistic for the optimisation 
of the parameters, which was used to apply to the behavioural data (Lerche et al., 
2017).  
 
While the drift diffusion model is a powerful tool to infer the latent psychological 
processes underlying simple choice decision-making, studies investigated neural 
mechanisms associated with evidence accumulation and decision threshold 
modulation often have low trial numbers in each condition, making it difficult to 
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estimate model parameters. Wiecki, Sofer & Frank (2013) have developed a 
Python-based toolbox, which uses hierarchical Bayesian parameter estimation 
methods to allow simultaneous estimation of individual subjective parameters and the 
group distribution that the parameters are drawn from, while also providing measures 
of uncertainty in these parameters in the posterior distribution. Figure 1.21 illustrates 
the framework of hierarchical drift diffusion model.  
 
Figure 1.21 Basic graphical hierarchical model implemented by HDDM for 
estimation of the drift-diffusion model. Round nodes represent random variables. 
Shaded nodes represent observed data. Directed arrows from parents to children 
visualize that parameters of the child random variable are distributed according to its 
parents. Plates denote that multiple random variables with the same parents and 
children exist. The outer plate is over subjects while the inner plate is over trials. 
Figure from Wiecki, T., Sofer, I., and Frank, M. (2013). 
 
Machine learning frameworks 
It has been proposed that PD patients with and without ICDs showed distinct 
behavioural patterns that may shed lights on explaining why some patients would 
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develop the impulsive behaviours and the others would not (Djamshidian et al., 2012, 
2014). The distinct behavioural patterns may thus be used as a factor in building 
predictive models that could serve as a screening tool for PD patient who are at high 
risk of developing ICDs as the disease progresses or induced by inappropriate 
treatments (e.g. high dosage of dopamine agonists). As previously discussed, PD 
patients have been reported to exhibit impaired perceptual decision-making processes 
and such impairment may lead to the onset of ICDs. To examine the potentiality of 
using behavioural patterns on a perceptual decision-making framework in predicting 
impulsive behaviours in PD patients, algorithms from the field of machine learning 
were used to construct predictive models. Figure 1.22 shows a general diagram for 
using machine learning in predictive modelling.  
 
 
Figure 1.22 A typical workflow diagram for using machine learning in predictive 
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modelling. Figure from Raschka (2015).  
 
 
1-5-3. Samples 
All PD patients recruited for the studies had a clinical diagnosis of idiopathic 
Parkinson's disease according to the Parkinson's Disease UK Brain Bank criteria 
(Hughes, Daniel, Kilford & Lees, 1992). The severity of patients’ motor symptoms 
and their stage of illness were rated on the Unified Parkinson's Disease Rating Scale 
(UPDRS; Fahn & Elton, 1987) and the Hoehn & Yahr (1967) scale respectively. The 
Mini Mental State Examination (MMSE, Folstein et al, 1975) and the Beck 
Depression Inventory (BDI, Beck, Steer & Brown, 1996) and the Starkstein Apathy 
Scale (Starkstein, 2012) were respectively used to ensure that the patients are not 
suffering from dementia or depression or apathy at the time of assessment. 
Age-matched healthy controls were recruited from among the spouses and friends of 
the patients and through local advertising. All age-matched healthy controls did not 
have any neurological, psychiatric illness, history of head injury, drug or alcohol 
abuse.  
Information from previous studies was used to measure the sample sizes necessary to 
obtain a statistically significant effect. For all study, the sample sizes were based on 
previous studies that investigated similar effects of dopaminergic medication or 
effects of STN DBS on perceptual decision-making processes/probabilistic reaction 
time task in PD patients (Galea et al., 2012; Green et al., 2013; Huang et al., 2015).  
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Effect sizes were reported for all the significant results to present the magnitude of the 
significant effects in a standardized metric that allow the practical significance, which 
represents the practical consequences of the findings for daily life (Lakens, 2013). 
The following formula provides calculation for effect size of between-subject design 
(given as Cohen’s d, Cohen, 1992): 
𝑑 =  
(𝜇1 − 𝜇2)
𝜎
 
Where 𝜇1 represents the mean of group 1, 𝜇2 represents the mean of group 2. σ1 
represents the standard deviation of group 1, whereas σ2 represents the standard 
deviation of group 2, and 𝜎 represents the pooled standard deviation of the two 
groups.  
𝜎 = √[(𝜎12 + 𝜎22)/2] 
For within-subject design, the dependence among means must be corrected; therefore 
the correlation between the two means needs to be considered during calculation 
(Morris & DeShon, 2002). Due to small sample sizes (n < 20) in all studies, Cohen’s 
d may be biased in giving estimate of the population effect size, therefore the 
corrected effect size (Lakens, 2013), also known as Hedge’s g (Hedges & Olkin, 1985) 
was reported for all the significant results: 
Hedge′s 𝘨 = 𝐶𝑜ℎ𝑒𝑛′𝑠 𝑑 × (1 −
3
4(𝑛1 + 𝑛2) − 9
)  
 
1-5-4. Ethics approval  
All studies have the approval of the Joint Ethics Committee of the Institute of 
Neurology and The National Hospital for Neurology and Neurosurgery, London. The 
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ethics approval number for the project is 01/N040. All participants were provided 
with an information sheet and encouraged to ask questions about the procedures of the 
study before participation. Written informed consent was obtained from each 
participant prior to the investigation.  
 
1-5-5. Statistical Analysis: 
Programming languages R and relevant packages (R Core Team, 2013), Python and 
relevant toolboxes (Oliphant, 2007; Millman & Aivazis, 2011; Walt, Colbert & 
Varoquaux, 2011) and IBM SPSS 20 software were used to analyse the data and 
construct needed models. A mixed repeated measures design combined with a 
between groups design to compare patients with age-matched controls is used in most 
studies. For statistical analyses, reaction times (RTs) and response accuracy were 
measured for each participant. Multiple measurements per subjects were taken due to 
the repeated-measure experimental design, which violates the assumption of linear 
model that requires data to be independent from each other. The visual stimuli in all 
studies of the thesis were randomly presented to each participant and each participant 
performed the task repeatedly, the dependent variables thus have two forms of 
dependencies: for subjects and for conditions.  
 
For the error data that were non-normally distributed and unbalanced experimental 
design (i.e. PD patients tested twice for OFF/ON medication or stimulation states and 
HCs tested only once), generalized linear mixed models (GLMM) and linear mixed 
model (LMM) were used to analyse the behavioural data. In addition, the models 
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allow the consideration of random effect such as individual difference to be taken 
account for. To select the best fitted model, the Akaike information criterion (AIC) 
was used during model selection (Bozdogan, 1987).  
 
To determine whether PD patients and healthy controls are matched, independent 
t-tests were used for age, global cognition measured on MMSE, depression and 
apathy scores on the Beck Depression Inventory-II (DBS-II) and the Starkstein 
Apathy Scale (SAS). Paired t-tests were used to compare UPDRS scores OFF versus 
ON medication or with STN-DBS OFF versus ON stimulation for patients to 
determine the effect of medication or STN DBS on ameliorating motor symptoms in 
PD. Where necessary, a Bonferroni correction was used to adjust the p value for 
multiple comparisons. Due to the relatively small sample sizes in the studies, for all 
the differences (between- and within-subjects) that reach a significant level, the effect 
size was calculated to emphasise the size of the differences using Hedges’ g as 
previously introduced.  
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Chapter 2  The acute manipulation of dopaminergic medication did not 
induce impaired context monitoring on a moving dots task in Parkinson’s disease 
patients with impulse control disorders history 
2-1 Abstract 
To investigate the ‘dopamine overdose hypothesis’, which suggests that dopamine 
medication may induce side effects on executive functions (EFs) in PD patients, the 
present study tested 11 patients with Parkinson’s disease (PD) who had been clinically 
diagnosed with impulse control disorders (ICDs) ON and OFF dopaminergic 
medication, and compared their performance to 14 age-matched healthy controls 
(HCs). Two versions of a moving dots task were used, one manipulated speed and 
accuracy instructions to assess the modulation of Speed and Accuracy trade-off (SAT), 
which is associated with the ability to dynamically switch between mental sets. The 
other manipulated the level of coherence (i.e. task difficulty) of the task, which are 
considered to be associated with information accumulation and updating in the 
present study. Both versions of task require abilities of ‘context monitoring’. The 
hierarchical drift diffusion model (HDDM) was fitted to the behavioural data to 
further analyse the underlying mental processes related to the basic EFs during the 
task. The results showed that acute manipulation of dopamine medication did not 
have significant effects on the performance of PD patients. From the behavioural 
point of view, PD patients both ON and OFF dopamine medication were able to 
perform the task as well as age-matched healthy controls in terms of reaction time 
(RT) and response accuracy. Likewise, the application of HDDM to the behavioural 
data showed no differences between PD patients with ICD history and age-matched 
HCs. Taken together, the acute manipulation of dopamine medication did not induce 
negative effects in PD patients with ICD history. The results may be due to the ceiling 
effect of the task as both groups of participants showed high response accuracy and 
fast RTs. In addition, scores from the neuropsychological tests shows that reducing 
dopamine agonists in long term care for PD patients who had developed ICDs, which 
is a common clinical approach for treating ICDs, does not induce negative effects on 
cognitive function in PD patients.   
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2-2 Introduction 
Impulse control disorders (ICDs) such as pathological gambling, shopping, binge 
eating, and hypersexuality involve “behaviours that are performed repetitively, 
excessively, and compulsively to an extent that interferes with major daily functioning” 
(Grant et al., 2011). In recent years, there has been increasing evidence suggesting 
that patients with Parkinson’s disease (PD) treated with dopaminergic medication are 
at increased risk of developing one or more ICDs (Voon & Fox, 2007; Weintraub et al., 
2015). In a cross-sectional study of 3,090 patients, the use of dopamine agonists in the 
treatment of the motor symptoms of PD has been shown to be associated to with 2- to 
3.5- fold increased odds of developing an ICD (Weintraub et al., 2010). Such an 
association between dopamine agonists and the onset of ICDs is now well-established 
(Voon et al., 2006; Voon & Fox, 2007, Weintraub et al., 2015).  
 
As discussed in Chapter 1, the dopamine overdose hypothesis proposed by Cools et al 
(2001) states that, the administration of dopamine medication to PD patients may 
replete dopamine-depleted regions such as the dorsal, rostral head of the caudate 
nucleus and the putamen, but may overstimulate relatively intact regions such as the 
ventral striatum in early PD, leading to poorer performance on tasks mediated through 
these circuits such as reversal learning (Cools et al, 2001), conditional associative 
learning (Gotham et al, 1988), complex discrimination learning (Swainson et al, 
2000), and probabilistic classification learning (Jahanshahi et al 2010). In addition, 
acute manipulation of medication state in PD patients has revealed that, PD patients 
tested ON medication are impaired in learning from negative feedback, and fail to 
 122 
 
make profitable decisions on certain gambling or decision-making tasks (Frank et al., 
2007; Djamshidian et al., 2010; Mimura et al., 2006; Pagonabarraga et al., 2007; 
Euteneuer et al., 2009; Huang et al., 2015), suggesting that dopaminergic medication 
may interfere with basic executive functions (EFs) such as shifting (i.e. switching 
flexibly between tasks and/or mental sets) and updating (i.e. constant monitoring and 
modifying working memory contents based on sampled information) in PD. It has 
been proposed that the deficit in learning from negative feedback other cognitive 
functions may relate to dopaminergic medication masking dips in dopamine release 
following negative feedback (Schultz, 2007; Frank, 2005), thus the development of 
ICDs in PD patients has been associated with the impaired cognitive functions 
induced by dopamine overdose. Imaging studies that investigated the mechanisms of 
ICDs in PD have revealed that compared to patients without ICDs, patients with ICDs 
such as pathological gambling show different patterns of brain activation in brain 
areas implicated in inhibition and impulse control (van Eimeren et al, 2009; 2010; Wu 
et al, 2013), particularly in response to dopaminergic medication (van Eimeren et al 
2010). Dopaminergic medication resulted in differential patterns of activation in the 
lateral orbitofrontal cortex, rostral cingulate, amygdala and external segment of the 
globus pallidus (GPe), with decreased dopamine-induced activation observed in PD 
patients with pathological gambling in contrast to increased dopamine-induced 
activation in these areas in patients without pathological gambling (van Eimeren et al, 
2010). Furthermore, chronic treatment with dopaminergic medication can interfere 
with the phasic and tonic activity of dopaminergic neurons, which could be associated 
with long-term neuro-adaptation including regulation of receptor and transporter 
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density (Voon et al., 2017). Reduced concentrations of striatal dopamine transporter 
(Smith, Xie, & Weintraub, 2016; Voon et al., 2014; Vriend et al., 2014), and altered 
striatal and cortical dopamine homeostasis (Rao et al., 2010; Ray et al., 2012) may 
potentially contribute to the development of ICDs. 
 
The ability to control behaviours in order to perform more context-appropriate actions 
is referred to as ‘context monitoring’, which requires the basic EFs such as 
information updating and the ability to adapt to the dynamically changing 
environment (i.e. shifting) (Chatham et al., 2012). While a number of studies have 
investigated the association between dopaminergic medication, inhibitory control and 
reward sensitivity as potential mechanisms of PD patients with ICDs (Rossi et al., 
2010; Bentivoglio et al., 2013; Djamshidian et al., 2010; Pineau et al., 2016; Voon et 
al., 2010, 2011; Housden et al., 2010; Leroi et al., 2013), the aim of the present study 
is to investigate the acute effect of dopaminergic medication on basic EFs associated 
with ‘context monitoring’ in PD patients with ICDs, using a moving dots task. In the 
present thesis, context monitoring was viewed as two components: (1) speed and 
accuracy (SAT) modulation that is considered to be associated with shifting between 
different mental sets (external drives to be fast or to be accurate), and (2) the rate of 
information accumulation, which is viewed as a type of updating ability. When 
making binary decisions in such tasks, an agent must gather perceptual information 
until a boundary separation (in the model this boundary separation is referred to as 
‘boundary separation’) is reached for one of the two options, then execute the action 
which is appropriate for that selected option.  
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In the present study, to determine how dopamine medication affects these two 
components in context monitoring in PD patients with ICDs, we used two versions of 
the ‘moving dots’ task and tested patients ON and OFF their medication. In one 
version, which was termed as the ‘SAT’ version, before each trial instructions would 
be presented so that the participants would be asked to either be fast or be accurate for 
the trial, the moving dots stimuli was set at a constant 50% coherence for all trials. In 
another version, we manipulated the level of coherence of the moving dots to modify 
the degree of decision conflict (i.e. task difficulty) so that the information needed to 
make responses differ between trials. A hierarchical drift diffusion model (HDDM) 
was fitted to the behavioural data (Wiecki et al., 2013), which enabled estimation of 
boundary separation, drift rate and non-decision time within a hierarchical Bayesian 
framework. The STA version of the task was used to investigate the ability to adapt to 
dynamically changing mental sets (i.e. to be fast or to be accurate), whereas the 
‘Difficulty’ version manipulated different was used to investigate the ability to sample 
and update sensory information from the stimuli presented when the level of 
coherence/task difficulty/degree of conflict was experimentally manipulated. It was 
hypothesised that PD patients with ICDs would show faster reaction times and lower 
response accuracy when tested ON medication than OFF medication due to 
‘dopamine overdose hypothesis’, and when compared to age-matched healthy 
controls (HCs). Furthermore, in a previous study we found that dopaminergic 
medication impaired evidence accumulation in PD patients without ICDs, particularly 
in the presence of decision conflict (Huang et al., 2015). On the basis of these results, 
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it was predicted that compared to the OFF medication state, being ON medication 
would influence information accumulation in high conflict (i.e. low coherence) 
conditions, such that the patients with ICDs would make more incorrect responses 
with increasing task difficulty/lower coherence versions of the task. 
 
Figure 2.1 A schematic framework on the hypothesis of the present study. For 
Parkinson’s disease (PD) patients, due to dopamine neuron degeneration, patients 
exhibited motor and non-motor symptoms. For PD patients ON medication, based on 
dopamine overdose hypothesis, patients showed impairments on basic executive 
functions (EFs) such as shifting, updating and inhibition. For PD patients with 
impulse control disorder (ICD), the development on the impulsive symptoms may be 
due to impaired EFs and/or abnormal reward sensitivity.  
 
2-3 Material and methods  
Participants 
• Dopamine neuron 
degeneration 
• Motor and Non-
motor symptoms
PD patients 
• Dopamine 
ovderdose 
hypothesis
• Impaired basic EFs 
PD patients ON 
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monitoring?
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Eleven patients (3 females) with Parkinson’s disease who had been clinically 
diagnosed with impulse control disorders (PD ICDs) and 14 age-matched healthy 
controls (HCs) (6 females) were recruited. PD patients had a clinical diagnosis of 
idiopathic Parkinson's disease according to the Parkinson's Disease UK Brain Bank 
criteria (Hughes et al., 1992). All patients had been additionally diagnosed as 
suffering from ICDs by a neurologist (average 6 years since last demonstrated active 
ICD symptoms).  The Questionnaire for Impulsive-Compulsive Disorders in 
Parkinson’s disease (QUIP) was used to screen for current or past impulsive 
behaviours for the ICD patients (Weintraub et al., 2009; Weintraub, et al., 2012). The 
Mini-Mental State Examination (cut-off score of 26; Folstein et al., 1975) was used to 
screen for cognitive impairment/dementia and the Beck Depression Inventory-II 
(BDI-II, Beck et al., 1996) was used to screen for depression (cut-off score of 24). 
None of the patients had cognitive impairment/dementia or clinical depression. None 
of the healthy controls had any neurological or psychiatric illness, head injury or drug 
or alcohol abuse. Patients were examined by a neurologist, both OFF and ON 
medication, and the severity of their motor symptoms and their stage of illness were 
rated on the Unified Parkinson's Disease Rating Scale (UPDRS; Fahn & Elton, 1987). 
Self-reported QUIP scores showed that among the eleven patients, ICDs consisted of 
both hypersexuality and compulsive shopping in 3, binge eating and compulsive 
shopping in 2, hypersexuality in 2, binge eating in 2 and repetitive punding 
behaviours in 2. All patients were currently on levodopa medication, with the mean 
levodopa equivalent dose presented in Table 2.1. Most patients reported to have 
previously taken the dopamine agonist Ropinirole, three were still taking the drug but 
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at a reduced dosage. All participants had normal or corrected-to-normal vision. The 
demographic and clinical details of the participants are presented in Table 2.1. 
 
Table 2.1. Demographic and clinical details of the sample. Table shows means and in 
brackets standard deviations.  
 HC PD patients with ICDs P 
Age 66.79(10.46) 59.91(7.57) p =.08 
MMSE 29.43(0.64) 29.18(1.08) p =.484 
BDI-II 6.46(5.09) 15.33(1.61) p =.001* +1 
Digit Span 17.93(3.89) 18.18(4.17) p =.877 
UPDRS-III  OFF: 28.00 (8.56) 
ON: 13.67 (7.65) 
p <.0001* +2 
Onset age   49.22(8.23)  
LEDD  950.45 (383.63)  
Disease 
Duration 
 8.78 years (5.78)  
QUIP  2.27 (2.20)  
PD=Parkinson’s disease; ICDs=impulse control disorders; MMSE=Mini Mental State Examination; BDI=Beck 
Depression Inventory; UPDRS=Unified Parkinson's Disease Rating Scale; LEDD=L-Dopa Equivalent Daily Dose; 
N/A=Not Applicable; NS=not significant; “*” = significant difference between groups (BDI) or ON vs. OFF 
medication for patients (UPDRS); +1= Effect size of BDI-II: Hedge’s g= 2.561; +2 = Effect size of UPDRS score 
III: paired sample Hedge’s g= 3.824 
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Design & Procedure 
A repeated measures design was used. All participants (patients and healthy controls) 
performed two versions of the moving dots task, which manipulated either speed 
versus accuracy instructions or level of coherence. Both tasks were performed by all 
participants in two testing sessions on the same day. For practical reasons, patients 
were first tested in the “OFF” state, after overnight withdrawal of dopaminergic 
medication for approximately 12–16 h. After finishing the session off medication they 
took their dopaminergic medication and were tested in the “ON” medication state at 
least one hour later. The ON an OFF medication states were confirmed by the UPDRS 
III ratings by a neurologist, which indicated that the motor symptoms of PD patients 
were significantly improved when they took their dopaminergic medication compared 
to the OFF state (t(10)=8.39, p<.001). The study was approved by the joint ethics 
committee of the UCL Institute of Neurology and the National Hospital for Neurology 
& Neurosurgery. Informed consent was obtained from all participants.  
 
The moving dots task 
In each session participants performed two versions of the moving dots task.  
The “speed–accuracy” version of the moving-dots task (Britten et al., 1992) required 
participants to decide whether a cloud of dots moved to the left or the right of the 
screen. The participants were given one of two different instructions before every trial: 
FAST (for speed) and ACCURATE (for accuracy), while the level of coherence was 
kept constant at 50%, that is half of the 120 dots moved coherently in the same 
direction, while the remainder moved randomly.  The participants then decided on 
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the direction of the moving dots by pressing one of two buttons with either their left 
(for dots moving left) or right (for dots moving right) index finger according to the 
instruction. The cues were pseudo-randomly intermixed and there were equal 
numbers of FAST and ACCURATE cues in a block of 100 trials. At the end of each 
trial, participants received feedback, which depended on the previously presented cue. 
When Speed was emphasized, whenever the participants made a response within 500 
ms, the feedback ‘in time’ was presented, otherwise a ‘too slow’ feedback. When 
Accuracy was emphasized, participants received the feedback ‘correct’ or ‘incorrect’ 
depending on their responses. ‘No response’ was presented on the screen if the 
participants failed to make any response on the trial within a time-frame of 1500ms.  
 
In the “task difficulty” version of the moving-dots, the participants were also required 
to decide the direction in which a cloud of dots moved. They were instructed to do the 
task as fast and as accurately as possible. No cues for speed or accuracy were used in 
this task. The coherence (“difficulty”) level of the moving dots were set at 5%, 10%, 
15%, 25%, 35% and 50%, making it harder (5%) or easier (50%) to decide the 
direction of the moving dots, since the higher the level of coherence was, the easier it 
was to judge the direction of the moving cloud of dots, thus leading to faster 
responses. At the end of each trial, participants received the feedback “incorrect”, 
“correct” or “no response” depending on their responses.  
 
The speed and accuracy version of the task contained two blocks with 100 trials each, 
whereas the difficulty version of the task contained one block with 120 trials. For 
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each of the two tasks, the numbers of trials were selected to obtain reliable measures 
of perceptual decision-making while at the same time avoiding causing fatigue for the 
patients. Figure 2.2 illustrates the speed and accuracy version of the task.  
 
 
Figure 2.2 The speed–accuracy version of the moving dots task. The task 
difficulty version of the task was similar but without the speed/accuracy instructions 
and the coherence of the dots varied from 5%, 10%, 15%, 25%, 35% to 50%. 
 
Data Analysis 
R (R Core Team, 2013) and IBM SPSS software were used to analyze the data. 
Reaction times (RTs) to the nearest s and response accuracy were measured as 
dependent variables. A linear mixed model (LMM) was used to fit reaction time with 
group (HC versus PD ICD), time (T1/OFF versus T2/ON), Type (i.e. different 
instructions, for Speed version of the task) or coherence (for Difficulty version of the 
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task) as fixed effects. Subject was assigned as a random effect to account for 
subject-by-subject variation in overall RTs. In addition to a random intercept, a 
random slope in Type (for Speed version of the task) or Coherence (for Difficulty 
version of the task) has also been added into the model, which means that the rate at 
which individuals made decisions based on the Speed/Accuracy instructions or the 
coherence of moving dots is different from person to person. Assuming the fixed 
effect of Coherence being positive, if an individual has a positive random effect, it 
suggests that the individual made responses more quickly with higher coherence level, 
while a negative random effect means that an individual would make slower 
responses with higher coherence level. Log base 10 transformation was performed to 
reduce the skewness of the data. To construct the mixed model, R package lme4 
(Bates, Maechler & Bolker, 2012) was used. The Maximum Llikelihood (ML) 
approach was used for parameter estimation. The Likelihood Ratio Test was used as a 
mean to attain p-values of the fixed effects, which compared models with full factors 
and reduced factors to determine the significance of a fixed effect.  
 
A generalized linear mixed model was used to fit the response accuracy data due to 
the data being non-normal. For the present data a binomial distribution with a logistic 
link was selected to construct the model, at the same time it was specified that the 
response accuracy could vary randomly across subjects. ML approach with Laplace 
approximation was used for parameter estimation. Group (HC versus PD ICD), time 
(T1/OFF versus T2/ON), instruction for Speed version of the task and coherence for 
Difficulty version of the task were assigned as fixed effects. Subject was assigned as a 
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random effect to account for by-subject variation in overall response accuracy. p<.05 
was used as a criterion for statistical significance. The Akaike information criterion 
(AIC), which estimates the relative quality of a statistical model given a specified data 
set, was used for model selection (Bozdogan, 1987). The relative quality of the model 
is indicated by the calculated information loss, therefore the model that has the 
minimised AIC would be chosen as the most fitted model given the specified dataset.  
 
 
Hierarchical Drift Diffusion Model 
The diffusion model has been widely used in investigating perceptual 
decision-making processes especially two-forced-choice tasks (Voss & Voss, 2007; 
Voss, Voss, & Lerche, 2015; Ratcliff, 1978; Ratcliff & McKoon, 2008). In the 
diffusion model, three variables were calculated and discussed: the boundary 
separation, the non-decision time and the drift rate. The boundary separation (a) 
represents the response threshold to reach a decision. Figure 2.3 illustrates the change 
of boundary separation in SAT. The longer the distance between the starting point and 
boundary separation, the longer the response time is and the longer it takes to make a 
decision, and fewer errors are likely to occur. Conversely, the shorter the distance 
between the starting point and the boundary separation, the faster a decision would be 
made, but the person is more likely to make errors. The decision-making process is 
defined as having three phases: perceptual processing (processing the stimulus) with a 
certain duration, decision phase with a certain duration and response phase with a 
certain duration. The non-decision time (t0) is defined as the sum of the perceptual 
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processing time plus the response time. Drift rate (v) represents the speed of the 
information accumulation process which begins from the starting point till one of the 
two decision boundaries is met. For the current experiment it represents the 
certainty/confidence to distinguish between noise and signal. A higher drift rate 
suggests a higher certainty/confidence to distinguish noise and signal and faster rate 
of information accumulation, which should be the case on easier higher coherence 
trials; whereas a lower drift rate at lower levels of coherence reflects a lower 
certainty/confidence to distinguish between noise and signal and to choose the 
direction of the moving dots on the harder trials and hence a slower rate of 
information accumulation.  
 
 
Figure 2.3 Simulated diffusion processes. The Left Panel: boundary separation 
changes with speed versus accuracy instructions. The Right Panel: drift rate varies 
with difficulty in stimulus discrimination and level of coherence. Figure from Ratcliff, 
R. and McKoon, G. (2008). 
 
 
To quantitatively fit the diffusion model to the behavioural data, a Python-based 
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hierarchical drift diffusion model (HDDM) toolbox (Wiecki et al., 2013) was used. 
HDDM uses hierarchical Bayesian parameter estimation methods for simultaneous 
estimation of subject parameters and the group distribution from which they are 
drawn, at the same time providing measures of uncertainty in the posterior 
distribution (Figure 2.4). In addition, HDDM requires less data per subject/condition 
than the non-hierarchical method, is able to deal with outliers and it allows for 
Bayesian data analysis. HDDM includes a regression model that allows estimation of 
trial-by-trial influences of a covariate onto model parameters. In the present study, 
HDDM was fitted to the behavioural data using the ‘HDDMRegressor’ function, 
which allows individual parameters to be described by a linear model specification. 
One of the benefits of estimating a model in a Bayesian framework is that significant 
testing can be directly performed on the posterior rather than relying on frequentist 
statistics. The Bayesian approach uses probability to quantify uncertainty and makes 
more precise probability statements about the state of the system by calculating the 
probability of a model given collected data (i.e. P(model | data)) (Puga, Krzywinski & 
Altman, 2015).  
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Figure 2.4 Basic graphical hierarchical model implemented by HDDM for 
estimation of the drift-diffusion model. Round nodes represent random variables. 
Shaded nodes represent observed data. Directed arrows from parents to children 
visualize that parameters of the child random variable are distributed according to its 
parents. Plates denote that multiple random variables with the same parents and 
children exist. The outer plate is over subjects while the inner plate is over trials. 
Figure from Wiecki, T., Sofer, I., and Frank, M. (2008). 
 
In addition, the HDDM uses Markov-Chain Monte Carlo (MCMC) to estimate the 
joint posterior distribution of all model parameters, which requires the chains of the 
model to have properly converged. When using the MCMC sampling, it is critical to 
examine the convergence of the model to make sure that the modelling is sampling 
from the actual posterior distribution. While there is no 100% fool-proof method to 
assess whether the chains are converged, one of the methods is to look at the traces of 
the posteriors. To visually examine the convergence of the model constructed for the 
study, the trace, the autocorrelation and the marginal posteriors were plotted. A 
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converged chain would have a stationary trace, low auto-correlation and normally 
distributed subject and group mean posteriors, while group variability posteriors are 
Gamma distributed. For brevity the figures examining the convergence of the created 
model were not shown here-please see Appendix A for the figures and the codes for 
creating the HDDMs. The models created in the present study seemed to be 
well-converged.  
 
2-4 Results 
Dopaminergic medication produced a significant improvement of the motor 
symptoms of PD, as reflected by a reduction of the UPDRS-III ratings (t(10)=8.39, 
p<.0001, paired sample Hedge’s g= 3.824; see Table 2.2).   
 
2-4.1 The analysis of data from the Speed/Accuracy version of the task 
Analysis of the Behavioural data for the Speed/Accuracy version of the task 
A LMM was used to analyse RTs of correct trials, which specified Group (HC/ PD 
ICD), Time (T1/OFF medication, T2/ON medication) and Type of instruction (Speed/ 
Accuracy) specified as the fixed effects and the subject specified as a random effect 
with Type as a random slope. In the LMM model contrast, all levels of the categorical 
variables are compared to the base level (reference category). Here the base levels are: 
HC (for Group), T1/OFF medication (for Time) and Accuracy (for Type). All effects 
are estimated with respect to the base levels.  
 
The model showed that all participants had faster RTs when Speed was emphasised 
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than when Accuracy was emphasised (t(9957)=-15.09, p<.0001, Hedge’s g=1.08). 
There was no difference on RTs for PD patients with ICD history ON versus OFF 
medication (t(9957)=-1.32, p=0.187) or for PD patients versus age-matched HCs 
(t(26)=0.15, p=0.881). RTs did not differ for age-matched HCs for the Time 1 versus 
Time 2 assessments (t(9957)=-0.66, p=0.527). No significant interactions were found. 
Figure 2.4 illustrates the results. Together the results suggest that (1) all participants 
adjusted responses with SAT, reflected as faster RTs when Speed was emphasized, (2) 
there was no effect of acute manipulation of dopaminergic medication on RTs for PD 
patients with ICD history and (3) PD patients with ICD history were able to perform 
the task as fast as age-matched HCs. 
 
 
Figure 2.5 Reaction time (s) for PD patients with ICD history tested ON versus 
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OFF medication and age-matched healthy controls (HCs) assessed twice (T1 versus 
T2) under Speed and Accuracy instructions. Error bars are the standard error of the 
means. The asterisk symbols denote statistically significant differences. T1=Time 1, 
T2= Time 2.  
 
 
A GLMM was used to analyse response accuracy, which specified Group (HC/ PD 
ICD), Time (T1/OFF medication, T2/ON medication) and Type of instruction (Speed/ 
Accuracy) specified as the fixed effects and the subject was specified as a random 
effect using binomial distribution. The model showed that all participants had higher 
response accuracy when Accuracy was emphasised than when Speed was emphasised 
(Z=-3.09, p=0.002, Hedge’s g= 0.72). There was no difference in response accuracy 
between PD patients with ICD history and age-matched HCs (Z=0.04, p=0.968). No 
difference was found in response accuracy between PD patients with ICD history ON 
versus OFF medication (Z=-0.01, p=0.990). Age-matched HCs performed equally 
accurately at Time 1 versus Time 2 (Z=-0.25, p=0.801). No interactions were found. 
Figure 2.5 illustrates the results. Taken together, the results suggest that (1) all 
participants modulated response accuracy according to SAT, reflecting a lower 
accuracy when Speed was emphasized, (2) there was no effect of acute manipulation 
of dopaminergic medication on response accuracy for PD patients with ICD history or 
repeated assessment for HCs and (3) PD patients with ICD history performed the task 
as accurately as age-matched HCs.  
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Figure 2.6 Response accuracy between PD patients with ICD history (ON versus 
OFF medication) and age-matched healthy controls (HCs) (T1 versus T2) under 
Speed and Accuracy instructions. Standard error means are presented as the error bars. 
The asterisk symbols denote statistically significant difference. T1=Time 1, T2= Time 
2. 
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Hierarchical drift diffusion model (HDDM) fitted to the behavioural data of the 
Speed-Accuracy trade-off (SAT) version of the task 
The above results show that Speed and Accuracy instructions had a strong impact on 
RTs and response accuracy for both PD patients with ICD history and age-matched 
HCs. However, no acute effect of dopaminergic medication was found on the 
behavioural data and no difference was found between PD patients and HCs.  
 
To investigate how experimental manipulations affect the underlying mental 
processes of moving dots tasks, the HDDM was used to fit the behavioural data. In 
the HDDM, the posterior distributions of three model parameters (i.e. the boundary 
separation, the non-decision time and the drift rate) were estimated as a function of 
task manipulations and their interactions. In the SAT version of the task, drift rate was 
considered to be unaffected by the Speed/Accuracy instructions because it was 
hypothesised that the drift rate was mainly associated with the quality of sensory 
evidence provided (e.g. coherence level, as manipulated in the Difficulty version of 
the task discussed in later sections). Three main factors were considered for 
behavioural switching in the model: Type of Instruction (Speed/ Accuracy), Time (T1 
(OFF medication)/ T2(ON medication)), and Group (HC/ PD ICD). Here an HDDM 
was constructed assuming that the boundary separation (a) and non-decision time (t), 
would be affected by all three factors, whereas drift rate (v) would be affected by 
factors Time and Group. As noted above, the boundary separation determines when to 
make responses, whereas non-decision time represents the time for non-decision 
processes such as stimulus encoding and response execution, and drift rate indicates 
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the rate of information accumulation among participants. The effects of factors are 
expressed relative to the intercept conditions. The base levels for the categorical 
variables are HCs (for Group), T1/OFF medication (for Time) and Accuracy (for 
Type).  
 
The main three goals of the SAT version of the task were to determine (1) whether the 
boundary separation for Speed instruction is lower than for Accuracy instruction that 
leads to faster but error-prone decisions, (2) whether the acute manipulation of 
dopaminergic medication would decrease the boundary separation for PD patients 
with ICD history (particularly when Speed was emphasized) and (3) whether the 
boundary separation for PD patients with ICD history is lower than for HCs. The 
HDDM showed that all participants had lower boundary separation when Speed was 
emphasised than when Accuracy was emphasised as most of the regression 
coefficients were smaller than zero. No difference on boundary separation was found 
between T1/OFF medication and T2/ON medication as the regression coefficient 
overlaps with zero. In addition, for all participants the effect of Speed instruction on 
decreasing boundary separation was enhanced during Time 2 as most of the 
regression coefficients were smaller than zero. There was no difference in boundary 
separation between PD patients with ICD history and age-matched HCs, as the 
regression coefficient overlaps with zero. Moreover, the HDDM showed a trend that 
PD patients with ICD history had lower drift rate than age-matched HCs as the 
regression coefficient is mostly smaller than zero, which suggests that PD patients 
with ICD history had a tendency to have lower drift rate when during information 
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accumulation. No significant interactions were found. The details of the created 
HDDM were presented in Appendix A.  
 
Taken together, the results showed that (1) all participants had lower boundary 
separations when Speed was emphasised than when Accuracy was emphasised, (2) 
the acute manipulation of dopaminergic medication did not produce negative effect on 
boundary separation modulation for PD patients with ICD history, (3) PD patients and 
age-matched HCs did not differ in boundary separation modulation during 
Speed/Accuracy trade-off.  
 
2-4.2 The analysis of data from the Difficulty version of the task 
Analysis of the Behavioural data from the Difficulty version of the task 
In the present section data from the Difficulty version of the task were analysed and 
presented. A LMM was used for analysing the RTs, with Group (HC/ PD ICD), Time 
(T1/OFF, T2/ON) and coherence Level (5%, 10%, 15%, 25%, 35% and 50%) 
specified as the fixed effect and the subject was specified as a random effect with 
Coherence as a random slope (Figure 2.11). The base levels of the categorical 
variables are HC (for Group), 5% (for Level) and T1/OFF medication (for Time). All 
levels of a factor are compared to the base level. All effects are estimated with respect 
to the base levels.  
 
The model showed that RTs were significantly decreased as coherence level increased 
(10%: t(5373)=-3.67, p<.0001, Hedge’s g=; 15%: t(5373)=-5.53, p<.0001, Hedge’s 
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g=; 25%: t(5373)=-12.33, p<.0001; Hedge’s g=, 35%: t(5373)=-14.22, p<.0001, 
Hedge’s g=; 50%: t(5373)=-15.70, p<.0001, Hedge’s g=). There was no difference in 
RTs for PD patients with ICD history ON versus OFF medication (t(5373)=-0.82, 
p=0.413). In addition, there was no difference in RTs between PD patients with ICD 
history and age-matched HCs (t(34)=0.01, p=0.990). No significant interaction was 
found. Figure 2.7 illustrates the results. Together the results suggest that (1) all 
participants responded equally well to different coherence levels, reflected as faster 
RTs during high coherence trials, (2) the acute manipulation of dopaminergic 
medication did not have any effect on RTs for PD patients with ICD history, and (3) 
PD patients were able to perform the task as fast as age-matched HCs. 
 
 
Figure 2.7 Reaction times in seconds (s) for PD patients with ICD history (ON 
versus OFF medication) and age-matched healthy controls (HCs) (T1 versus T2) 
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under different coherence levels of the moving dots. The error bars are standard error 
of the mean. The asterisk symbols denote significant differences as a function of level 
of coherence. T1=Time 1, T2= Time 2. 
 
A GLMM was used for analysing response accuracy, with Group (HC/ PD ICD), 
Time (T1/OFF, T2/ON) and Level (5%/ 10%/ 15%/ 25%/ 35%/ 50%) specified as the 
fixed effect and the subject was specified as a random effect with Coherence as a 
random slope. The base levels of the categorical variables are HC (for Group), 5% 
(for Level) and T1/OFF medication (for Time). All levels of a factor are compared to 
the base level. All effects are estimated with respect to the base levels. The model 
showed that response accuracy was significantly increased as coherence level 
increased (10%: Z=3.80, p<.0001, Hedge’s g=0.41; 15%: Z=6.48, p<.0001, Hedge’s 
g=0.56; 25%: Z=6.16, p<.0001; Hedge’s g=0.64, 35%: Z=-5.88, p<.0001, Hedge’s 
g=0.89; 50%: Z=5.89, p<.0001, Hedge’s g=1.04). There was no difference in 
response accuracy for PD patients with ICD history ON versus OFF medication 
(Z=-1.49, p=0.136). In addition, there was no difference in response accuracy 
between PD patients with ICD history and age-matched HCs (Z=-0.23, p=0.819). No 
significant interactions were found. Figure 2.8 illustrates the results of the model. 
Together the results suggest that (1) all participants responded equally well to the 
coherence levels, reflected as higher response accuracy during high coherence level 
trials, (2) the acute manipulation of dopaminergic medication did not have any effect 
on response accuracy for PD patients with ICD history, and (3) PD patients were able 
to perform the task as well as age-matched HCs. 
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Figure 2.8 Response accuracy for PD patients with ICD history (ON versus OFF 
medication) and age-matched healthy controls (HCs) (T1 versus T2) under different 
coherence levels of the moving dots. The error bars are standard error of the mean. 
The asterisk symbols denote significant differences. T1=Time 1, T2= Time 2. 
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Hierarchical drift diffusion model fitted to the behavioural data of the Difficulty 
version of the task 
As previously introduced, in the HDDM, three model parameters: the boundary 
separation (a), the non-decision time (t) and the drift rate (v) were estimated under the 
effects and the interactions of experimental manipulations. In the Difficulty version of 
the task, drift rate was considered to be associated with the ability of extracting 
sensory information in guiding perceptual decision-making. Such an ability is 
hypothesised to be associated with the quality of sensory information (i.e. Coherence 
levels). In addition, boundary separation and non-decision time were considered 
unaffected by the Coherence level because it was hypothesised that both factors are 
mainly associated with the Speed/Accuracy trade-offs (as manipulated in the SAT 
version of the task discussed in the previous section).  
 
Here the main three goals of the Difficulty version of the task were to assess (1) how 
decisions conflict/level of task difficult/coherence affects sensory evidence 
accumulation - i.e. if drift rate would be higher when the coherence levels were higher, 
leading to more accurate and faster RTs, (2) how drift rate differs between PD patients 
with ICD history when ON versus OFF medication, and (3) how drift rate differs 
between PD patients with ICD history and age-matched HCs. Three main factors were 
considered in the model: Level (as in coherence levels) (10%/ 15%/ 25%/ 35%/ 50%), 
Time (T1/ T2), and Group (PD ICD/ HC). Here an HDDM was constructed assuming 
that the boundary separation (a) and non-decision time (t), of which the former 
determines when to make responses whereas the later represents time for non-decision 
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processes such as stimulus encoding and response execution, would be affected by 
factors Time and Group, whereas drift rate (v) was considered to be affected by all 
factors.  
 
The model shows that all participants had higher drift rate when coherence level was 
high as the regression coefficient was larger than zero. There was no difference in 
drift rate between PD patients with ICD history and HCs as the regression coefficient 
overlaps with zero. For all participants, boundary separation was lower during Time 2 
than Time 1 as most of the regression coefficients were smaller than zero. There was 
no difference in boundary separation between PD patients with ICD history and 
age-matched HCs as the regression coefficient overlaps with zero. In addition, for all 
participants non-decision time was higher during Time 2 than Time 1 as most of the 
regression coefficient were larger than zero. There was no difference in non-decision 
time between PD patients with ICD history and age-matched HCs as the regression 
coefficient overlaps with zero. The details of the created HDDM were presented in 
Appendix A. Table 2.2 summarises the findings of the study. 
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Table 2.2 The main findings of the effect of speed-accuracy instructions and task 
difficulty on the different variables of the moving dots task  
 Speed/Accuracy version of 
the task 
Difficulty version of the task 
Behavioural 
data (RTs, 
Response 
Accuracy) 
¾ All participants had faster 
RTs and lower response 
accuracy when Speed was 
emphasized. 
¾ The acute manipulation of 
dopaminergic medication 
had no effects on the 
behavioural data. 
¾ There was no difference 
between PD patients with 
ICD history and 
age-matched HCs.  
¾  All participants had faster RTs 
and higher response accuracy 
when coherence level was high.  
¾ The acute manipulation of 
dopaminergic medication had no 
effects on the behavioural data. 
¾ There was no difference between 
PD patients with ICD history 
and age-matched HCs. 
Parameters 
derived 
from the 
HDDMs 
(boundary 
separation, 
drift rate 
and 
non-decision 
time) 
¾ For all participants, 
boundary separation was 
lower when Speed was 
emphasized than when 
Accuracy was 
emphasized. 
¾ For all participants, 
non-decision time was 
lower when Speed was 
emphasized than when 
Accuracy was 
emphasized.  
¾ PD patients with ICD 
history had a tendency to 
have lower drift rate than 
age-matched HCs. 
¾ For all participants, boundary 
separation was lower during 
T2/ON medication than T1/OFF 
medication. 
¾ For all participants, non-decision 
time was higher during T2/ON 
medication than T1/OFF 
medication. 
¾ For all participants, drift rate 
was higher during T2/ON 
medication and when coherence 
levels were high.  
RTs= reaction times, HDDM= hierarchical drift diffusion model, T2= Time 2, HCs= healthy controls 
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Correlational analysis with levodopa-equivalent dose and Power analysis 
Because of the relatively small number of participants (n=11 for PD ICDs; n=14 for 
HCs), a power analysis was performed on the findings between PD patients ON 
versus OFF medication, and between PD patients and age-matched HCs. For 
behavioural comparison between PD patients ON versus OFF medication, the effect 
sizes were all below 0.05 (Hedge’s g <0.05), and the statistical power equates to 0.05. 
To increase the power up to 0.95, more than 10000 participants would be needed for 
each group, which suggests that the non-significant results between PD patients with 
ICD history ON versus OFF medication are reliable. Moreover, for behavioural data 
compared between PD patients with ICD history and HCs, the effect sizes were all 
below 0.05 (Hedge’s g <0.05), and the statistical power equates to 0.05. To increase 
the power up to 0.95, at least 10375 participants would be needed for each group, the 
analysis thus suggests that the non-significant results between PD patients with ICD 
history and age-matched HCs are reliable. In addition, seven of the PD ICD patients 
were on dopamine agonists in addition to levodopa. As expected, the levodopa 
equivalent daily dose was significantly higher in those who took both dopamine 
agonists and levodopa compared to those who took levodopa only (t(9)=-3.97, 
p=.003). However, when the results of the patients with or without additional 
dopamine agonist medication were analyzed, there were no differences on any of the 
behavioural measures.  The correlation of the levodopa equivalent daily dose was 
examined for each patient with the RT measures.  None of these correlations were of 
notable magnitude or significant.  
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2-5 Discussion  
Behaviourally, the results showed that when under Speed instruction, all participants 
had lower response accuracy and faster RTs, which suggest that all participants 
demonstrated SAT when making perceptual decisions. On the other hand, when 
coherence level was high, participants had faster RTs and better response accuracy, 
indicating that extent of task difficulty/decision conflict (i.e. the quality of the sensory 
information) plays an important role in guiding behaviours. These significant effects 
of task manipulation indicated that the two versions of the task were reliable in 
assessing the mental processes of SAT modulation and information accumulation 
across the two groups, and that all participants had been able to follow the instructions. 
Moreover, for the SAT version of the task all participants had faster RTs (< 500 ms), 
whereas for the Difficulty version of the task even for the same dots coherence (50%), 
RTs were slower (> 500 ms). This could reflect as the task-induced context for 
performing the two tasks: as the SAT version of the task introduced the speed pressure 
when making responses, participants would hold the information in mind therefore 
overall the RTs were faster in the STA version task than the Difficulty version of the 
task (without the demand to make faster responses). Contrary to predictions, no acute 
effect of medication was found on task performance for PD patients with ICD history. 
Surprisingly, no difference was found between PD patients with ICD history and 
age-matched HCs.  
 
Potential reasons for the contrary-to-prediction results 
Despite the fact that sample size was relatively small in the present study, power 
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analysis has shown that the non-significant behavioural results were reliable. A few 
reasons may contribute to the non-significant results of the present study: firstly, 
despite the significant effects of task manipulations such as coherence and SAT 
instructions, the tasks selected may have a ceiling effect. As the behavioural data 
shown, the response accuracy for all participants were more than 50% even for the 
difficult trails, and for the SAT version of the task both groups had a response 
accuracy as high as more than 95%, suggesting that the task may not be challenging 
enough to reflect the effects of medication, as well as the difference between patient 
group and age-matched healthy control group. Secondly, in the current study the 
recruited PD ICD patients did not have active ICD symptoms. Due to difficulties in 
recruiting for PD patients with active ICD symptoms, we recruited PD patients with 
ICD history instead. Reducing or withdrawing dopamine agonist intake, which is a 
common clinical treatment for PD ICD, may have contributed to the non-significant 
effect of the medication in the present study. PD patients recruited for the study had 
received adjustment on their medication to treat ICDs, therefore their current 
medication treatments may be unlikely to induce side effects on EFs. Although a 
study has demonstrated that treated PD patients without clinically apparent ICDs still 
exhibited impairments in subjectively accumulating sufficient information when 
making decisions in a beads task (Djamshidian et al., 2012), in the present study we 
did not find difference on task performance between the two groups. Thirdly, due to 
practical reasons, PD ICD patients were assessed first then ON medication. Such an 
experimental design prevented the separation between medication effects and practice 
effects. Results from the HDDMs revealed some effects of Time (practice) on 
 152 
 
boundary separation, drift rate and non-decision time even though there was no 
difference between T1/OFF medication and T2/ON medication on the behavioural 
data (RTs and response accuracy). The results thus indicate that practice effects 
influence the underlying mental processes when making performing the moving dots 
tasks. Future studies attempt to examine the medication effects should introduce a 
counter-balanced task design. Fourthly, the present study is consistent with previous 
studies showing that PD patients with active ICDs did not show deficits in tasks that 
manipulate decision conflict such as the Simon task (Wylie et al., 2012) and the 
Stroop interference task (Djamshidian et al., 2011). Fifthly, the moving dots paradigm 
has been proposed to be related to motor inhibition (Eagle, Bari, & Robbins, 2008; 
Djamshidian et al., 2014; Sharma, Markon, & Clark, 2014), the present results are 
consistent with previous studies in showing that PD patients with active ICD 
symptoms/ICD history have no deficits on motor inhibition (Claassen et al., 2015; 
Leroi et al., 2013). In spite of the negative results, the present study could be further 
discussed in two ways: (1) from the dopamine medication point of view and (2) from 
PD patients who developed ICDs point of view.  
 
Dopamine overdose hypothesis 
In the present study, the acute manipulation of dopamine medication did not produce 
any effects (neither negative nor positive effects) on task performance, which may 
result from the ceiling effect of the tasks being not challenging enough to reflect any 
difference (i.e. response accuracy higher than 95% for both groups). However, a 
pervious study using the exact same task procedure has found a significant negative 
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effect of medication on overall response accuracy in PD patients without ICD history 
compared to age-matched HCs (Huang et al., 2015). Such an inconsistent result may 
be due to (1) individual variance on task performance, (2) different statistical analysis 
methods, and (3) PD patients with ICD history (average age: 59.91) were younger 
compared to those who did not have ICD history recruited in previous study (average 
age: 61.62; Huang et al., 2015). In addition to the ceiling effect, the results may 
suggest that the moving dots tasks are suboptimal in examining dopamine overdose 
hypothesis. As discussed previously, PD patients treated with dopamine medication 
may show deficits on reversal learning (Cools et al, 2001), conditional associative 
learning (Gotham et al, 1988), complex discrimination learning (Swainson et al, 
2000), probabilistic classification learning (Jahanshahi et al 2010), learning from 
negative feedback, and fail to make profitable decisions on certain gambling or 
decision-making tasks (Frank et al., 2007; Djamshidian et al., 2010; Mimura et al., 
2006; Pagonabarraga et al., 2007; Euteneuer et al., 2009). All of the above tasks 
consist of the element of learning, which involves more complex processes than the 
basic EFs. The role of dopamine and reinforcement learning have been 
well-established (Hollerman & Schultz, 1998; Holroyd & Coles, 2002; Montague, 
Dayan, & Sejnowski, 1996). As discussed in Chapter 1, the neural mechanisms of 
dopamine release can be viewed as the expression of two dopamine subgroups of 
receptors: D1 and D2. The D1 receptor is predominately expressed in the direct ‘Go’ 
pathway that promotes the repeat of an action and favoured outcomes, whereas the D2 
group is mainly expressed in the indirect ‘No Go’ pathway, which supresses an action 
to avoid negative outcomes (Keefe & Gerfen, 1995; Gerfen, 2000; Frank, 2005). The 
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dopamine over dose hypothesis is also supported by computational models (Frank, 
2005) and dopamine synthesis studies using animal models (Sawaguchi, Matsumura, 
& Kutoba, 1990; Wang & Goldman-Rakic, 2004; Williams & Goldman-Rakic, 1995; 
Seamans, Durstewitz, Christie, Stevens, & Sejnowski, 2001). In addition, a 
pharmacological study in healthy human subjects has shown that participants with 
high baseline striatal dopamine synthesis would be overstimulated by D2 receptor 
agonist, leading to impaired reversal leaning performance when being on drug (Cools 
et al., 2009). Moreover, D2 receptors have been suggested to be more abundant in the 
basal ganglia, which supports the hypothesis that the basal ganglia may serve as a 
dynamic gating mechanism for updating working memory in the frontal cortex (Frank, 
Loughry, & O’Reilly, 2001).  
 
Furthermore, impulsivity and impaired reward processing have also been associated 
with dopamine overdose hypothesis (Robert et al., 2009; Wiecki & Frank, 2010), of 
which the present study did not investigate. The development of ICD in PD patients 
has been suggested to be closely associated with pharmacological treatment (Molina 
et al., 2010; Dodd et al., 2005). In addition, studies have shown that PD patients ON 
medication showed deficits when performing gambling tasks (Shohamy et al., 2006; 
Perretta, Pari, & Beninger, 2005; Pagonabarraga et al., 2007; Kobayakawa, Koyama, 
Mimura, & Kawamura, 2008; Sáez-Francàs et al., 2014, 2016; Mapelli, Rosa, 
Cavalletti, Schiff, & Tamburin, 2014; Xi et al., 2015; Kobayakawa, Tsuruya, & 
Kawamura, 2010; Evens, Hoefler, Biber, & Lueken, 2016). The impairment of PD on 
the performance of gambling tasks is often reflected as impulsive choices that lead to 
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large losses. Furthermore, it has been shown that PD patients treated with 
dopaminergic medication, especially dopaminergic agonists, increases risk of 
developing ICDs (Voon & Fox, 2007; Wu, Politis & Piccini, 2009; Weintraub et al., 
2015). Dopamine-receptor binding profiles may provide a neurobiological 
explanation for the association between dopamine agonist treatment and ICDs. It has 
been shown that 93 % of the prescribed dopamine agonists that were associated with 
ICDs were relatively selective for the dopamine D3 receptors (Dodd et al., 2005). D3 
receptors are proposed to be abundant in the ventral striatum (Gurevich & Joyce, 
1999), which is also a brain region that is associated with the hedonic response to 
amphetamine, addictions and impulsivity (Drevets et al., 2001; Lee et al., 2009). 
Taken from the above studies, future studies investigating the effect of dopaminergic 
medication in PD patients with ICDs should focus on the relationships between 
dopamine, learning and impulsivity, which involve prospect of reward sensitivity, and 
the related neural mechanisms. 
 
PD patients with ICD 
In addition to behavioural results, psychological measures such as the random number 
task and MMSE have revealed no difference between PD patient group and 
age-matched HC group. Moreover, scores from the UPDRS-III tested ON versus OFF 
medication showed that dopamine medication significantly improves motor 
symptoms in PD patients. Together these results may suggest that (1) long term 
reducing/withdrawing from dopamine agonists does not induce negative effects on 
cognitive function in PD patients with ICDs, and (2) motor improvement induced by 
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medication did not sacrifice after medication adjustment. Although PD patients 
showed significantly higher scores in BDI-II, suggesting that patients had mild 
depression compared to age-matched HCs, such an observation may be related to the 
disease itself instead of the pure effects of dopamine medication. The relationships 
between depression and PD have been extensively discussed in other studies 
(Cummings, 1992; Reijnders, Ehrt, Weber, Aarsland, & Leentjens, 2008; Aarsland, 
Pahlhagen, Ballard, Ehrt, & Svenningsson, 2012).  
 
In recent years, more awareness has been made on the risk of PD patients developing 
ICDs that may lead to devastating consequences such as financial loss, divorce, career 
crisis, and increased health risk (Weintraub et al., 2015). Moreover, ICDs are 
associated with low quality of life (Phu et al., 2014), increased caregiver burden 
(Leroi, McDonald, Pantula, & Harbishettar, 2012) and greater functional impairment 
(Voon et al., 2011). It has been suggested that up to 25% of PD patients treated with 
minimally therapeutic dosage of dopamine agonist may experience an ICD (Hassan et 
al., 2011; Weintraub et al., 2015). The DOMINION study reported a prevalence of 
17.1% in treated PD patients that received dopamine agonist treatment, whereas a 
prevalence of 6.9% was found in PD patients who did not receive dopamine agonist 
treatment (Weintraub et al., 2010). In the review that discussed chronic dopaminergic 
stimulation in PD patients on inducing motor and behavioural side-effects, Voon et al 
(2009) suggested that chronic dopaminergic medication (both levodopa and 
dopaminergic agonists) seems to alter presynaptic dopamine transmission that leads to 
both levodopa-induced dyskinesias and ICDs. In addition to dopamine medication, 
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factors such as personal or family history of alcoholism or gambling; younger age; 
impulsive or novelty-seeking traits; gender (male for hypersexuality, female for binge 
eating and pathological shopping); early onset of PD; being unmarried; depressive 
symptoms, and past or current cigarette smoking can all be associated with the 
development of ICDs in PD (Voon & Fox, 2007; Weintraub et al., 2010; Joutsa, 
Martikainen, Vahlberg, Voon, & Kaasinen, 2012; Weintraub et al., 2015). The 
association of ICDs with other risk factors may suggest the involvement of a 
complicated network in human impulsivity and compulsivity.  
 
In addition, studies have shown that PD patients with and without ICDs showed 
different behavioural patterns in decision-making even after PD patients with ICDs 
are treated, which may suggest that PD patients who are at risk of developing ICDs 
show difference on certain functions that could be predictable prior to medication 
administration (Djamshidian et al., 2010; Djamshidian et al., 2012). While all PD 
patients showed impairments on updating information before making a decision, PD 
patients without ICDs showed a behavioural pattern similar to pathological gamblers, 
whereas PD patients with ICDs exhibited a pattern resembling more to substance 
users (Djamshidian et al., 2012). In addition, PD patients with behavioural addictions 
are impaired in generating useful beliefs that would predict future outcomes with the 
accumulated information (Averbeck et al., 2013). The studies are in consistent with 
the hypothesis that PD patients with ICDs are less able to update stimulus value 
through negative prediction errors in reinforcement learning models (Voon et al., 
2010b; Piray et al., 2014). Conversely, PD patients without ICDs performed worse on 
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working memory tests (Djamshidian et al., 2012) Moreover, it has also been shown 
that PD patients are unable to combine previously learned information with current 
sensory information to guide behaviours (Perugini, Ditterich & Basso, 2016; Herz, 
Bogacz & Brown, 2016). These studies thus suggest that PD patients with and without 
ICDs show different behavioural patterns that may provide certain insights on 
predicting those who are prone to develop ICDs. 
 
Summary 
In terms of the clinical implications of these results for the management of ICDs, the 
present study showed that long term withdrawal/reducing dopamine agonists (due to 
the fact that the patients recruited were not actively showing ICD symptoms) did not 
induce impairments on cognition and motor functions when performing a moving dots 
task in PD. Future studies investigating the effects of dopaminergic medication on 
inducing impulsivity in PD patients with ICDs should focus on the relationships 
between dopamine and reward sensitivity. On the other hand, despite the present 
results showed no significant difference when directly comparing task performance 
between PD patients with ICD history and age-matched HCs, studies have suggested 
that PD patients with and without ICDs may be distinguishable by using classification 
predictive modelling on certain task performance patterns, therefore my next study 
would be building predictive models to investigate such hypothesis.  
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Chapter 3 Using the performance on a moving dots task to classify the 
membership between PD patients with and without impulse control disorders 
(ICDs) within a machine-learning framework  
3-1 Abstract 
Following previous results, it is hypothesised that behavioural data from moving dots 
tasks may be used to build classification predictive models to distinguish PD patients 
with impulse control disorders (ICDs) from PD patients without ICDs. Such an 
approach may potentially help finding a tool to predict vulnerability to develop 
impulsivity in PD patients. The present study attempted to use the behavioural 
performance on two types of moving dots tasks, one of which manipulated different 
instructions (i.e. Speed and Accuracy) with constant coherence level, whereas the 
other one manipulated task difficulty (i.e. 5% dots coherence), as one of the input 
factors to predict the membership between PD patients who developed impulse 
control disorders (ICDs) and PD patients who did not develop the ICDs. Machine 
learning algorithms were used to find patterns and make predictive models given the 
input variables. Models that produced the highest accuracy in making predictions on 
the membership would be selected for further validation. Factors such as reaction 
times (RTs) during incorrect trials, age when being assessed, age of PD onset and 
averaged levodopa daily dose were taken as input variables to train the predictive 
models. The results showed that the behavioural patterns, such as RTs of incorrect 
trials under Speed instruction and under 5% dots coherence, had high accuracy in 
correctly classifying membership between PD patients with and without ICDs, using a 
classification and regression tress algorithm. The present study thus supports that 
tasks require speed and accuracy trade-off modulation and/or sensory information 
integration may be suitable for screening for vulnerability to develop ICDs in PD 
patients.  
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3-2 Introduction 
Impulsive control disorders (ICDs) in patients with Parkinson’s disease (PD) have 
been recognised to be a psychiatric complication that would lead to devastating 
consequences not only for the patients but also the caregivers (Weintraub et al., 2015; 
Antonini et al., 2016).  
 
As discussed in previous chapter, ICDs involve “behaviours that are performed 
repetitively, excessively, and compulsively to an extent that interferes with major 
daily functioning” such as pathological gambling, shopping, binge eating, and 
hypersexuality (Grant, Schreiber, & Odlaug, 2011). PD patients developing ICDs may 
lead to devastating consequences such as financial loss, divorce, career crisis, and 
increased health risk (Weintraub et al., 2015). Moreover, ICDs are associated with 
low quality of life (Phu et al., 2014), increased caregiver burden (Leroi et al., 2012) 
and greater functional impairment (Voon et al., 2011). The onset of ICDs in PD 
patients had been closely associated with the use of dopamine agonist (Cools et al., 
2003; Voon et al., 2006; Voon & Fox, 2007, Voon et al., 2010; Weintraub et al., 2015; 
Antonini et al., 2016). It has been suggested that therapeutic dosage of dopamine 
agonist may be a risk factor in PD patients to develop ICDs (Weintraub et al., 2010; 
Hassan et al., 2011; Weintraub et al., 2015). While dopamine agonist is closely 
associated with the onset of ICDs in PD patients, recent studies have also suggested 
that deep brain stimulation (DBS) of the subthalamic nucleus (STN) might induce 
impulsivity in treated PD patients (Frank et al., 2007; Lu, Bharmal, & Suchowersky, 
2006; Smeding et al., 2007; Halbig et al., 2009; Moum et al., 2012). These studies 
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together suggest that treatments for PD, be it dopaminergic medication or DBS, could 
potentially induce the onset of ICDs. Therefore, it is important for preventive 
strategies to early identify risk factors before performing any treatments on PD 
patients to avoid the onset of ICDs (Halbig et al., 2009).  
 
Risk factors such as personal or family history of alcoholism or gambling; younger 
age; impulsive or novelty-seeking personality traits; gender (male for hypersexuality, 
female for binge eating and pathological shopping); early onset of PD; being 
unmarried; and past or current cigarette smoking have all been identified to be 
associated with the development of ICDs in PD (Voon & Fox, 2007; Weintraub et al., 
2010; Weintraub et al., 2015). It has been proposed that purely cognitive measures of 
executive functions can predict individual difference in clinically behaviours 
(Friedman et al., 2007; Friedman, Miyake, Robinson, & Hewitt, 2011; Young et al., 
2009). Following such hypothesis, it is possible that cognitive measures could be used 
to predict future behaviours, even predicting the likelihood of developing certain 
disorders. In line with the hypothesis, a study has shown that treated PD+ICD patients 
showed distinguishable task performance compared to PD patients without ICDs on a 
beads task (Djamshidian et al., 2012). The beads task assesses how much information 
participants would gather before making a decision, while both groups of PD patients 
sampled significantly less information, the researchers found that PD patients with 
ICDs showed behavioural patterns similar to substance users, whereas PD patients 
without ICDs showed behavioural patterns that were more closely resembled 
substance users (Djamshidian et al., 2012). In addition, an opposite interaction 
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between medication state and learning was found on PD patients with ICDs compared 
to PD patients without ICDs, which suggests that when being OFF medication, PD 
patients with ICDs showed decreased learning from negative feedback and increased 
learning from positive feedback (Djamshidian et al., 2011). These studies therefore 
indicate that PD patients with and without ICDs have distinguishable traits that could 
be identified. Moreover, previous studies have associated impaired perceptual 
decision-making processes to the development of impulsive behaviour in PD patients 
(Frank et al., 2007; Green et al., 2013; Djamshidian et al., 2012; Huang et al., 2015; 
Zaehle et al., 2017). Performance on the moving dots paradigm, which is considered 
to be a perceptual decision-making task, may thus be used as model inputs in building 
predictive models, leading to a potential screen tool for possible development of 
impulsive behaviours that could lead to the onset of ICDs for PD patients.  
 
The era of big data has arrived with recent rapid increase on the generation of digital 
data and rapid development of computer science that provides efficient methods to 
extract new insights from massive datasets (Lee & Yoon, 2017). In the healthcare area, 
predictive models have been used for diagnostic and prognostic tasks (Dreiseitl & 
Ohno-Machado, 2002; Martin et al., 2009; Rosenfeld & Breslow, 2008; Masood & 
Al-Jumaily, 2013). Data acquired from actual cases could be used to build these 
models with machine learning algorithms. Big data enable the identification of health 
intervention targets through the analysis of high volume and high variety datasets, and 
the refinement of the ensuing interventions using high velocity feedback mechanisms 
(Mooney, Westreich & El-Sayed, 2015). Machine learning is defined as a set of 
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methods that can automatically detect patterns in data, use the uncovered patterns to 
predict future data, or to perform decision-making under uncertainty (Murphy, 2014). 
Machine learning can be divided into three types: supervised, unsupervised and 
reinforcement learning.  
 
For the supervised learning approach, which is the most common type of machine 
learning, the goal is to use the algorithm to find the most optimal mapping function 
between a given input and output. Such a mapping function would be accurate in 
predicting future outputs. Supervised learning receives its name because the process 
of the algorithms learning from a training dataset can be thought of as a teacher 
supervising the learning process in which correct answers are known. Learning would 
stop when the algorithm reaches a certain degree of performance (i.e. accurately 
predicting the outputs). For example, the algorithm that could be used for Spam 
detection in current e-mail systems, certain characters (e.g. the word ‘discount’ or 
‘great offer’ in the subject title) of the e-mail would lead to being labelled as Spam 
and other characters such as the word ‘meeting’ may be labelled as important. There 
are correct answers when learning the patterns of the dataset in this example. 
Unsupervised learning, on the other hand, is referred to when there exist only input 
data but no corresponding outputs. Unlike supervised leaning, there are no correct 
answers and no supervision. The algorithms have to find the structure of the input 
data relying on their own computational ability. For example, an on-line 
recommendation system could categorize different groups of customers based on their 
purchasing behaviour (i.e. preference), clustering similar data and provide future 
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recommendations. There are no correct answers given in this situation. Lastly, the 
reinforcement learning approach takes into account how to maximise the accumulated 
reward in guiding the learning process. The machine using the reinforcement learning 
approach is allowed to learn the most optimal behaviour that maximises the reward 
based on feedback. In handling large amount of data, machine learning is therefore a 
powerful approach to find patterns and provide future predictions in guiding 
behaviours.  
 
The present study thus attempted to use performance of individual participants on two 
versions of a moving dots task to predict impulsivity in PD patients using algorithms 
from the field of machine learning for data classification. In addition, behavioural 
data from two versions of the moving dots were selected: speed and accuracy 
trade-off (SAT) version and the ‘Difficulty’ version. The former manipulated speed 
and accuracy instructions to motivate participants to make fast or accuracy responses 
whereas the later manipulated dots coherence to introduce task difficulty. Reaction 
times (RTs) of incorrect trials collected from the moving dots task were used to 
classify group membership between PD patients with (PD+ICD) and without ICD 
history (PD-ICD). To be more precise, six sets of data were selected as model inputs: 
RTs of incorrect trials under Speed instruction for PD patients ON medication and 
OFF medication, RTs of incorrect trials under Accuracy instruction for PD patients 
ON medication and OFF medication, and RTs of incorrect trials under 5% dots 
coherence ON medication and OFF medication. The data were selected based on the 
following hypotheses: PD patients with ICD history may show different behavioural 
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patterns compared to PD patients without ICD history when acting under (1) speed 
pressure, (2) the need to be accurate and (3) high decision conflict. Moreover, 
previous studies have demonstrated that medication state plays an important role in 
controlling behaviours in PD patients, therefore medication state has also been taken 
into account in selecting model inputs. In addition to the behavioural data, age when 
being assessed, PD onset age and averaged levodopa daily dose (LEDD) were also 
included in the model as input variables. 
 
3-3 Methods 
Dataset & programming language libraries 
The behavioural data were taken from thirteen PD-ICD (Huang et al, 2015) and 
eleven PD+ICD patients (Chapter 2) from previous studies. Demographic details of 
the patients are presented in Table 3.1. Python and SciPy platform were used for the 
classification of the data (Millman & Aivazis, 2011; Jones, Oliphant, & Peterson, 
2001). The data collected from the Speed and Accuracy trade-off (SAT) version and 
Difficulty version of the moving dots tasks were used as input variables. RTs during 
incorrect trials were used and separated between Speed instruction and Accuracy 
instruction. Behavioural data were also compared for different medication states. The 
aim of the study is to identify the difference between PD+ICD group and PD-ICD 
group when making decisions under SAT and when decision conflict was presented, 
during ON medication state and OFF medication state. Moreover, using the identified 
behavioural parameter to predict future possibility of PD patients developing ICDs. 
The python codes for performing data classification were modified from Brownlee 
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(2016) (Please see Appendix for the codes and outputs). The SAT version of the 
moving dots task consisted of 100 trials, which asked participants to make perceptual 
decisions on the direction (left or right) of a cloud of moving dots based on 
instructions given before the appearance of sensory stimuli. Coherence of the moving 
dots was fixed at a constant 50% level. The instructions either emphasised Speed (i.e. 
Fast) or Accuracy (i.e. Accurate). Participants were instructed to make response in 
accordance to the given instruction. On the other hand, for the Difficulty version of 
the task, dots coherence was manipulated to vary from 5%, 10% 15%, 25%, 35% and 
50%. There were no Speed or Accuracy instructions presented before each trial for 
this version of the task. RTs of incorrect trials of the 5% dots coherence were selected 
as model inputs due to the hypothesis that PD patients with ICD may show impaired 
EFs associated with updating information under high decision conflict. For the details 
of the moving dots task please refer to previous chapters.  
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Table 3.1 Demographic details of PD-ICD and PD+ICD patients.  
 Gender Age when 
being assessed 
Age of PD 
onset 
LEDD 
(Levodopa 
Daily 
Dose) 
 Gender Age when 
being 
assessed 
Age of PD 
onset 
LEDD 
(Levodopa 
Daily 
Dose) 
PD-ICD 01 m 71 64 600 PD+ICD 01 m 54 50 300 
PD-ICD 02 m 69 69 900 PD+ICD 02 m 58 50 600 
PD-ICD 03 m 67 60 500 PD+ICD 03 m 70 57 700 
PD-ICD 04 f 42 37 850 PD+ICD 04 m 56 47 800 
PD-ICD 05 f 60 50 1431 PD+ICD 05 f 57 54 825 
PD-ICD 06 m 86 83 300 PD+ICD 06 m 60 52 880 
PD-ICD 07 f 68 51 810 PD+ICD 07 m 57 35 960 
PD-ICD 08 m 52 45 1530 PD+ICD 08 f 45 38 1000 
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PD-ICD 09 f 43 38 910 PD+ICD 09 f 67 65 1390 
PD-ICD 10 m 67 55 980 PD+ICD 10 m 70 62 1400 
PD-ICD 11 f 58 48 650 PD+ICD 11 m 65 60 1600 
PD-ICD 12 m 77 75 600      
PD-ICD 13 m 41 32 750      
Mean (SD)  61.62 (13.96) 54.38 (15.31) 831.62  
(344.02) 
Mean (SD)  59.91 (7.57) 51.82 (9.3
8) 
950.45  
(383.63) 
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Data Classification  
The supervised machine learning approach can be further categorised into regression and 
classification. The main goal of the regression approach is to predict a continuous numerical 
variable, whereas the aim of the classification approach is to identify to which category an 
object belongs. Here in the present study a classification approach was used to identify 
different groups of PD patients (i.e. PD+ICD and PD-ICD) based on age when being assessed, 
PD onset age, mean LEDD and RTs on incorrect trials of the moving dots task. The aim of 
classifying data is to decide the class membership (y') of an unknown input (x') based on a 
dataset consists of data items xi with known class membership yi. The input variables are 
often multi-dimensional vectors. There are two different approaches for data classification: 
the first considers only the distinction between the two classes and labels either 1 or 0 to an 
unknown input variable; the second approach models the probabilistic posterior distribution 
P(y|x), which not only provides a class label for each input variable but also a probability of 
class membership (Dreiseitl & Ohno-Machad, 2002). Due to small sample sizes in the studies, 
the RTs of incorrect trials were seen as indepent examples for each class. There are only 4 
attributes and less than 400 rows, suggesting that the data set is small and relatively simple. 
The aim of the study is to examine the hypothesis of whenther it is possible to use 
behavioural data as predictors in making predictions, it is not the main focus to find the best 
algorithm in fitting all types of data, therefore the models are created using the simplest 
techniques.  
 
Six different algorithms including logistic regression (LR), linear discriminant analysis 
(LDR), K-nearest neighbors (KNN), classification and regression tress (CART), Gaussian 
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naive Bayes (NB) and support vector machines (SVM) were evaluated to select the model 
with best performance (Bishop, 2006; Browlee, 2016). Among the six algorithms logistic 
regression and linear discriminant analysis are linear algorithms and the other four are 
non-linear. The results were directly comparable because the models created using the six 
algorithms used the exact same data splits during elevation. Models with the highest accuracy 
score were selected. Two methods were used to test the accuracy of the selected models: the 
hold-out method and cross validation. The hold-out method splits the data into two groups: 
training set is used to train the classifier whereas the test set is used to estimate the error rate 
of the trained claddifier. The amount of data required for building predictive models depends 
on many factors such as the complexity of questions of interest and the complexity of the 
learning algorithm and is thus unknowable (Brownlee, 2017). The present study used 70% of 
the dataset as the training set and 30% of it as the testing set (Gholami, Chau, Fadaee, 
Torkaman, & Ghaffari, 2015). In addition, K-fold cross validation (conventionally K=10) 
was also used to estimate accuracy of the model. The validation dataset was to prevent errors 
during the training processes such as overfitting to the training set or a data leak, which 
would negatively affect the accuracy of the model.  
 
Logistic Regression (LR) 
Logistic regression, borrowed from the field of statistics by machine learning, uses the 
logistic function (also referred to as Sigmoid function), which is the inverse form of the logit 
function, to solve linear and binary classification problems. Despite the name, logistic 
regression is a model for classification rather than regression (Raschka, 2015). In general, a 
logistic regression model predicts the probability of certain samples belonging to one of the 
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two categories (labelled with value 1 in the model) in the data set:  
𝑃(1|𝑥, 𝛼)  =  
1
1 + 𝑒−(𝛼∙𝑥)
 
, where x represents the data items and α represents the parameter vector. The probability for 
the other class (labelled with value 0) would thus be calculated as P(0| x, α) = 1- P(1| x, α) 
(Dreiseitl & Ohno-Machado, 2002). Figure 3.1 illustrates the general concept of logistic 
regression: the algorithm receives the inputs of a sample X and combined with the weights W 
to compute the net input, which would be passed onto the activation function (here the 
sigmoid function) for the prediction of class membership (Raschka, 2015).  
 
  
Figure 3.1 The general concept of logistic regression. The output produced by the 
sigmoid function is interpreted as the probability of certain sample belonging to one of the 
two classes, given the features parameterized by the weights. The predicted probability is 
converter into a binary outcome via a quantizer. Figure from Raschka, (2015). 
 
Linear Discriminant Analysis (LDA) 
Linear discriminant analysis (LDA) was proposed by R. Fischer in 1936, which consists in 
finding the projection hyperplane that minimizes the interclass variance and maximized the 
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distance between the projected means of the classes (Xanthopoulos, Pardalos & Trafalis, 
2013). The general concept behind the LDA is to find the feature subspace that optimizes 
class separability (Raschka, 2015). One assumption in the LDA is that the data is normally 
distributed, in addition, it is assumed that the classes have identical covariance matrices and 
that the features are statistically independent of each other. However, in dimensionality 
reducntion and classification tasks, LDA may still work reasonally well even if the above 
assumptions are violated (Duda, Hart, & Stork, 2012). Figure 3.2 illustrates the concept of 
LDA for a two-class data classification. 
  
Figure 3.2 The concept of linear discriminant analysis (LDA) for a two-class data 
classification. Samples from class 1 are shown as crosses whereas samples from class 2 are 
shown as circles. The linear discriminant 1 (LD 1) on the x-axis separates the two normally 
distributed classes. The linear discriminant 2 (LD 2) on the y-axis, while captures the general 
variance in the dataset, would not be an ideal linear discriminant as is does not capture any of 
the information that discriminates the two classes. Figure from Raschka, (2015).  
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K-nearest neighbours (KNN) 
The K-nearest neighbours (KNN) algorithm classifies each unlabelled example by the 
majority label among its k-nearest neighbours in the training dataset (Weinberger, Blitzer & 
Saul, 2006). Instead of learning a discriminative function from the training datamm, the KNN 
algorithm memorizes the training dataset. Namelym the KNN finds the k samples in the 
training dataset that are closest (or most similar) to the point that is to be classifies, the class 
of the point is then determined by a majority vote among the k nearest neighbours (Raschka, 
2015). KNN is considered a nonparametric model that uses memory-based approach. Such an 
approach may work more optimally when the dataset has very few dimentions because the 
computational complexity for classifying new samples grows linearly with the increasing 
number of samples in the training dataset (Friedman, Bentley, & Finkel, 1976). As Figure 5.3 
shows, the data point “?” is classified as triangle class label based on the k (in this example, 5) 
nearest neighbours of the sample.  
  
Figure 3.3 The concept of the k-nearest neighbour classifier (KNN). The question mark 
“?”represents the data point that is to be classified. The three symbols (triangle, the plus sign 
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and the minus sign) indicate different class labels. Based on the majority vote of the 5 nearest 
(k=5) neighbours, the data point is therefore classified as class triangle. Figure from Raschka, 
(2015). 
 
Classification and regression trees (CART) 
For classification and regression tree methods, the models are constructed by recursively 
partitioning the data space and fitting a simple prediction model within each partition (Loh, 
2011). The partitioning can be graphically presented as a decision tree classifier, which can 
be thought of as breaking down the data by making decisions based on asking a series of 
questions. Namely, the deicison tree model learns a series of questions to infer the class lables 
of the samples (Raschka, 2015). Classification trees are designed for inputs that take a finite 
number of unordered values, with misclassification cost measured as prediction error. (Loh, 
2011). Regression trees, on the other hand are designed for inputs that take continuous or 
ordered discrete values, with the squared difference between the observed and predicted 
values measured as prediction error (Loh, 2011). The approach in practice may reasly lead to 
overfitting as the decision tree grows deeper, therefore it is better to set a limit for the 
maximal depth of the decision tree. Figure 3.4 illustrates an example of a one-day activity 
being decided within the decision tree framework.   
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Figure 3.4 An example of decision tree deciding upon an activity on a particular day. 
While the figure illustrates the concepts of decision tree based on categorical labels, the same 
concepts applies for numerical datasets. Figure from Raschka, (2015). 
 
Gaussian Naïve Bayes (GNB) 
Naïve Bayes is a linear classifier that can be effectively applied to high-dimensional datasets, 
which predicts the probability of each class based on the feature vector for given continuous 
big data with a prior distribution of the probability. The naive aspect of the algorithms is that 
it assumes all of the input dimensions are independent from each other (Raizada & Lee, 
2013). Gaussian Naïve Bayes (GNB) classifier referred to Naïve Bayes classifier that 
considers the bid data is generated through a Gaussian process with normal distribution, 
which allows the z-score distance to be converted into a p-value. Figure 3.5 illustrates the 
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concept of GNB, showing that the z-score distance of each data point x was calculated  
 
Figure 3.5 The concept of Gaussian Naïve Bayes (GNB) classifier. The distance between 
the data point x and the class mean divided by the standard deviation of the class is the 
z-score distance of x. Because the model assumes the data to be normally distributed, each 
z-score distance is allowed to be converted directly into a p-value. Figure from Raizada & 
Lee (2013).  
 
Support vector machines (SVM) 
The SVM algorithms are the most representatives of the data classification approach that 
considers only a dichotomous difference between the two classes. A support vector machine 
classified the input variables by finding the hyperplane that maximizes the margin (i.e. the 
distance between the optimal hyperplane and input data points) between the two classes. The 
SVM concerns the problem of constructing consistent estimators from data, namely, how to 
estimate the model performance on an unknown dataset, given the characteristic of the model 
and its performance on a training dataset (Dreiseitl & Ohno-Machado, 2002).  
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Figure 
3.6. The support vector machine (SVM). The aim of the SVM is to find a hyperplane that 
optimally separate the two classes. The optimization is to maximize the margin, which is 
defined as the distance between the separating hyperplane (decision boundary) and the 
training samples that are closest to this hyperplane, which are the co-called support vectors. 
Figure from Raschka, (2015).   
 
 
3-4 Results  
RTs from incorrect trials under Accuracy instruction (ON/OFF medication) to predict 
PD+ICD/PD-ICD membership 
Six models were created using six different algorithms discussed in the previous section. For 
the codes and figures please refer to the Appendix. The metric of accuracy was used to 
evaluate the models. Figure 3.7 illustrates the spread and the mean accuracy of each model. 
Each algorithm was evaluated 10 times with the 10-fold cross validation, thus each model 
had a population of accuracy measures. As shown in the figure, the spread of the samples 
indicates that many samples reached 100% accuracy in model CART, whereas the other five 
models had less accuracy in predicting the classification of the data.  
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Figure 3.7 Model evaluation results that compare the spread and the mean accuracy of each model 
created with different algorithms. The left figure represents the results from models using OFF 
medication data set, whereas the right figure represents the results from models using ON medication 
data set. LR= logistic regression, LDA= linear discriminant analysis, KNN= K-Nearest Neighbors, 
CART= Classification and Regression Trees, NB= Gaussian Naive Bayes, SVM = Support Vector 
Machines. 
 
The score of accuracy represented the ratio of the number of correctly predicted cases divided 
by the total number of cases in the database. The results showed that the model created with 
classification and regression tree algorithm had the highest accuracy score. Table 3.2 shows 
the estimated accuracy score for each model. 
 
Table 3.2 Estimated accuracy score for each model using data of incorrect responses funder 
Accuracy instructions 
 Models LR LDA KNN CART NB SVM 
OFF Mean 0.89 0.90 0.87 0.98 0.84  0.74 
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medication 
data set  
Estimated 
Accuracy  
(0.08) (0.03) (0.11) (0.03) (0.04) (0.12) 
ON 
medication 
data set 
Mean 
Estimated 
Accuracy  
0.79 
(0.07) 
0.82 
(0.08) 
0.79 
(0.08) 
0.98 
(0.03) 
0.79 
(0.09) 
0.78 
(0.07) 
LR= logistic regression, LDA= linear discriminant analysis, KNN= K-Nearest Neighbors, CART= 
Classification and Regression Trees, NB= Gaussian Naive Bayes, SVM = Support Vector Machines. 
The estimated accuracy score was given as the mean with the standard deviation in parentheses. 
 
The CART algorithm was the most accurate model among the six models created and tested. 
The validation dataset was used to further examine the accuracy of the selected model. The 
results showed a 97% precision in making predictions on the validation dataset. Table 3.3 
shows the classification report of the models, which indicates how well the models worked. 
The uneven number of each class may contribute to the high precision of the model, therefore 
a confusion matrix was calculated to see the types of the errors the model made when making 
predictions. 
 
Table 3.3 The classification report of the classification and regression tree (CART) models 
created with OFF/ON medication under Accuracy instruction data sets 
OFF medication data set 
 Precision Recall F1-Score Support 
PD+ICD 1.00 0.86 0.92 14 
PD-ICD 0.92 1.00 0.96 23 
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Avg. /Total 0.95 0.95 0.94 37 
ON medication data set 
 Precision Recall F1-Score Support 
PD+ICD 0.88 0.88 0.88 8 
PD-ICD 0.96 0.96 0.96 24 
Avg. /Total 0.94 0.94 0.94 32 
Precision: precision in successfully classifying each case; Recall: accuracy in predicting the classes 
for each case; F1-Score: a weighted average of the precision and recall; Support: number of cases 
given by the validation dataset. 
 
As shown in Table 3.4, for the OFF medication data set, the type of the error appeared in two 
cases when two PD+ICD data points were misclassified as PD-ICD, whereas PD-ICD data 
were all accurately classified. The Table showed that there were 14 cases in class PD+ICD 
and 24 cases in class PD-ICD. 2 of the 14 cases in the class PD+ICD were correctly classified 
(recall: 12/14=0.86) whereas all the cases in the class PD-ICD were correctly classified 
(recall: 23/23=1.00). For the 12 cases classified as class PD+ICD in the model, all of them 
were actually labelled as PD+ICD, leading to the 1.00 precision (12/12=1.00). On the other 
hand, for the 25 cases classified as PD-ICD in the model, only 23 of them actually belonged 
to the PD-ICD class, the precision was therefore calculated as 23/25= 0.92. On the other hand, 
for the ON medication data set, the type of the error appeared in one case when a PD+ICD 
data point was misclassified as PD-ICD, and when a PD-ICD data point was misclassified as 
PD+ICD. The Table showed that there were 8 cases in class PD+ICD and 24 cases in class 
PD-ICD. 7 of the 8 cases in the class PD+ICD were correctly classified (recall: 7/8=0.88) 
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whereas 23 out of the 24 cases in the class PD-ICD were correctly classified (recall: 
23/24=0.96). For the 8 cases classified as class PD+ICD in the model, 7 of them were 
accurately labelled as PD+ICD, leading to the 0.88 precision (7/8=0.88). On the other hand, 
for the 24 cases classified as PD-ICD in the model, only 23 of them actually belonged to the 
PD-ICD class, the precision was therefore calculated as 23/24= 0.96. 
 
Table 3.4 The confusion matrix of the classification and regression tree (CART) models 
OFF medication data set 
 PD+ICD (Predicted) PD-ICD (Predicted) Total 
PD+ICD (Input) 12 2 14 
PD-ICD (Input) 0 23 23 
ON medication data set 
 PD+ICD (Predicted) PD-ICD (Predicted) Total 
PD+ICD (Input) 7 1 8 
PD-ICD (Input) 1 23 24 
 
 
RTs from incorrect trials under Speed instruction (ON/OFF medication) to predict 
PD+ICD/PD-ICD membership 
Likewise, here six models were created using six different algorithms using data sets of 
Speed instructions. For the codes and figures please refer to Appendix C. The metric of 
accuracy was used to evaluate the models. Figure 3.8 illustrates the spread and the mean 
accuracy of each model. Each algorithm was evaluated 10 times with the 10-fold cross 
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validation, thus each model had a population of accuracy measures. As shown in the figure, 
the spread of the samples indicates that many samples reached 100% accuracy in model 
CART, whereas the other five models had less accuracy in predicting the classification of the 
data.  
 
 
Figure 3.8 Model evaluation results that compare the spread and the mean accuracy of each model 
created with different algorithms. The left figure represents the results from models using OFF 
medication data set, whereas the right figure represents the results from models using ON medication 
data set. LR= logistic regression, LDA= linear discriminant analysis, KNN= K-Nearest Neighbors, 
CART= Classification and Regression Trees, NB= Gaussian Naive Bayes, SVM = Support Vector 
Machines. 
 
The score of accuracy represented the ratio of the number of correctly predicted cases divided 
by the total number of cases in the database. The results showed that the model created with 
classification and regression tree algorithm had the highest accuracy score. Table 3.5 shows 
the estimated accuracy score for each model. 
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Table 3.5 Estimated accuracy score for each model 
 Models LR LDA KNN CART NB SVM 
OFF 
medication 
data set  
Mean 
Estimated 
Accuracy 
0.69 
(0.08) 
0.67  
(0.10) 
0.84 
(0.10) 
1.00 
(0.00) 
0.65 
(0.07) 
0.73 
(0.09) 
ON 
medication 
data set 
Mean 
Estimated 
Accuracy  
0.74 
(0.06) 
0.73 
(0.07) 
0.87 
(0.08) 
0.99 
(0.01) 
0.76 
(0.09) 
0.79 
(0.06) 
LR= logistic regression, LDA= linear discriminant analysis, KNN= K-Nearest Neighbors, CART= 
Classification and Regression Trees, NB= Gaussian Naive Bayes, SVM = Support Vector Machines. 
The estimated accuracy score was given as the mean with the standard deviation in parentheses. 
 
The CART algorithm was the most accurate model among the six models created and tested. 
The validation dataset was used to further examine the accuracy of the selected model. The 
results showed a 100% precision in making predictions on the validation dataset. Table 3.6 
shows the classification report of the models, which indicates how well the models worked. 
The uneven number of each class may contribute to the high precision of the model, therefore 
a confusion matrix was calculated to see the types of the errors the model made when making 
predictions. 
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Table 3.6 The classification report of the classification and regression tree (CART) models 
created with OFF/ON medication under Speed instruction data sets 
OFF medication data set 
 Precision Recall F1-Score Support 
PD+ICD 1.00 1.00 1.00 12 
PD-ICD 1.00 1.0 1.00 47 
Avg. /Total 1.00 1.00 1.00 59 
ON medication data set 
 Precision Recall F1-Score Support 
PD+ICD 1.00 1.00 1.00 21 
PD-ICD 1.00 1.00 1.00 56 
Avg. /Total 1.00 1.00 1.00 77 
Precision: precision in successfully classifying each case; Recall: accuracy in predicting the classes 
for each case; F1-Score: a weighted average of the precision and recall; Support: number of cases 
given by the validation dataset. 
 
As shown in Table 3.7, for both ON and OFF medication data sets, PD+ICD and PD-ICD 
data points were all accurately classified. The Table showed that for OFF medication data set, 
there were 12 cases in class PD+ICD and 59 cases in class PD-ICD. All 12 cases in the class 
PD+ICD were correctly classified (recall: 12/12=1.00). Similarly, all the cases in the class 
PD-ICD were correctly classified (recall: 47/47=1.00). For the 12 cases classified as class 
PD+ICD in the model, all of them were actually labelled as PD+ICD, leading to the 1.00 
precision (12/12=1.00). In addition, for the 47 cases classified as PD-ICD in the model, all 47 
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cases actually belonged to the PD-ICD class, the precision was therefore calculated as 47/47= 
1.00. For the ON medication data set, all data points were correctly classified. The Table 
showed that there were 21 cases in class PD+ICD and 56 cases in class PD-ICD. All 21 of the 
21 cases in the class PD+ICD were correctly classified (recall: 21/21=1.00). Moreover, all 56 
cases in the class PD-ICD were correctly classified (recall: 56/56=1.00). For the 21 cases 
classified as class PD+ICD in the model, all 21 of them were accurately labelled as PD+ICD, 
leading to the 1.00 precision (21/21=1.00). For the 56 cases classified as PD-ICD in the 
model, all 56 of them actually belonged to the PD-ICD class, the precision was therefore 
calculated as 56/56= 1.00. 
 
Table 3.7 The confusion matrix of the classification and regression tree (CART) models 
OFF medication data set 
 PD+ICD (Predicted) PD-ICD (Predicted) Total 
PD+ICD (Input) 12 0 12 
PD-ICD (Input) 0 47 59 
ON medication data set 
 PD+ICD (Predicted) PD-ICD (Predicted) Total 
PD+ICD (Input) 21 0 21 
PD-ICD (Input) 0 56 56 
 
 
RTs from incorrect trials under 5% dots coherence (ON/OFF medication) to predict 
PD+ICD/PD-ICD membership 
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Six models were created using six different algorithms discussed in the previous section. For 
the codes and figures please refer to Appendix C. The metric of accuracy was used to 
evaluate the models. Figure 3.9 illustrates the spread and the mean accuracy of each model. 
Each algorithm was evaluated 10 times with the 10-fold cross validation, thus each model 
had a population of accuracy measures. As shown in the figure, the spread of the samples 
indicates that many samples reached 100% accuracy in model CART, whereas the other five 
models had less accuracy in predicting the classification of the data.  
 
 
Figure 3.9 Model evaluation results that compare the spread and the mean accuracy of each model 
created with different algorithms. The left figure represents the results from models using OFF 
medication data set, whereas the right figure represents the results from models using ON medication 
data set. LR= logistic regression, LDA= linear discriminant analysis, KNN= K-Nearest Neighbors, 
CART= Classification and Regression Trees, NB= Gaussian Naive Bayes, SVM = Support Vector 
Machines. 
 
The score of accuracy represented the ratio of the number of correctly predicted cases divided 
by the total number of cases in the database. The results showed that the model created with 
classification and regression tree algorithm had the highest accuracy score. Table 3.8 shows 
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the estimated accuracy score for each model. 
 
Table 3.8 Estimated accuracy score for each model 
 Models LR LDA KNN CART NB SVM 
OFF 
medication 
data set  
Mean 
Estimated 
Accuracy 
0.61 
(0.15) 
0.59 
(0.16) 
0.64 
(0.16) 
1.00 
(0.00) 
0.76 
(0.11) 
0.62 
(0.12) 
ON 
medication 
data set 
Mean 
Estimated 
Accuracy  
0.54 
(0.10) 
0.53 
(0.10) 
0.70 
(0.13) 
0.98 
(0.03) 
0.64 
(0.13) 
0.56 
(0.12) 
LR= logistic regression, LDA= linear discriminant analysis, KNN= K-Nearest Neighbors, CART= 
Classification and Regression Trees, NB= Gaussian Naive Bayes, SVM = Support Vector Machines. 
The estimated accuracy score was given as the mean with the standard deviation in parentheses. 
 
The CART algorithm was the most accurate model among the six models created and tested. 
The validation dataset was used to further examine the accuracy of the selected model. The 
results showed a 100% precision in making predictions on the validation dataset. Table 3.9 
shows the classification report of the models, which indicates how well the models worked. 
The uneven number of each class may contribute to the high precision of the model, therefore 
a confusion matrix was calculated to see the types of the errors the model made when making 
predictions. 
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Table 3.9 The classification report of the classification and regression tree (CART) models 
created with OFF/ON medication under 5% dots coherence data sets 
OFF medication data set 
 Precision Recall F1-Score Support 
PD+ICD 1.00 1.00 1.00 8 
PD-ICD 1.00 1.0 1.00 16 
Avg. /Total 1.00 1.00 1.00 24 
ON medication data set 
 Precision Recall F1-Score Support 
PD+ICD 1.00 1.00 1.00 11 
PD-ICD 1.00 1.00 1.00 27 
Avg. /Total 1.00 1.00 1.00 38 
Precision: precision in successfully classifying each case; Recall: accuracy in predicting the 
classes for each case; F1-Score: a weighted average of the precision and recall; Support: 
number of cases given by the validation dataset. 
 
As shown in Table 3.10, for both ON and OFF medication data sets, PD+ICD and PD-ICD 
data points were all accurately classified. The Table showed that for OFF medication data set 
there were 8 cases in class PD+ICD and 16 cases in class PD-ICD. All 8 cases in the class 
PD+ICD were correctly classified (recall: 8/8=1.00). Similarly, all the cases in the class 
PD-ICD were correctly classified (recall: 16/16=1.00). For the 8 cases classified as class 
PD+ICD in the model, all of them were actually labelled as PD+ICD, leading to the 1.00 
precision (8/8=1.00). In addition, for the 16 cases classified as PD-ICD in the model, all 16 
 189 
 
cases actually belonged to the PD-ICD class, the precision was therefore calculated as 16/16= 
1.00. For the ON medication data set, all data points were correctly classified. The Table 
showed that there were 11 cases in class PD+ICD and 27 cases in class PD-ICD. All 11 of the 
11 cases in the class PD+ICD were correctly classified (recall: 11/11=1.00). Moreover, all 27 
cases in the class PD-ICD were correctly classified (recall: 27/27=1.00). For the 11 cases 
classified as class PD+ICD in the model, all 11 of them were accurately labelled as PD+ICD, 
leading to the 1.00 precision (11/11=1.00). For the 27 cases classified as PD-ICD in the 
model, all 27 of them actually belonged to the PD-ICD class, the precision was therefore 
calculated as 27/27= 1.00. 
 
Table 3.10 The confusion matrix of the classification and regression tree (CART) models 
OFF medication data set 
 PD+ICD (Predicted) PD-ICD (Predicted) Total 
PD+ICD (Input) 8 0 8 
PD-ICD (Input) 0 16 16 
ON medication data set 
 PD+ICD (Predicted) PD-ICD (Predicted) Total 
PD+ICD (Input) 11 0 11 
PD-ICD (Input) 0 27 27 
 
 
3-5 Discussion 
In the present study, the results showed that RTs from incorrect trials of a moving dots 
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paradigm, especially RTs of incorrect trials under Speed instruction and under 5% dots 
coherence, could be used to classify the membership between PD+ICD and PD-ICD groups 
in PD patients. While all constructed models had high accuracy in making predictions, the 
models created with different datasets (i.e. one used incorrect trials under Speed instruction 
whereas the other one used incorrect trails under Accuracy instruction) were not comparable 
because they were created from different datasets. Therefore, it is difficult to directly 
compare the performance of the models with regard to data classification. However, the total 
classes of the models indicate that RTs on incorrect trials under Speed instruction may 
provide better predictions for data classification on categorising the PD+ICD/PD-ICD 
membership. 
 
Predictive modelling approach in the field of health care and limitations of the present study 
The present results suggest a possibility to use behavioural data as a predictor in predicting 
the vulnerability in developing ICDs in PD aptients. To develop the best/most suitable 
predictive model is not the main research interest of the study. In recent years, predictive 
modelling approaches have been received much attention in the field of health care (Choi et 
al., 2016; Hatzmann, Maurice-Stam, Heymans, & Grootenhuis, 2009), such as in gene 
expression analysis (Shi et al., 2010). However, few studies discuss the possibility to use 
behavioural data as screening tool in disease prevention.  
 
The quality of a predictive model depends on three factors: the quality of the input data in 
building the model, the caution when choosing the adjustable parameters, and evaluation 
criteria when reporting the results of model processing. Given the current dataset the CART 
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model was selected for the best performance in making predictions on the classification. 
Despite the results suggest a possibility to use the behavioural data in predicting PD patients 
prone to develop ICDs, there are a few limitations of the present study should be 
acknowledged. First, while the dataset consists of 24 patients and up to 389 response trials, it 
was a relatively small sample size. Second, due to the small sample size, each response trial 
as considered as a dependent data point, which may have produced bias in the dataset when 
estimating the accuracy of the model. Third, the models created in the present study were 
designed in the simplest manner to avoid too much noise in the data, however this may result 
in high accuracy but less interoretability (Hall, 2016). Fourthly, the classification approach 
used in the present study requires numeric input variable thus other predictive factors that 
were associated with the development of PD ICD such as gender (binary vector), marital 
status, and personal/family history experience of using psychostimulants (Weintraub et al., 
2015) were not included in the models. Approaches that are able to construct models with 
more input variables from multiple dimensions may be more informative on screening for the 
development of ICDs in PD patients in future studies. For such models, which are far more 
complicated that the ones constructed in current study, algorithms such sequential backward 
selection (SBS) could be used to select the most important features at the same time maintain 
the accuracy of the model. While the accuracy in making predictions on the membership of 
PD patients is high given the present data, future studies are required to further investigate 
the reliability and validity of using behavioural patterns in a moving dots task as a clinical 
screening tool to predict impulsive behaviours in PD patients. As previously discussed, ICDs 
in PD patients would cause devastating consequences to patients and the caregivers 
(Weintraub et al., 2015; Phu et al., 2014; Leroi et al., 2012; Voon et al., 2011), and that the 
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onset of the ICDs is likely to be induced by treatments such as dopaminergic medication 
(especially dopamine agonist) (Cools et al., 2003; Voon et al., 2007, 2011; Weintraub et al., 
2010, 2015) and STN DBS (Hälbig et al., 2009; Moum et al., 2012). The behavioural tasks 
can therefore be administered on untreated PD patients and the data can be used for building 
predictive models that help guiding further treatment to prevent the onset of the ICDs.  
 
Note that in the present study it is not the main purpose to determine which input variable in 
the model had the most impact on making the predictions, because impulsivity is not a 
unitary construct and the onset of a disease or a disorder is hardly determined by only one 
factor. The aim of the models is to use the input variables (e.g. behavioural patterns and 
factors such as age) in making predictions on PD patients that may potentially develop ICDs 
in the future, rather than finding the potential factors that may be the cause of the 
development of the ICDs. Such concept is supported by the idea of the big data, which focus 
on temporal stability of the association, rather than on causal relationship (Lee & Yoon, 2017). 
Moreover, PD+ICD patients recruited in the study were not actively showing symptoms of 
ICDs, yet the patients still showed different behavioural patterns compared to PD-ICD 
patients. The results are in line with previous study in suggesting that PD+ICD and PD-ICD 
patients had distinct behavioural pattern, which may shed insights on why some PD patients 
developed ICDs and the others did not (Djamshidian et al., 2012, 2014). 
 
Behavioural classification in PD patients with and without ICDs 
Previously, Djamshidian et al (2012) have used a linear discriminant analysis to classify PD 
patients with and without ICDs using the performance on a beads task. The beads task 
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requires participants to decide from which of the two cups coloured beads were being drawn. 
The cups differed in the proportion of blue and green beads they contained (e.g. one cup is 
80% Green and 20% Blue whereas the other cup contains 20% Green and 80% Blue). 
Participants were first shown a bead draw, which was either blue or green. Then the 
participants could choose between drawing another bead and guessing from which cup the 
bead was drawing from. Participants are allowed to draw as many beads as they need to make 
decisions. The number of draws is associated with the subjective certainty of making the 
decision. The essence of the beads task is that participants are allowed to gather as much 
information as subjectively needed. During ambiguous trials, participants would gather more 
information to guide the decision. Conversely, participants would gather less information 
during trials that are much clearer. The number of beads draws therefore represents the 
amount of information gathered before making optimal decisions. Both PD-ICD and 
PD+ICD patients have been shown to draw significantly less beads compared to age-matched 
healthy controls, indicating that PD patients showed reflection impulsivity when making 
decisions (Djamshidian et al., 2012). Furthermore, the authors used the data in the 80/20 
condition to predict the class membership of PD-ICD and PD+ICD patients by using the 
number of draws in the 80/20 condition to predict group membership between different 
groups of patients, which produced a 96% accuracy in making predictions on the membership 
of PD patients. Djamshidian et al (2012) thus proposed that the behavioural patterns for the 
beads task were a powerful tool to screen for impulsive behaviours in PD patients. The 
present results were in line with the study in showing that PD patients with and without ICDs 
have different behavioural patterns, and that tools may be developed to screen for PD patient 
that are vulnerable to develop ICDs based on such difference.  
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Summary 
In summary, the results suggest that by using data classification methods, it may be possible 
to classify PD patients into PD+ICD and PD-ICD groups with certain behavioural tasks, 
which could further be used as a clinical assessment in unmedicated PD patients to reduce the 
chance of ICD onset. Here in the present study, it is shown that tasks manipulated speed 
pressure and decision conflict may be suitable for screening vulnerability to develop ICDs in 
PD patients. Future studies are in need to further investigate the type of measures and 
develop more proper models and algorithms in predicting ICDs onset in PD patients before 
treatment.  
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Chapter 4 The acute effects of deep brain stimulation of the subthalamic nucleus on 
task-switching within the framework of moving dots paradigm in PD patients 
 
4-1 Abstract 
Conflict monitoring during the information processes is one of the key characteristics of task 
switching. Evidence has shown that deep brain stimulation (DBS) of the subthalamic nucleus 
(STN) would induce deficits by disrupting the normal function of the STN on information 
processing during task switching in patients with Parkinson’s disease (PD). To investigate 
such a hypothesis, ten PD patients treated with bilateral STN DBS were recruited to perform 
on a block-designed moving dots task, where parts of the task consisted of 100% dot 
coherence blocks (i.e. automatic behaviours) and other parts consisted of various coherence 
levels (5%-50%) (i.e. controlled behaviours). The beahavioural performance of PD patients 
was compared to twelve age-matched healthy controls (HC). The results show that the acute 
manipulation of STN DBS did not induce deficits on task switching for PD patients, instead 
STN DBS improved the performance on the moving dots task. However, PD patients with 
STN DBS ON did show impairments on the Inhibition/Switching section of Colour Word 
Interference Test, which supports the negative effect induced by STN DBS in PD patients. 
The evidence suggests that task-switching may involve fundamentally different but related 
cognitive processes, which are controlled by distinct brain areas. Moreover, the above results 
are in line with the hypothesis that the reliability of sensory information plays an important 
role on modulating SAT. Furthermore, PD patients still showed subtle difference on 
underlying cognitive components under the effects of DBS, which supports a role of the STN 
on modulating boundary separation and sensory information integration during task 
performance.  
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4-2 Introduction 
Most daily behaviours are well-learned routines that evoke the same actions, from time to 
time decisions must be made to switch from the habitual/automatic behaviour to controlled 
behaviour in order to adjust to the changes. Such a process requires context monitoring and 
the control of motor inhibition to supress an intended/initiated action in order to activate an 
alternative action that is more context appropriate.  
 
The subthalamic nucleus (STN) has been proposed to play an important role in motor control. 
As discussed in Chapter 1, the hyperdirect pathway of the basal ganglia (Nambu, Tokuno & 
Takada, 2002) consists of glutamatergic excitatory neurons that transmit signals quickly from 
the cerebral cortex to the substantia nigra pars compacta (SNr)/ the internal segment of the 
globus pallidus (GPi) via the STN, producing a net effect of motor inhibition, and that lesions 
of the STN induced involuntary movements in rodents (Crossman et al., 1984) and alleviated 
akinetic-rigid syndromes in parkinsonian monkeys (Aziz et al., 1992; Aziz, Peggs, Sambrook 
& Crossman, 1991; Bergman et al., 1990). In a primate study Isoda & Hikosaka (2008) found 
that the STN neurons showed activation during task switching. Moreover, the activation of 
the STN neurons was similar but slightly slower that the activation of the pre-SMA neurons, 
which supports the hypothesis that the STN receives signals regarding behaviour switching 
from the pre-SMA and activates its function of motor inhibition to supress the old ongoing 
but invalid actions in order to execute new adaptive actions (Hikosaka & Isoda, 2010). In 
addition to motor inhibition, it has been proposed that the STN also plays an important role in 
cognitive flexibility (Aron & Poldrack, 2006; Isoada & Hikosaka, 2008; Hikosaka & Isoda, 
2010), which suggests that the STN activity is associated with supressing automatic and fast 
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actions to initiate controlled and slow actions. In particular, the STN receives direct 
projections from the pre-SMA and cingulate cortex that compose conflict monitoring systems, 
which allows the STN to implement cognitive control by sending NoGo signals via diffuse 
excitatory projections to basal ganglia output nuclei (Mink, 1996; Parent & Hazrati, 1995; 
Frank et al., 2007). Frank (2006) has proposed a computational role of the STN in 
dynamically controlling the threshold for executing a response, which is fundamentally 
modulated by the intensity of competing possible actions. In other words, STN is essential to 
integrate all information before action selection, thereby prevents premature responses 
especially in high-conflict situations. Studies have shown that high-frequency stimulation 
induced impairments during decision-making when decision conflict was presented in PD 
patients (Frank et al., 2007; Green et al., 2013). One potential hypothesis for the impairment 
could be the stimulation-induced disruption of the activity of the limbic circuit between the 
ACC and the ventral striatum as revealed by the imaging study of Schroeder et al. (2002). 
Consistent with the proposed computational role of the STN, Cavanagh et al (2011) showed 
that mPFC activity increased and decision threshold decreased with STN DBS on during 
conflict. In line with the above hypothesis, PD patients treated with deep brain stimulation 
(DBS) of the STN have been found to be impaired in slowing down when facing high 
decision conflict (Frank et al., 2007; Wylie et al., 2010; Green et al., 2013) and task switching 
during a Stroop interference task, where participants are required to supress the habit of 
saying the names of colours (automatic behaviours) and say the ink colour of the name 
printed instead (controlled behaviour) (Jahanshahi et al., 2000; Schroeder et al., 2002; Witt et 
al., 2008). 
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Here the present study used a block-designed moving dots task including automatic blocks 
and controlled blocks, which attempted to not only study behavioural switching but also 
simulate the dynamic environment during action selection (implemented by varied 
coherences of the moving dots and the explicit instructions on informing participants to be 
fast or accurate) in PD patients. Acute manipulation of STN DBS was adopted to assess the 
effect of STN DBS on behaviours in PD patients. Moreover, performance of PD patients was 
compared to age-matched healthy controls (HCs). In addition to behavioural switching, the 
moving dots paradigm also allows the investigation on the acute effect of STN DBS on 
mental processes associated with speed/accuracy trade-off (SAT) and information integration, 
which in the present PhD thesis are considered to be associated with the basic executive 
functions including switching, shifting and inhibition. Two studies examining the acute 
effects of STN DBS on the same moving dots paradigm have found that (1) STN DBS 
significantly influenced task performance especially under high decision conflict (i.e. high 
task difficulty) when accuracy was emphasized, indicating that stimulation reduced the 
effects of task difficulty/level of coherence of the moving dots on reaction times (RTs) (Green 
et al., 2013), and (2) when coherence level was kept constant at a relatively easy level, STN 
DBS had a stronger impact on moving dots task performance when speed was emphasized 
that led to fast and incorrect responses (Pote et al., 2016). Both studies suggest a role of the 
STN in and that STN DBS would induce negative impact on inhibitory control in PD patients. 
Following results from the above studies, it is hypothesised that when being ON stimulation 
PD patients would have impaired task switching, resulting in faster reaction time (RT) and 
more incorrect responses. Computational models were applied to the behavioural data to 
further study the underlying mental processes of SAT modulation and sensory information 
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integration. Three parameters including boundary separation, drift rate and non-decision time 
would be derived from the model. It is predicted that PD patients ON stimulation would have 
lower boundary separation and lower drift rate that are associated with impaired abilities of 
cognitive flexibility on the task. 
 
 
Figure 4.1 Difference between Parkinson’s disease (PD) patients treated with deep brain 
stimulation (DBS) of subthalamic nucleus (STN) and healthy controls on the functions of the 
STN.  
 
4-3  Material and methods  
Participants 
Ten patients (2 females) with Parkinson’s disease treated with bilateral STN DBS at least 6 
months or longer after surgery and twelve age-matched healthy controls (HCs) (5 females) 
were recruited. PD patients had a clinical diagnosis of idiopathic Parkinson's disease 
according to the Parkinson's Disease UK Brain Bank criteria (Hughes et al., 1992). The Mini 
• Controls motor inhibtion 
• Modualtes cogntivie flexibility
• Supports task switching
Noraml STN in healthy 
controls
• Improves motor symptoms in PD
• Impaires cognitive flexibility 
• Impaires task switching
DBS of the STN in PD 
patients
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Mental State Examination (cut-off score of 26; Folstein et al., 1975) was used to screen for 
dementia. The Starkstein Apathy Scale (SAS) was used to screen for apathy symptoms 
(cut-off score of 14; Starkstein et al., 1992). The Beck Depression Inventory II (BDI-II, Beck 
et al., 1996) was used to screen for depression (cut-off score of 24). None of the patients had 
dementia or clinical depression. Even though the patients had significantly higher levels of 
apathy than the controls on the SAS, none had clinical levels/diagnosis of apathy. None of the 
healthy controls had any neurological or psychiatric illness, head injury or drug or alcohol 
abuse. Patients were examined by a neurologist, both ON and OFF stimulation, the severity 
of their motor symptoms and their stage of illness were rated on the Unified Parkinson's 
Disease Rating Scale (UPDRS; Fahn & Elton, 1987). All participants had normal or 
corrected-to-normal vision. The clinical details of all participants are presented in Table 4.1, 
whereas the clinical data of patients with Parkinson’s disease are listed in Table 4.2. 
 
Table 4.1. Demographic and clinical details of the participants. Table shows means with 
standard deviations in parenthesis.  
 PD (n=10) HC (n=12) p value 
Handedness (RH:LH) 10:0  12:0  N/A 
Mini Mental State Examination  29.10 (1.10) 29.82 (0.39) p=.070 
Beck Depression Inventory  8.45 (5.54) 6.91 (5.80) p=.542 
Starkstein Apathy Scale  12.83 (4.34) 8.71 (3.25) p=.141 
Barratt Impulsivity Scale  65.4 (10.98) 57.27 (8.87) p=.085 
Digit Span forward and backwards total score 17.8 (3.85) 20.55 (3.50) p=.103 
Trail Making Test-part A  
Completion time (seconds) 
Trail Making Test-part B  
Completion time (seconds) 
 
52.5 (22.96) 
 
90.5 (30.63) 
 
45.1 (10.27) 
 
82.27 (24.22) 
 
p=.270 
 
p=.358 
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Colour Word Interference Test-colour naming  
Errors 
Completion Time (seconds) 
 
0.9 (1.10) 
36.1 (7.74) 
 
0.36 (0.65) 
31.91 (4.83) 
 
p=.178 
p=.110 
Colour Word Interference Test-word reading  
Errors 
Completion Time (seconds) 
 
0.5 (0.53) 
24.4 (4.25) 
 
0.00 (0.00) 
22.82 (4.29) 
 
p=.006* +1 
p=.253 
Colour Word Interference Test-Inhibition  
Errors 
Completion Time (seconds) 
 
2.2 (2.74) 
65.1 (12.93) 
 
1.18 (1.38) 
61.09 (13.36) 
 
p=.660 
p=.376 
Colour Word Interference Test-Inhibition/Switching 
Errors 
Completion Time (seconds) 
 
4.00 (2.49) 
81.9 (22.97) 
 
1.00 (0.82) 
58.09 (8.79) 
 
p=.002* +2 
p=.008* +3 
Age of onset (years) 46.6 (8.44) N/A N/A 
Disease duration (years) 14.9 (5.30) N/A N/A 
UPDRS score III 
PD STN-DBS ON 
PD STN-DBS OFF 
 
15.6 (7.14) 
29.5 (16.77) 
 
N/A 
 
p=.018*+4 
UPDRS= Unified Parkinson’s Disease Rating Scale, PD = Parkinson’s disease, STN-DBS = Deep brain stimulation of the 
subthalamic nucleus, N/A= Not Applicable, *= Statistically significant differences between groups  
+1= Effect size of Errors of Colour Word Interference Test-word reading: Hedge’s g= -1.817 
+2= Effect size of Errors of Colour Word Interference Test-Inhibition/Switching: Hedge’s g = -1.753 
+3= Effect size of Completion Time of Colour Word Interference Test-Inhibition/Switching: Hedge’s g = -1.444 
+4= Effect size of UPDRS score III: paired sample Hedge’s g = -2.504 
 
Design and Procedure 
A repeated measures design was used. All patients performed two blocks (i.e. auto and 
control blocks) of the moving dots task twice (in total four blocks), once ON stimulation and 
once OFF stimulation, with the order counterbalanced between participants. Due to the 
moving dots stimui were presented psudo-randomly, it was assumed that no here were no 
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learning/practice effects on the task performance. In addition, a study using the same task 
paradigm has suggested that there were no learning/practice effects on the behavioural 
parameters for the moving dots task (Huang et al., 2015), therefore the healthy controls 
performed the task once. In addition, it should affect the behavioural parameters for PD 
patients whether they were tested ON then OFF stimulation or OFF then ON stimulation. The 
task and all the questionnaires were performed by all participants on the same day. The study 
was approved by the joint ethics committee of the UCL Institute of Neurology and the 
National Hospital for Neurology & Neurosurgery. Informed consent was obtained from all 
participants. Clinical data of PD patients were shown in Table 4.2. 
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Table 4.2 Clinical data of patients with Parkinson’s disease. 
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The moving dots task 
In the present study, a moving dots task paradigm (Britten et al., 1992) with block 
design was used to assess the task switching behaviour. As introduced in previous 
Chapters, the moving dots paradigm requires participants to decide the direction of a 
cloud of moving dots on a computer screen. The coherence levels of the moving dots 
may be manipulated for experimental purpose. For the ‘Automatic’ blocks, all trials 
contained moving dots with 100% coherence, which makes it very easy for the 
participants to decide the direction of the moving dots. For the ‘Controlled’ blocks, 
the dots coherence varied from 5% to 50% (including 5%, 10%, 15%, 25%, 35% and 
50%), which required participants to decide under conflicts that would take more 
cognitive processing to make correct responses. All participants went through the 
order of ‘Auto block- Control block- Auto block’ to investigate task switching 
behaviours. In addition to the task switching behaviour, the moving dots paradigm 
also provides a chance to investigate the modulation of SAT and the ability to sample 
and integrate sensory information in guiding responses. The numbers of trials in for 
each block were selected to obtain reliable parameter estimation in diffusion 
modelling while at the same time avoiding fatigue for the patients (Lerche et al., 
2017).  
 
Data Analysis 
R (R Core Team, 2013) and IBM SPSS software were used to analyze the data. 
Reaction times (RTs) of correct trials and response accuracy were measured as 
dependent variables. Linear mixed model (LMM) was used to fit reaction time with 
DBS (DBS ON/ DBS OFF/ HC), and Blocks (B1/ B2/ B3) as fixed effects. Subject 
was assigned as a random effect to account for subject-by-subject variation in overall 
RTs. In addition to a random intercept, a random slope in Type has also been added 
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into the model, which means that the rate at which individuals made decisions based 
on the Speed/Accuracy instructions is different from person to person.  
 
To construct the mixed model, R package lme4 (Bates, Maechler & Bolker, 2012) was 
used. The Maximum Llikelihood (ML) approach was used for parameter estimation. 
The Likelihood Ratio Test was used as a mean to attain p-values of the fixed effects, 
which compared models with full factors and reduced factors to determine the 
significance of a fixed effect. Moreover, a generalized linear mixed model (GLMM) 
was used to fit the response accuracy data due to the data being non-normal. For the 
present data a binomial distribution with a logistic link was selected to construct the 
model, at the same time it was specified that the response accuracy could vary 
randomly across subjects. ML approach with Laplace approximation was used for 
parameter estimation. DBS (DBS ON/ DBS OFF/ HC), and Blocks (B1/ B2/ B3) were 
assigned as fixed effects. Subject was assigned as a random effect to account for 
by-subject variation in overall response accuracy. p<.05 was used as a criterion for 
statistical significance. The Akaike information criterion (AIC), which estimates the 
relative quality of a statistical model given a specified data set, was used for model 
selection (Bozdogan, 1987). The relative quality of the model is indicated by the 
calculated information loss, therefore the model that has the minimised AIC would be 
chosen as the most fitted model given the specified dataset.  
 
Hierarchical Drift Diffusion Model (HDDM) 
In addition to the behavioural measurement, computational model was applied to 
derived underlying cognitive mechanisms during SAT modulation and sensory 
information integration. The diffusion model has been widely used in investigating 
underlying cognitive processes especially for two-forced-choice tasks (Voss & Voss, 
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2007; Voss et al., 2015; Ratcliff, 1978; Ratcliff & McKoon, 2008). In the diffusion 
model, three variables were calculated and discussed: the boundary separation, the 
non-decision time and the drift rate. The boundary separation (a) represents the 
response threshold to reach a decision/response. The longer the distance between the 
starting point and boundary threshold, the longer the response time is and the longer it 
takes to make a decision/response, and lesser errors are likely to occur. Conversely, 
the shorter the distance between the starting point and the boundary ` threshold, the 
faster a decision would be made, but the person is more likely to make errors. The 
components of the process are defined as having three phases: perceptual processing 
(processing the stimulus) with a certain duration, decision phase with a certain 
duration and response phase with a certain duration. The non-decision time (t0) is 
defined as the sum of the perceptual processing time plus the response time. Drift rate 
(v) refers to as the as the speed of the information accumulation process which leads 
to one of the two decision boundaries, for the current experiment it represents the 
certainty/confidence to distinguish between noise and signal. A higher drift rate 
suggests a higher certainty/confidence to distinguish noise and signal, which should 
be the case on easier higher coherence trials, whereas a lower drift rate at lower levels 
of coherence reflects a lower certainty/confidence to distinguish between noise and 
signal and to choose the direction of the moving dots on the harder trials.  
 
To quantitatively fit the diffusion model to the behavioural data, a Python-based 
hierarchical drift diffusion model (HDDM) toolbox (Wiecki et al., 2013) was used. 
HDDM uses hierarchical Bayesian parameter estimation methods for simultaneous 
estimation of subject parameters and the group distribution from which they are 
drawn, at the same time providing measures of uncertainty in the posterior 
distribution (Figure 4.2). In addition, HDDM requires less data per subject/condition 
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than the non-hierarchical method, is able to deal with outliers and it allows for 
Bayesian data analysis. HDDM includes a regression model that allows estimation of 
trial-by-trial influences of a covariate onto model parameters. In the present study, 
HDDM was fitted to the behavioural data using the ‘HDDMRegressor’ function, 
which allows individual parameters to be described by a linear model specification. 
One of the benefits of estimating a model in a Bayesian framework is that significant 
testing can be directly performed on the posterior rather than relying on frequentist 
statistics. The Bayesian approach uses probability to quantify uncertainty and makes 
more precise probability statements about the state of the system by calculating the 
probability of a model given collected data (i.e. P(model | data)) (Puga et al., 2015). 
  
 
Figure 4.2 Basic graphical hierarchical model implemented by HDDM for 
estimation of the drift-diffusion model. Round nodes represent random variables. 
Shaded nodes represent observed data. Directed arrows from parents to children 
visualize that parameters of the child random variable are distributed according to its 
parents. Plates denote that multiple random variables with the same parents and 
children exist. The outer plate is over subjects while the inner plate is over trials. 
Figure from Wiecki, T., Sofer, I., and Frank, M. (2013). 
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4-4. Results 
The results are presented form three perspectives: (1) behavioural data from task 
switching and moving dots task (SAT modulation and sensory information integration) 
points of view, (2) application of computational model on the behavioural data, and (3) 
comparisons between current and previous studies using the same moving dots task. 
 
4-4-1 The analyses of the behavioural data 
Response accuracy and RTs during task switching 
Firstly, to examine how well participants performed the task, a GLMM was created 
using response accuracy as the dependent variable, with DBS (STN DBS ON/ DBS 
OFF/ HC) and Block (Block 1/ Block 2/ Block 3) set as fixed effects and subject as a 
random effect. For the variable ‘Block’, Block 1 represents the first block that was an 
Auto block with 100% dot coherence, following by a Control block (Block 2) with 
varied dots coherence and finally another Auto block (Block 3). Such order of blocks 
includes both switching from automatic behaviour to control behaviour, and switching 
from controlled behaviour to automatic behaviour. Note that the effects of all factors 
are expressed relative to the intercept conditions, which were set as the baselines. 
Here STN DBS ON was set as the intercept condition for DBS factor, whereas Block 
1 was set as the intercept condition for Block. 
 
The model showed a significant difference on response accuracy between Block 1 and 
Block 2 (Z=-4.348, p<.0001), suggesting that for all participants the performance on 
Block 1 (automatic block) was significantly better than on Block 2 (controlled block), 
which is in line with predictions. In addition, for PD patients ON stimulation, there is 
a possible negative trend on response accuracy between Block 3 and Block 1 
(Z=-1.705, p=0.088), suggesting that PD patients with STN DBS ON had a trend to 
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have worse performance during Block 3 than Block 1. Both Block 3 and Block 1 were 
Auto blocks with 100% dot coherence; such a negative trend may potentially be the 
results of impaired task switching induced by DBS interrupting the function of STN 
on proactive switching in PD patients. However, the effect size of the trend is 
considered small (Hedge’s g = 0.216). There was no difference on response accuracy 
(Z=-0.387, p=0.699) between PD patients ON versus OFF stimulation. In contrast, 
there is a significant difference on response accuracy between PD patients with STN 
DBS ON and age-matched HCs (Z=3.169, p=0.002), indicating that HCs had better 
performance than PD patients during Block 1. The effect size for the difference on 
response accuracy between PD patients with STN DBS ON during Block 1 is medium 
(Hedge’s g = 0.568). Moreover, the two-factor interaction Block x DBS showed a 
significant difference (Z=-3.244, p=0.001), which suggested that the difference on 
response accuracy for the two blocks was larger for HCs than for PD patients with 
STN DBS ON. The effect size of difference between Block 1 and Block 2 for HCs is 
large (Hedge’s g = 1.003) and the effect size of difference between Block 1 and Block 
2 for PD patients with STN DBS ON is medium (Hedge’s g = 0.561). As shown in 
Figure 4.3, such a difference was reflected by the significantly better performance for 
HCs during automatic blocks. 
 
The results together suggest that (1) all participants had higher response accuracy 
during Auto blocks than Control blocks; (2) the acute manipulation of STN DBS had 
no effects on response accuracy, and (3) PD patients were able to perform the Control 
blocks as well as age-matched HCs, however during Auto blocks PD patients across 
both stimulation states had significantly lower response accuracy than HCs. Figure 
4.3 illustrates the response accuracy during task switching for all participants.  
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Figure 4.3 Response accuracy during task switching. Standard error means are 
presented as the error bars. The asterisk symbols denote statistically significant 
difference. 
 
 
To further examine how the participants perform the behavioural task, reaction times 
(RTs) of correct trials were analysed with linear mixed models (LMMs). The LMM 
took RTs of correct trials as the dependent variable, with DBS (STN DBS ON/ STN 
DBS OFF/ HC) and Block (Block 1/ Block 2/ Block 3) set as the fixed effects and 
subject as the random effect. Note that the effects of all factors are expressed relative 
to the intercept conditions, which were set as the baselines. Here STN DBS ON was 
set as the intercept condition for DBS factor, whereas Block 1 was set as the intercept 
condition for Block.  
 
The model showed that there was a significant difference on RTs between Block 2 and 
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Block 1 for PD patients ON stimulation (t=9.561, p<.0001), indicating that RTs during 
Block 2 RTs were significantly slower (higher) than during Block 1, which is in line 
with the prediction that RTs during Control blocks would be higher than during Auto 
blocks. The effect size of the significant effect of Block on RTs for PD patients with 
STN DBS ON is larger (Hedge’s g = -1.107). There was no difference between Block 
1 and Block 3 for PD patients ON stimulation (t=-1.279, p=0.201), indicating that PD 
patients ON stimulation had faster RTs when switching from controlled behaviour to 
automatic behaviour. During Block 1, there was no difference between PD patients 
ON stimulation and age-matched HCs (t=-1.245, p=0.224). There was a significant 
two-factor interaction between Block x DBS (t=2.895, p=0.004), showing that the 
difference on RTs between the two blocks are higher for HCs than for PD patients ON 
stimulation. In addition, the effect size of difference between Block 1 and Block 2 for 
HCs is larger (Hedge’s g = -1.720) than the effect size of difference between Block 1 
and Block 2 for PD patients with STN DBS ON (Hedge’s g= -1.107), which suggests 
that the difference is larger for HCs than for PD patients with STN DBS ON. Together 
the results suggest that HCs were actually more sensitive during task switching 
compared to PD patients with STN DBS ON. In summary the results indicate that (1) 
all participants had successful task-switching behaviour reflecting as significantly 
higher (slower) RTs during Control blocks than Auto blocks, (2) STN DBS improved 
the RTs of PD patients to a degree that were as fast as age-matched HCs, and (3) 
however, PD patients ON stimulation had different behavioural patterns than OFF 
stimulation and age-matched HCs. Surprisingly the different behavioural patterns 
mainly occurred during Auto blocks when sensory information was sufficient (Table 
4.3). Figure 4.4 illustrates the RTs of correct trials during task witching for all 
participants. 
  
 212 
 
 
Figure 4.4 RTs of correct trials for PD patients with STN DBS ON and OFF 
stimulation and for healthy controls (HC). Standard error means are presented as the 
error bars. The asterisk symbols denote statistically significant difference. Visually the 
slopes of DBS OFF and HC seem to be parallel, however the slop of DBS ON seems 
to be steeper, indicating a trend of different behavioural pattern for PD patients ON 
stimulation.  
 
 
Table 4.3 Summary of main findings of the behavioural data.  
 Task switching from Auto blocks to Control blocks 
Response 
accuracy 
¾ All participants had successful task switching behaviour reflecting as 
better task performance during Auto blocks than Control blocks. 
¾ The acute manipulation of STN DBS had no effects on response 
accuracy. 
¾ PD patients were able to perform the Control blocks as well as 
age-matched HCs, however during Auto blocks PD patients had 
significantly lower response accuracy than HCs.  
RTs of correct 
trials 
¾ All participants had faster RTs during Auto blocks than Control blocks. 
¾ Acute manipulation of STN DBS improved RTs for PD patients. 
¾ PD patients ON stimulation showed different behavioural patterns 
* 
* 
* 
* 
* 
* 
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compared to age-matched HCs and when being OFF stimulation. 
 
Response accuracy and RTs under the effects of Speed/Accuracy instructions and 
dots coherence 
Response accuracy 
In addition to task switching, behavioural data were also analysed under the effects of 
Speed/Accuracy instructions and dots coherence to study the potential effects of STN 
DBS on the underlying mental processes of SAT modulation and information 
integration. Initially data analyses were performed using factors Type (Speed/ 
Accuracy), Level (5%/ 10%/ 15%/ 25%/ 35%/ 50%/ 100%) and DBS (STN DBS 
ON/STN DBS OFF/ HC) on dependent variables response accuracy and RTs (the 
results are shown in the Appendix B). However, such a procedure raised a problem 
that each coherence level may contain too small of trial numbers comparing to the 
100% moving dots trials therefore decreases the power of the model. To decrease this 
difference on the trial number, instead of comparing each individual coherence level, 
the various coherence levels were divided into three groups: Low coherence levels 
(5%, 10%, 15%), High coherence levels (25%, 35%, 50%) and 100% coherence level 
(automatic behaviour). To examine how participants performed the task as a function 
of Speed/Accuracy instructions and dots coherence, a GLMM was created using 
response accuracy as the dependent variable, with Type (Speed/ Accuracy), 
Coherence (Low coherence/ High coherence/ 100% coherence) and DBS (STN DBS 
ON/STN DBS OFF/ HC) set as fixed effects and subject as a random effect. all levels 
of the categorical variables are compared to the base level (reference category). Here 
the base levels are: Accuracy (Type), 100% coherence (for Coherence) and STN DBS 
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ON (for DBS).  
 
The model shows that all participants had higher response accuracy when Accuracy 
was emphasized (Z=-4.27, p<.0001, Hedge’s g = 0.55). The effect of Type on 
response accuracy was significantly reversed during Low coherence trials (Z=2.06, 
p=0.039, Hedge’s g =0.04) suggesting that when sensory information was insufficient, 
SAT had less impact on task performance for all participants. In addition, 
age-matched HCs had higher response accuracy than PD patients ON/OFF stimulation 
(Z=3.46, p<.0001, Hedge’s g =0.37) during 100% coherence trials. PD patients (both 
ON and OFF stimulation) had higher response accuracy during 100% than Low 
coherence trials (Z=-5.4, p<.0001, Hedge’s g = 0.4), however, response accuracy did 
not differ between 100% coherence trials and High coherence trials (Z=0.60, p=0.546) 
for PD patients. On the other hand, task performance of age-matched HCs was 
significantly related to dots coherence as response accuracy was significantly lower 
for High coherence trials (Z=-2.7, p=0.007, Hedge’s g =0.44) and for Low coherence 
trials (Z=-3.2, p=0.001, Hedge’s g =1.54) compared to 100% coherence trials. No 
other significant interaction was found. The results showed that (1) all participants 
had higher response accuracy when Accuracy was emphasized during 100% 
coherence and High coherence trials but not Low coherence trials, (2) the acute 
manipulation of STN DBS did not produce negative effects on response accuracy for 
PD patients, (3) age-matched HCs had higher response accuracy than PD patients 
when dots coherence was 100%, and (4) age-matched HCs had higher response 
accuracy as the dots coherence increased. However, for PD patients both ON and OFF 
stimulation, such an effect of dots coherence on response accuracy was only observed 
between Low coherence trials and 100% coherence trials but not between High 
coherence trials and 100% trials. Figure 4.5 illustrates the above results.  
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Figure 4.5 Response accuracy under the effects of Accuracy and Speed instructions and various dots coherence for PD patients with STN 
DBS ON (DBS ON), STN DBS OFF (DBS OFF) and age-matched healthy controls (HCs). Data of PD patients ON stimulation are presented in 
colour red, data of PD patients OFF stimulation are presented in colour blue, and HCs are presented in colour green. The standard error of the 
mean presented as the error bars. The asterisk symbols denote statistically significant differences. 
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Reaction Times 
Furthermore, to examine how participants performed the task as a function of 
Speed/Accuracy instructions and dots coherence, a LMM was created using RTs of correct 
responses as the dependent variable, with Type (Speed/ Accuracy), Coherence (Low 
coherence/ High coherence/ 100% coherence) and DBS (STN DBS ON/ DBS OFF/ HC) set 
as fixed effects and subject as a random effect. All levels of the categorical variables are 
compared to the base level (reference category). Here the base levels are: Accuracy (Type), 
100% coherence (for Coherence) and STN DBS ON (for DBS).  
 
The model shows that all participants had faster RTs when Speed was emphasized 
(t(4823)=-5.99, p<.0001, Hedge’s g = 0.32) for all coherence trials, except for the 100% 
coherence trials such an effect of Speed instruction was significantly reversed for 
age-matched HCs (t(4823)=2.75, p=0.006, Hedge’s g =0.30), which means that for HCs there 
was no effect of Speed/Accuracy instructions on RTs during 100% coherence. All participants 
had faster RTs when dots coherence was 100% compared to High coherence trials 
(t(4823)=3.04, p=0.002, Hedge’s g =0.50) and compared to Low coherence trials 
(t(4823)=11.11, p<.0001, Hedge’s g =0.86). PD patients had faster RTs when ON than OFF 
stimulation (t(4823)=4.86, p<.0001, Hedge’s g =0.66). No difference was found in RTs 
between PD patients ON stimulation and age-matched HCs (t(26)=-1.69, p=0.104). No other 
significant interactions were found. The results showed that (1) all participants had faster RTs 
when Speed was emphasized, except for when dots coherence was 100%, such an effect of 
Speed instruction was eliminated for age-matched HCs, (2) all participants had faster RTs 
when decision conflicts were low (i.e. when dots coherence was high), (3) the acute 
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manipulation of STN DBS significantly decreased RTs for PD patients to the level of the RTs 
of HCs.   
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Figure 4.6 Reaction time of correct trials under the effects of Accuracy and Speed instructions and various dots coherence (Low coherence/ 
High coherence/ 100% coherence) for PD patients with STN DBS ON (DBS ON), STN DBS OFF (DBS OFF) and age-matched healthy controls 
(HCs). Data of PD patients ON stimulation are presented in colour red, data of PD patients OFF stimulation are presented in colour blue, and 
HCs are presented in colour green. Standard error of the mean is presented as the error bars. The asterisk symbols denote statistically significant 
differences. 
* 
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4-4-2 The application of the Hierarchical drift diffusion model (HDDM) to the 
behavioural data of task switching 
HDDM fitted to the behavioural data for task switching 
The above results show that PD patients with STN DBS ON had different behavioural 
patterns during task switching compared to when being OFF stimulation and age-matched 
HCs, which is in line with the hypothetical role of the STN on proactive switching and the 
hypothesis that DBS of the STN interrupts such role that leads to impaired task switching in 
PD patients.  
 
As discussed in previous chapter, the application of the HDDM allows the study of how task 
manipulations affect the underlying cognitive processes when performing the task for all 
participants. In the HDDM, the posterior distribution of three model parameters (i.e. the 
decision threshold, the non-decision time and the drift rate) was estimated under the effects of 
task manipulations and their interactions. Two main factors were considered for behavioural 
switching in the model: DBS (BDS ON/ DBS OFF/ HC) and Block (Block 1/ Block 2/ Block 
3). Here an HDDM was constructed assuming that the decision threshold (a) and 
non-decision time (t), of which the former determines when to make responses whereas the 
later represents time for non-decision processes such as stimulus encoding and response 
execution, would vary between participants (i.e affected by the factor DBS) but would not be 
affected by the factor Block. In addition, the model considered drift rate (v) to vary under the 
effects of both DBS and Block, the former indicates difference on the ability of information 
accumulation among different participants and the later indicates the difference on the quality 
of sensory information provided by different blocks. For brevity the figures of the model are 
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not shown here, please refer to Appendix B. In summary the results from HDDMs show that 
(1) overall HCs had lower decision threshold, higher non-decision time and higher drift rate 
than PD patients, and (2) all participants had higher drift rate during Block 1 and lower drift 
rate during Block 2 (potentially due to task manipulations on moving dots coherence), 
however PD patients with STN DBS ON were less influenced by the switching of blocks on 
drift rate compared to being STN DBS OFF and age-matched HCs.  
 
HDDM fitted to the behavioural data under the effects of speed/accuracy instructions and 
dots coherence 
In previous HDDMs, the models were constructed using factors DBS and Block to assess the 
underlying cognitive components. To look into the data from the perceptual decision-making 
point of view, an HDDM using DBS (STN DBS ON/ STN DBS OFF/ HC), Type (i.e. type of 
the instruction: Speed/Accuracy) and Coherence (Low coherence/ High coherence/ 100% 
coherence) as fixed factors were further created. Here the HDDM was constructed assuming 
that the decision threshold (a) would vary between participants (DBS), different types of 
instructions (Type) and the quality of sensory evidence (Coherence). In addition, the model 
considered drift rate (v) to vary under the effects of DBS and Coherence but unaffected by 
Type. Non-decision time was eliminated from the model due to failed convergence of the 
model.  
 
Table 4.4 The effect of Speed instructions on decreasing boundary separation (a) for all 
participants 
The effect of Speed instructions on decreasing boundary separation (a) 
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 Low Coherence  High Coherence 100% Coherence 
STN DBS ON O O O 
STN DBS OFF — + — 
HC O O — 
‘O’= the effect of Speed instructions occurred, ‘—’= the effect of Speed instructions 
decreased, ‘+’= the effect of Speed instructions increased. Note that in the model data from 
STN DBS ON were set as the reference level for comparison.  
 
Taken together, the HDDM shows that (1) all participants had higher decision threshold and 
lower drift rate when moving dots coherence decreased, (2) PD patients with STN DBS ON 
had lower decision threshold and lower drift rate than age-matched HCs but higher decision 
threshold and higher drift rate than being STN DBS OFF, (3) the acute manipulation of STN 
DBS had impacts on how PD patients performed the moving dots task under the effects of 
moving dots coherence and Speed/Accuracy instructions (Table 4.5). 
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Table 4.5 Summary of the behavioural data and the application of hierarchical drift diffusion model (HDDM) on the behavioural data 
 
SAT=Speed and Accuracy trade-off; RTs= reaction times; PD=Parkinson’s disease; HCs=heanthy controls 
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4-4-3 Comparison between previous and present studies 
In addition to behavioural data analysis and application of computational model, to see 
whether current data replicated the results of Green et al (2013) study or the Pote et al (2016) 
study, the data were further analysed as following. 
 
Comparing to Green et al (2013) study 
First the trials from the controlled blocks (of which the coherence levels ranged from 5%, 
10%, 15%, 25%, 35% to 50%) were analysed. A GLMM was created using response 
accuracy as the dependent variable, with Type (Speed/ Accuracy), Coherence (5%/ 10%/ 
15%/ 25%/ 35%/ 50%) and DBS (STN DBS ON/ DBS OFF/ HC) set as fixed effects and 
subject as a random effect. All levels of the categorical variables are compared to the base 
level (reference category). Here the base levels are: Accuracy (for Type), 5% coherence (for 
Coherence) and STN DBS ON (for DBS). For brevity the output of the GLMM is not shown. 
Figure 3.4 illustrates the results of the model. Type of instruction had no effects on response 
accuracy for all participants (PD patients with DBS ON: Z= -0.01, p=0.992; PD patients with 
DBS OFF: Z=0.35, p=0.726; HCs: Z=0.93, p=0.354), suggesting that Speed/Accuracy 
instruction had limited influence on response accuracy. For all participants, as the coherence 
level increased response accuracy also significantly increased (15%: Z=2.56, p=0.011, 
Hedge’s g= 0.27; 25%: Z=4.02, p<.0001, Hedge’s g=0.43; 35%: Z=4.41, p<.0001, Hedge’s 
g=0.54; 50%: Z=4.41, p<.0001, Hedge’s g=0.60), indicating that response accuracy was 
closely related to the quality of sensory information. There was no difference in response 
accuracy between PD patients ON versus OFF stimulation (Z=0.93, p=0.354) or between PD 
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patients ON/OFF stimulation and HCs (Z=0.35, p=0.726). No significant interactions were 
found. 
 
Second, a LMM was created using RTs as the dependent variable, with Type (Speed/ 
Accuracy), Coherence (5%/ 10%/ 15%/ 25%/ 35%/ 50%) and DBS (STN DBS ON/ DBS 
OFF/ HC) set as fixed effects and subject as a random effect. All levels of the categorical 
variables are compared to the base level (reference category). Here the base levels are: 
Accuracy (for Type), 5% coherence (for Coherence) and STN DBS ON (for DBS). For 
brevity the output of the LMM is not shown. Figure 3.5 illustrates the results of the model. 
Type had a significant effect on RTs for all participants (t(3693)=-4.88, p<.0001, Hedge’s 
g=0.40), suggesting that all participants responded faster when Speed was emphasised. 
Moreover, for all participants RTs decreased/became faster as the dots coherence increased 
(25%: t(3638)=-4.30, p<.0001, Hedge’s g=0.38; 35%: t(3639)=-5.92, p<.0001, Hedge’s 
g=0.50; 50%: t(3638)=5.31, p<.0001, Hedge’s g=0.53), indicating that when sensory 
information was sufficient (i.e. higher dots coherence), all participants made responses faster. 
There was no differences in RTs between PD patients ON versus OFF stimulation 
(t(3638)=1.55, p=0.122) or between PD patients ON/OFF stimulation and HCs (t(58)=-0.52, 
p=0.803). No significant interaction was found. The results showed that, contrary to the 
Green et al study, which found that STN DBS reduced the effect of the present data did not 
find that acute manipulation of STN DBS had no significant effect when making decisions 
under conflict for PD patients. Figure 4.7 illustrates the above results.  
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Figure 4.7 Response accuracy and Reaction time (ms) under the effects of Speed (SP)/Accuracy (AC) instructions and dots coherence from 
5% to 50% for PD patients with STN DBS ON (DBS ON), STN DBS OFF (DBS OFF) and age-matched healthy controls (HCs). Data of PD 
patients ON stimulation are presented in colour red, data of PD patients OFF stimulation are presented in colour blue, and HCs are presented in 
colour green. The standard error of the mean is presented as the error bars. The asterisk symbols denote statistically significant differences. 
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Comparing to Pote et al (2016) study 
To further compare current data with the Pote et al (2016) study, behavioural parameters from 
50% trials (derived from the various coherence blocks) and automatic blocks (constant 100% 
dots coherence) were analyzed with GLMM and LMM. Type (Speed/ Accuracy) and DBS 
(STN DBS ON/ DBS OFF/ HC) were set as fixed effects and subject was set as a random 
effect. All levels of the categorical variables are compared to the base level (reference 
category). Here the base levels are: Accuracy (for Type) and STN DBS ON (for DBS). For 
brevity the outputs of the models are not shown. Figure 3.6 & Figure 3.7 illustrates the results 
of the models.  
 
For 50% dots coherence trials, all participants responded faster (t(593)=-3.14, p=0.002, 
Hedge’s g=0.24) and made more errors (Z=-2.18, p=0.029, Hedge’s g=0.33) when Speed was 
emphasised. There was no difference in response accuracy between PD patients ON versus 
OFF stimulation (Z=0.86, p=0.389) and no difference in response accuracy between PD 
patients and age-matched HCs (Z=0.78, p=0.437). PD patients made faster responses when 
ON stimulation than OFF stimulation (t(593)=3.36, p=0.001, Hedge’s g=0.28). There was no 
difference on RTs between PD patient with DBS ON stimulation and age-matched HCs 
(t(41)=-0.81, p=0.422). No significant interaction was found. Figure 3.6 illustrates the 
behavioural results of 50% dots coherence trials. The results from 50% trials suggest that the 
acute manipulation of STN DBS did not specifically induce faster RTs especially when Speed 
instruction was emphasised for PD patients. Instead, PD patients with STN DBS ON were 
able to perform as fast as age-matched HCs and did not sacrifice the accuracy, which may 
suggest an improvement on motor function produced by STN DBS. However, note that the 
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data from 50% trials were derived from a block with various dots coherence therefore the 
trail numbers are small, and that the various coherence was presented pseudo-randomly, 
therefore it is not possible to neglect the effect of coherence order. These two confounding 
factors may interfere with drawing a concrete conclusion on the effect of STN DBS and 
Speed/Accuracy instruction on making perceptual decisions for PD patients independently of 
task difficulty, if by simply looking at data from the 50% coherence trials. The results from 
100% coherence blocks were therefore analysed to provide more evidence on how STN DBS 
and Speed/Accuracy instruction affect decision-making under conditions which decision 
conflicts were absent. For 100% dots coherence blocks, all participants had higher response 
accuracy when Accuracy was emphasised (Z=-4.25, p<.0001, Hedge’s g=0.2). No difference 
was found between PD patients ON versus OFF stimulation in response accuracy (Z=-0.35, 
p=0.724). Age-matched HCs had higher response accuracy than PD patients (Z=3.27, 
p=0.001, Hedge’s g=0.28). No significant interactions were found for response accuracy. 
Moreover, during 100% coherence trials PD patients ON stimulation had faster RTs than OFF 
stimulation (t(3756)=5.35, p<.0001, Hedge’s g=0.37). Age-matched HCs did not have faster 
RTs when Speed was emphasised during the 100% dots coherence trials due to the effect of 
Speed was significantly reversed for HCs (t(3756)=3.39, p=0.001, Hedge’s g=0.21), which 
suggests that during 100% coherence the effect of Speed/Accuracy instructions was 
eliminated for HCs but not to a degree that RTs were faster under Accuracy instructions 
(Figure 3.7). There was no difference on RTs between PD patients ON stimulation and HCs 
(t(24)=-1.38, p=0.180). No other significant interaction was found. Figure 3.7 illustrates the 
behavioural results of 100% dots coherence trials. By showing that PD patients with STN 
DBS ON had faster RTs along with making more incorrect responses than being OFF 
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stimulation especially under speed pressure, Pote et al (2016) suggested that STN stimulation 
induced impulsive actions in patients when acting under speed pressure independently of task 
difficulty. However, in the present study PD patients with STN DBS ON did not make more 
errors despite having in general faster RTs compared to being OFF stimulation when dots 
coherence was 100%. The decrease in RTs for PD patients ON stimulation was not induced 
by the speed pressure, but could likely be a result of the benefits of STN DBS on motor 
function, when performing moving dots task without decision conflicts. Therefore, the results 
showed that the acute manipulation of STN DBS in the present study did not induce 
impulsive behaviours (faster RTs along with more incorrect responses) when under Speed 
pressure during a constant dots coherence or 50% dots coherence. Figure 4.8 illustrates the 
above results.  
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Figure 4.8 Response accuracy and Reaction time (ms) under the effects of Speed (SP)/Accuracy (AC) instructions and dots coherence from 
5% to 50% for PD patients with STN DBS ON (DBS ON), STN DBS OFF (DBS OFF) and age-matched healthy controls (HCs). Data of PD 
patients ON stimulation are presented in colour red, data of PD patients OFF stimulation are presented in colour blue, and HCs are presented in 
colour green. The standard error of the mean is presented as the error bars. The asterisk symbols denote statistically significant differences.
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4-5 Discussion 
The present study investigated the acute manipulation of STN DBS in PD patients on task 
switching. In addition, by using a block-design moving dots task that also manipulated 
Speed/Accuracy instructions and various moving dots coherence, the acute effects of STN 
DBS on SAT modulation and sensory information integration were analysed as well. The 
main findings of the above results are: (1) from task switching point of view, the acute 
manipulation of STN DBS did not significantly induce deficits on behaviours for PD patients, 
(2) from the SAT modulation and sensory information integration point of view, acute effects 
of STN DBS improved RTs and underlying cognitive components (i.e. drift rate and 
boundary separation) but impaired making responses during 100% coherence trials in PD 
patients, and (3) the acute manipulation of STN DBS had impacts on behavioural patterns for 
PD patients. Similar to the results section, the following discussion is presented from three 
aspects: (1) the effects of STN DBS on behavioural switching, (2) the effects of STN DBS on 
SAT modulation and sensory information integration, and (3) comparison between present 
and previous results using similar moving dots tasks.  
 
The effects of STN DBS on behavioural switching 
The results from the present behavioural task did not show that the acute manipulation of 
STN DBS had significant influences on behavioural switching from Auto blocks to Control 
blocks in PD patients. Instead, both behavioural data and computational parameters suggest 
that PD patients had impaired mental processes during Auto blocks, which would be further 
discussed in the next section. PD patients with STN DBS ON had a possible negative trend to 
have worse performance during Block 3 than Block 1. Since both Block 3 and Block 1 were 
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Auto blocks with 100% dot coherence; such a negative trend may potentially be the results of 
impaired task switching induced by DBS interrupting the function of STN on proactive 
switching in PD patients. However no acute effect of STN DBS was found on behavioural 
switching from Auto blocks to Control blocks in PD patients. A few reasons may contribute 
to the non-significant results on task switching: firstly, the attentional demands of the Control 
blocks were within the available resources of PD patients. Brown & Marsden (1988) 
proposed a hypothesis that the locus of attentional control is an important aspect in 
determining the presence and/or the magnitude of cognitive deficits in PD patients, which 
suggests that PD patients may not show deficits performing that task if the demands of the 
task are within the available attentional resource. The results are in line with the hypothesis 
showing that performance of PD patients during the Control blocks maintained despite the 
increased task demands. Secondly, previous studies have shown that PD patients with STN 
DBS ON had impairments on performing Stroop interference task, which requires 
participants to withhold a predominant/automatic response (i.e. word reading) and activate a 
more controlled one (i.e. reading ink colour instead of word) (Combs et al., 2015; Troster, 
Jankovic, Tagliati, Peichel, & Okun, 2017). In the present study, the automatic behaviours 
were defined as responding to 100% of the dots moving to the same direction, which is not as 
predominantly encoded in the brain as word reading. Suck task difference may contribute to 
the non-significant results.   
 
Despite the behavioural results showing no significant negative effects on task switching, the 
psychological tests showed that PD patients with STN DBS ON had robustly slower RTs and 
lower response accuracy than age-matched HCs on the Colour Word Interference 
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Test-Inhibition/Switching (i.e. Stroop interference task, see Table 4.1). The test requires 
participants to say the ink colours of the printed colour words but when encountering a 
certain cue (e.g. when the printed word was in a rectangular text box), participants are 
instructed to say the printed colour words instead of the ink colours. Note that PD patients 
only performed the task once (when being STN DBS ON), therefore it is unknown that 
whether such deficits were induced by the acute effect of STN DBS. Nevertheless, the results 
from this task indicate that PD patients with STN DBS ON had impaired behavioural/mental 
set switching. This is consistent with previous studies showing that PD patients were 
impaired in performing tasks that require mental sets/rules switching (Combs et al., 2015; 
Troster et al., 2017). In addition to the role of STN, behavioural and imaging studies show 
that patients who suffered from frontal lobe damage showed deficits in task switching (Owen 
et al., 1993; Holroyd & Coles, 2002; Rushworth et al., 2004; Botvinick et al., 2004; Sakai, 
2008), which may indicate that the cortico-basal ganglia loops are closely involved in 
controlling task switching. Together the evidence suggests that task-switching may involve 
fundamentally different but related cognitive processes, which are controlled by distinct brain 
areas. Future studies are required to investigate these different connections on controlling 
task switching. 
 
Modulation of SAT requires the optimal estimation on the precision of the sensory input 
The results reported above show that Speed and Accuracy instructions had stronger impacts 
on behavioural data especially during high coherence level trials but not when coherence 
levels were low, which indicates that the modulation of boundary separation and potentially 
SAT requires the reliability of the sensory evidence to be known. In the theoretical 
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frameworks of a two-alternative-forced-choice task such as the diffusion model, the optimal 
decision-making processes are described as information integration to a threshold (Gold & 
Shadlen, 2002; Ratcliff & McKoon, 2008). However, Deneve (2012) proposed that such 
analogy hides a problem that to know how much information to be accumulated and set the 
optimal decision threshold, firstly the reliability of the sensory evidence must be known. 
Under the Bayesian framework, the modulation of decision threshold is thus associated with 
the reliability of sensory evidence and the inner drive to be fast/accurate. The present results 
not only support the involvement of the reliability of sensory information on drift rate, but 
also support the role of the reliability of sensory information on modulating decision 
threshold that affects the accuracy of the decisions.  
 
Interestingly, the above results show that during Control blocks PD patients were able to react 
as well as age-matched HCs, however during Auto blocks, PD patients not only had poorer 
performance and slower RTs, but also had lower drift rate and higher decision threshold 
compared to age-matched HCs. Moreover, PD patients with STN DBS ON had different 
behavioural patterns compared to being OFF stimulation and compared to age-matched HCs, 
reflecting as both HCs and PD patients with STN DBS OFF had bigger difference on RTs 
between Auto blocks and Control blocks, however for PD patients with STN DBS ON such a 
difference was significantly smaller (Figure 4.4). The results indicate that PD patients with 
STN DBS ON were slow in making decisions when sensory information was sufficient. 
Moreover, the application of the HDDM showed that PD patients with STN DBS ON, though 
had higher decision threshold, were less influenced by task switching on drift rate. One of the 
possible reasons may be the involvement of the Speed/Accuracy instructions that interrupted 
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the decision-making processes for PD patients with STN DBS ON. As shown in Table 4.4, 
for PD patients with STN DBS ON only, the modulation of decision threshold was influenced 
by Speed/Accuracy instructions during 100% coherence trials. For age-matched HCs and PD 
patients with STN DBS OFF, when sensory information was sufficient, the high reliability of 
the sensory information increased confidence in making decisions and surpassed the effect of 
Speed/Accuracy instructions on processing the decisions. However, for PD patients with STN 
DBS ON, even when the reliability of the sensory information was high, the effect of 
Speed/Accuracy instructions remained strongly on modulating decision threshold, resulting 
in slower RTs. 
 
Bogacz (2010) proposed four theories that explain the part of the cortico-basal ganglia circuit 
that modulates the Speed/Accuracy trade-off, including ‘cortical’, ‘striatal’, ‘STN’ and 
‘synaptic’ theories. All of the four theories are based on the mechanism that the Speed 
instructions increase the baseline of cortical integrators and cause changes in one of the four 
circuits. However these theories neglected the potential effect of the reliability of the sensory 
information, which in the present study has been shown to be important when making 
perceptual decisions. Future studies are in need to investigate (1) how normal STN activity 
modulates decision thresholds when simultaneously taking into accounts of the reliability of 
the sensory information, and (2) how DBS of the STN would affect this process in PD 
patients that lead to impairments when performing tasks require sensory information 
integration. 
 
Comparison between previous and present studies 
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As shown in introduction, two studies examining the acute effects of STN DBS on moving 
dots tasks found that (1) STN DBS induced significantly lower response accuracy and faster 
RTs under high decision conflict (1.6%, 4.8%, 8.0%) especially when accuracy was 
emphasized, indicating that stimulation reduced the effect of task difficulty/level of 
coherence of the moving dots on reaction times (RTs) (Green et al., 2013), and (2) when 
coherence level was kept constant at a relatively easy level (50%), STN DBS induced faster 
RTs and lower response accuracy for PD patients when Speed was emphasised (Pote et al., 
2016). Contrary to the Green et al (2013) study, the present study did not find an effect of 
STN DBS on reducing the effects of dot coherence, which potentially results from the fact 
that even the low coherence trials (5%, 10%, 15%) had higher coherence levels compared to 
the Green et study (2013) (1.6%, 4.8%, 8.0%). On the other hand, the present study showed 
that PD patients with STN DBS ON had significantly lower response accuracy when Speed 
was emphasised during High coherence trials but no significant difference on RTs compared 
to when being STN DBS OFF, which did not fully support the hypothesis that Speed pressure 
induces fast and low response accuracy in PD patients. Such an observation could result from 
the complex design of the current experiment, which may not be optimal in terms of studying 
the impulsive behaviours induced by STN DBS in PD. In addition, the Green et al (2013) 
study tested PD patients ON versus OFF stimulation OFF dopamine medication, whereas 
Pote et al (2016) study tested PD patients ON dopamine medication, therefore the effects of 
dopamine medication could not ne neglected. Despite the different procedures and 
behavioural results, the previous two studies and the present study all suggest a role of the 
STN and effects of DBS on affecting SAT, and modulating boundary threshold potentially via 
encoding the reliability of sensory information that is associated with the dots coherence. 
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Future studies are required to further investigate the effects of STN DBS on affecting SAT 
modulation, the direction of such effects, and the possibility of inducing negative effects on 
behaviours in PD patients.  
 
 
 237 
 
Table 4.6 Behavioural data comparison between previous studies and the present result 
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Summary 
The present study shows no negative effect on task switching behaviours induced by the 
acute manipulations of STN DBS on a block-designed moving dots task. However, PD 
patients with STN DBS ON did show deficits on task switching during the 
Inhibition/Switching part of the Colour Word Interference Test compared to age-matched 
HCs. The evidence suggests that task-switching may involve fundamentally different but 
related cognitive processes, which are controlled by distinct brain areas. Moreover, the above 
results are in line with the hypothesis that the reliability of sensory information plays an 
important role on modulating SAT. Furthermore, PD patients still showed subtle difference on 
underlying cognitive components under the effects of DBS, which supports a role of the STN 
on SAT and sensory information integration. To further investigate how DBS may affect STN 
function on cognitive and motor control, in the next chapter I would study PD patients with 
STN DBS using a behavioural task that manipulated unexpected sensroy events which leads 
to ‘action reprogramming’.   
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Chapter 5 The effect of deep brain stimulation of the subthalamic nucleus on action 
reprogramming when encountering unexpected events 
5-1. Abstract  
Following previous results indicating that the deep brain stimulation (DBS) of the 
subthalamic nucleus (STN) may disrupt the role of the STN in inhibition in Parkinson’s 
disease (PD) patients, the present study aimed to investigate the potential effect of DBS STN 
on reprogramming actions when facing unexpected sensory events. The STN has been 
proposed to play a prominent role in motor inhibition, reprogramming planned actions and is 
involved in interruption of cognitive functions and attentional reorientation when 
encountering unexpected sensory events. To investigate such a role of the STN, ten patients 
with Parkinson’s disease (PD) treated with bilateral deep brain stimulation (DBS) of the STN 
were recruited to participate in the study using a probabilistic reaction time (RT) task. PD 
patients performed the task twice, once ON stimulation and once OFF stimulation, with a 
counterbalanced design. The performance of PD patients was also compared to twelve 
age-matched healthy controls (HCs). The results show that all participants were able to react 
fast during Predictable blocks/Probable trials than Unpredictable blocks/Improbable trials. In 
addition, response accuracy did not differ between Predictable and Unpredictable blocks for 
all participants, but for HCs response accuracy was higher during Probable trials than 
Improbable trials, such a difference was not observed in PD patients across stimulation states. 
Furthermore, PD patients exhibited robust speed and accuracy trade-offs when performing 
the probabilistic RT task, which may indicate that PD patients, especially PD patients OFF 
stimulation, were predominately aiming to act fast therefore sacrificed response accuracy. 
The results thus indicate that PD patients with STN DBS OFF could act as fast as 
age-matched HCs, however such fast responses would cost response accuracy. The present 
study did not show an effect of DBS on inducing impaired action reprogramming, however it 
did not rule out the the possibility of STN DBS to impaire motor/cognition control through 
inhibiton in PD patients. Moreover, in the present study PD patients treated with STN DBS 
were assessed ON medication, which may be the reason why the results did not reflect the 
hypothetical effects of DBS on interrupting the role of STN in cognitive and motor control. 
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5-2 Introduction 
Facing unexpected events is inevitable in daily life, which may lead to slowness in movement 
and cognitive distraction. When facing a surprising or an unexpected event, the brain has to 
inhibit the execution of a planned action, gather more information and generate a new action 
in order to reach a better outcome given the changed circumstance. Such a process of action 
adjustment is referred to as ‘action reprogramming’ (Mar, Piekema, Coles, Hulstijn, & Toni, 
2007).  
 
A significant feature of action reprogramming is the slowness in reaction time (RT) when 
encountering unexpected events. Such slowness has been associated with a global mechanism 
of motor inhibition via the frontal-basal ganglia connections (Wessel & Aron, 2013, 2015). In 
addition, evidence has shown that multiple routes are involved in an interaction between the 
primary motor area and the frontal cortex to mediate action inhibition during action 
reprogramming: a direct cortical route and a subcortical route via the basal ganglia, including 
the subthalamic nucleus (STN) (Neuber, Mars, Buch, Olivier, & Rushworth, 2010). Local 
field potential recordings on Parkinson’s disease (PD) patients undergoing DBS revealed that 
elevated STN activity is associated with post-error slowing of RTs, which suggests a role for 
the STN in motor adjustments following errors (Siegert et al., 2014). It has been 
well-established that the STN is involved in motor inhibition (Aron & Poldrack, 2006; van 
den Wildenberg et al., 2006; Kim & Hikosaka, 2015; Alegre et al, 2013; Obeso et al, 2014). 
Human imaging studies also provide evidence supporting the prominent role of the STN in 
suppressing an ongoing movement, and that decreasing STN activity releases the brain from 
inhibition (Aron &Poldrack, 2006; Aron, Behrens, Smith, Frank, & Poldrack, 2007; Li et al, 
2008; Forstmann et al, 2010). Such a mechanism is possibly through the ‘hyperdirect’ 
pathway in which the STN receives signals from the cerebral cortex and projects to the 
SNr/GPi (Nambu, Tokuno, & Takada, 2002; Kim & Hikosaka, 2015). Furthermore, in 
primate studies, the STN has been shown to mediate the control signals from cortex and 
implement action switching from automatic to controlled behaviours via its connections with 
the basal ganglia output nuclei (Isoda & Hikosaka, 2008; Hikosaka & Isoda, 2010). The STN 
has also been proposed to serve as a brake to allow more information to be integrated before 
making an optimal response, which is believed to be relevant to its role in motor inhibition 
(Frank, 2006). Moreover, computational models of the basal ganglia have suggested that the 
degree of decision conflict dynamically modulates STN activity, which contributes to 
optimally delaying action selection in a given situation in order to decrease the uncertainty 
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when making decisions (Frank, 2006; Bogacz & Gurney, 2007; Bogacz, Wagenmakers, 
Forstmann, & Nieuwenhuis, 2010). In addition, a recent study of local filed potentials from 
the STN in deep brain stimulation (DBS) treated PD patients has shown that encountering 
unexpected events increases STN activity, which leads to the decrement of verbal working 
memory, and is related to attentional reorientation (Wessel et al., 2016). Wessel et al (2016) 
further proposed that surprise (i.e. unexpectedness) interrupts cognition via the same 
fronto-basal ganglia mechanism that interrupts action, which may lead to a new theory of 
distraction that involves a cortico-basal ganglia network that underlies motor suppression but 
also affects cognitive function. These studies together suggest that the STN, being part of the 
global suppressive mechanism of the basal ganglia, also participates in mediating cognitive 
functions such as making decisions under decision conflict and/or in response to encountering 
unexpected events. In line with such a hypothesis, the STN may potentially be involved in 
controlling action reprogramming.  
 
STN DBS is an effective procedure for treating the motor symptoms in patients with 
Parkinson’s disease (PD) (Deuschl et al, 2006; Weaver et al., 2012; Williams et al, 2010). It 
has been hypothesised that high-frequency stimulation of the STN supresses the over 
enhancement of oscillatory β activity in PD patients, which is closely associated with the 
deterioration of flexible behavioural and cognitive control (Engel & Fries, 2010), therefore is 
associated with the therapeutic motor improvement of DBS in PD patients (Kühn et al., 2008). 
Consistent with the hypothesised computational role of the STN, DBS of the STN has been 
shown to induce faster reaction times (RT) during high-conflict decision contexts in PD 
patients, potentially due to stimulation of the STN interfering with the normal STN activity 
on inhibiting premature responses (Jahanshahi et al, 2000; Witt et al, 2006; Frank et al., 2007; 
Green et al., 2013; Pote et al, 2016). While the exact mechanism underlying the beneficial 
effects of STN DBS on the motor symptoms of PD remains unknown (Vitek, 2002; McIntyre, 
Savasta, Kerkerian-Le Goff, & Vitek, 2004), it is hypothesised that high frequency 
stimulation decreased STN activity, which releases the brain from motor inhibition. 
Furthermore, PD patients treated with DBS of the STN have been shown to have impairments 
in response inhibition (Hershey et al., 2004, 2010; Ballanger et al., 2009; Favre et al., 2013; 
Obeso et al., 2013; Georgiev et al, 2016; Williams et al, 2015) and making accurate decisions 
under decision conflict ON stimulation compared to OFF stimulation (Jahanshahi et al., 2000; 
Schroeder et al., 2002; Frank et al, 2007; Witt et al., 2008; Wylie et al., 2010). To examine the 
hypothesis that STN modulates reactions to unexpected events, a probabilistic RT task 
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created by Galea et al (2012) was used to assess the effect of STN DBS on perceiving 
unexpected sensory events and action reprogramming on PD patients. PD patients receiving 
both STN DBS and dopaminergic medication and age-matched healthy controls were 
recruited for the study. Patients were tested OFF and ON stimulation ON their usual 
dopaminergic medication. The probabilistic RT task used a predictable first-order Markov 
sequence to generate order of stimulus presentation, which enabled the participants to predict 
the stimulus in current trial based on what appeared in the previous trial. Trials that violated 
the expectedness/prediction were defined as improbable and thus created a sense of 
unexpectedness. 
 
Thus two kinds of blocks were included in the behavioural task: one was unpredictable and 
the other was predictable. Within the predictable trials there were probable trials and 
improbable trials, which were designed to create the sense of unexpectedness. The sense of 
unexpectedness is quantified by the frequency of stimulus appearance. Unexpected events, as 
Wessel & Aron (2017) categorised in their review, can be of three different types: (1) action 
error, (2) unexpected action outcome and (3) unexpected perceptual events. The unexpected 
events manipulated in the present study were unexpected perceptual events. In addition, the 
unexpectedness of the sensory event in the present task was task relevant as participants had 
to make responses in accordance to the presented imperative stimulus (IS), which may not 
only affect the interruption of behaviour but also involve interrupting cognition. While there 
may exist different underlying neural mechanisms in the brain that would be triggered by the 
three different types of unexpected events, Wessel & Aron (2017) further proposed a unified 
theory on how these unexpected events affect motor and cognitive functions. Namely, when 
unexpected events activate the fronto-basal ganglia network that modulates suppression of 
ongoing motor function, cognitive functions (e.g. verbal working memory) at the same time 
will be interrupted by the activation of the same network, involving the pre-SMA/right 
inferior frontal cortex and the STN. It is hypothesised that the STN would ordinarily be 
involved in perceiving surprising events via the same mechanism as motor inhibition, and 
that STN DBS which reduces STN hyperactivity in PD would interfere with this ‘unexpected’ 
function such that when tested ON STN DBS, PD patients would have overall faster RTs but 
impaired action reprogramming relative to DBS OFF, which leads to more incorrect 
responses during the improbable trials.  
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5-3 Materials and Methods 
Participants 
Ten PD patients (2 females) treated with Parkinson’s disease treated with bilateral STN DBS at 
least 6 months or longer after surgery and twelve age-matched healthy controls (HCs) (5 
females) were recruited for the study. All patients met the United Kingdom Brain Bank 
criteria for idiopathic PD (Hughes, Daniel, Kilford, & Lees, 1992). For all participants, there 
was no history of any other neurological disease, head injury, psychiatric illness, or 
drug/alcohol abuse. The Mini Mental State Examination (cut-off score of 26; Folstein, 
Folstein, & McHugh, 1975) was used to screen for dementia and the Beck Depression 
Inventory (Beck, Steer, & Brown, 1996) was used to screen for depression (cut-off score of 
24). None of the patients had dementia or clinical depression. Patients were examined by a 
neurologist, both ON and OFF stimulation, and the severity of their motor symptoms and 
their stage of illness were rated on the Unified Parkinson's Disease Rating Scale (UPDRS; 
Fahn & Elton, 1987). All participants had normal or corrected-to-normal vision. The clinical 
details of all participants are presented in Table 5.1. Demographic information and clinical 
data of patients with Parkinson’s disease are listed in Table 5.2. 
 
Table 5.1.  Demographic and clinical details of the participants. Table shows means with 
standard deviations in parenthesis.  
 PD (n=10) HC (n=12) p value 
Age (years) 61.5 (10.10) 68.17 (9.47) p=.107 
Handedness (RH:LH) 10:0 (100% 
RH) 
12:0 (100% 
RH) 
N/A 
Mini Mental State Examination  29.10 (1.10) 29.82 (0.39) p=.070 
Beck Depression Inventory-II  8.45 (5.54) 6.91 (5.80) p=.542 
Starkstein Apathy Scale  12.83 (4.34) 8.71 (3.25) p=.141 
Barratt Impulsivity Scale  65.4 (10.98) 57.27 (8.87) p=.085 
Digit Span forward and backwards total 
score 
17.8 (3.85) 20.55 (3.50) p=.103 
Trail Making Test-part A  
Completion time (seconds) 
Trail Making Test-part B  
Completion time (seconds) 
 
52.5 (22.96) 
 
90.5 (30.63) 
 
45.1 (10.27) 
 
82.27 (24.22) 
 
p=.270 
 
p=.358 
Colour Word Interference Test-colour 
naming  
Errors 
Completion Time (seconds) 
 
0.9 (1.10) 
36.1 (7.74) 
 
0.36 (0.65) 
31.91 (4.83) 
 
p=.178 
p=.110 
Colour Word Interference Test-word reading 
Errors 
Completion Time (seconds) 
 
0.5 (0.53) 
24.4 (4.25) 
 
0.00 (0.00) 
22.82 (4.29) 
 
p=.006* 
+1 
p=.253 
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Colour Word Interference Test-Inhibition 
Errors 
Completion Time (seconds) 
 
2.2 (2.74) 
65.1 (12.93) 
 
1.18 (1.38) 
61.09 (13.36) 
 
p=.660 
p=.376 
Colour Word Interference 
Test-Inhibition/Switching 
Errors 
Completion Time (seconds) 
 
4.00 (2.49) 
81.9 (22.97) 
 
1.00 (0.82) 
58.09 (8.79) 
 
p=.002* 
+2 
p=.008* 
+3 
Age of onset (years) 46.6 (8.44) N/A N/A 
Disease duration (years) 14.9 (5.30) N/A N/A 
UPDRS score III 
PD STN-DBS ON 
PD STN-DBS OFF 
 
15.6 (7.14) 
29.5 (16.77) 
 
N/A 
 
p=.018* 
+4 
RH= right handed, LH= left handed, UPDRS= Unified Parkinson’s Disease Rating Scale, PD = Parkinson’s disease, 
STN-DBS = Deep brain stimulation of the subthalamic nucleus, N/A= Not Applicable, *= Statistically significant differences 
between groups  
+1= Effect size of Errors of Colour Word Interference Test-word reading: Hedge’s g = -1.89 
+2= Effect size of Errors of Colour Word Interference Test-Inhibition/Switching: Hedge’s g = -1.81 
+3= Effect size of Completion Time of Colour Word Interference Test-Inhibition/Switching: Hedge’s g = -1.50 
+4= Effect size of UPDRS score III: Hedge’s g = -2.60 
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Table 5.2 Clinical data of patients with Parkinson’s disease. 
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Behavioural Task 
 
PD patients completed two sessions on the same day: once ON stimulation and once OFF 
stimulation, with breaks in between as the participants needed. The session order was 
counterbalanced across patients. Control participants completed the session once. The 
unbalanced experimental design of the present study was in reference to the experimental 
design of the Galea et al (2012) study, which compared the effect of dopaminergic medication 
on PD patients. Originaly the age-matched HCs were designed to perform the task twice (the 
same as PD patients for comparison), however some participants declined to perform the task 
for the second time because they thought it was too time-consuming for them and make them 
tired. In addition, since there was no monetary reimbursement, the participantion rate was 
low. Therefore, for practical reasons such as saving time and increasing willingness for HCs 
to participate in the study, age-matched HCs was asked to perform the task once. To reduce 
the disadvantage of such unbalanced design, generalized linear mixed models (GLMM) and 
linear mixed model (LMM) were used to analyse the behavioural data. In addition, because 
of the probabilistic nature of the behaviourla task, it is assumed that there are no practice 
effects for performing the task. 
 
The behavioural task was introduced to the participants on a computer with a custom button 
box with four buttons. The participants were instructed to place each one of their fingers on 
each of the four buttons and to maintain this position throughout the task. Initially, an 
un-informative warning cue (“!”) was displayed for 250 ms. After a fixation cross was 
presented for 1000 ms, one of the four imperative stimuli (IS) was shown in the centre of the 
screen for 250 ms. The fixation cross then reappeared during the response period (2500 ms). 
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During this time, the participants were required to respond to the IS as fast and as accurately 
as possible. Each IS image was associated with pressing a specific button. The 
stimulus-response mapping was acquired through trial and error. During the training session 
composed of 200 trials, feedback either ‘correct!!!’ or ‘wrong’, was presented after each 
response, indicating whether the participants had selected the correct response associated 
with the particular stimulus.   
 
During the main experiment, the feedback was removed. The task was divided into 4 blocks, 
with block 1 and 4 being unpredictable conditions where the probability of each IS being 
presented at trail t equals to 0.25. On the other hand, blocks 2 and 3 were designed as 
predictable conditions, where the IS was drawn from a predictable first-order Markov 
sequence. Each block contained 100 trials. This design created predictable sequences that the 
current stimulus on trial t was conditionally dependent on the stimulus of the previous trial, 
t-1. In other words, the type of IS on previous trials t-1 provides information to predict the 
type of IS on the current trial t. The distribution specified in the transition matrix quantified 
the dependence among consecutive stimuli, which generated the predictable sequences in 
which IS order 1-2-3-4 occurred with high probability (Figure 5.1 C). There were 16 possible 
combinations that determined the relationship between the IS on trial t and on trial t-1. The 
overall probability of each IS should be equal across all blocks.  The experimental design 
provided a probabilistic context that allowed participants to reduce uncertainty before an 
event occurred (Harrison et al, 2006). Because of the probabilistic nature of the generated 
sequences, occasionally unexpected (surprising) stimuli would appear that was not expected 
based on the predictability of the sequence. When these unexpected (surprising) stimuli were 
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presented, participants would need to inhibit the planned response based on prior 
expectations about the forthcoming stimuli. It is important to note that no explicit information 
about the underlying patterns in each block was provided to participants. Participants were 
simply instructed to react with speed and accuracy. 
 
 
Figure 5.1 Experimental design. (A) Schematic representation of a single trial. A visual 
warning signal was followed by one of four novel IS. Participants were told to react as fast as 
possible to the IS. The order of the visual stimuli could either be unpredictable (B: blocks 1, 4) 
or predictable (C; blocks 2, 3). Predictable sequences were generated from a first-order 
Markov sequence in which there were 16 combinations that determined the relationship 
between the IS on trial t and on trial t-1. Numbers within the probability matrices represent 
the transition probabilities. The overall probability of each IS on trial t was equal across all 
blocks. Figure and caption from Galea et al., (2012).  
 
Data Analysis 
R (R Core Team, 2013) and IBM SPSS software were used to analyze the data. Reaction 
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times (RTs) and response accuracy were measured as dependent variables. For all correct 
responses, RTs were calculated as the time between IS onset and the subsequent button press. 
Moreover, RTs in predictable conditions were further compared between probable and 
improbable trials. A simple linear mixed model (LMM) was used to fit RTs with Group (HC 
versus PD), Stimulation (DBS OFF versus ON), Response Accuracy (Correct responses 
versus Incorrect responses) and Probability (Improbable versus Unpredictable, Improbable 
versus Probable) as fixed effects. Subject was assigned as a random effect to account for 
by-subject variation in overall RTs. Log base 10 transformation was performed to reduce the 
skewness of the data. 
Generalized linear mixed models (GLMM) were used to fit the response accuracy data due to 
the data being non-normal. For the present data a binomial distribution with a logistic link 
was selected to construct the model, at the same time it was specified that the response 
accuracy could vary randomly across subjects. A simple GLMM that defined Group (HC 
versus PD), Stimulation (DBS OFF versus ON), Probability (Improbable versus 
Unpredictable, Improbable versus Probable) as fixed effects was fitted to the behavioural data.  
ML approach with Laplace approximation was used for parameter estimation. p<.05 was used 
as a criterion for statistical significance. The Akaike information criterion (AIC), which 
estimates the relative quality of a statistical model given a specified data set, was used for 
model selection (Bozdogan, 1987). The relative quality of the model is indicated by the 
calculated information loss, therefore the model that has the minimised AIC would be chosen 
as the most fitted model given the specified dataset. 
 
R package lme4 (Bates, Maechler & Bolker, 2012) was used to construct the LMMs and the 
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GLMMs. Maximum likelihood (ML) approach was used for parameter estimation for the 
LMMs. Likelihood Ratio Test was used as a mean to attain p-values of the fixed effects, 
which compared models with full factors and reduced factors to determine the significance of 
a fixed effect. For all the significant results, the effect sizes were given as Hedge’s g.  
 
5-4 Results 
Effects of Predictability on response accuracy and reaction time of correct trials 
A GLMM was created to examine how well participants performed the task. Two main 
factors were considered to affect response accuracy in the model: Predictability (Predictable/ 
Unpredictable) and DBS (DBS ON/ DBS OFF/ HC). In the GLMM, all levels of the 
categorical variables are compared to the base level (reference category). Here the base levels 
are: Predictable (for Predictability) and DBS ON (for DBS). All effects are estimated with 
respect to the base levels. The model showed that age-matched HCs had higher response 
accuracy than PD patients with stimulation ON (Z=2.88, p=0.004, Hedge’s g=0.32), whereas 
PD patients with STN DBS ON had higher response accuracy than OFF stimulation (Z=-3.85, 
p<.0001, Hedge’s g=0.27). For all participants, response accuracy did not differ between 
Predictable and Unpredictable blocks (Z=-0.52, p=0.602). The results suggest that (1) all 
participants performed equally well for Predictable and Unpredictable blocks, (2) PD patients 
with STN DBS ON had better performance than when OFF stimulation, however the small 
effect size shows that the significant difference on response accuracy between PD patients 
ON versus OFF STN DBS was not very robust, and (3)  age-matched HCs had better 
response accuracy than PD patients (both ON and OFF stimulation), but again the small 
effect size suggest that such a difference was not very robust. Figure 5.2 illustrates the above 
 251 
 
results.  
 
Figure 5.2 Response accuracy for Unpredictable (light grey bar) and Predictable (dark 
grey bar) for healthy control (HC), PD patients with deep brain stimulation (DBS) ON (DBS 
ON) and OFF (DBS OFF). Standard error of the mean is set as the error bars. The asterisk 
symbols denote the statistical significance.  
 
A LMM was created using RTs as the dependent variable. Two main factors were considered 
to affect response accuracy in the model: Predictability (Predictable/ Unpredictable) and DBS 
(DBS ON/ DBS OFF/ HC). In the model contrast of the LMM, all levels of the categorical 
variables are compared to the base level (reference category). Here the base levels are: 
Predictable (for Predictability) and DBS ON (for DBS). All effects are estimated with respect 
to the base levels. For all participants, RTs were faster during Predictable blocks 
(t(10610)=6.63, p<.0001, Hedge’s g= 0.41). There was no difference on RTs between PD 
patients ON versus OFF stimulation (t(10310)=-0.67, p=0.505). Age-matched HCs had faster 
RTs during Predictable trials than PD patient with STN DBS ON (t(10610)=2023, p=0.003, 
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Hedge’s g= 0.41) but not during Unpredictable trials (t(23)=-0.52, p=0.606). The results 
suggest that (1) all participants performed equally fast for Unpredictable blocks but HCs were 
the fastest during Predictable blocks, and (2) the acute manipulation of STN DBS did not 
have effects on RTs for PD patients. Figure 5.3 illustrates the above results. 
 
Figure 5.3 RTs of correct trials during Predictable and Unpredictable blocks for PD 
patients with STN DBS ON (DBS ON) and OFF (DBS OFF), and for healthy controls (HC). 
Standard error of the mean is presented as the error bars. The asterisk symbols denote 
statistically significant differences. As shown in the figures, all participants had similar 
behavioural patterns when responding to Predictable/Unpredictable blocks. The main 
difference is that age-matched HCs were much faster than PD patients (both ON/OFF 
stimulation) when responding to Predictable blocks.  
 
Effects of Trial type on response accuracy and reaction times (RTs) of correct trials  
Figure 4.4 shows the average RT for each of the 16 possible combinations of IS on the 
previous and the current trial, during predictable blocks. Due to the probabilistic nature of the 
task, some participants may not experience all 16 combinations. Therefore, these data were 
* * * 
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not suitable to be statistically analysed. However, from a pure observational point of view, in 
general there seems to be little difference between HCs and PD patients in both stimulation 
states. As shown by faster RTs to the highly probable combinations, it is clear that HCs were 
able to learn the relative probabilities between consecutive IS. For PD patients both ON and 
OFF stimulation, RTs for some combinations were faster despite the lower relative 
probabilities but does not seem to differ robustly between HCs (Figure 5.4). 
 
 
Figure 5.4 Average ± SEM group reaction times (RTs) for each of the 16 possible 
imperative stimulus (IS) combinations between the IS on trial t and t-1 for all three groups 
Healthy controls (HC) Parkinson’s disease patients (PD) with stimulation OFF (PD OFF) or 
ON (PD ON).  
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To further investigate how participants responded to Probable and Improbable trials in 
Predictable blocks, behavioural data was analysed with GLMM and LMM. Here a GLMM 
was creased using response accuracy as the dependent variable, with Probability 
(Improbable/Probable) and DBS (DBS ON/ DBS OFF/ HC) set as the fixed effects and 
subject as a random effect. The base levels in the present GLMM are Improbable (for 
Probability) and DBS ON (for DBS). All levels of the categorical variables are compared to 
the base level (reference category). Across Probable and Improbable trials, for PD patients, 
response accuracy was higher when ON stimulation than OFF stimulation (Z=-2.26, p=0.024, 
Hedge’s g= 0.22). PD patients did not differ in response accuracy between Probable and 
Improbable trials ON (Z=0.29, p=0.769) or OFF stimulation (Z=0.37, p=0.713). In addition, 
age-matched HCs had higher response accuracy than PD patients (Z=-2.90, p=0.004, Hedge’s 
g= 0.32). Taken together, the results indicate that (1) HCs had significantly higher response 
accuracy than PD patients, (2) PD patients with STN DBS ON had higher response accuracy 
than STN DBS OFF, despite the fact that effect sizes showed that such differences on task 
performance on probable vs improbable trials may not be robust across Probable and 
Improbable trial, and (3) age-matched HCs were more sensitive in reacting to 
Probable/Improbable trials. Figure 5.5 illustrates the above results.  
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Figure 5.5 Response accuracy for healthy controls (HCs), Parkinson’s disease patients 
with deep brain stimulation (DBS) of subthalamic nucleus (STN) OFF (DBS OFF) and ON 
(DBS ON). The error bars are standard error of the mean. The asterisk symbols denote the 
statistical significance. 
 
Moreover, a LMM was created using RTs of correct trials as the dependent variable, with 
Probability (Improbable/Probable) and DBS (DBS ON/ DBS OFF/ HC) set as the fixed 
effects and subject as a random effect. The base levels in the present LMM are Improbable 
(for Probabiliy) and DBS ON (for DBS). All levels of the categorical variables are compared 
to the base level (reference category). For all participants, RTs were faster for Probable than 
Improbable trials (t(6203)=-6.78, p<.0001, Hedge’s g= 0.82). PD patients did not differ on 
RTs between DBS ON versus OFF during Probable (t(6204)=-1.73, p=0.083) and Improbable 
trials (t(6203)=-1.75, p=0.080). There was no difference on RTs between PD patients and 
age-matched HCs (t(25)=-0.07, p=0.941). Taken together, the results indicate that (1) all 
participants had faster RTs during Probable trials than Improbable trials, (2) the acute 
manipulation of STN DBS did not affect RTs, and (3) there was no difference on RTs 
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between PD patients and age-matched HCs. Figure 5.6 illustrates the above results. 
 
 
Figure 5.6 RTs of correct trials during Probable and Improbable trials of Predictable 
blocks for PD patients with STN DBS ON and OFF, and for healthy controls (HC). Standard 
error of the mean is presented as the error bars. The asterisk symbols denote statistically 
significant differences. As shown in the figures, all participants had similar behavioural 
patterns when responding to Probable/Improbable trials. The main difference is that 
age-matched HCs were much faster than PD patients (both ON/OFF stimulation) when 
responding to Probable trials.  
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Table 5.3 Summary of the main findings of the behavioural data. 
 Predictable versus Unpredictable 
blocks 
Probable versus Improbable trials of 
Predictable blocks 
Response 
accuracy 
¾ All participants performed 
equally well on Predictable and 
Unpredictable blocks. 
¾ HCs had better performance on 
Probable trials than Improbable 
trials, but not PD patients.  
¾ PD patients had better performance ON than OFF stimulation 
¾ HCs had better performance than PD patients (both ON and OFF 
stimulation). 
RTs ¾ All participants responded faster to Predictable blocks/Probable trials than 
Unpredictable blocks/Improbable trials.  
¾ The acute manipulation of STN DBS did not affect RTs for PD patients. 
¾ All participants reacted equally fast when performing the task. 
 
5-5. Discussion  
The above analysis examined the effects of Predictability of blocks and Trial type (probable 
vs improbable) on response accuracy and RTs of correct trials. In terms of task manipulation, 
all participants had faster RTs during Predictable blocks and slower RTs for Improbable trials, 
which indicates that the task was reliable in examining action reprogramming (i.e. slowness 
after encountering surprising events). From a behavioural point of view, the results show that 
(1) all participants had faster RTs during Predictable blocks than Unpredictable blocks, and 
that the predictability did not make different on response accuracy for all participants, (2) the 
acute manipulation of STN DBS did not have effects on RTs but significantly improved task 
performance, and (3) PD patients were able to respond as fast as age-matched HCs however 
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the response accuracy was sacrificed, resulting in a behavioural speed and accuracy trade-off.  
 
The effects of STN DBS on action reprogramming 
Contrary to expectation, the acute manipulation of STN DBS did not render negative effects 
on decreasing RTs and/or producing more incorrect responses when trial types were 
improbable. Instead PD patients with STN DBS ON had higher overall response accuracy 
than when being OFF stimulation, although the effect sizes for the singifcant results were 
small (around 0.2). The hypothesis of the present study was that DBS of the STN would 
impaire inhibition when encountering unexpected sensory events (potentially by decreasing 
STN-beta power), resulting in faster RTs when encountering unexpected events. One possible 
factor may contribute to the observed results: for the current study PD patients were assessed 
ON medication to reduce discomfort, therefore the effects of medication may interfere with 
the effects of STN DBS. Moerover, unlike age-matched HCs, response accuracy did not 
differ between Probable and Improbable trials for PD patients, which may suggest that 
patients had certain difference in processing Probable versus Improbable events. Previous 
studies have shown that the sense of ‘Surprise’ or unexpectedness is closely related to 
prediction errors and thus may be associated with the level of dopamine in the brain 
(Bestmann et al., 2008; Galea et al., 2012; Shomaker & Meeker, 2015). On the other hand, 
the results may also suggest that the behavioural task requires certain improvements, as the 
results showed, PD patietns reacted to Improbable trials as fast as age-matched HCs. The 
difference seemed to appear when reacting to Probable trials, where age-matched HCs 
responded significantly faster than patients. This may suggest that the Improbable trials in the 
present study did not properly reflect the unexpectedness that would create robust action 
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reprogramming that was intended to study. Despite in the present study the results did not 
show speficits effects of STN DBS on action reprogramming, pervious studies have shown 
that the STN plays a major role in motor inhibition (Nambu et al., 2002; Aron &Poldrack, 
2006; Aron, Behrens, Smith, Frank, & Poldrack, 2007; Li et al, 2008; Forstmann et al, 2010; 
Kim & Hikosaka, 2015) and that DBS of the STN may interrupt such functions that leads to 
impaired inhibiton resulting in cognitive side effects in PD patients (Hershey et al., 2004, 
2010; Ballanger et al., 2009; Favre et al., 2013; Obeso et al., 2013; Georgiev et al, 2016; 
Williams et al, 2015). The inconsistent results of effects of STN DBS on behavioural data in 
PD patients may results from confounding factors such as individual difference, tasks used, 
experimental design, disease duration, and surgical procedures.   
 
Speed and Accuracy trade-offs (SAT) potentially affected task performance in PD patients  
For PD patients with both STN DBS ON and OFF, there was no effect of 
Probable/Improbable trials nor effect of Predictable/Unpredictable blocks on response 
accuracy. On the other hand, for age-matched HCs there were significant effects of these 
manipulations of probabilities on response accuracy. Furthermore, in the present studies PD 
patients were able to made responses as fast as HCs. However, PD patients both OFF and ON 
stimulation had lower response accuracy than HCs. Such an observation could potentially 
result from the SAT for PD patients, namely, in order to act fast the accuracy was sacrificed 
when performing the task. The inner drive to perform fast prevailed over performing 
accurately for PD patients. 
 
Four theories have been proposed to account for the underlying neural mechanisms of such a 
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trade-off: the cortical theory, the striatal theory, the STN theory and the synaptic theory, 
which stand for different circuits that modulate the balance between making a fast or making 
an accurate response (for details please see the review of Bogacz, 2010). The present study 
supports the striatal theory, which proposed that when speed is emphasised during 
decision-making (to select and make a response), the striatum receives excitatory signals 
from the cortical area that releases the inhibitory function of the basal ganglia, thus facilitates 
faster RTs but may lead to premature responses. Since PD patients in the current study were 
tested ON medication state, the SAT may thus be associated with dopaminergic medication 
increasing the activity of the striatum. On the other hand, in the present study acute 
manipulation on the effect of STN DBS increased the response accuracy but did not alter the 
RTs in PD patients, which in a sense may also be consistent with the STN theory, which 
suggests that in order to make accurate responses, the increased activity STN produced slow 
but accurate responses. Grossly speaking the effect of DBS is theoretically assumed to reduce 
the STN activity, such improvement on the task performance may be due to the optimal 
balance between dopaminergic medication and the STN DBS. Moreover, in the current study 
participants did not receive feedback after making responses therefore were unable to adjust 
decisions based on feedback. The potential effect of forgetting the stimulus-response 
mapping may also have contributed to the lower response accuracy for PD patients. 
 
In addition, PD patients with STN DBS ON had better response accuracy than when STN 
DBS was OFF, which may be hypothetically associated with the benefits of the treatment. 
The shift of attention is closely related to cognitive control and post-error slowing (Notebaert 
et al., 2009). It has been proposed that the basal ganglia play a role in focusing, which has 
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further suggested that dopamine suppresses the unwanted expected action and facilitates the 
initiation of the unexpected action (Redgrave et al., 199l; Cools et al., 2001; Frank, 2005; 
Isoda & Hikosaka, 2007; Hikosaka & Isoda, 2010). The ON medication state of PD patients 
in the present study therefore potentially facilitated the RTs when responding to 
Unpredictable/Predictable blocks and Probable/Improbable trials.  
 
Non-DBS treated PD patients had prolonged RTs in reacting to surprising events when OFF 
medication 
The occurrence of unexpected events and the need of action reprogramming can be seen as 
reflecting the sensorimotor system having issued a prediction error (Bestmann et al., 2008; 
Galea et al., 2012). Making decisions requires a certain degree of confidence, which 
represents the graded beliefs of the likelihood about the desired outcomes. Such confidence 
in making decisions could be derived from a mapping between the decision variables (i.e. 
accumulated sensory evidence) and the probability that the decision based on these decision 
variables is correct and leads to the desired outcome (Zylberberg et al., 2016; Kiani et al., 
2014). A previous study using the same probabilistic RT task as the present study had shown 
that non-DBS treated PD patients tested OFF dopaminergic medication had impaired action 
reprogramming, which demonstrates that prediction error, which relates to dopamine levels, 
modulates the action reprogramming deficits in PD patients (Galea et al., 2012). Moreover, in 
such a framework PD patients OFF medication have low dopamine levels and are less 
confident about the new sensory evidence thus are more reliant on top-down predictions, 
which results in prolonged RTs when prediction error occurs for PD patients OFF medication 
(Galea et al., 2012). Furthermore, dopamine is considered to reflect the precision or reliability 
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of sensory information. Computational studies have proposed a role of dopamine in encoding 
the precision of prediction errors that generate actions by simulating dopaminergic 
neurotransmission at a different level of a hierarchical mode (Friston et al., 2012; FitzGerald, 
Schwartenbeck, Moutoussis, Dolan, & Friston., 2015). Together, evidence from previous 
studies suggests that dopamine plays a major role in encoding the precision of prediction 
error and the confidence in updating prior beliefs with accumulated sensory information, 
therefore controls action reprogramming. PD patients in the present study were assessed ON 
medication, which potentially contributes to the non-sifnificant results of acute manipulations 
of STN DBS.  
 
To ameliorate the motor deficits in PD patients, clinically DBS STN and dopaminergic 
medication are combined depending on each patient’s motor symptoms. Many studies have 
been conducted separately in examining the effects of STN DBS and the effects of dopamine 
medication (Frank et al., 2007; Galea et al., 2012; Green et al., 2013; Djamshidian et al., 
2012, 2014; Huang et al., 2015; Pote et al., 2016) on cognition and motor function, however, 
for PD patients treated with both DBS and medication, it may not be easy to disentangle the 
effects of one treatment from the other even with acute manipulation of ON or OFF these 
treatments. It remains unclear how the relationship between dopaminergic medication and the 
STN together affect the motor and cognitive function in PD patients. Novel approaches 
should be developed in assessing the effects of both treatments for PD in order to reach better 
disease management for patients and carers and provide insights on the brain networks in 
future. 
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Summary 
To sum up, the results show that the acute manipulation of STN DBS did not render negative 
effects on RTs during action reprogramming. In addition, PD patients exhibited a robust SAT 
when performing the probabilistic task. However, it is not to say that DBS of STN would not 
interfere with the STN functions on inhibition and cognitive/motor control that may result in 
side effects in PD patients. Future studies are required to (1) investigate the role of STN on 
interrupting cognition such as working memory after encountering unexpected events, and (2) 
the connections between dopaminergic medication and STN DBS on modulating SAT in PD 
patients. 
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Chapter 6 General Discussion 
6-1 Main findings from each study 
Evidence from previous studies, as discussed in Chapter 1, has suggested that treatments for 
Parkinson’s disease (PD) such as dopamine medication and deep brain stimulation (DBS) of 
the subthalamic nucleus (STN) would induce side effects on basic executive functions (EFs) 
including abilities of shifting, updating and cognitive flexibility in patients, possibly due to 
the ‘dopamine overdose hypothesis’ and the hypothetical effects of DBS on the role of the 
STN in inhibitory control and sensory information integration, leading to impairments on 
performing certain behavioural tasks. Studies in the present PhD thesis thus focused on 
assessing the acute effects of both treatments (i.e. dopamine medication and STN DBS) for 
PD patients on behaviours associated with speed and accuracy trade-off (SAT) modulation 
and sensory information sampling and updating, using behavioural tasks such as a moving 
dots task and a probabilistic reaction time (RT) task. The studies assessed how PD patients 
perform the behavioural tasks ON versus OFF treatments in relative to age-matched healthy 
controls (HC). In addition, hierarchical drift diffusion models (HDDM) were applied to the 
behavioural data to further derive the underlying cognitive components during task 
performance. In general, there were no robustly negative effects induced by acute 
manipulation of both treatments on behavioural data. Despite the limitations of the task 
design, the behavioural results combining psychological test scores suggest that while some 
evidence shows that medical and surgical treatments can induce negative side effects on 
cognition for PD patients, such side effects may be small and specific to individuals, 
indicating that both treatments are safe and reliable procedures in ameliorating motor 
symptoms of PD without inducing negative side-effects on cognitive functions. 
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However, while the acute manipulations of both treatments produced no significantly 
negative effects on general task performance, PD patients were found to show subtle defects 
on cognitive components involving the ability to update and sample the environmental 
sensory information, which may further lead to the subtle impairments on the modulation of 
SAT. In Chapter 2, the results showed that PD patients who had been clinically diagnosed 
with impulse control disorders (ICD) were able to perform the moving dots tasks as well as 
age-matched healthy controls (HC) in terms of RTs and response accuracy. A ceiling effect 
may exist for the selected moving dots task as most participants had response accuracy as 
high as more than 95%, therefore the task may not be challenging enough to reflect the 
effects of medication, as well as the difference between patient group and age-matched 
healthy control group. Nevertheless, the results indicate that the clinical approaches on 
reducing dopamine agonist to treat impulsive behaviour did not induce any negative side 
effects on motor or cognitive functions for PD patients who developed with ICDs. Despite 
showing no significant acute effects of dopamine medication, PD patients with ICD history 
and PD patients without ICDs showed different behavioural patterns on the same moving 
dots task (Huang et al., 2015). The results are in line with previous studies showing that PD 
patients with and without ICDs showed different behavioural patterns in decision-making 
even after PD patients with ICDs are treated, which may suggest that PD patients who are at 
risk of developing ICDs show difference on certain functions that could be predictable prior 
to medication administration (Djamshidian et al., 2010; Djamshidian et al., 2012). Chapter 3 
thus introduced a study using behavioural data collected from the moving dots tasks to build 
classification predictive models, in order to investigate the hypothesis on PD patients with 
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and without ICDs may be distinguishable by building classification predictive modelling with 
certain task performance patterns. The results show that difference on performance of certain 
tasks between PD patients who developed ICDs and PD patients who did not have ICDs is 
distinguishable using a machine learning algorithm. Such distinct behavioural pattern could 
therefore be used as a screen tool to predict PD patients who have high risk to develop ICDs 
thus preventing the onset of the disorders. Moreover, previous evidence suggests that PD 
patients with ICDs showed different behavioural patterns on a task required sensory 
information updating compared to PD patients without ICDs (Djamshidian et al., 2012). 
Together, the results suggest that tasks involving information updating and SAT modulation 
may be powerful in predicting vulnerability to develop ICDs in PD patients.  
 
In addition to the effects of dopamine medication on behaviours in PD patients, the present 
thesis also aimed to investigate the effects of STN DBS PD in PD patients. In Chapter 4, a 
block-designed moving dots task was used to investigate the hypothesis on PD patients with 
STN DBS may show deficits on task switching. In addition, the nature of moving dots task 
could provide a chance to study the effects of STN DBS on SAT modulation and sensory 
information updating. The results show that the acute manipulation of STN DBS did not 
induce deficits on task switching for PD patients in a block-desinged moving dots task. 
However, PD patients with STN DBS ON did show impairments on a psychological test 
assessing the ability of task switching, which supports that DBS of the STN impairs certain 
task-swithcing abilities in PD patients. The evidence suggests that task-switching may 
involve fundamentally different but related cognitive processes, which are controlled by 
distinct brain areas. Moreover, the above results are in line with the hypothesis that the 
 267 
 
reliability of sensory information plays an important role on modulating SAT. Moreover, PD 
patients still showed subtle difference on underlying cognitive components under the effects 
of DBS, which supports a role of the STN on modulating SAT and sensory information 
integration during task performance. To further investigate on how STN DBS may affect the 
function of STN on imformation updating and inhibitory control, a probabilistic RT task was 
used to assess the effect of STN DBS on reprogramming actions when encountering 
unexpected sensory events in PD patients. The results show that the acute manipulation of 
STN DBS did not induce negative effects on the probabilistic RT task for PD patients. The 
results may be due to the task design not properly inducing the unexpectedness that would 
create robust action reprogramming that was intended to study. In addition, PD patients 
exhibited robust SAT when performing the probabilistic RT task, which may indicate that PD 
patients were predominately aiming to act fast therefore sacrificed response accuracy. 
Moverover, PD patients treated with STN DBS were assessed ON medication, which may be 
the reason why the results did not reflect the hypothetical effects of DBS on interrupting the 
role of STN in motor control that induce fast RTs and more incorrect responses in PD 
patients. 
 
6-2 Clinical and theoretical implications 
The present thesis investigated the acute effect of dopamine medication and STN DBS on 
EFs in PD patients by assessing PD patients ON versus OFF treatments with behavioural 
tasks associated with the abilities of updating, shifting and inhibition, therefore may shed 
lights on the role of dopamine medication and DBS of the STN on motor inhibition and 
cognitive control in patients with PD. Overall speaking, in the studies of present PhD thesis 
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both dopaminergic medication and STN DBS were effective in ameliorating motor deficits in 
PD patients and produced no significantly negative effects on behaviours. Moreover, PD 
patients did not show significantly negative effects on most of the psychological tests 
compared to age-matched HCs, except for affective psychiatric tests such as depression 
inventory scores and apathy scale. Combining the previous and present results, both 
dopamine medication and STN DBS are considered to be safe and effective methods in 
treating PD. Despite the results showing no significant side effects produced by the acute 
manipulations of both treatments, it is not to say that long term administration of both 
treatments would not induce side effects in PD patients. 
 
As discussed in Chapter 1, the dopamine overdose hypothesis proposed by Cools et al (2001) 
states that, the administration of dopamine medication to PD patients may replete 
dopamine-depleted regions such as the dorsal, rostral head of the caudate nucleus and the 
putamen, but may overstimulate relatively intact regions such as the ventral striatum in early 
PD, leading to poorer performance on tasks mediated through these circuits such as reversal 
learning (Cools et al, 2001), conditional associative learning (Gotham et al, 1998), complex 
discrimination learning (Swainson et al, 2000), and probabilistic classification learning 
(Jahanshahi et al 2010). In addition, Weintraub et al (2010) proposed that ICDs were more 
common in patients treated with dopamine agonists, showing higher probabilities of inducing 
ICDs for dopamine agonist treatment. In the present study the acute manipulation of 
dopamine medication did not affect task performance but did improve motor functions in PD 
patients with ICD history, which may result from (1) in the present study the recruited PD 
patients were not early PD, therefore the ventral striatum may be dopamine depleted as the 
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disease progressed and that medication would not overstimulate the area, (2) the dopamine 
overdoes hypothesis does not apply to treated PD+ICD patiens as their medication treamtents 
have been adjusted to a level that no signifricant behavioural impairments would be observed, 
and (3) the dopamine overdoes hypopthesis does not apply to the processes of the moving 
dots tasks performance. It is difficult to determine how disease progress affects the 
degeneration of dopamine neurons in different striatal regions in different PD patients, and 
how dopamine medication stimulate or overstimulate certain regions in treating PDs. 
However, the results of Chapter 3 provide a possibility that the onset of PD+ICD may be 
predictable by analysing performance on behavioural tasks associated with EFs.   
 
In addition to dopamine overdose hypothesis, it has been suggested that dopamine agnosit is 
closely related to the onset of ICDs (Voon & Fox, 2007; Weintraub et al., 2015). Moreover, it 
has been suggested that obsessive-compulsiveness is closely related to impulsivity in 
individuals (Li & Chen, 2007; Isaias et al., 2008). Impulsivity is not a unitary phenomenon 
and has several distinct components (Evenden, 1999; Dalley, Everitt, & Robbins, 2011). First, 
delayed motor inhibition (‘impulsive action’). Second, a failure to take time to reflect and 
adequately sample evidence before making a decision (‘reflection impulsivity’). Third, an 
inability to delay gratification shown as a tendency to accept small immediate rewards over 
larger delayed rewards (‘impulsive choice’). Fourth, engagement in risky behaviours such as 
gambling. Different experimental tasks tap different components of impulsivity. Table 6.1 
summarises the studies that have used different behavioural tasks to examine the four 
components of impulsivity in PD patients with ICDs. In general, most of the behavioural 
studies showed that PD patients with ICDs made more impulsive and risky choices on 
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behavioural tasks except for one study that found no difference between PD patients with or 
without ICDs (Pineau et al., 2016) (see Table 6.1). Furthermore, PD patients with ICDs were 
not impaired on motor inhibition assessed on the stop signal task (Claassen et al,2015; Leroi 
et al, 2013). Also, hasty decisions under conflict on tasks such as the Simon task (Wylie et al., 
2012) or the Stroop interference test (Djamshidian et al., 2011) were not observed in PD 
patients with ICDs, such results are in line with results from Chapter 2. Thus, the available 
evidence suggests that PD patients with ICDs exhibit specific forms of impulsivity and do not 
have a generalized deficit in inhibitory control. These results contradict with the hypothesis 
that PD patients with impaired EFs such as motor inhibition are more prone to develop ICDs 
(Weintraub et al., 2010, 2015). 
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Table 6.1. Behavioural studies examining different aspects of impulsivity in non-surgically treated patients with Parkinson’s disease (PD) who 
developed impulse control disorders (ICDs).  
Type of Impulsivity 
Assessed 
Authors Behavioural Tasks Main findings 
Impulsive Action 
(failure of motor inhibition) 
Claassen et al (2015) 
Leroi et al (2013) 
Stop Signal Task PD+ICD patients did not show impulsive action. 
Reflection Impulsivity 
(Sample less information 
before making decisions) 
Djamshidian et al 
(2012) 
Wylie et al (2012) 
Djamshidian et al 
(2011) 
Beads Task 
Simon Conflict Task 
Stroop Task 
All PD patients (PD+ICD patients and PD-ICD patients) 
had similar performance on all behavioural tasks 
 
Djamshidian et al 
(2014) 
Simple Reaction time task/ 
Perceptual 
decision-making task 
PD+ICDs had faster RTs on the simple reaction time task, 
and had fastest RTs on incorrect trials on perceptual 
decision-making task 
Impulsive Choice 
(choose small but 
immediate reward over 
large but delayed rewards) 
Voon et al (2010) 
Voon et al (2011) 
Leroi et al (2013) 
Discounting Task 
Risk task 
PD+ICD patients made more risky choices and had 
impaired EFs with greater anterior insular activity 
compared to PD-ICD patients 
Housden et al (2010) self-rated Kirby delay 
discounting 
questionnaire /Delay 
Discounting Task 
PD+ICD patients showed highly elevated delay 
discounting than PD-ICD patients  
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Risky Behaviour (on 
gambling tasks) 
Bentivoglio et al 
(2013) 
Rossi et al (2009) 
Pineau et al (2016) 
Iowa Gambling Task PD+ICD patients showed a statistical trend to make more 
risky choices than PD-ICD patients  
Djamshidian et al 
(2010) 
Gambling Task PD+ICD patients were more risk prone than PD-ICD 
patients  
PD+ICD: Parkinson’s disease patients with impulse control disorders; PD-ICD: Parkinson’s disease patients without impulse control disorders; 
HCs: healthy controls; PD+DA: Parkinson’s disease patients treated with dopamine agonists; PD-DA: Parkinson’s disease patients treated 
without dopamine agonist.
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In the present thesis, the acute manipulation of STN DBS did not render significant 
negative effects on task performance. The results are consistent with previous 
follow-up studies showing that STN DBS produced no negative effects on global 
motor and cognitive functions (Funkiewiez et al., 2004; Temel et al., 2006; Schüpbach 
et al., 2005; Troster et al., 2017). However, It remains unclear how exactly DBS 
affects the STN functions, the studies have suggested that DBS of the STN decreases 
beta-band oscillations that leads to motor improvement in PD patients (Kuhn, Kupsch, 
Schneider, & Brown., 2006; Kuhn et al., 2008). Moreover, the effect of DBS on the 
STN in PD patients is hypothesised to interrupt with the theoretical role of the STN 
on information integration and serving as a brake in the brain comes from its 
involvement in global motor inhibition via the hyperdirect pathway, leading to 
impaired inhibition and motor/cognitive control.  
 
On the other hand, previous studies have shown that the STN plays a role in 
information integration when decision conflicts are presented, leading PD patients 
with DBS ON to have impulsive decisions/behaviours (Frank et al., 2007; Green et al., 
2013). Computational models of decision-making hypothesise that the STN mediates 
the function of slowing down when facing difficult decisions by elevating decision 
thresholds so that more evidence could be sampled before making an optimal 
response (Bogacz & Gurney, 2007; Frank, 2005; Frank et al., 2007; Bogacz, 2010; 
Mansfield, Karayanidis, Jamadar, Heathcote, & Forstmann, 2011; Cavanagh et al., 
2011; Green et al., 2013). In addition, the present thesis also supports the 
‘urgency-gating model’ proposed by Thura & Cisek (2017), which suggest that the 
basal ganglia are hypothesised to control the SAT between committing to a choice 
versus continuing the selection. However, Thura & Cisek (2017) suggested that 
instead of contributing to the choice between potential movements, the basal ganglia 
 274 
 
actually provide a time-dependent signal that controls the urgency to commit to a 
choice, which could lead to the adjustment of the SAT when making decisions. In the 
present study it is not determined whether the STN is involved in providing such 
time-dependent signal. Future studies are in need to investigate on how the STN is 
involved within the urgency-gating model. 
 
Taken together, studies in the present thesis showed that (1) while dopamine 
medication is closely related to the onset of ICDs, it is possible to identify PD patients 
who may be prone to develop ICDs before medication treatments, which could have 
clinical benefits for desease prevention, and that (2) in both studies PD patients 
treated with STN DBS were assessed ON medication, which may be the reason why 
the results did not reflect the hypothetical effects of DBS on interrupting the role of 
STN in cognitive and motor control. It may be hypothesised that the impaired 
inhibitory control could be diminished by dopamine medication. In addition, DBS of 
the STN may not induce impaired inhibitory control in all conditions, however the 
rpesent studies did not rule out the the possibility of STN DBS to impaire 
motor/cognition control in PD patients. It requires more studies on determining the 
distinct effects of dopamine medication and STN DBS on these functions in PD 
patients, which may also shed lights on the normal functions of dopamine and the 
STN on cognitive functions.  
 
6-4 Limitations  
There are a few limitations of the studies, some of which have been addressed in each 
experimental chapter. In this section I will briefly review these limitations and provide 
potential ways to improve these flaws for future studies.  
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Firstly, the design of the chosen behavioural tasks in the present studies appeared to 
be suboptimal in examing the executive functions interested of topic. For example, the 
moving dots task used in Chapter 2 seemed to have a ceiling effect. In addition, 
contrary to previous studies showing that treatments of PD have effects on the task 
performance (Frank et al., 2007; Green et al., 2013; Pote et al., 2016; Galea et al., 
2012), the present studies revealed no robust effects of acute manipulations of 
treatments. The inconsistent results may be due to difference on task design (such as 
the dots coherence in the Green study and present study being different), experimental 
procedure and individual difference. Approches should be developed in account for 
the potential effects of the above confounding factors (Whitsett & Shoda, 2014; 
Hayward, 2007).  
 
Secondly, small sample sizes have been a general issue in all studies due to difficulties 
in recruiting participants that would be discussed later. To diminish the disadvantages 
of small sample sizes, effect sizes were calculated for each significant effect of 
treatment manipulation and each significant difference between groups using Hedges’ 
g. For moderate to large effect sizes, it suggests that the effects are robust despite the 
small sample sizes. For the present studies, although most of the effect sizes reported 
were small to moderate effect sizes, due to the participants being patient groups, small 
effect sizes may still indicate beneficial improvements or noticeable impairments that 
are worth investigating. One of the reasons for the small sample sizes in the present 
thesis was because the experimental design of all behavioural studies was to examine 
the acute effects of treatments on cognitive and motor functions. Patients were 
therefore required to be OFF treatment for at least 2-3 hours to assess the behavioural 
data. This was a great concern for most patients therefore many of them refused to 
participate in studies because they did not want to be OFF treatments. In addition, the 
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participation of the study was purely voluntary, which means that the participants 
received no monetary reimbursement. This drawback could make it less motivated for 
patients to participate in the studies. To reduce the difficulties in recruiting patients to 
participate in behavioural studies, better communication should be formed between 
patients and experimenters. The experimenters have the responsibilities to make the 
experiments clear and relevant to the patients in order to increase their willingness to 
take parts in by carefully designing the experiments and explaining the aims in details 
to the patients. During the process of designing the experimental tasks, most concerns 
have been put onto the convenience of the experimenters. It should be considered with 
more carefulness the balance between the aims of the research, the procedures of the 
experiments and how it would affect the patients. For example, being OFF treatments 
would no doubt cause discomforts to patients therefore it is understandable why 
patients would refuse to participate in the studies. It is therefore important to consider 
if the acute manipulation of treatments is a necessary design to achieve the aims of the 
research. If it is necessary for the purpose of the study, the experimenters should be 
dedicated to make the experimental environment trustworthy and somehow closer to 
comfortable for patients to be willing to participate in the study. These important 
issues should be carefully considered when designing experimental procedures 
especially for recruiting the patient groups as experimental participants.  
 
Third and correspondingly, due to the difficulties in recruiting PD participants, same 
patients have been repeatedly calling back to do other studies. Bias may occur such as 
patients who are willingly to participant in scientific research repeatedly have certain 
personality traits that may potentially affect behaviours. The results collected from the 
same group of patients may therefore not be robust in representing larger patient 
population. For future studies, it is therefore important to increase sample sizes and 
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PD patient group. This could be achieved by spreading news via social media pages 
(e.g. Twitter, Facebook and Instagram) and charity foundation (e.g. Parkinson’s UK) 
so that more PD patients would know about the study therefore increasing the 
probability of participation. 
 
Fourthly, ICD patients were treated OFF medication than ON medication for practical 
reasons, practice effect thus could not be distinct from the effect of medication. In 
order to make certain that the effect of dopaminergic medication was completely OFF 
when testing patients for OFF session, it is required for patients to have an overnight 
withdrawal (approximately 12-16 hours) from their normal medication prior to testing. 
Previous study has shown no practice effect for age-matched HCs on the moving dots 
task therefore when designing the experiment it did not strike me as a problem. 
However, the present results proved that there was a practice effect for HCs and the 
effect of dopaminergic medication could therefore not be ruled out for PD patients. In 
order to prevent such misunderstanding, it is recommended to assess the effect of 
dopaminergic medication in a counter-balanced design in the future. In addition, in 
the present studies the tasks seem to have a ceiling effect as both patient group and 
healthy control groups had more than 95% response accuracy. The task difficulty 
should also be carefully designed in future studies to investigate proposed hypotheses.  
Fourth, PD patients treated with bilateral STN DBS were assessed ON medication 
state. The effects of dopaminergic medication (especially dopamine agonists) could 
therefore not be ruled out. In animal studies, STN high-frequency stimulation (HFS) 
has been demonstrated to increase striatal dopamine release and metabolism (Bruet et 
al., 2001; Meissner et al., 2003; Lacombe et al., 2007; Zhao et al., 2009; Pazo, Hocht, 
Barcelo, Fillipini and Lomastro, 2010), such increase is hypothesised to cause the 
improvement of movement deficits in PD. However, human studies on DBS-STN 
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have found no evidence supporting the hypothesis that DBS-STN increase the striatal 
dopamine level (Hilker et al., 2003; Strafella, Sadikot & Dagher, 2003; Nozaki et al., 
2013). Clinical observations on PD patients have shown that patients treated with 
STN DBS decrease the intake of dopamine medication. Nevertheless, the interactions 
between STN DBS and dopaminergic medication and the underlying neural 
mechanisms on improving motor and (possibly) cognitive functions remain unclear. 
Future studies are in need to shed lights on the connections between the treatments 
and the way they work in better understanding PD and how to treat the symptoms.  
 
6-5 Direction for future research 
The present thesis provides several different directions for the future studies.  
 
In terms of the effects of dopamine medication, Chapter 2 suggests that in line with 
previous studies, PD patients with ICD history were able to perform as well as 
age-matched HCs on a moving dots task manipulating decision conflict, and that the 
acute effect of medication did not produce negative influences on task performance. 
Voon et al (2017) proposed that chronic treatment with dopamine medication can 
interfere with the phasic and tonic activity of dopaminergic neurons, which could be 
associated with long-term neuro-adaptation including regulation of receptor and 
transporter density. It has also been suggested that reduced concentrations of striatal 
dopamine transporter (Smith et al., 2016; Voon et al., 2014; Vriend et al., 2014), and 
altered striatal and cortical dopamine homeostasis (Rao et al., 2010; Ray et al., 2012) 
may potentially contribute to the development of ICDs. Moreover, factors such as 
personal or family history of alcoholism or gambling; younger age; impulsive or 
novelty-seeking traits; gender (male for hypersexuality, female for binge eating and 
pathological shopping); early onset of PD; being unmarried; and past or current 
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cigarette smoking can all be associated with the development of ICDs in PD (Voon & 
Fox, 2007; Weintraub et al., 2010; Weintraub et al., 2015). Future studies should 
therefore focus on the chronic effects of dopamine medication, especially dopamine 
agonist, and identify risky factors on inducing risky behaviours and choices in PD 
patients, in order to prevent the onset of ICDs in patients, which may also shed lights 
on the underlying neural mechanisms. The effects of dopamine agonist on inducing 
impulsive choices may also provide insights on how abnormal dopamine transmission 
would lead to pathological gambling and addiction. Future studies investigating the 
development of ICDs in PD patients should focus on impulsive choices and risky 
behaviour that involve rewarding effect and corresponding neural mechanisms such as 
the mesolimbic dopaminergic pathways. On the other hand, the present thesis 
indicates PD patients developed ICDs may potentially be identified before medication 
treatment through tasks associated with EFs 
 
In addition, dopamine has been well established to be involved in major cognitive 
functions such as reinforcement learning, decision-making and motor/cognitive 
control. Most of the dopamine neurons reside in the midbrain and form three cell 
groups: (1) the retrorubral nucleus (RRN, cell group A8 in the rat); (2) the substantia 
nigra pars compacta (SNpc, A9) and (3) the ventral tegmental area (VTA, A10) (Daw 
& Tobler, 2014). Over the past several decades, two aspects have been proposed to be 
the major functions of dopamine in the striatum: (1) movement control and (2) 
modulating motivation and reward. The majority of studies have been focused on how 
the brain resolves the reinforcement learning problem via the midbrain dopamine 
neurons (Glimcher, 2011; Niv, 2009; Daw & Tobler, 2014; Schultz, Dayan & 
Montague, 1997). Besides the reinforcement learning framework in explaining 
learning and decision-making, Friston, Daunizeau & Kiebel (2009) have proposed 
 280 
 
that optimal behaviours could be guided by the adjustment of the agents’ internal 
states and external sampling of sensory evidence to minimise free energy, which 
discard the notion of reward, value or utility. Such framework is termed as ‘active 
inference’ (Friston et al., 2009). It has been suggested that the brain can be regarded 
as an inference machine, which governs the processes involved in accumulation of 
sensory information and making inference about the external world (Helmholtz, 1866; 
Gregory, 1980; Rao & Ballard, 1995; Friston et al., 2005; Friston, 2010). Friston et al 
(2012) have considered dopamine neurotransmission as an integral part of 
Bayes-optimal perception and sensorimotor integration that responds to the perceptual 
cues in an environment with a fixed level of uncertainty. In active inference, 
behaviour emerges as a natural consequence of high-level sensorimotor 
representations that are maintained by bottom-up prediction errors in both sensory and 
motor modalities (Friston, Daunizeau, Kilner & Kiebel, 2010; Friston et al., 2013; 
Friston & Kiebel, 2009). In other words, dopamine is involved in selecting the 
proprioceptive (motor) and exteroceptive (sensory) signals (prediction errors) that 
compete for higher level explanation by controlling their precision, which means that 
dopamine is in a position to select an attribute of a probabilistic representation that 
determines the confidence about what is presented (Friston et al., 2012). Moreover, 
confidence in making a decision can be associated with decision itself (i.e. to obtain 
more information and/or prediction of a reward) and a link between previous decision 
outcomes and the strategy on guiding the following decisions (van den Berg et al., 
2016a). Confidence, choice and RTs are further proposed to be elements in a bounded 
evidence accumulation process (van den Berg et al., 2016b). Together previous studies 
have suggested an important role of dopamine in reinforcement learning and making 
inference, how dopamine depletion may affect these functions in PD patients could 
therefore bring insights on the supporting the hypothetical role of dopamine in the 
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brain. 
 
Following the results of Chapter 2, the machine learning study described in Chapter 3 
suggests that it is possible to use behavioural pattern as an input factor in building 
predictive models that serve as a screening tool to distinguish patients who may be 
more likely to develop ICDs in the future. Previous studies have also suggested the 
existence of pre-motor markers that may predict high risk in developing PD for some 
people (Chaudhuri & Schapira, 2009; Büttner et al., 1995; Postuma et al., 2006). 
Moreover, the application of machine learning on clinical data may also be powerful 
and useful to monitor disease progress for patients with long-term diseases such as PD. 
Diseases are not caused by one single factor but various factors interacting on various 
levels. Interdisciplinary research programmes are needed to better monitor the 
progress of chronic diseases. In 2014, New York University’s Institute for the Study 
of Decision Making and the Kavli Foundation have initiated an interdisciplinary 
research platform named The HUMAN Projects (URL: 
https://www.thehumanproject.org/), which attempts to link the connections between 
human minds, bodies and environment to build a comprehensive understanding of the 
factors and the interactions between these factors that shape how people live and 
affect their health and well-being (Azmak et al., 2015). These factors and the 
interactions between the factors may further help to form new theories, therapeutics 
and policies that improve the quality of life. Chronic diseases such as PD and 
Alzheimer’s disease result from interactions between many different factors on 
various levels, and the disease progress also highly correlated with theses interactions. 
If similar research platform could be built for patients who have chronic diseases, 
clinicians, caregivers and patients themselves could benefit from the data and be more 
efficient in monitoring the disease progress. Smartphone applications can be used to 
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help track each patient’s individual data on various levels such as medication intake, 
food intake, mood, and the amount of exercise... etc. These data could be further 
analysed and used for building customized models that help to improve the quality of 
live for both patients and caregivers, especially for long-term degenerative diseases 
such as Parkinson’s disease. 
 
On the other hand, Chapter 4 supports the hypothesis that the STN plays a role in task 
switching. Moreover, the evidence suggests that task-switching may involve 
fundamentally different but related cognitive processes, which are controlled by 
distinct brain areas. The results are also in line with the hypothesis that the reliability 
of sensory information plays an important role on modulating SAT (Devene, 2012). 
Furthermore, PD patients still showed subtle difference on underlying cognitive 
components under the effects of DBS, which supports a role of the STN on 
modulating boundary separation and sensory information integration. While some 
studies suggest that when decision conflict was presented, PD patients with STN DBS 
ON would show impulsive behaviours when response accuracy was emphasised 
(Bogacz & Gurney, 2007; Frank, 2005; Frank et al., 2007; Bogacz, 2010; Mansfield et 
al., 2011; Cavanagh et al., 2011; Green et al., 2013), one suggested that speed 
pressure without decision conflict could induce impulsive behaviours (Pote et al., 
2016), and others proposed that the inability to slow down when making decisions 
during high decision conflict conditions and the exhibition of reflection impulsivity 
by PD patients who had undergone functional neurosurgery was associated with 
dopamine agonists rather than with DBS (Djamshidian et al., 2013; Djamshidian et al., 
2014). Future studies are needed to determine how these multiple factors (i.e. STN 
DBS, dopamine agonist, decision conflict and SAT) and their interactions affect PD 
patients when making perceptual decisions. Moreover, future studies may be 
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developed to investigate how the STN is involved in modulating decision thresholds 
during value-based decision making, which may provide insights on how 
cortico-basal ganglia circuits participate in the computation of the associations 
between action and outcome, and the evaluation of the rewards that are associated 
with the different outcomes.  
 
Moreover, Chapter 5 shows that the acute manipulation of STN DBS improved task 
performance on the probabilistic RT task for PD patients. The observation indicates 
that PD patients with STN DBS ON slowed down when encountering surprising 
events but not to a degree that would induce abnormally slowed behaviours. Such an 
observation contradicts the hypothesis that DBS in PD patients would disrupt the 
function of the STN in serving as a brake in the brain that would allow more 
information to be accumulated during ambiguous conditions, resulting in impulsive 
decisions/actions and impaired action reprogramming (Frank et al., 2007; Green et al., 
2013). Future studies are therefore required to determine the role of the STN in 
making decisions under ambiguity. Moreover, PD patients exhibited a robust SAT 
when performing the probabilistic task. Four theories have been proposed to account 
for the underlying neural mechanisms of such a trade-off: the cortical theory, the 
striatal theory, the STN theory and the synaptic theory, which stand for different 
circuits that modulate the balance between making a fast or making an accurate 
response (for details please see the review of Bogacz, 2010). The present results 
support both striatal and the STN theory on modulating the SAT. Future studies may 
be developed to determine the underlying neural mechanisms.  
 
In addition, Wessel et al (2016) found that encountering unexpected events increases 
STN activity, which leads to the decrement of verbal working memory, and is related 
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to attentional reorientation. The authors therefore proposed that encountering 
surprising events would interrupt cognition via the same fronto-basal ganglia 
mechanism that interrupts action, which may lead to a new theory of distraction that 
involves a cortico-basal ganglia network that underlies motor suppression but also 
affects cognitive function (Wessel et al., 2016). Studies are in need to investigate the 
role of STN on interrupting cognition such as working memory after encountering 
unexpected events, and the connections between dopaminergic medication.  
 
Overall speaking, the present PhD thesis suggests that both STN DBS and dopamine 
medication are effective in treating motor dysfunction in PD and the potential siede 
effects induced by treatments may be specific to individuals under certain coditions. 
However, the results do not rule out the potential side effects thay may be induced by 
treatments which would result in devastating consequnces to certain patients and their 
families. As prevention is better than cure, it is useful to further explore the 
possibilities of developing screening tools to identify risk factors for developing other 
disorders such as ICDs and dementia in individual patients, in order to reach better 
patient-centered care, which focuses on the individual's particular health care needs.  
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Appendices
In [5]:
Plotting a_Intercept 
Plotting a_C(type)[T.SP] 
Plotting a_C(time)[T.T2] 
Plotting a_C(Group)[T.PD ICD] 
Plotting a_C(type)[T.SP]:C(time)[T.T2] 
Plotting a_C(type)[T.SP]:C(Group)[T.PD ICD] 
Plotting a_C(time)[T.T2]:C(Group)[T.PD ICD] 
Plotting a_C(type)[T.SP]:C(time)[T.T2]:C(Group)[T.PD ICD] 
Plotting v_Intercept 
Plotting v_C(time)[T.T2] 
Plotting v_C(Group)[T.PD ICD] 
Plotting v_C(time)[T.T2]:C(Group)[T.PD ICD] 
Plotting t_Intercept 
Plotting t_C(type)[T.SP] 
Plotting t_C(time)[T.T2] 
Plotting t_C(Group)[T.PD ICD] 
Plotting t_C(type)[T.SP]:C(time)[T.T2] 
Plotting t_C(type)[T.SP]:C(Group)[T.PD ICD] 
Plotting t_C(time)[T.T2]:C(Group)[T.PD ICD] 
Plotting t_C(type)[T.SP]:C(time)[T.T2]:C(Group)[T.PD ICD] 
#plot the figures to examine the convergence of the model
m_Speed.plot_posteriors()
plt.show()









In [6]: a_Intercept, a_Group, a_Time, a_Type, a_Group_Time, a_Group_Type, a_Time_Type, a_
#Plot the posterior distribution of decision threshold (a) under the influence of
hddm.analyze.plot_posterior_nodes([a_Group])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(a_Group < 0)=", (a_Group.trace() < 0).mean()
#Plot the posterior distribution of decision threshold (a) under the influence of
hddm.analyze.plot_posterior_nodes([a_Time])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(a_Time < 0)=", (a_Time.trace() < 0).mean()
#Plot the posterior distribution of decision threshold (a) under the influence of
hddm.analyze.plot_posterior_nodes([a_Type])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(a_Type < 0)=", (a_Type.trace() < 0).mean()
#Plot the posterior distribution of decision threshold (a) under the inflence of 
hddm.analyze.plot_posterior_nodes([a_Group_Time])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(a_Time_Group < 0)=", (a_Group_Time.trace() < 0).mean()
#Plot the posterior distribution of decision threshold (a) under the influence of
hddm.analyze.plot_posterior_nodes([a_Group_Type])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(a_Type_Group < 0)=", (a_Group_Type.trace() < 0).mean()
#Plot the posterior distribution of decision threshold (a) under the influence of
hddm.analyze.plot_posterior_nodes([a_Time_Type])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(a_Type_Time < 0)=", (a_Time_Type.trace() < 0).mean()
#Plot the posterior distribution of decision threshold (a) under the influence of
hddm.analyze.plot_posterior_nodes([a_Group_Time_Type])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(a_Type_Time_Group < 0)=", (a_Group_Time_Type.trace() < 0).mean()
P(a_Group < 0)= 0.56797979798 
P(a_Time < 0)= 0.602616161616 
P(a_Type < 0)= 0.996454545455 
P(a_Time_Group < 0)= 0.668545454545 
P(a_Type_Group < 0)= 0.801767676768 
P(a_Type_Time < 0)= 0.976848484848 
P(a_Type_Time_Group < 0)= 0.265282828283 
In [7]:
P(v_Group < 0)= 0.924080808081 
P(v_Time < 0)= 0.759595959596 
v_Intercept, v_Group, v_Time, v_Group_Time = m_Speed.nodes_db.loc[['v_Intercept'
#Plot the posterior distribution of drift rate (v) under the influence of group 
hddm.analyze.plot_posterior_nodes([v_Group])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_Group < 0)=", (v_Group.trace() < 0).mean()
#Plot the posterior distribution of drift rate (v) under the influence of time (i
hddm.analyze.plot_posterior_nodes([v_Time])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_Time < 0)=", (v_Time.trace() < 0).mean()
#Plot the posterior distribution of drift rate (v) under the influence of group*t
hddm.analyze.plot_posterior_nodes([v_Group_Time])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_Time_Group < 0)=", (v_Group_Time.trace() < 0).mean()
P(v_Time_Group < 0)= 0.470424242424 
In [8]: t_Intercept, t_Group, t_Time, t_Type, t_Group_Time, t_Group_Type, t_Time_Type, t_
#Plot the posterior distribution of non-decision time (t) under the influence of 
hddm.analyze.plot_posterior_nodes([t_Group])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(t_Group < 0)=", (t_Group.trace() < 0).mean()
#Plot the posterior distribution of non-decision time (t) under the influence of 
hddm.analyze.plot_posterior_nodes([t_Time])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(t_Time < 0)=", (t_Time.trace() < 0).mean()
#Plot the posterior distribution of non-decision time (t) under the influence of 
hddm.analyze.plot_posterior_nodes([t_Type])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(t_Type < 0)=", (t_Type.trace() < 0).mean()
#Plot the posterior distribution of non-decision time (t) under the inflence of g
hddm.analyze.plot_posterior_nodes([a_Group_Time])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(a_Time_Group < 0)=", (a_Group_Time.trace() < 0).mean()
#Plot the posterior distribution of non-decision time (t) under the influence of 
hddm.analyze.plot_posterior_nodes([t_Group_Type])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(t_Type_Group < 0)=", (t_Group_Type.trace() < 0).mean()
#Plot the posterior distribution of non-decision time (t) under the influence of 
hddm.analyze.plot_posterior_nodes([t_Time_Type])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(t_Type_Time < 0)=", (t_Time_Type.trace() < 0).mean()
#Plot the posterior distribution of non-decision time (t) under the influence of 
hddm.analyze.plot_posterior_nodes([t_Group_Time_Type])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(t_Type_Time_Group < 0)=", (t_Group_Time_Type.trace() < 0).mean()
P(t_Group < 0)= 0.71904040404 
P(t_Time < 0)= 0.718494949495 
P(t_Type < 0)= 1.0 
P(a_Time_Group < 0)= 0.668545454545 
P(t_Type_Group < 0)= 0.350101010101 
P(t_Type_Time < 0)= 0.00207070707071 
P(t_Type_Time_Group < 0)= 0.573404040404 
In [1]:
In [5]:
In [6]:
In [7]:
/Users/Nicole/anaconda2/lib/python2.7/site-packages/IPython/parallel.py:13: Sh
imWarning: The `IPython.parallel` package has been deprecated. You should impo
rt from ipyparallel instead. 
  "You should import from ipyparallel instead.", ShimWarning) 
Adding these covariates: 
['a_Intercept', 'a_C(Time)[T.T2]', 'a_C(Group)[T.PD ICD]', 'a_C(Time)[T.T2]:C
(Group)[T.PD ICD]'] 
Adding these covariates: 
['v_Intercept', 'v_C(Level)[T.L2]', 'v_C(Level)[T.L3]', 'v_C(Level)[T.L4]', 'v
_C(Level)[T.L5]', 'v_C(Level)[T.L6]', 'v_C(Time)[T.T2]', 'v_C(Group)[T.PD IC
D]', 'v_C(Level)[T.L2]:C(Time)[T.T2]', 'v_C(Level)[T.L3]:C(Time)[T.T2]', 'v_C
(Level)[T.L4]:C(Time)[T.T2]', 'v_C(Level)[T.L5]:C(Time)[T.T2]', 'v_C(Level)[T.
L6]:C(Time)[T.T2]', 'v_C(Level)[T.L2]:C(Group)[T.PD ICD]', 'v_C(Level)[T.L3]:C
(Group)[T.PD ICD]', 'v_C(Level)[T.L4]:C(Group)[T.PD ICD]', 'v_C(Level)[T.L5]:C
(Group)[T.PD ICD]', 'v_C(Level)[T.L6]:C(Group)[T.PD ICD]', 'v_C(Time)[T.T2]:C
(Group)[T.PD ICD]', 'v_C(Level)[T.L2]:C(Time)[T.T2]:C(Group)[T.PD ICD]', 'v_C
(Level)[T.L3]:C(Time)[T.T2]:C(Group)[T.PD ICD]', 'v_C(Level)[T.L4]:C(Time)[T.T
2]:C(Group)[T.PD ICD]', 'v_C(Level)[T.L5]:C(Time)[T.T2]:C(Group)[T.PD ICD]', 
'v_C(Level)[T.L6]:C(Time)[T.T2]:C(Group)[T.PD ICD]'] 
Adding these covariates: 
['t_Intercept', 't_C(Time)[T.T2]', 't_C(Group)[T.PD ICD]', 't_C(Time)[T.T2]:C
(Group)[T.PD ICD]'] 
 [-----------------100%-----------------] 10001 of 10000 complete in 20136.0 s
ec
Out[7]: <pymc.MCMC.MCMC at 0x11f1925d0>
#import the related toolboxes
import hddm
import pandas as pd
import matplotlib.pyplot as plt
#import the data
Difficulty = hddm.load_csv('/Users/Nicole/Desktop/HDDM_DotsPD/Difficulty.csv')
#Instead of estimating one static threshold per subject across trials, this model
m_Difficulty = hddm.HDDMRegressor(Difficulty, ["a ~ C(Time)*C(Group)","v ~ C(Leve
#Start drawing 10000 samples and discarding 1000 as burn-in
m_Difficulty.sample(10000, burn=1000)
Appendix - Programming codes for Chapter 2 
In [8]:
Plotting a_Intercept 
Plotting a_C(Time)[T.T2] 
Plotting a_C(Group)[T.PD ICD] 
Plotting a_C(Time)[T.T2]:C(Group)[T.PD ICD] 
Plotting v_Intercept 
Plotting v_C(Level)[T.L2] 
Plotting v_C(Level)[T.L3] 
Plotting v_C(Level)[T.L4] 
Plotting v_C(Level)[T.L5] 
Plotting v_C(Level)[T.L6] 
Plotting v_C(Time)[T.T2] 
Plotting v_C(Group)[T.PD ICD] 
Plotting v_C(Level)[T.L2]:C(Time)[T.T2] 
Plotting v_C(Level)[T.L3]:C(Time)[T.T2] 
Plotting v_C(Level)[T.L4]:C(Time)[T.T2] 
Plotting v_C(Level)[T.L5]:C(Time)[T.T2] 
Plotting v_C(Level)[T.L6]:C(Time)[T.T2] 
Plotting v_C(Level)[T.L2]:C(Group)[T.PD ICD] 
Plotting v_C(Level)[T.L3]:C(Group)[T.PD ICD] 
Plotting v_C(Level)[T.L4]:C(Group)[T.PD ICD] 
Plotting v_C(Level)[T.L5]:C(Group)[T.PD ICD] 
/Users/Nicole/anaconda2/lib/python2.7/site-packages/matplotlib/pyplot.py:524: 
RuntimeWarning: More than 20 figures have been opened. Figures created through 
the pyplot interface (`matplotlib.pyplot.figure`) are retained until explicitl
y closed and may consume too much memory. (To control this warning, see the rc
Param `figure.max_open_warning`). 
  max_open_warning, RuntimeWarning) 
Plotting v_C(Level)[T.L6]:C(Group)[T.PD ICD] 
Plotting v_C(Time)[T.T2]:C(Group)[T.PD ICD] 
Plotting v_C(Level)[T.L2]:C(Time)[T.T2]:C(Group)[T.PD ICD] 
Plotting v_C(Level)[T.L3]:C(Time)[T.T2]:C(Group)[T.PD ICD] 
Plotting v_C(Level)[T.L4]:C(Time)[T.T2]:C(Group)[T.PD ICD] 
Plotting v_C(Level)[T.L5]:C(Time)[T.T2]:C(Group)[T.PD ICD] 
Plotting v_C(Level)[T.L6]:C(Time)[T.T2]:C(Group)[T.PD ICD] 
Plotting t_Intercept 
Plotting t_C(Time)[T.T2] 
Plotting t_C(Group)[T.PD ICD] 
Plotting t_C(Time)[T.T2]:C(Group)[T.PD ICD] 
#plot the figures to examine the convergence of the model
m_Difficulty.plot_posteriors()
plt.show()
#As the figure shown, the model seems to be well-converged













In [9]:
P(a_Group < 0)= 0.670666666667 
P(a_Time < 0)= 1.0 
#Extract the posterior distribution of decision threshold (a) under the effects o
a_Intercept, a_Group, a_Time, a_Group_Time = m_Difficulty.nodes_db.loc[['a_Interc
#Plot the posterior distribution of decision threshold (a) under the influence of
hddm.analyze.plot_posterior_nodes([a_Group])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(a_Group < 0)=", (a_Group.trace() < 0).mean()
#As the figure shown, the regression coefficient overlaps with zero, indicating t
#Plot the posterior distribution of decision threshold (a) under the influence of
hddm.analyze.plot_posterior_nodes([a_Time])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(a_Time < 0)=", (a_Time.trace() < 0).mean()
#The regression coefficient is negative with more than 99% of it being begative, 
#Plot the posterior distribution of decision threshold (a) under the influence of
hddm.analyze.plot_posterior_nodes([a_Group_Time])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(a_Time_Group < 0)=", (a_Group_Time.trace() < 0).mean()
#The regression coefficient overlaps with zero, showing no effect of the Group*Ti
P(a_Time_Group < 0)= 0.233 
In [22]: #Extract the posterior distribution of each parameter under the effects of diffen
v_Intercept, v_Group, v_Time, v_L2, v_L3, v_L4, v_L5, v_L6 = m_Difficulty.nodes_d
#Plot the posterior distribution of drift rate (v) under the influence of the gro
hddm.analyze.plot_posterior_nodes([v_Group])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_Group < 0)=", (v_Group.trace() < 0).mean()
# As the figure and the probability shown, the regression coefficient overlaps wi
#Plot the posterior distribution of drift rate (v) under the influence of the tim
hddm.analyze.plot_posterior_nodes([v_Time])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_Time < 0)=", (v_Time.trace() < 0).mean()
#The regression coefficient was zero with more than 99% of it being negative, ind
                                                                                 
#Plot the posterior distribution of drift rate (v) under the influence of the Coh
hddm.analyze.plot_posterior_nodes([v_L2, v_L3, v_L4, v_L5, v_L6])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_L2 < 0)=", (v_L2.trace() < 0).mean()                                  
print "P(v_L3 < 0)=", (v_L3.trace() < 0).mean()   
print "P(v_L4 < 0)=", (v_L4.trace() < 0).mean()
print "P(v_L5 < 0)=", (v_L5.trace() < 0).mean()
print "P(v_L6 < 0)=", (v_L6.trace() < 0).mean()
#The regression coefficient of all coherence level is positive and more than 99% 
#Extract the posterior distribution of drift rate (v) under the effects of diffen
v_Group_Time, v_Group_L2, v_Group_L3, v_Group_L4, v_Group_L5, v_Group_L6 = m_Diff
#Plot the posterior distribution of drift rate (v) under the influence of the gro
hddm.analyze.plot_posterior_nodes([v_Group_Time])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_Time_Group < 0)=", (v_Group_Time.trace() < 0).mean()
#The regression coefficient overlaps with zero, indicating that the Group*Time in
#Plot the posterior distribution of drift rate (v) under the influence of the gro
hddm.analyze.plot_posterior_nodes([v_Group_L2, v_Group_L3, v_Group_L4, v_Group_L5
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_L2_Group < 0)=", (v_Group_L2.trace() < 0).mean()                      
print "P(v_L3_Group < 0)=", (v_Group_L3.trace() < 0).mean()   
print "P(v_L4_Group < 0)=", (v_Group_L4.trace() < 0).mean()
print "P(v_L5_Group < 0)=", (v_Group_L5.trace() < 0).mean()
print "P(v_L6_Group < 0)=", (v_Group_L6.trace() < 0).mean()
#The regression coefficient overlaps with zero, indicating that the Group*Coheren
                                                                                 
#Extract the posterior distribution of drift rate (v) under the effects of diffen
v_Time_L2, v_Time_L3, v_Time_L4, v_Time_L5, v_Time_L6 = m_Difficulty.nodes_db.loc
#Plot the posterior distribution of drift rate (v) under the influence of the tim
hddm.analyze.plot_posterior_nodes([v_Time_L2, v_Time_L3, v_Time_L4, v_Time_L5, v_
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_L2_Time < 0)=", (v_Time_L2.trace() < 0).mean()                        
print "P(v_L3_Time < 0)=", (v_Time_L3.trace() < 0).mean()   
print "P(v_L4_Time < 0)=", (v_Time_L4.trace() < 0).mean()
print "P(v_L5_Time < 0)=", (v_Time_L5.trace() < 0).mean()
<matplotlib.figure.Figure at 0x1282a3c10>
<matplotlib.figure.Figure at 0x128a3da50>
P(v_Group < 0)= 0.619666666667 
P(v_Time < 0)= 0.992444444444 
print "P(v_L6_Time < 0)=", (v_Time_L6.trace() < 0).mean()
#As the figure and the probability shown, as the Coherence level increases, the r
#Extract the posterior distribution of drift rate (v) under the effects of diffen
v_Group_Time_L2, v_Group_Time_L3, v_Group_Time_L4, v_Group_Time_L5, v_Group_Time_
#Plot the posterior distribution of drift rate (v) under the influence of the gro
hddm.analyze.plot_posterior_nodes([v_Group_Time_L2, v_Group_Time_L3, v_Group_Time
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_L2_Time_Group < 0)=", (v_Group_Time_L2.trace() < 0).mean()            
print "P(v_L3_Time_Group < 0)=", (v_Group_Time_L3.trace() < 0).mean()   
print "P(v_L4_Time_Group < 0)=", (v_Group_Time_L4.trace() < 0).mean()
print "P(v_L5_Time_Group < 0)=", (v_Group_Time_L5.trace() < 0).mean()
print "P(v_L6_Time_Group < 0)=", (v_Group_Time_L6.trace() < 0).mean()            
#The regression coefficient overlaps with zero, indicating that the Group*Time*Co
P(v_L2 < 0)= 0.0 
P(v_L3 < 0)= 0.0 
P(v_L4 < 0)= 0.0 
P(v_L5 < 0)= 0.0 
P(v_L6 < 0)= 0.0 
P(v_Time_Group < 0)= 0.473222222222 
P(v_L2_Group < 0)= 0.631444444444 
P(v_L3_Group < 0)= 0.742111111111 
P(v_L4_Group < 0)= 0.629666666667 
P(v_L5_Group < 0)= 0.638555555556 
P(v_L6_Group < 0)= 0.631666666667 
P(v_L2_Time < 0)= 0.392111111111 
P(v_L3_Time < 0)= 0.0556666666667 
P(v_L4_Time < 0)= 0.000333333333333 
P(v_L5_Time < 0)= 0.0 
P(v_L6_Time < 0)= 0.0 
P(v_L2_Time_Group < 0)= 0.460444444444 
P(v_L3_Time_Group < 0)= 0.340666666667 
P(v_L4_Time_Group < 0)= 0.485111111111 
P(v_L5_Time_Group < 0)= 0.520777777778 
P(v_L6_Time_Group < 0)= 0.62 
In [23]:
P(t_Group < 0)= 0.828111111111 
P(t_Time < 0)= 0.0 
#Extract the posterior distribution of non-decision time (t) under the effects of
t_Intercpet, t_Group, t_Time, t_Group_Time = m_Difficulty.nodes_db.loc[['t_Interc
#Plot the posterior distribution of non-decision time (t) under the influence of 
hddm.analyze.plot_posterior_nodes([t_Group])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(t_Group < 0)=", (t_Group.trace() < 0).mean()
#The regression coefficient overlaps with zero, indicating that the Group*Time*Co
#Plot the posterior distribution of non-decision time (t) under the influence of 
hddm.analyze.plot_posterior_nodes([t_Time])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(t_Time < 0)=", (t_Time.trace() < 0).mean()
#The regression coefficient is positive with more than 99% of it being larger tha
#Plot the posterior distribution of non-decision time (t) under the influence of 
hddm.analyze.plot_posterior_nodes([t_Group_Time])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(t_Time_Group < 0)=", (t_Group_Time.trace() < 0).mean()
#The regression coefficient overlaps with zero, indicating that the Group*Time in
In [ ]:
P(t_Time_Group < 0)= 0.582777777778 
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In [149]:
In [150]:
import pandas as pd
import scipy
import matplotlib.pyplot as plt
import numpy as np
import sklearn
from pandas.tools.plotting import scatter_matrix 
from sklearn import model_selection
from sklearn.metrics import classification_report 
from sklearn.metrics import confusion_matrix
from sklearn.metrics import accuracy_score
from sklearn.linear_model import LogisticRegression
from sklearn.tree import DecisionTreeClassifier
from sklearn.neighbors import KNeighborsClassifier
from sklearn.discriminant_analysis import LinearDiscriminantAnalysis 
from sklearn.naive_bayes import GaussianNB
from sklearn.svm import SVC
#Create predictive model with RTs of incorrect trials under Accuracy instruction OFF med
#Input variables: age (when being assessed), onset age, LEDD, RTs of incorrect trials of 0.05 coherence
path = "/Users/yu-tinghuang/Documents/ML_Data/ML_AC_OFF.csv"
names = ['Age', 'Age of PD onset', 'LEDD', 'RT' ,'class']
dataset = pd.read_csv(path, names=names)
 
y = dataset.iloc[0:128, 4].values
y = np.where(y== 'PD-ICD', -1, 1)
X = dataset.iloc[0:185, [2, 3]].values
plt.scatter(X[:128,0], X[:128, 1], color='blue', marker='x', label='PD-ICD'
plt.scatter(X[128:185,0], X[128:185, 1], color='red', marker='o', label
plt.xlabel('LEDD')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
y = dataset.iloc[0:128, 4].values
y = np.where(y== 'PD-ICD', -1, 1)
X = dataset.iloc[0:185, [1, 3]].values
plt.scatter(X[:128,0], X[:128, 1], color='blue', marker='x', label='PD-ICD'
plt.scatter(X[128:185,0], X[128:185, 1], color='red', marker='o', label
plt.xlabel('Age of PD onset')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
y = dataset.iloc[0:128, 4].values
y = np.where(y== 'PD+ICD', -1, 1)
X = dataset.iloc[0:185, [1, 3]].values
plt.scatter(X[:128,0], X[:128, 1], color='blue', marker='x', label='PD-ICD'
plt.scatter(X[128:185,0], X[128:185, 1], color='red', marker='o', label
plt.xlabel('Age')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
 
#box and whisker plots
Appendix - Programming codes for Chapter 3
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#box and whisker plots
dataset.plot(kind='box', subplots=True, layout=(2,2), sharex=False, sharey
plt.show()
 
#scatter plot matrix 
scatter_matrix(dataset)
plt.show()
 
#Split-out validation dataset 
array = dataset.values
X = array[:,0:4]
Y = array[:,4]
validation_size = 0.20
seed = 7
X_train, X_validation, Y_train, Y_validation = model_selection.train_test_split
 
# Spot Check Algorithms
models = []
models.append(('LR', LogisticRegression()))
models.append(('LDA', LinearDiscriminantAnalysis()))
models.append(('KNN', KNeighborsClassifier()))
models.append(('CART', DecisionTreeClassifier()))
models.append(('NB', GaussianNB()))
models.append(('SVM', SVC()))
# evaluate each model in turn
results = []
names = []
for name, model in models:
    kfold = model_selection.KFold(n_splits=10, random_state=seed)
    cv_results = model_selection.cross_val_score(model, X_train, Y_train
    results.append(cv_results)
    names.append(name)
    msg = "%s: %f (%f)" % (name, cv_results.mean(), cv_results.std())
    print(msg)
    
#Compare Algorithms
fig = plt.figure()
fig.suptitle('Algorithm Comparison')
ax = fig.add_subplot(111)
plt.boxplot(results)
ax.set_xticklabels(names)
plt.show()
 
# Make predictions on validation dataset
cart = DecisionTreeClassifier()
cart.fit(X_train, Y_train)
predictions = cart.predict(X_validation)
print(accuracy_score(Y_validation, predictions))
print(confusion_matrix(Y_validation, predictions))
print(classification_report(Y_validation, predictions))
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/anaconda3/lib/python3.6/site-packages/ipykernel_launcher.py:40: Fut
ureWarning: 'pandas.tools.plotting.scatter_matrix' is deprecated, im
port 'pandas.plotting.scatter_matrix' instead.
LR: 0.886190 (0.078894)
LDA: 0.899048 (0.032423)
KNN: 0.865714 (0.107535)
CART: 0.979524 (0.031302)
NB: 0.844762 (0.041959)
SVM: 0.737143 (0.120181)
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In [151]:
0.9459459459459459
[[12  2]
 [ 0 23]]
             precision    recall  f1-score   support
     PD+ICD       1.00      0.86      0.92        14
     PD-ICD       0.92      1.00      0.96        23
avg / total       0.95      0.95      0.94        37
#Create predictive model with RTs of incorrect trials under Accuracy instruction ON med
#Input variables: age (when being assessed), onset age, LEDD, RTs of incorrect trials of 0.05 coherence
path = "/Users/yu-tinghuang/Documents/ML_Data/ML_AC_ON.csv"
names = ['Age', 'Age of PD onset', 'LEDD', 'RT' ,'class']
dataset = pd.read_csv(path, names=names)
y = dataset.iloc[0:121, 4].values
y = np.where(y== 'PD-ICD', -1, 1)
X = dataset.iloc[0:157, [2, 3]].values
plt.scatter(X[:121,0], X[:121, 1], color='blue', marker='x', label='PD-ICD'
plt.scatter(X[121:157,0], X[121:157, 1], color='red', marker='o', label
plt.xlabel('LEDD')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
y = dataset.iloc[0:121, 4].values
y = np.where(y== 'PD-ICD', -1, 1)
X = dataset.iloc[0:157, [1, 3]].values
plt.scatter(X[:121,0], X[:121, 1], color='blue', marker='x', label='PD-ICD'
plt.scatter(X[121:157,0], X[121:157, 1], color='red', marker='o', label
plt.xlabel('Age of PD onset')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
y = dataset.iloc[0:121, 4].values
y = np.where(y== 'PD+ICD', -1, 1)
X = dataset.iloc[0:157, [1, 3]].values
plt.scatter(X[:121,0], X[:121, 1], color='blue', marker='x', label='PD-ICD'
plt.scatter(X[121:157,0], X[121:157, 1], color='red', marker='o', label
plt.xlabel('Age')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
 
#box and whisker plots
dataset.plot(kind='box', subplots=True, layout=(2,2), sharex=False, sharey
plt.show()
 
#scatter plot matrix 
scatter_matrix(dataset)
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scatter_matrix(dataset)
plt.show()
 
 
#Split-out validation dataset 
array = dataset.values
X = array[:,0:4]
Y = array[:,4]
validation_size = 0.20
seed = 7
X_train, X_validation, Y_train, Y_validation = model_selection.train_test_split
 
# Spot Check Algorithms
models = []
models.append(('LR', LogisticRegression()))
models.append(('LDA', LinearDiscriminantAnalysis()))
models.append(('KNN', KNeighborsClassifier()))
models.append(('CART', DecisionTreeClassifier()))
models.append(('NB', GaussianNB()))
models.append(('SVM', SVC()))
# evaluate each model in turn
results = []
names = []
for name, model in models:
    kfold = model_selection.KFold(n_splits=10, random_state=seed)
    cv_results = model_selection.cross_val_score(model, X_train, Y_train
    results.append(cv_results)
    names.append(name)
    msg = "%s: %f (%f)" % (name, cv_results.mean(), cv_results.std())
    print(msg)
 
#Compare Algorithms
fig = plt.figure()
fig.suptitle('Algorithm Comparison')
ax = fig.add_subplot(111)
plt.boxplot(results)
ax.set_xticklabels(names)
plt.show()
 
# Make predictions on validation dataset
cart = DecisionTreeClassifier()
cart.fit(X_train, Y_train)
predictions = cart.predict(X_validation)
print(accuracy_score(Y_validation, predictions))
print(confusion_matrix(Y_validation, predictions))
print(classification_report(Y_validation, predictions))
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/anaconda3/lib/python3.6/site-packages/ipykernel_launcher.py:39: Fut
ureWarning: 'pandas.tools.plotting.scatter_matrix' is deprecated, im
port 'pandas.plotting.scatter_matrix' instead.
LR: 0.785256 (0.067734)
LDA: 0.817308 (0.075153)
KNN: 0.792949 (0.077829)
CART: 0.976923 (0.035251)
NB: 0.785256 (0.091343)
SVM: 0.775641 (0.069751)
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In [153]:
0.9375
[[ 7  1]
 [ 1 23]]
             precision    recall  f1-score   support
     PD+ICD       0.88      0.88      0.88         8
     PD-ICD       0.96      0.96      0.96        24
avg / total       0.94      0.94      0.94        32
#Create predictive model with RTs of incorrect trials under Speed instruction OFF med
#Input variables: age (when being assessed), onset age, LEDD, RTs of incorrect trials of 0.05 coherence
path = "/Users/yu-tinghuang/Documents/ML_Data/ML_SP_OFF.csv"
names = ['Age', 'Age of PD onset', 'LEDD', 'RT' ,'class']
dataset = pd.read_csv(path, names=names)
 
y = dataset.iloc[0:215, 4].values
y = np.where(y== 'PD-ICD', -1, 1)
X = dataset.iloc[0:292, [2, 3]].values
plt.scatter(X[:215,0], X[:215, 1], color='blue', marker='x', label='PD-ICD'
plt.scatter(X[215:292,0], X[215:292, 1], color='red', marker='o', label
plt.xlabel('LEDD')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
y = dataset.iloc[0:215, 4].values
y = np.where(y== 'PD-ICD', -1, 1)
X = dataset.iloc[0:292, [1, 3]].values
plt.scatter(X[:215,0], X[:215, 1], color='blue', marker='x', label='PD-ICD'
plt.scatter(X[215:292,0], X[215:292, 1], color='red', marker='o', label
plt.xlabel('Age of PD onset')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
y = dataset.iloc[0:215, 4].values
y = np.where(y== 'PD-ICD', -1, 1)
X = dataset.iloc[0:292, [1, 3]].values
plt.scatter(X[:215,0], X[:215, 1], color='blue', marker='x', label='PD-ICD'
plt.scatter(X[215:292,0], X[215:292, 1], color='red', marker='o', label
plt.xlabel('Age')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
 
#box and whisker plots
dataset.plot(kind='box', subplots=True, layout=(2,2), sharex=False, sharey
plt.show()
 
#scatter plot matrix 
scatter_matrix(dataset)
plt.show()
 
#Split-out validation dataset 
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#Split-out validation dataset 
array = dataset.values
X = array[:,0:4]
Y = array[:,4]
validation_size = 0.20
seed = 7
X_train, X_validation, Y_train, Y_validation = model_selection.train_test_split
 
#Spot Check Algorithms
models = []
models.append(('LR', LogisticRegression()))
models.append(('LDA', LinearDiscriminantAnalysis()))
models.append(('KNN', KNeighborsClassifier()))
models.append(('CART', DecisionTreeClassifier()))
models.append(('NB', GaussianNB()))
models.append(('SVM', SVC()))
# evaluate each model in turn
results = []
names = []
for name, model in models:
    kfold = model_selection.KFold(n_splits=10, random_state=seed)
    cv_results = model_selection.cross_val_score(model, X_train, Y_train
    results.append(cv_results)
    names.append(name)
    msg = "%s: %f (%f)" % (name, cv_results.mean(), cv_results.std())
    print(msg)
    
 
#Compare Algorithms
fig = plt.figure()
fig.suptitle('Algorithm Comparison')
ax = fig.add_subplot(111)
plt.boxplot(results)
ax.set_xticklabels(names)
plt.show()
 
# Make predictions on validation dataset
cart = DecisionTreeClassifier()
cart.fit(X_train, Y_train)
predictions = cart.predict(X_validation)
print(accuracy_score(Y_validation, predictions))
print(confusion_matrix(Y_validation, predictions))
print(classification_report(Y_validation, predictions))
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/anaconda3/lib/python3.6/site-packages/ipykernel_launcher.py:40: Fut
ureWarning: 'pandas.tools.plotting.scatter_matrix' is deprecated, im
port 'pandas.plotting.scatter_matrix' instead.
LR: 0.690942 (0.078403)
LDA: 0.669203 (0.096520)
KNN: 0.840580 (0.104659)
CART: 1.000000 (0.000000)
NB: 0.652355 (0.072275)
SVM: 0.729891 (0.087391)
1.0
[[12  0]
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In [154]:
 [ 0 47]]
             precision    recall  f1-score   support
     PD+ICD       1.00      1.00      1.00        12
     PD-ICD       1.00      1.00      1.00        47
avg / total       1.00      1.00      1.00        59
#Create predictive model with RTs of incorrect trials under Speed instruction ON med
#Input variables: age (when being assessed), onset age, LEDD, RTs of incorrect trials of 0.05 coherence
path = "/Users/yu-tinghuang/Documents/ML_Data/ML_SP_ON.csv"
names = ['Age', 'Age of PD onset', 'LEDD', 'RT' ,'class']
dataset = pd.read_csv(path, names=names)
 
y = dataset.iloc[0:295, 4].values
y = np.where(y== 'PD-ICD', -1, 1)
X = dataset.iloc[0:385, [2, 3]].values
plt.scatter(X[:295,0], X[:295, 1], color='blue', marker='x', label='PD-ICD'
plt.scatter(X[295:385,0], X[295:385, 1], color='red', marker='o', label
plt.xlabel('LEDD')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
y = dataset.iloc[0:295, 4].values
y = np.where(y== 'PD-ICD', -1, 1)
X = dataset.iloc[0:385, [1, 3]].values
plt.scatter(X[:295,0], X[:295, 1], color='blue', marker='x', label='PD-ICD'
plt.scatter(X[295:385,0], X[295:385, 1], color='red', marker='o', label
plt.xlabel('Age of PD onset')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
y = dataset.iloc[0:295, 4].values
y = np.where(y== 'PD+ICD', -1, 1)
X = dataset.iloc[0:385, [1, 3]].values
plt.scatter(X[:295,0], X[:295, 1], color='blue', marker='x', label='PD-ICD'
plt.scatter(X[295:385,0], X[295:385, 1], color='red', marker='o', label
plt.xlabel('Age')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
 
#box and whisker plots
dataset.plot(kind='box', subplots=True, layout=(2,2), sharex=False, sharey
plt.show()
 
#scatter plot matrix 
scatter_matrix(dataset)
plt.show()
 
#Split-out validation dataset 
array = dataset.values
X = array[:,0:4]
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X = array[:,0:4]
Y = array[:,4]
validation_size = 0.20
seed = 7
X_train, X_validation, Y_train, Y_validation = model_selection.train_test_split
 
# Spot Check Algorithms
models = []
models.append(('LR', LogisticRegression()))
models.append(('LDA', LinearDiscriminantAnalysis()))
models.append(('KNN', KNeighborsClassifier()))
models.append(('CART', DecisionTreeClassifier()))
models.append(('NB', GaussianNB()))
models.append(('SVM', SVC()))
# evaluate each model in turn
results = []
names = []
for name, model in models:
    kfold = model_selection.KFold(n_splits=10, random_state=seed)
    cv_results = model_selection.cross_val_score(model, X_train, Y_train
    results.append(cv_results)
    names.append(name)
    msg = "%s: %f (%f)" % (name, cv_results.mean(), cv_results.std())
    print(msg)
    
#Compare Algorithms
fig = plt.figure()
fig.suptitle('Algorithm Comparison')
ax = fig.add_subplot(111)
plt.boxplot(results)
ax.set_xticklabels(names)
plt.show()
 
# Make predictions on validation dataset
cart = DecisionTreeClassifier()
cart.fit(X_train, Y_train)
predictions = cart.predict(X_validation)
print(accuracy_score(Y_validation, predictions))
print(confusion_matrix(Y_validation, predictions))
print(classification_report(Y_validation, predictions))
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/anaconda3/lib/python3.6/site-packages/ipykernel_launcher.py:40: Fut
ureWarning: 'pandas.tools.plotting.scatter_matrix' is deprecated, im
port 'pandas.plotting.scatter_matrix' instead.
LR: 0.743441 (0.057030)
LDA: 0.733763 (0.074991)
KNN: 0.866989 (0.078139)
CART: 0.993548 (0.012903)
NB: 0.760000 (0.093203)
SVM: 0.789032 (0.057974)
1.0
[[21  0]
 [ 0 56]]
             precision    recall  f1-score   support
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In [155]:
     PD+ICD       1.00      1.00      1.00        21
     PD-ICD       1.00      1.00      1.00        56
avg / total       1.00      1.00      1.00        77
#Create predictive model with RTs of incorrect trials under 0.05 coherence OFF med
#Input variables: age (when being assessed), onset age, LEDD, RTs of incorrect trials of 0.05 coherence
path = "/Users/yu-tinghuang/Documents/ML_Data/Difficulty_0.05_OFF.csv"
names = ['Age', 'Age of PD onset', 'LEDD', 'RT' ,'class']
dataset = pd.read_csv(path, names=names)
 
y = dataset.iloc[0:46, 4].values
y = np.where(y== 'PD+ICD', -1, 1)
X = dataset.iloc[0:118, [2, 3]].values
plt.scatter(X[:46,0], X[:46, 1], color='red', marker='o', label='PD+ICD'
plt.scatter(X[46:118,0], X[46:118, 1], color='blue', marker='x', label=
plt.xlabel('LEDD')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
y = dataset.iloc[0:46, 4].values
y = np.where(y== 'PD+ICD', -1, 1)
X = dataset.iloc[0:118, [1, 3]].values
plt.scatter(X[:46,0], X[:46, 1], color='red', marker='o', label='PD+ICD'
plt.scatter(X[46:118,0], X[46:118, 1], color='blue', marker='x', label=
plt.xlabel('Age of PD onset')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
y = dataset.iloc[0:46, 4].values
y = np.where(y== 'PD+ICD', -1, 1)
X = dataset.iloc[0:118, [1, 3]].values
plt.scatter(X[:46,0], X[:46, 1], color='red', marker='o', label='PD+ICD'
plt.scatter(X[46:118,0], X[46:118, 1], color='blue', marker='x', label=
plt.xlabel('Age')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
 
#box and whisker plots
dataset.plot(kind='box', subplots=True, layout=(2,2), sharex=False, sharey
plt.show()
 
#scatter plot matrix 
scatter_matrix(dataset)
plt.show()
 
#Split-out validation dataset 
array = dataset.values
X = array[:,0:4]
Y = array[:,4]
validation_size = 0.20
seed = 7
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seed = 7
X_train, X_validation, Y_train, Y_validation = model_selection.train_test_split
 
# Spot Check Algorithms
models = []
models.append(('LR', LogisticRegression()))
models.append(('LDA', LinearDiscriminantAnalysis()))
models.append(('KNN', KNeighborsClassifier()))
models.append(('CART', DecisionTreeClassifier()))
models.append(('NB', GaussianNB()))
models.append(('SVM', SVC()))
# evaluate each model in turn
results = []
names = []
for name, model in models:
    kfold = model_selection.KFold(n_splits=10, random_state=seed)
    cv_results = model_selection.cross_val_score(model, X_train, Y_train
    results.append(cv_results)
    names.append(name)
    msg = "%s: %f (%f)" % (name, cv_results.mean(), cv_results.std())
    print(msg)
 
#Compare Algorithms
fig = plt.figure()
fig.suptitle('Algorithm Comparison')
ax = fig.add_subplot(111)
plt.boxplot(results)
ax.set_xticklabels(names)
plt.show()
 
# Make predictions on validation dataset
cart = DecisionTreeClassifier()
cart.fit(X_train, Y_train)
predictions = cart.predict(X_validation)
print(accuracy_score(Y_validation, predictions))
print(confusion_matrix(Y_validation, predictions))
print(classification_report(Y_validation, predictions))
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/anaconda3/lib/python3.6/site-packages/ipykernel_launcher.py:40: Fut
ureWarning: 'pandas.tools.plotting.scatter_matrix' is deprecated, im
port 'pandas.plotting.scatter_matrix' instead.
LR: 0.606667 (0.147506)
LDA: 0.585556 (0.164133)
KNN: 0.642222 (0.163662)
CART: 1.000000 (0.000000)
NB: 0.755556 (0.111886)
SVM: 0.617778 (0.119174)
1.0
[[ 8  0]
 [ 0 16]]
             precision    recall  f1-score   support
     PD+ICD       1.00      1.00      1.00         8
     PD-ICD       1.00      1.00      1.00        16
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In [156]:
avg / total       1.00      1.00      1.00        24
#Create predictive model with RTs of incorrect trials under 0.05 coherence ON med
#Input variables: age (when being assessed), onset age, LEDD, RTs of incorrect trials of 0.05 coherence
path = "/Users/yu-tinghuang/Documents/ML_Data/Difficulty_0.05_ON.csv"
names = ['Age', 'Age of PD onset', 'LEDD', 'RT' ,'class']
dataset = pd.read_csv(path, names=names)
 
y = dataset.iloc[0:76, 4].values
y = np.where(y== 'PD+ICD', -1, 1)
X = dataset.iloc[0:187, [2, 3]].values
plt.scatter(X[:76,0], X[:76, 1], color='red', marker='o', label='PD+ICD'
plt.scatter(X[76:187,0], X[76:187, 1], color='blue', marker='x', label=
plt.xlabel('LEDD')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
y = dataset.iloc[0:76, 4].values
y = np.where(y== 'PD+ICD', -1, 1)
X = dataset.iloc[0:187, [1, 3]].values
plt.scatter(X[:76,0], X[:76, 1], color='red', marker='o', label='PD+ICD'
plt.scatter(X[76:187,0], X[76:187, 1], color='blue', marker='x', label=
plt.xlabel('Age of PD onset')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
y = dataset.iloc[0:76, 4].values
y = np.where(y== 'PD+ICD', -1, 1)
X = dataset.iloc[0:187, [1, 3]].values
plt.scatter(X[:76,0], X[:76, 1], color='red', marker='o', label='PD+ICD'
plt.scatter(X[76:187,0], X[76:187, 1], color='blue', marker='x', label=
plt.xlabel('Age')
plt.ylabel('RT')
plt.legend(loc='upper left')
plt.show()
 
#box and whisker plots
dataset.plot(kind='box', subplots=True, layout=(2,2), sharex=False, sharey
plt.show()
 
#scatter plot matrix 
scatter_matrix(dataset)
plt.show()
 
#Split-out validation dataset 
array = dataset.values
X = array[:,0:4]
Y = array[:,4]
validation_size = 0.20
seed = 7
X_train, X_validation, Y_train, Y_validation = model_selection.train_test_split
 
# Spot Check Algorithms
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# Spot Check Algorithms
models = []
models.append(('LR', LogisticRegression()))
models.append(('LDA', LinearDiscriminantAnalysis()))
models.append(('KNN', KNeighborsClassifier()))
models.append(('CART', DecisionTreeClassifier()))
models.append(('NB', GaussianNB()))
models.append(('SVM', SVC()))
# evaluate each model in turn
results = []
names = []
for name, model in models:
    kfold = model_selection.KFold(n_splits=10, random_state=seed)
    cv_results = model_selection.cross_val_score(model, X_train, Y_train
    results.append(cv_results)
    names.append(name)
    msg = "%s: %f (%f)" % (name, cv_results.mean(), cv_results.std())
    print(msg)
    
#Compare Algorithms
fig = plt.figure()
fig.suptitle('Algorithm Comparison')
ax = fig.add_subplot(111)
plt.boxplot(results)
ax.set_xticklabels(names)
plt.show()
 
# Make predictions on validation dataset
cart = DecisionTreeClassifier()
cart.fit(X_train, Y_train)
predictions = cart.predict(X_validation)
print(accuracy_score(Y_validation, predictions))
print(confusion_matrix(Y_validation, predictions))
print(classification_report(Y_validation, predictions))
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/anaconda3/lib/python3.6/site-packages/ipykernel_launcher.py:40: Fut
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/anaconda3/lib/python3.6/site-packages/ipykernel_launcher.py:40: Fut
ureWarning: 'pandas.tools.plotting.scatter_matrix' is deprecated, im
port 'pandas.plotting.scatter_matrix' instead.
LR: 0.543810 (0.101280)
LDA: 0.530476 (0.097315)
KNN: 0.698571 (0.133164)
CART: 0.980000 (0.030551)
NB: 0.643810 (0.131429)
SVM: 0.564286 (0.118403)
1.0
[[11  0]
 [ 0 27]]
             precision    recall  f1-score   support
     PD+ICD       1.00      1.00      1.00        11
     PD-ICD       1.00      1.00      1.00        27
avg / total       1.00      1.00      1.00        38
In [1]:
In [5]:
In [10]:
In [11]:
/Users/Nicole/anaconda2/lib/python2.7/site-packages/IPython/parallel.py:13: Sh
imWarning: The `IPython.parallel` package has been deprecated. You should impo
rt from ipyparallel instead. 
  "You should import from ipyparallel instead.", ShimWarning) 
Adding these covariates: 
['a_Intercept', 'a_C(DBS)[T.HC]', 'a_C(DBS)[T.STN DBS OFF]'] 
Adding these covariates: 
['v_Intercept', 'v_C(Block)[T.B2]', 'v_C(Block)[T.B3]', 'v_C(DBS)[T.HC]', 'v_C
(DBS)[T.STN DBS OFF]', 'v_C(Block)[T.B2]:C(DBS)[T.HC]', 'v_C(Block)[T.B3]:C(DB
S)[T.HC]', 'v_C(Block)[T.B2]:C(DBS)[T.STN DBS OFF]', 'v_C(Block)[T.B3]:C(DBS)
[T.STN DBS OFF]'] 
Adding these covariates: 
['t_Intercept', 't_C(DBS)[T.HC]', 't_C(DBS)[T.STN DBS OFF]'] 
 [-----------------100%-----------------] 10001 of 10000 complete in 7494.0 se
c
Out[11]: <pymc.MCMC.MCMC at 0x1267d0c90>
#import the related toolboxes
import hddm
import pandas as pd
import matplotlib.pyplot as plt
#load the data
data = hddm.load_csv('/Users/Nicole/Desktop/Latest drafts3/DBS_switching/DBS_swit
#Create the model with all available data
m1 = hddm.HDDMRegressor(data, ["a ~ C(DBS)","v ~ C(Block)*C(DBS)","t ~ C(DBS)"])
#Start drawing 10000 samples and discarding 1000 as burn-in 
m1.sample(10000, burn=1000)
Appendix - Programming codes for Chapter 4
In [12]:
Plotting a_Intercept 
Plotting a_C(DBS)[T.HC] 
Plotting a_C(DBS)[T.STN DBS OFF] 
Plotting v_Intercept 
Plotting v_C(Block)[T.B2] 
Plotting v_C(Block)[T.B3] 
Plotting v_C(DBS)[T.HC] 
Plotting v_C(DBS)[T.STN DBS OFF] 
Plotting v_C(Block)[T.B2]:C(DBS)[T.HC] 
Plotting v_C(Block)[T.B3]:C(DBS)[T.HC] 
Plotting v_C(Block)[T.B2]:C(DBS)[T.STN DBS OFF] 
Plotting v_C(Block)[T.B3]:C(DBS)[T.STN DBS OFF] 
Plotting t_Intercept 
Plotting t_C(DBS)[T.HC] 
Plotting t_C(DBS)[T.STN DBS OFF] 
#Plot the figures to examine the convergence of the model
m1.plot_posteriors()
plt.show()
#A converged chain would have a stationary trace (upper left plots), 
#low auto-correlation (lower left plots), 
#and normally distributed subject and group mean posteriors, 
#while group variability posteriors are Gamma distributed (right plots).






In [13]:
P(a_HC < 0)= 1.0 
P(a_DBSOFF < 0)= 0.681666666667 
#Extract the estimated decision threshold (a) from the created model 
a_Intercept, a_DBS_HC, a_DBS_OFF = m1.nodes_db.loc[['a_Intercept', 'a_C(DBS)[T.HC
#Plot the posterior distribution of decision threshold (a) under the influence of
hddm.analyze.plot_posterior_nodes([a_DBS_HC, a_DBS_OFF])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(a_HC < 0)=", (a_DBS_HC.trace() < 0).mean()
print "P(a_DBSOFF < 0)=", (a_DBS_OFF.trace() < 0).mean()
In [14]:
P(v_HC < 0)= 0.001 
P(v_DBSOFF < 0)= 0.995444444444 
v_Intercept, v_DBS_HC, v_DBS_OFF = m1.nodes_db.loc[['v_Intercept', 'v_C(DBS)[T.HC
v_Block2, v_Block3, v_Block2_HC, v_Block3_HC, v_Block2_DBSOFF, v_Block3_DBSOFF = 
#Plot the posterior distribution of drift rate (v) under the influence of the DBS
hddm.analyze.plot_posterior_nodes([v_DBS_HC, v_DBS_OFF])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_HC < 0)=", (v_DBS_HC.trace() < 0).mean()
print "P(v_DBSOFF < 0)=", (v_DBS_OFF.trace() < 0).mean()
#Plot the posterior distribution of drift rate (v) under the influence of the Blo
hddm.analyze.plot_posterior_nodes([v_Block2, v_Block3])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_Block2 < 0)=", (v_Block2.trace() < 0).mean()
print "P(v_Block3 < 0)=", (v_Block3.trace() < 0).mean()
#Plot the posterior distribution of drift rate (v) under the influence of the two
hddm.analyze.plot_posterior_nodes([v_Block2_HC, v_Block3_HC])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_Block2_HC < 0)=", (v_Block2_HC.trace() < 0).mean()
print "P(v_Block3_HC < 0)=", (v_Block3_HC.trace() < 0).mean()
#Plot the posterior distribution of drift rate (v) under the influence of the two
hddm.analyze.plot_posterior_nodes([v_Block2_DBSOFF, v_Block3_DBSOFF])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_Block2_DBSOFF < 0)=", (v_Block2_DBSOFF.trace() < 0).mean()
print "P(v_Block3_DBSOFF < 0)=", (v_Block3_DBSOFF.trace() < 0).mean()
P(v_Block2 < 0)= 1.0 
P(v_Block3 < 0)= 0.092 
P(v_Block2_HC < 0)= 1.0 
P(v_Block3_HC < 0)= 0.524888888889 
P(v_Block2_DBSOFF < 0)= 0.920444444444 
P(v_Block3_DBSOFF < 0)= 0.836444444444 
In [15]:
In [ ]:
P(t_HC < 0)= 0.0 
P(t_DBSOFF < 0)= 0.195888888889 
#Extract the estimated non-decision time (t) from the created model 
t_Intercept, t_DBS_HC, t_DBS_OFF = m1.nodes_db.loc[['t_Intercept', 't_C(DBS)[T.HC
#Plot the posterior distribution of non-decision time under the influence of the 
hddm.analyze.plot_posterior_nodes([t_DBS_HC, t_DBS_OFF])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(t_HC < 0)=", (t_DBS_HC.trace() < 0).mean()
print "P(t_DBSOFF < 0)=", (t_DBS_OFF.trace() < 0).mean()
In [1]:
In [4]:
In [5]:
In [6]:
/Users/Nicole/anaconda2/lib/python2.7/site-packages/IPython/parallel.py:13: Sh
imWarning: The `IPython.parallel` package has been deprecated. You should impo
rt from ipyparallel instead. 
  "You should import from ipyparallel instead.", ShimWarning) 
Adding these covariates: 
['a_Intercept', 'a_C(Type)[T.SP]', 'a_C(Coherence)[T.High]', 'a_C(Coherence)
[T.Low]', 'a_C(DBS)[T.HC]', 'a_C(DBS)[T.STN DBS OFF]', 'a_C(Type)[T.SP]:C(Cohe
rence)[T.High]', 'a_C(Type)[T.SP]:C(Coherence)[T.Low]', 'a_C(Type)[T.SP]:C(DB
S)[T.HC]', 'a_C(Type)[T.SP]:C(DBS)[T.STN DBS OFF]', 'a_C(Coherence)[T.High]:C
(DBS)[T.HC]', 'a_C(Coherence)[T.Low]:C(DBS)[T.HC]', 'a_C(Coherence)[T.High]:C
(DBS)[T.STN DBS OFF]', 'a_C(Coherence)[T.Low]:C(DBS)[T.STN DBS OFF]', 'a_C(Typ
e)[T.SP]:C(Coherence)[T.High]:C(DBS)[T.HC]', 'a_C(Type)[T.SP]:C(Coherence)[T.L
ow]:C(DBS)[T.HC]', 'a_C(Type)[T.SP]:C(Coherence)[T.High]:C(DBS)[T.STN DBS OF
F]', 'a_C(Type)[T.SP]:C(Coherence)[T.Low]:C(DBS)[T.STN DBS OFF]'] 
Adding these covariates: 
['v_Intercept', 'v_C(Coherence)[T.High]', 'v_C(Coherence)[T.Low]', 'v_C(DBS)
[T.HC]', 'v_C(DBS)[T.STN DBS OFF]', 'v_C(Coherence)[T.High]:C(DBS)[T.HC]', 'v_
C(Coherence)[T.Low]:C(DBS)[T.HC]', 'v_C(Coherence)[T.High]:C(DBS)[T.STN DBS OF
F]', 'v_C(Coherence)[T.Low]:C(DBS)[T.STN DBS OFF]'] 
 [-----------------100%-----------------] 10001 of 10000 complete in 13535.5 s
ec
Out[6]: <pymc.MCMC.MCMC at 0x1194e03d0>
#import the related toolboxes
import hddm
import pandas as pd
import matplotlib.pyplot as plt
#load the data
data = hddm.load_csv('/Users/Nicole/Desktop/Latest drafts3/DBS_switching/DBS.csv
#Create the model with all available data
m = hddm.HDDMRegressor(data, ["a ~ C(Type)*C(Coherence)*C(DBS)","v ~ C(Coherence
#Start drawing 10000 samples and discarding 1000 as burn-in 
m.sample(10000, burn=1000)
Appendix - Programming coeds for Chapter 4 
In [7]:
Plotting t 
Plotting a_Intercept 
Plotting a_C(Type)[T.SP] 
Plotting a_C(Coherence)[T.High] 
Plotting a_C(Coherence)[T.Low] 
Plotting a_C(DBS)[T.HC] 
Plotting a_C(DBS)[T.STN DBS OFF] 
Plotting a_C(Type)[T.SP]:C(Coherence)[T.High] 
Plotting a_C(Type)[T.SP]:C(Coherence)[T.Low] 
Plotting a_C(Type)[T.SP]:C(DBS)[T.HC] 
Plotting a_C(Type)[T.SP]:C(DBS)[T.STN DBS OFF] 
Plotting a_C(Coherence)[T.High]:C(DBS)[T.HC] 
Plotting a_C(Coherence)[T.Low]:C(DBS)[T.HC] 
Plotting a_C(Coherence)[T.High]:C(DBS)[T.STN DBS OFF] 
Plotting a_C(Coherence)[T.Low]:C(DBS)[T.STN DBS OFF] 
Plotting a_C(Type)[T.SP]:C(Coherence)[T.High]:C(DBS)[T.HC] 
Plotting a_C(Type)[T.SP]:C(Coherence)[T.Low]:C(DBS)[T.HC] 
Plotting a_C(Type)[T.SP]:C(Coherence)[T.High]:C(DBS)[T.STN DBS OFF] 
Plotting a_C(Type)[T.SP]:C(Coherence)[T.Low]:C(DBS)[T.STN DBS OFF] 
Plotting v_Intercept 
Plotting v_C(Coherence)[T.High] 
/Users/Nicole/anaconda2/lib/python2.7/site-packages/matplotlib/pyplot.py:524: 
RuntimeWarning: More than 20 figures have been opened. Figures created through 
the pyplot interface (`matplotlib.pyplot.figure`) are retained until explicitl
y closed and may consume too much memory. (To control this warning, see the rc
Param `figure.max_open_warning`). 
  max_open_warning, RuntimeWarning) 
Plotting v_C(Coherence)[T.Low] 
Plotting v_C(DBS)[T.HC] 
Plotting v_C(DBS)[T.STN DBS OFF] 
Plotting v_C(Coherence)[T.High]:C(DBS)[T.HC] 
Plotting v_C(Coherence)[T.Low]:C(DBS)[T.HC] 
Plotting v_C(Coherence)[T.High]:C(DBS)[T.STN DBS OFF] 
Plotting v_C(Coherence)[T.Low]:C(DBS)[T.STN DBS OFF] 
#Plot the figures to examine the convergence of the model
m.plot_posteriors()
plt.show()
#As the figures shown, the model doesn't seem to be we











In [9]:tract the estimated decision threshold (a) from the created model 
ntercept, a_Type, a_High, a_Low, a_HC, a_DBSOFF = m.nodes_db.loc[['a_Intercept', '
ype_High, a_Type_Low, a_Type_HC, a_Type_DBSOFF = m.nodes_db.loc[['a_C(Type)[T.SP]:
igh_HC, a_Low_HC, a_High_DBSOFF, a_Low_DBSOFF = m.nodes_db.loc[['a_C(Coherence)[T.
ype_High_HC, a_Type_Low_HC, a_Type_High_DBSOFF, a_Type_Low_DBSOFF = m.nodes_db.loc
m.analyze.plot_posterior_nodes([a_Type])
xlabel('Regression Coefficient')
ylabel('Posterior Probability')
show()
nt "P(a_Type < 0)=", (a_Type.trace() < 0).mean()
m.analyze.plot_posterior_nodes([a_High, a_Low])
xlabel('Regression Coefficient')
ylabel('Posterior Probability')
show()
nt "P(a_High < 0)=", (a_High.trace() < 0).mean()
nt "P(a_Low < 0)=", (a_Low.trace() < 0).mean()
m.analyze.plot_posterior_nodes([a_HC, a_DBSOFF])
xlabel('Regression Coefficient')
ylabel('Posterior Probability')
show()
nt "P(a_HC < 0)=", (a_HC.trace() < 0).mean()
nt "P(a_DBSOFF < 0)=", (a_DBSOFF.trace() < 0).mean()
m.analyze.plot_posterior_nodes([a_Type_HC, a_Type_DBSOFF])
xlabel('Regression Coefficient')
ylabel('Posterior Probability')
show()
nt "P(a_HC < 0)=", (a_HC.trace() < 0).mean()
nt "P(a_DBSOFF < 0)=", (a_DBSOFF.trace() < 0).mean()
m.analyze.plot_posterior_nodes([a_Low_HC, a_High_HC, a_Low_DBSOFF, a_High_DBSOFF])
xlabel('Regression Coefficient')
ylabel('Posterior Probability')
show()
nt "P(a_Low_HC < 0)=", (a_Low_HC.trace() < 0).mean()
nt "P(a_High_HC < 0)=", (a_High_HC.trace() < 0).mean()
nt "P(a_Low_DBSOFF < 0)=", (a_Low_DBSOFF.trace() < 0).mean()
nt "P(a_High_DBSOFF < 0)=", (a_High_DBSOFF.trace() < 0).mean()
m.analyze.plot_posterior_nodes([a_Type_Low_HC, a_Type_High_HC, a_Type_Low_DBSOFF, 
xlabel('Regression Coefficient')
ylabel('Posterior Probability')
show()
nt "P(a_Type_Low_HC < 0)=", (a_Type_Low_HC.trace() < 0).mean()
nt "P(a_Type_High_HC < 0)=", (a_Type_High_HC.trace() < 0).mean()
nt "P(a_Type_Low_DBSOFF < 0)=", (a_Type_Low_DBSOFF.trace() < 0).mean()
nt "P(a_Type_High_DBSOFF < 0)=", (a_Type_High_DBSOFF.trace() < 0).mean()
P(a_Type < 0)= 1.0 
P(a_High < 0)= 0.007 
P(a_Low < 0)= 0.0991111111111 
P(a_HC < 0)= 0.0 
P(a_DBSOFF < 0)= 0.951333333333 
P(a_HC < 0)= 0.0 
P(a_DBSOFF < 0)= 0.951333333333 
P(a_Low_HC < 0)= 1.0 
P(a_High_HC < 0)= 0.973888888889 
P(a_Low_DBSOFF < 0)= 0.944111111111 
P(a_High_DBSOFF < 0)= 0.272777777778 
P(a_Type_Low_HC < 0)= 0.418888888889 
P(a_Type_High_HC < 0)= 0.922555555556 
P(a_Type_Low_DBSOFF < 0)= 0.099 
P(a_Type_High_DBSOFF < 0)= 0.954777777778 
In [11]:
P(v_High < 0)= 0.357444444444 
P(v_Low < 0)= 1.0 
P(v_HC < 0)= 0.0 
P(v_DBSOFF < 0)= 0.999555555556 
v_Intercept, v_High, v_Low, v_HC, v_DBSOFF = m.nodes_db.loc[['v_Intercept', 'v_C
v_High_HC, v_Low_HC, v_High_DBSOFF, v_Low_DBSOFF= m.nodes_db.loc[['v_C(Coherence
hddm.analyze.plot_posterior_nodes([v_High, v_Low])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_High < 0)=", (v_High.trace() < 0).mean()
print "P(v_Low < 0)=", (v_Low.trace() < 0).mean()
hddm.analyze.plot_posterior_nodes([v_HC, v_DBSOFF])
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_HC < 0)=", (v_HC.trace() < 0).mean()
print "P(v_DBSOFF < 0)=", (v_DBSOFF.trace() < 0).mean()
hddm.analyze.plot_posterior_nodes([v_High_HC, v_Low_HC, v_High_DBSOFF, v_Low_DBSO
plt.xlabel('Regression Coefficient')
plt.ylabel('Posterior Probability')
plt.show()
print "P(v_High_HC < 0)=", (v_High_HC.trace() < 0).mean()
print "P(v_Low_HC < 0)=", (v_Low_HC.trace() < 0).mean()
print "P(v_High_DBSOFF < 0)=", (v_High_DBSOFF.trace() < 0).mean()
print "P(v_Low_DBSOFF < 0)=", (v_Low_DBSOFF.trace() < 0).mean()
In [ ]:
P(v_High_HC < 0)= 1.0 
P(v_Low_HC < 0)= 1.0 
P(v_High_DBSOFF < 0)= 0.789333333333 
P(v_Low_DBSOFF < 0)= 0.822555555556 
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Control information sheet: 
 
UCLH Project ID number: 07/Q0512/27 
Version number: 28/10/15 
 
Study title Perceptual Decision-Making on patients with Parkinson’s disease 
 
You are invited to take part in a research study. Before you decide, it is important for you to 
understand why the research is being done and what it will involve. Please take time to read 
the following information carefully and discuss it with others if you wish. Ask us if there is 
anything that is not clear or if you would like more information. Take time to decide whether 
or not you wish to take part. 
 
What is the purpose of the study? 
The aim of this study is to provide information about the ability to change movement speed to 
achieve either fast or accurate movements and how this may be changed in people with 
Parkinson’s disease.  
  
Why have I been chosen? 
You have been invited to take part because you are a similar age to many people with 
Parkinson’s disease and do not have significant mobility or cognitive problems or depression. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you decide to take part, you will be 
asked to sign a consent form. If you decide to take part you are still free to withdraw at any 
time and without giving a reason. A decision to withdraw at any time, or a decision not to 
take part, will not affect your medical care or your future relationship with the Institute of 
Neurology or the National Hospital for Neurology and Neurosurgery. Your medical records 
may be inspected by competent researchers, but if any information is released, this will be 
done in a coded form so that confidentiality is strictly maintained. Participation in this study 
will in no way affect your legal rights.  
 
What will happen to me if I take part? 
You will be asked to participate in a behavioural study. The behavioural study will take place 
at the Sobell Department, Institute of Neurology, UCL at 33 Queen Square, London. Testing 
will take about 30 minutes to complete.  
 
 
Are there any risks or side effects? 
We don’t anticipate any risks or side-effects from participation in the study. 
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What do I have to do? 
On arriving at the Sobell Department you will complete some pre-experiment pen-and-paper 
questionnaires. Then you will complete a computerized task.  On each trial you will see a 
series of dots and your task is to decide whether the majority of the dots are moving to the 
left or to the right by pressing buttons with your left or right index fingers.  This task will be 
performed under speed (make your decision as quickly as possible) or accuracy (make your 
decision so that it is accurate) with different levels of task difficulty.  
 
What is being tested? 
By measuring your speed of reactions or reaction times, we can compare your performance 
under speed and accuracy instructions and determine if so-called speed-accuracy trade-offs in 
people with Parkinson’s disease are similar or different to healthy people of the same age.  
 
What are the possible benefits of taking part? 
Participation in this study may not give you any direct benefit. But the information we obtain 
from this study may help us understand Parkinson’s disease better and particularly contribute 
to improving mobility in Parkinson’s disease. We will reimburse you for your travel costs to 
and from Queen Square. 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential. Any information about you which leaves the hospital will have your 
name and address removed so that you cannot be recognised from it.  
 
What information about me will be held? 
We will keep a record of your name, age, address, contact details, physical and mental 
examinations. The results will be stored on computer for analysis. All information which is 
collected about you during the course of the study will stay strictly confidential and remain 
within the Institute of Neurology / UCL. Any information about you which leaves the 
Institute of Neurology will have your name, address, birth date and identifiable information 
removed so that you cannot be recognised from it. The principal investigator, Prof. Marjan 
Jahanshahi, will be in charge of ensuring that the security and confidentiality of your 
information is maintained.  
 
What will happen to the results of the research study? 
The data will be analysed and published in scientific journals and presented at scientific 
conferences. It should be emphasised that your name or any information that could identify 
you (e.g. your date of birth) will not be published. We will be happy to provide you with a 
copy of the completed article for you to keep. 
 
What can I do if I am harmed during this study or wish to make a complaint? 
We will welcome your feedback on your experience of this experiment and at the end of each 
session you will have a chance to record any comments on the experiment in writing. These 
comments will be shown (without identifying the person it came from) to the clinician 
involved in the study to ensure that the experiments do not produce too much discomfort. 
Please remember that you are free to withdraw at any point without giving a reason. 
 
If you are harmed by taking part in this research project, there are no special compensation 
arrangements. NHS Indemnity does not offer no-fault compensation i.e. for non-negligent 
harm, and NHS bodies are unable to agree in advance to pay compensation for non-negligent 
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harm. If you are harmed due to someone’s negligence, then you may have grounds for a legal 
action but you may have to pay for it. 
 
Regardless of this, if you wish to complain, or have any concerns with this study, the normal 
National Health Service complaints mechanisms should be available to you.  
 
Who is organising and funding the research? 
This research is being conducted by members of the Sobell Department of Motor 
Neuroscience and Movement Disorders, Institute of Neurology, Queen’s Square, London. 
This study has been reviewed by the Programme Panel of the Sobell Department of Motor 
Neuroscience and Movement Disorders and approved by the National Hospital for Neurology 
and Neurosurgery/Institute of Neurology Joint Research Ethics Committee. The study is 
sponsored by University College London Hospitals Trust. 
 
Contact for further information 
Please do not hesitate to contact the principal investigator Prof Jahanshahi (contact details given 
below) should you have any questions at any stage of the research study: 
 
Miss Yu-Ting Huang  
Sobell Department of Motor Neuroscience and Movement Disorders 
UCL Institute of Neurology,  
33 Queen Square, London, WC1N 3BG 
Mobile:  07940452298 , email: yth1975@gmail.com 
 
Prof. Marjan Jahanshahi 
Sobell Department of Motor Neuroscience and Movement Disorders 
UCL Institute of Neurology 
33 Queen Square, London, WC1N 3BG. 
Tel:0203 4488733, email: m.jaahnshahi@ucl.ac.uk 
 
Prof. Patricia Limousin 
Sobell Department of Motor Neuroscience and Movement Disorders 
UCL Institute of Neurology 
33 Queen Square, London, WC1N 3BG 
!
 
 
 
 
UCL Hospitals is an NHS Trust incorporating the Eastman Dental Hospital, Elizabeth Garrett 
Anderson & Obstetric Hospital, The Heart Hospital, Hospital for Tropical Diseases, The 
Middlesex Hospital, National Hospital for Neurology & Neurosurgery, The Royal London 
Homoeopathic Hospital and University College Hospital. 
 
 
National Hospital for Neurology and Neurosurgery 
Queen Square, 
London.  WC1N 3BG  
 
Telephone: 020 3448 8733 
!
!
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Information sheet – PD participants 
 
UCLH Project ID number: 07/Q0512/27 
Version number: 05/10/12, version 6b 
 
Study title Behavioural studies of paradoxical kinesis in Parkinson’s disease 
 
You are invited to take part in a research study. Before you decide, it is important for you to 
understand why the research is being done and what it will involve. Please take time to read 
the following information carefully and discuss it with others if you wish. Ask us if there is 
anything that is not clear or if you would like more information. Take time to decide whether 
or not you wish to take part. 
 
What is the purpose of the study? 
The aim of this study is to provide information about the ability to change movement speed to 
achieve either fast or accurate movements and how this may be changed in people with 
Parkinson’s disease. This study is part of a larger project in which we are seeking to (i) 
understand the mobility problems in Parkinson’s disease and (ii) develop techniques and aids 
for improving them. 
  
Why have I been chosen? 
You have been invited to take part because you are under STN DBS treatment for 
Parkinson’s disease. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you decide to take part, you will be 
asked to sign a consent form. If you decide to take part you are still free to withdraw at any 
time and without giving a reason. A decision to withdraw at any time, or a decision not to 
take part, will not affect your medical care or your future relationship with the Institute of 
Neurology or the National Hospital for Neurology and Neurosurgery. Your medical records 
may be inspected by competent researchers, but if any information is released, this will be 
done in a coded form so that confidentiality is strictly maintained. Participation in this study 
will in no way affect your legal rights.  
 
What will happen to me if I take part? 
You will be asked to participate in a behavioural study.  We will be happy to reimburse you 
for your travel costs to and from Queen Square. 
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The behavioural study will take place at the Sobell Department, Institute of Neurology, UCL 
at 33 Queen Square, London. Testing will take about 3½ hours to complete.  
 
Are there any risks or side effects? 
We don’t anticipate any risks or side-effects from participation in the study. 
 
What do I have to do? 
On arriving at the Sobell Department you will complete some pre-experiment pen-and-paper 
questionnaires. Then you will complete a computerized task.  On each trial you will see a 
series of dots and your task is to decide whether the majority of the dots are moving to the 
left or to the right and then to press a right hand or left hand response button.  This task will 
be performed under speed (make your decision as quickly as possible) or accuracy (make 
your decision so that it is accurate) and with different levels of task difficulty.  
 
What is being tested? 
By measuring your speed of reactions or reaction times, we can compare your performance 
under speed and accuracy instructions and determine if so-called speed-accuracy trade-offs in 
people with Parkinson’s disease are similar or different to healthy people of the same age.  
 
What are the possible benefits of taking part? 
Participation in this study may not give you any direct benefit. But the information we obtain 
from this study may help us understand Parkinson’s disease better and particularly contribute 
to improving mobility in Parkinson’s disease. We will reimburse you for your travel costs to 
and from Queen Square. 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential. Any information about you which leaves the hospital will have your 
name and address removed so that you cannot be recognised from it.  
 
What information about me will be held? 
We will keep a record of your name, age, address, contact details, physical and mental 
examinations. The results will be stored on computer for analysis. All information which is 
collected about you during the course of the study will stay strictly confidential and remain 
within the Institute of Neurology / UCL. Any information about you which leaves the 
Institute of Neurology will have your name, address, birth date and identifiable information 
removed so that you cannot be recognised from it. The principal investigator, Prof. Marjan 
Jahanshahi, will be in charge of ensuring that the security and confidentiality of your 
information is maintained.  
 
What will happen to the results of the research study? 
The data will be analysed and published in scientific journals and presented at scientific 
conferences. It should be emphasised that your name or any information that could identify 
you (e.g. your date of birth) will not be published. We will be happy to provide you with a 
copy of the completed article for you to keep. 
 
What can I do if I am harmed during this study or wish to make a complaint? 
We will welcome your feedback on your experience of this experiment and at the end of each 
session you will have a chance to record any comments on the experiment in writing. These 
comments will be shown (without identifying the person it came from) to the clinician 
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involved in the study to ensure that the experiments do not produce too much discomfort. 
Please remember that you are free to withdraw at any point without giving a reason. 
 
If you are harmed by taking part in this research project, there are no special compensation 
arrangements. NHS Indemnity does not offer no-fault compensation i.e. for non-negligent 
harm, and NHS bodies are unable to agree in advance to pay compensation for non-negligent 
harm. If you are harmed due to someone’s negligence, then you may have grounds for a legal 
action but you may have to pay for it. 
 
Regardless of this, if you wish to complain, or have any concerns with this study, the normal 
National Health Service complaints mechanisms should be available to you.  
 
Who is organising and funding the research? 
This research is being conducted by members of the Sobell Department of Motor 
Neuroscience and Movement Disorders, Institute of Neurology, Queen’s Square, London. 
This study has been reviewed by the Programme Panel of the Sobell Department of Motor 
Neuroscience and Movement Disorders and approved by the National Hospital for Neurology 
and Neurosurgery/Institute of Neurology Joint Research Ethics Committee. The study is 
sponsored by University College London Hospitals Trust. 
 
Contact for further information 
Please do not hesitate to contact the principal investigator Prof Jahanshahi (contact details given 
below) should you have any questions at any stage of the research study: 
 
Ms Yu Ting Huang  
Sobell Department of Motor Neuroscience and Movement Disorders 
UCL Institute of Neurology,  
33 Queen Square, London, WC1N 3BG 
Mobile:  07940452298 , email: yth1975@gmail.com 
 
Prof. Marjan Jahanshahi 
Sobell Department of Motor Neuroscience and Movement Disorders 
UCL Institute of Neurology 
33 Queen Square, London, WC1N 3BG. 
Tel:0203 4488733, email: m.jaahnshahi@ucl.ac.uk 
 
Prof. Patricia Limousin 
Sobell Department of Motor Neuroscience and Movement Disorders 
UCL Institute of Neurology 
33 Queen Square, London, WC1N 3BG 
!
  
UCL Hospitals is an NHS Trust incorporating the Eastman Dental Hospital, Elizabeth Garrett 
Anderson & Obstetric Hospital, The Heart Hospital, Hospital for Tropical Diseases, The 
Middlesex Hospital, National Hospital for Neurology & Neurosurgery, The Royal London 
Homoeopathic Hospital and University College Hospital. 
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Information sheet – HC participants 
 
UCLH project number: 07/Q0512/27 
Version Number: Version 2, 27/10/2015 
 
Study title Action Reprogramming on PD patients treated with STN DBS 
 
You are invited to take part in a research study. Before you decide whether you want to do 
this, it is important for you to understand why the research is being done and what you will 
have to do.  
 
Please take time to read the following information carefully and talk to others about it if you 
wish. Ask us if you have any questions. Take time to decide whether or not you wish to take 
part.  
 
 
What is the purpose of this study?  
The aim of the study that you are asked to participate in is to see how deep brain stimulation 
(DBS) on subthalamic nucleus (STN) affects the action reprogramming as surprise events 
takes place. You will take part in two studies. The aim of the first study is to examine your 
action responses to simple visual stimuli on a computer screen. The aim of the second study 
is to examine your action responses to simple visual stimuli on a computer screen after 
learning. We will compare the responses to visual stimuli in Parkinson’s disease patients ON 
and OFF DBS and to healthy individuals. These studies advance our knowledge about the 
integration of mental and motor systems affected by Parkinson’s disease and how we can 
improve it. All information is anonymous and confidential.  
 
Why have I been chosen?   
You have been invited to take part because you are of similar age to many people with 
Parkinson’s disease and do not have significant mobility or cognitive problems or depression. 
 
Do I have to take part?  
You can decide whether or not you want to take part. If you decide to take part, we will ask 
you to sign a consent form. You are still free to withdraw at any time without giving a reason.  
 
  
UCL Hospitals is an NHS Trust incorporating the Eastman Dental Hospital, Elizabeth Garrett 
Anderson & Obstetric Hospital, The Heart Hospital, Hospital for Tropical Diseases, The 
Middlesex Hospital, National Hospital for Neurology & Neurosurgery, The Royal London 
Homoeopathic Hospital and University College Hospital. 
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Your medical care won’t be affected if you decide not to take part in the study, or if you take 
part and then withdraw from the study later on. Also, this will not affect future relationship 
with the Institute of Neurology or the National Hospital for Neurology and Neurosurgery.  
 
Compete researchers may look at your medical records. If any information is released, your 
name will be left out, so that everything stays strictly confidential. Participation in this study 
does not affect your legal rights.  
 
What will happen to me if I take part? 
You will be interviewed by a researcher who will ask you for some information about your 
physical and mental health. You will then complete a computer-based reaction time task by 
pressing buttons on a response box with your fingers. During the task, there will be four 
different kinds of visual stimuli image presented on a computer screen. Each visual stimuli 
image will be associated with pressing a specific button. You will perform the reaction-time 
task twice. 
 
Are there any risks or side effects? 
There are no major risk or side effects in this study. The manipulation has been used 
previously and no negative effects have been documented.  
 
What do I have to do?  
We would like you to complete the tests described below. The purpose of each test will be 
explained to you, followed by a demonstration of what you have to do. On some tests such as 
the questionnaire measures of mood, there are no right or wrong answers and we are simply 
interested in how you are feeling a the time you are completing the form. The assessment will 
take about 2.5 hours with short breaks in between tests. 
1. Computer-based reaction time test: You will be asked to complete a reaction time task by 
pressing buttons on a response box. When you see specific image on the computer screen, 
simply respond by pressing a specific button. The task would require you to be fully 
focused due to the presenting time of the images may be fast. 
2. Questionnaires: An experimenter will do small examinations on your cognitive functions 
such as memory, mood...etc.  
 
What is being tested? 
The aim is to determine the execution of action reprogramming, namely how fast can one re-
initiate an action when surprising events occur. The reaction time and accuracy would be 
recorded.  
 
What are the possible benefits of taking part? 
Participation in this study means that you will be making an important contribution to 
scientific research, helping us understand how Parkinson’s disease and its treatment affecting 
the integration of cognitive functions and motor movement.  
 
Will my taking part in this study be kept confidential?  
All information collected about you during the course of the research will be kept strictly 
confidential. Any information about you that leaves the hospital will remove your name and 
address so that you cannot be recognised from it. 
  
UCL Hospitals is an NHS Trust incorporating the Eastman Dental Hospital, Elizabeth Garrett 
Anderson & Obstetric Hospital, The Heart Hospital, Hospital for Tropical Diseases, The 
Middlesex Hospital, National Hospital for Neurology & Neurosurgery, The Royal London 
Homoeopathic Hospital and University College Hospital. 
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What information about me will be held?  
We will keep a record of your name, age, address, contact details, physical and mental 
examinations and data collected during the study.  
 
The results will be stored on computer for analysis. All information collected about you 
during the study will stay strictly confidential and remain within the Institute of 
Neurology/UCL. Any information about you that leaves the Institute of Neurology will have 
your name, date of birth, address, contact details, and identifiable information removed so 
that you cannot be recognised from it. The principal investigator, Prof. Marjan Jahanshahi, 
will be in charge of ensuring that the security and confidentiality of your information is 
maintained.  
 
What will happen to the results of the research study? 
The data will be analysed and published in scientific journals and presented at scientific 
conferences. We will NOT publish your name or any information that could identify you (e.g. 
your date of birth). We will be happy to give you a copy of the completed article for you to 
keep.  
 
What can I do of I am harmed during this study or I wish to make a complaint?  
We will welcome your feedback on your experience of this experiment and at the end of each 
session you will have a chance to record any comments on the experiment in writing. These 
comments will be shown (without identifying the person it came from) to the clinician 
involved in the study to ensure that the experiments do not produce too much discomfort. 
Please remember that you are free to withdraw at any point without giving a reason.  
 
If you are harmed by taking part in this research project, there are no special compensation 
arrangements. NHS Indemnity does not offer no-fault compensation i.e. for non-negligent 
harm, and NHS bodies are unable to agree in advance to pay compensation for non-negligent 
harm. If you are harmed due to someone’s negligence, then you may have grounds for a legal 
action but you may have to pay for it. 
 
Regardless of this, if you wish to complain, or have any concerns with this study, the normal 
National Health Service complaints mechanisms should be available to you.  
 
Who is organising and funding the research? 
This research is being conducted by members of the Sobell Department of Motor 
Neuroscience and Movement Disorders, Institute of Neurology, Queen’s Square, London. 
This study has been reviewed by the Programme Panel of the Sobell Department of Motor 
Neuroscience and Movement Disorders and approved by the National Hospital for Neurology 
and Neurosurgery/Institute of Neurology Joint Research Ethics Committee. The study is 
sponsored by University College London Hospitals Trust. 
  
UCL Hospitals is an NHS Trust incorporating the Eastman Dental Hospital, Elizabeth Garrett 
Anderson & Obstetric Hospital, The Heart Hospital, Hospital for Tropical Diseases, The 
Middlesex Hospital, National Hospital for Neurology & Neurosurgery, The Royal London 
Homoeopathic Hospital and University College Hospital. 
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Contact for further information 
Please do not hesitate to contact the principal experimenter Miss Yu-Ting Huang (contact 
details given below) should you have any questions at any stage of the research study. 
 
Miss Yu-Ting Huang  
Sobell Department of Motor Neuroscience and Movement Disorders 
UCL Institute of Neurology,  
33 Queen Square, London, WC1N 3BG 
E-mail: yu.huang.13@ucl.ac.uk 
 
Prof. Marjan Jahanshahi 
Sobell Department of Motor Neuroscience and Movement Disorders 
UCL Institute of Neurology 
33 Queen Square, London, WC1N 3BG. 
Tel:0203 4488733, email: m.jaahnshahi@ucl.ac.uk 
 
Prof. Patricia Limousin 
Sobell Department of Motor Neuroscience and Movement Disorders 
UCL Institute of Neurology 
33 Queen Square, London, WC1N 3BG 
 
  
UCL Hospitals is an NHS Trust incorporating the Eastman Dental Hospital, Elizabeth Garrett 
Anderson & Obstetric Hospital, The Heart Hospital, Hospital for Tropical Diseases, The 
Middlesex Hospital, National Hospital for Neurology & Neurosurgery, The Royal London 
Homoeopathic Hospital and University College Hospital. 
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Information sheet – PD participants 
 
UCLH project number: 07/Q0512/27 
Version Number: Version 2, 27/10/2015 
 
Study title Action Reprogramming on PD patients treated with STN DBS 
 
You are invited to take part in a research study. Before you decide whether you want to do 
this, it is important for you to understand why the research is being done and what you will 
have to do.  
 
Please take time to read the following information carefully and talk to others about it if you 
wish. Ask us if you have any questions. Take time to decide whether or not you wish to take 
part.  
 
 
What is the purpose of this study?  
The aim of the study that you are invited to participate in is to see how deep brain stimulation 
(DBS) on subthalamic nucleus (STN) affects the action reprogramming as surprise events 
takes place. You will take part in two studies. The aim of the first study is to examine your 
action responses to simple visual stimuli on a computer screen when being ON DBS. The aim 
of the second study is to examine your action responses to simple visual stimuli on a 
computer screen when being OFF DBS. We will compare the responses to visual stimuli in 
Parkinson’s disease patients ON and OFF DBS and to healthy individuals. These studies 
advance our knowledge about the integration of mental and motor systems affected by 
Parkinson’s disease and how we can improve it. All information is anonymous and 
confidential.  
 
Why have I been chosen?   
You have been invited to take part because you are under STN DBS treatment for 
Parkinson’s disease. 
 
Do I have to take part?  
You can decide whether or not you want to take part. If you decide to take part, we will ask 
you to sign a consent form. You are still free to withdraw at any time without giving a reason.  
  
UCL Hospitals is an NHS Trust incorporating the Eastman Dental Hospital, Elizabeth Garrett 
Anderson & Obstetric Hospital, The Heart Hospital, Hospital for Tropical Diseases, The 
Middlesex Hospital, National Hospital for Neurology & Neurosurgery, The Royal London 
Homoeopathic Hospital and University College Hospital. 
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Your medical care won’t be affected if you decide not to take part in the study, or if you take 
part and then withdraw from the study later on. Also, this will not affect future relationship 
with the Institute of Neurology or the National Hospital for Neurology and Neurosurgery.  
 
Compete researchers may look at your medical records. If any information is released, your 
name will be left out, so that everything stays strictly confidential. Participation in this study 
does not affect your legal rights.  
 
What will happen to me if I take part? 
You will be interviewed by a researcher who will ask you for some information about your 
physical and mental health. You will then complete a computer-based reaction time task by 
pressing buttons on a response box with your fingers. During the task, there will be four 
different kinds of visual stimuli image presented on a computer screen. Each visual stimuli 
image will be associated with pressing a specific button. You will perform the task twice, one 
ON stimulation and one OFF stimulation. 
 
Are there any risks or side effects? 
There are no major risk or side effects in this study. The manipulation has been used 
previously and no negative effects have been documented.  
 
What do I have to do?  
We would like you to complete the tests described below. The purpose of each test will be 
explained to you, followed by a demonstration of what you have to do. On some tests such as 
the questionnaire measures of mood, there are no right or wrong answers and we are simply 
interested in how you are feeling a the time you are completing the form. The assessment will 
take about 2.5 hours with short breaks in between tests. 
1. Computer-based reaction time test: You will be asked to complete a reaction time task by 
pressing buttons on a response box. When you see specific image on the computer screen, 
simply respond by pressing a specific button. The task would require you to be fully 
focused due to the presentation of the images may be fast. 
2. Questionnaires: An experimenter will do small examinations on your cognitive functions 
such as memory, mood...etc.  
 
What is being tested? 
The aim is to determine the execution of action reprogramming, namely how fast can one re-
initiate an action when surprising events occur. The reaction time and accuracy would be 
recorded.  
 
What are the possible benefits of taking part? 
Participation in this study means that you will be making an important contribution to 
scientific research, helping us understand how Parkinson’s disease and its treatment affecting 
the integration of cognitive functions and motor movement.  
 
Will my taking part in this study be kept confidential?  
  
UCL Hospitals is an NHS Trust incorporating the Eastman Dental Hospital, Elizabeth Garrett 
Anderson & Obstetric Hospital, The Heart Hospital, Hospital for Tropical Diseases, The 
Middlesex Hospital, National Hospital for Neurology & Neurosurgery, The Royal London 
Homoeopathic Hospital and University College Hospital. 
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All information collected about you during the course of the research will be kept strictly 
confidential. Any information about you that leaves the hospital will remove your name and 
address so that you cannot be recognised from it. 
 
What information about me will be held?  
We will keep a record of your name, age, address, contact details, physical and mental 
examinations and data collected during the study.  
 
The results will be stored on computer for analysis. All information collected about you 
during the study will stay strictly confidential and remain within the Institute of 
Neurology/UCL. Any information about you that leaves the Institute of Neurology will have 
your name, date of birth, address, contact details, and identifiable information removed so 
that you cannot be recognised from it. The principal investigator, Prof. Marjan Jahanshahi, 
will be in charge of ensuring that the security and confidentiality of your information is 
maintained.  
 
What will happen to the results of the research study? 
The data will be analysed and published in scientific journals and presented at scientific 
conferences. We will NOT publish your name or any information that could identify you (e.g. 
your date of birth). We will be happy to give you a copy of the completed article for you to 
keep.  
 
What can I do of I am harmed during this study or I wish to make a complaint?  
We will welcome your feedback on your experience of this experiment and at the end of each 
session you will have a chance to record any comments on the experiment in writing. These 
comments will be shown (without identifying the person it came from) to the clinician 
involved in the study to ensure that the experiments do not produce too much discomfort. 
Please remember that you are free to withdraw at any point without giving a reason.  
 
If you are harmed by taking part in this research project, there are no special compensation 
arrangements. NHS Indemnity does not offer no-fault compensation i.e. for non-negligent 
harm, and NHS bodies are unable to agree in advance to pay compensation for non-negligent 
harm. If you are harmed due to someone’s negligence, then you may have grounds for a legal 
action but you may have to pay for it. 
 
Regardless of this, if you wish to complain, or have any concerns with this study, the normal 
National Health Service complaints mechanisms should be available to you.  
 
Who is organising and funding the research? 
This research is being conducted by members of the Sobell Department of Motor 
Neuroscience and Movement Disorders, Institute of Neurology, Queen’s Square, London. 
This study has been reviewed by the Programme Panel of the Sobell Department of Motor 
  
UCL Hospitals is an NHS Trust incorporating the Eastman Dental Hospital, Elizabeth Garrett 
Anderson & Obstetric Hospital, The Heart Hospital, Hospital for Tropical Diseases, The 
Middlesex Hospital, National Hospital for Neurology & Neurosurgery, The Royal London 
Homoeopathic Hospital and University College Hospital. 
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Neuroscience and Movement Disorders and approved by the National Hospital for Neurology 
and Neurosurgery/Institute of Neurology Joint Research Ethics Committee. The study is 
sponsored by University College London Hospitals Trust. 
 
Contact for further information 
Please do not hesitate to contact the principal experimenter Miss Yu-Ting Huang (contact 
details given below) should you have any questions at any stage of the research study: 
 
Miss Yu-Ting Huang  
Sobell Department of Motor Neuroscience and Movement Disorders 
UCL Institute of Neurology,  
33 Queen Square, London, WC1N 3BG 
E-mail: yu.huang.13@ucl.ac.uk 
 
Prof. Marjan Jahanshahi 
Sobell Department of Motor Neuroscience and Movement Disorders 
UCL Institute of Neurology 
33 Queen Square, London, WC1N 3BG. 
Tel:0203 4488733, email: m.jaahnshahi@ucl.ac.uk 
 
Prof. Patricia Limousin 
Sobell Department of Motor Neuroscience and Movement Disorders 
UCL Institute of Neurology 
33 Queen Square, London, WC1N 3BG 
 
UCL INSTITUTE OF NEUROLOGY 
THE NATIONAL HOSPITAL FOR NEUROLOGY AND  
NEUROSURGERY 
QUEEN SQUARE 
LONDON WC1N 3BG 
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Sobell Department of Motor Neuroscience and Movement Disorders 
 
Professor Marjan Jahanshahi BSc, MPhil (Clinical Psychol), PhD 
Head, Cognitive Motor Neuroscience Group 
Tel: 020 3448 8733 
Fax: 020 7419 1860   
E-mail:  m.jahanshahi@ucl.ac.uk 
 
 
  
 
 
   
 
UCLH Project ID number: 07/Q0512/27 
Version number: 05/09/2012, version 6b 
 
CONSENT FORM 
 
Study title: Study title Behavioural studies of paradoxical kinesis in Parkinson’s disease  
 
Name of Principal Investigator: Prof. Marjan Jahanshahi 
 
  Please 
initial 
box 
1 I confirm that I have read and understood the information 
sheet for the above study and have had the opportunity to 
ask questions 
 
 
2 I confirm that I have had enough time to consider whether or 
not I want to be included in the study. 
 
 
 
3 I understand that my participation is voluntary and that I am 
free to withdraw at any time, without giving any reason, 
without my medical care or legal rights being affected. 
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______________________  _________  ____________________ 
Name of participant   Date   Signature 
 
 
 
 
________________________        _________ ____________________ 
Name of Person taking consent Date   Signature 
(if different from researcher) 
    
Name of the researcher to be contacted if there are any problems: 
 
Ms Yu Ting Huang 
email: yth1975@gmail.com 
Mobile:  07940452298 
 
Professor Jahanshahi; (contact details as above) 
       
Comments or concerns during the study  
 
If you have any comments or concerns you may discuss these with 
the investigator.   If you wish to go further and complain about any 
aspect of the way you have been approached or treated during the 
course of the study, you should write or get in touch with the 
Complaints Manager, University College Hospitals.  Please quote 
the UCLH project number at the top of this consent form. 
  
Please 
initial 
box 
4. I understand that sections of any of my medical notes may be 
looked at by responsible individuals from the Institute of 
Neurology, where it is relevant to my taking part in research.  I 
give permission for these individuals to have access to my 
records. 
 
 
5. 
 
I agree to take part in the above study. 
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Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease 
 (QUIP-Anytime During PD-Short)  
 
 
Reported by:  _____ Patient  _____ Informant*  _____ Patient and Informant   
Patient name: __________________________________________ 
Date:   __________________________________________ 
 
*If information reported by an informant, answer questions based on your understanding of the patient. 
 
Answer ALL QUESTIONS based on BEHAVIORS ANYTIME DURING PD  
LASTING AT LEAST 4 WEEKS 
 
 
A. GAMBLING 
1. Do [Did] you or others think you have [had] an issue with too much gambling behaviors (such as casinos, 
internet gambling, lotteries, scratch tickets, betting, or slot or poker machines)?   __Yes    __No 
 
2. Do [Did] you have difficulty controlling your gambling behaviors (such as increasing them over time, or 
having trouble cutting down or stopping them)?       __Yes    __No  
 
B. SEX 
1. Do [Did] you or others think you have [had] an issue with too much sex behaviors (such as making sexual 
demands on others, promiscuity, prostitution, change in sexual orientation, masturbation, internet or telephone 
sexual activities, or pornography)?          __Yes    __No 
 
2. Do [Did] you think too much about sex behaviors (such as having trouble keeping thoughts out of your mind 
or feeling guilty)?           __Yes    __No 
 
C. BUYING 
1. Do [Did] you or others think you have [had] an issue with too much buying behaviors (such as too much of 
the same thing or things that you don't need or use)?      __Yes    __No 
 
2. Do [Did] you engage in activities specifically to continue the buying behaviors (such as hiding what you are 
[were] doing, lying, hoarding things, borrowing from others, accumulating debt, stealing, or being involved in 
illegal acts)?             __Yes    __No 
 
D. EATING 
1. Do [Did] you or others think you have [had] an issue with too much eating behaviors (such as eating larger 
amounts or different types of food than in the past, more rapidly than normal, until feeling uncomfortably full, 
or when not hungry)?           __Yes    __No 
 
2. Do [Did] you have urges or desires for eating behaviors that you feel are [felt were] excessive or cause 
[caused] you distress (including becoming restless or irritable when unable to participate in the behavior)?  
            __Yes    __No 
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Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease 
 (QUIP-Anytime During PD-Short)  
 
 
E. OTHER BEHAVIORS  
Do [Did] you or others think that you spend [spent] too much time….  
 
1. On specific tasks, hobbies or other organized activities (such as writing, painting, gardening, repairing or 
dismantling things, collecting, computer use, working on projects, etc.)?  __Yes    __No 
 
2. Repeating certain simple motor activities (such as cleaning, tidying, handling, examining, sorting, 
ordering, or arranging objects, etc.)?                     __Yes    __No 
 
3. Walking or driving with no intended goal or specific purpose?   __Yes    __No 
  
 
F. MEDICATION USE 
1. Do [Did] you or others (including your physicians) think that you consistently take [took] too much of your 
Parkinson’s medications?         __Yes    __No 
 
2. Do [Did] you have difficulty controlling your use of Parkinson’s medications (such as experiencing a strong 
desire for more medication, or having worse mood or feeling unmotivated at a lower dosage)?  
            __Yes    __No 
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Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease 
 (QUIP-Current-Short)  
 
Reported by:  _____ Patient  _____ Informant*  _____ Patient and Informant   
Patient name: __________________________________________ 
Date:   __________________________________________ 
 
*If information reported by an informant, answer questions based on your understanding of the patient. 
 
Answer ALL QUESTIONS based on CURRENT BEHAVIORS  
LASTING AT LEAST 4 WEEKS 
 
A. GAMBLING 
1. Do you or others think you have an issue with too much gambling behaviors (such as casinos, internet 
gambling, lotteries, scratch tickets, betting, or slot or poker machines)?    __Yes    __No 
 
2. Do you have difficulty controlling your gambling behaviors (such as increasing them over time, or having 
trouble cutting down or stopping them)?        __Yes    __No 
 
 
B. SEX 
1. Do you or others think you have an issue with too much sex behaviors (such as making sexual demands on 
others, promiscuity, prostitution, change in sexual orientation, masturbation, internet or telephone sexual 
activities, or pornography)?           __Yes    __No 
  
2. Do you think too much about sex behaviors (such as having trouble keeping thoughts out of your mind or 
feeling guilty)?           __Yes    __No 
  
 
C. BUYING 
1. Do you or others think you have an issue with too much buying behaviors (such as too much of the same 
thing or things that you don't need or use)?        __Yes    __No 
 
2. Do you engage in activities specifically to continue the buying behaviors (such as hiding what you’re doing, 
lying, hoarding things, borrowing from others, accumulating debt, stealing, or being involved in illegal acts)?   
           __Yes    __No 
 
D. EATING 
1. Do you or others think you have an issue with too much eating behaviors (such as eating larger amounts or 
different types of food than in the past, more rapidly than normal, until feeling uncomfortably full, or when not 
hungry)?            __Yes    __No 
 
2. Do you have urges or desires for eating behaviors that you feel are excessive or cause you distress (including 
becoming restless or irritable when unable to participate in the behavior)?    __Yes    __No 
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Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease 
 (QUIP-Current-Short)  
 
 
E. OTHER BEHAVIORS  
Do you or others think that you spend too much time….  
 
1. On specific tasks, hobbies or other organized activities (such as writing, painting, gardening, repairing or 
dismantling things, collecting, computer use, working on projects, etc.)?  __Yes    __No 
 
2. Repeating certain simple motor activities (such as cleaning, tidying, handling, examining, sorting, 
ordering, or arranging objects, etc.)?                     __Yes    __No 
 
3. Walking or driving with no intended goal or specific purpose?   __Yes    __No 
 
  
F. MEDICATION USE 
1. Do you or others (including your physicians) think that you consistently take too much of your Parkinson’s 
medications?           __Yes    __No 
 
2. Do you have difficulty controlling your use of Parkinson’s medications (such as experiencing a strong desire 
for more medication, or having worse mood or feeling unmotivated at a lower dosage)? __Yes    __No 
 




MINI MENTAL STATE 
      EXAMINATION
             (MMSE)
Patient's name:
Hospital number:
ORIENTATION
REGISTRATION
ATTENTION AND CALCULATION
RECALL
LANGUAGE
COPYING
Year    Month     Day     Date     Time
Country     Town      District     Hospital     Ward
Examiner names 3 objects (eg apple, table, penny)
Patient asked to repeat (1 point for each correct).
Subtract 7 from 100,  then repeat from result.
Continue 5 times:  100  93  86  79  65
THEN patient to learn the 3 names repeating until
correct.
Ask for names of 3 objects learned earlier.
Name a pencil and watch.  
Repeat "No ifs, ands, or buts".
Give a 3 stage command.  Score 1 for each stage.
Eg. "Place index finger of right hand on your nose
and then on your left ear".
Ask patient to read and obey a written command 
on a piece of paper stating "Close your eyes".
Ask the patient to write a sentence. Score if it is 
sensible and has a subject and a verb.
Ask the patient to copy a pair of intersecting
pentagons:
TOTAL
____/5
____/5 ____/5 ____/5 ____/5
____/5____/5 ____/5
____/5 ____/5____/5____/5
____/2
____/1
____/3 ____/3 ____/3
____/2 ____/2 ____/2
____/1 ____/1 ____/1
____/3
____/3____/3 ____/3 ____/3
____/3 ____/3 ____/3 ____/3
____/1 ____/1 ____/1 ____/1
____/1____/1____/1 ____/1
____/1 ____/1____/1____/1
DATE
____/30 ____/30 ____/30 ____/30
ONE POINT FOR EACH ANSWER
Alternative: spell "WORLD" backwards - dlrow.

